12,635 Matching Annotations
  1. Jun 2023
    1. Reviewer #1 (Public Review):

      The blood-brain barrier separates neural tissue from blood-borne factors and is important for maintaining central nervous system health and function. Endothelial cells are the site of the barrier. These cells exhibit unique features relative to peripheral endothelium and a unique pattern of gene expression. There remains much to be learned about how the transcriptome of brain endothelial cells is established in development and maintained throughout life.

      The manuscript by Sadanandan, Thomas et al. investigates this question by examining transcriptional and epigenetic changes in brain endothelial cells in embryonic and adult mice. Changes in transcript levels and histone marks for various BBB-relevant transcripts, including Cldn5, Mfsd2a and Zic3 were observed between E13.5 and adult mice. To perform these experiments, endothelial cells were isolated from E13.5 and adult mice, then cultured in vitro, then sequenced. This approach is problematic. It is well-established that brain endothelial cells rapidly lose their organotypic features in culture (https://elifesciences.org/articles/51276). Indeed, one of the primary genes investigated in this study, Cldn1, exhibits very low expression at the transcript level in vivo but is strongly upregulated in cultured ECs.

      (https://elifesciences.org/articles/36187 ; https://markfsabbagh.shinyapps.io/vectrdb/)

      This undermines the conclusions of the study.

      An additional concern is that for many experiments, siRNA knockdowns are performed without validation of the efficacy of the knockdown.

      Some experiments in the paper are promising, however. For example, the knockout of HDAC2 in endothelial cells resulting in BBB leakage was striking. Investigating the mechanisms underlying this phenotype in vivo could yield important insights.

    2. Reviewer #2 (Public Review):

      Sadanandan et al describe their studies in mice of HDAC and Polycomb function in the context of vascular endothelial cell (EC) gene expression relevant to the blood-brain barrier, (BBB). This topic is of interest because the BBB gene expression program represents an interesting and important vascular diversification mechanism. From an applied point of view, modifying this program could have therapeutic benefits in situations where BBB function is compromised.

      The study involves comparing the transcriptomes of cultured CNS ECs at E13 and adult stages and then perturbing EC gene expression pharmacologically in cell culture (with HDAC and Polycomb inhibitors) and genetically in vivo by EC-specific conditional KO of HDAC2 and Polycomb component EZH2.

      This reviewer has several critiques of the study.

      First, based on published data, the effect of culturing CNS ECs is likely to have profound effects on their differentiation, especially as related to their CNS-specific phenotypes. Related to this, the authors do not state how long the cells were cultured.

      Second, the use of qPCR assays for quantifying ChIP and transcript levels is inferior to ChIPseq and RNAseq. Whole genome methods, such as ChIPseq, permit a level of quality assessment that is not possible with qPCR methods. The authors should use whole genome NextGen sequencing approaches, show the alignment of reads to the genome from replicate experiments, and quantitatively analyze the technical quality of the data.

      Third, the observation that pharmacologic inhibitor experiments and conditional KO experiments targeting HDAC2 and the Polycomb complex perturb EC gene expression or BBB integrity, respectively, is not particularly surprising as these proteins have broad roles in epigenetic regulation in a wide variety of cell types.

    1. Reviewer #2 (Public Review):

      In the study by Hreich et al, the potency of P2RX7 positive modulator HEI3090, developed by the authors, for the treatment of Idiopathic pulmonary fibrosis (IPF) was investigated. Recently, the authors have shown that HEI3090 can protect against lung cancer by stimulating dendritic cell P2RX7, resulting in IL-18 production that stimulates IFN-γ production by T and NK cells (DOI: 10.1038/s41467-021-20912-2). Interestingly, HEI3090 increases IL-18 levels only in the presence of high eATP. Since the treatment options for IPF are limited, new therapeutic strategies and targets are needed. The authors first show that P2RX7/IL-18/IFNG axis is downregulated in patients with IPF. Next, they used a bleomycin-induced lung fibrosis mouse model to show that the use of a positive modulator of P2RX7 leads to the activation of the P2RX7/IL-18 axis in immune cells that limits lung fibrosis onset or progression. Mechanistically, treatment with HEI3090 enhanced IL-18-dependent IFN-γ production by lung T cells leading to a decreased production of IL-17 and TGFβ, major drivers of IPF. The major novelty is the use of the small molecule HEI3090 to stimulate the immune system to limit lung fibrosis progression by targeting the P2RX7, which could be potentially combined with current therapies available. However, there is the lack of information on the reproducibility of data, especially for the data presented in Figures 3 and 4, and related supplementary figures, as well as the lack of support data for experiments that emphasize the role of P2RX7 expressed on immune cells (e.g. frequency of transferred cells compared to endogenous cells).

    2. Reviewer #3 (Public Review):

      Idiopathic pulmonary fibrosis (IPF) is an aggressive interstitial lung disease with progressive and irreversible deterioration of respiratory functions that lacks curative therapies. The authors investigated a new therapeutic approach to treat idiopathic pulmonary fibrosis by targeting P2RX7/IL-18/IFNG axis.

      The current data are mainly based on P2RX7 activator HEI3090 and genetic experiments are lacking to support the primary claim that activation P2RX7/IL-18/IFNG axis is beneficial for IPF.

      - Parenteral systemic administration of IFN-γ failed in clinical trials (INSPIRE; NCT00075998). However, this study used i.p. administration of P2RX7 activator HEI3090 to activate P2RX7/IL-18/IFNG axis.

      - Activation of P2RX7 NLRP3 inflammasome triggers cell death and the current experiments do not explore IL-18 as a potential therapy that would avoid harmful cell death as a consequence of P2RX7/NLRP3 inflammasome activation.

      - Reciprocal bone marrow chimera model is needed to demonstrate the requirement of a hematopoietic compartment for HEI3090's antifibrotic effect.

      - There is no evidence to show whether P2RX7 interferes with bleomycin during the generation of the IPF model. Independent IPF models would validate the therapeutic effect of P2RX7.

    1. Reviewer #1 (Public Review):

      The paper describes a robotic system that can be used for prolonged recording of forced activity in crawling Drosophila larvae. This is mostly intended to be a proof of principle description of a tool potentially useful for the community. The system - whose value lies completely in its reproducibility and adoption - is only superficially described in the paper, but a more detailed description is made available through Github, along with the software used for the collection and analysis of data.

      There is good, convincing evidence this can work as some sort of "larval conveyor belt", used to artificially prolong food crawling behaviour in the animals. More could be said about the ecological implications of the assay (for instance: how relevant is it to an animal's natural behaviour? Does the system introduce artifactual distortions in the analysis, driven by the fact that animals crawl greater distances than they would normally crawl in nature? Will this extensive activity affect their development to pupation or adulthood?).

    2. Reviewer #2 (Public Review):

      This study describes the development of a robotic system that allows investigators to track the movements of Drosophila larvae for extremely long time durations. Prior studies were limited by the fact that tracking of larval movements needed to be stopped whenever the animal reached the edge of a behavioral arena. This new study overcomes this limitation with a robot arm that gently picks up the larvae when they reach the edge of the arena and then gently releases them again so that tracking can be resumed. The very long periods of data acquisition are performed with a video camera that provides a low-resolution 64x64 pixel representation of the larvae. Nevertheless, the authors are able to extract postural information from the animals using a sophisticated machine vision based neural network. The authors use this system to continuously track the behaviors of individual larvae for six hours in the presence or absence of a thermal gradient. They argue that high inter-animal variability in a navigation index occurs in the presence of a thermal gradient but not in its absence. The intra-animal mean navigation also appears to be bimodal, apparently switching between "non-navigating" and "strongly navigating" states (not the authors' words). Interestingly, when only the population means are investigated a single mode is indicated with an overall weak navigation index. This comparison very nicely illustrates the power of this method to reveal richness in the data that leads to insights that cannot be observed with short-term measurements. Another impressive feature of the robotic system design is that it is capable of delivering small droplets of food to individual larvae. This allowed the authors to track a single larva for a remarkable 30 hours in which it is seen to crawl for more than 48 meters. Overall, the robotic system presented here will allow the researchers to investigate behaviors of larvae in long-term experiments in ways that were previously unimaginable.

    3. Reviewer #3 (Public Review):

      "Continuous, long-term crawling behavior characterized by a robotic transport system" by Yu et al. presents their new robotic device to track, reposition, and feed Drosophila larvae as they crawl on an arena. By using a water droplet (or if necessary, suction) to transport larvae from the edge of the arena to the middle, long behavior trajectories can be recorded without losing larvae from the arena or camera field of view. The picker robot is also able to dispense small amounts of apple juice at precise locations to keep larvae alive for extended periods although the food was not sufficient to trigger molting and the development to the next instar stage.

      The approach is interesting, but the authors could provide more details on why the approach is necessary for non-expert readers. For example, what are the advantages of using the robot picker compared to simply confining larvae in a closed arena? It's not obvious (to me) that being picked back to the center of the arena is a smaller perturbation compared to running into a chamber wall and changing direction.

      The first paragraph of the introduction emphasizes the multiple time scales that are relevant for behavior from rapid stimulus response up to developmental times. This is to set the context of the authors' contribution but I'm not sure it's a fair representation of the state of the art. For example, the authors state that high-bandwidth measurement over long times is prohibitive and cite three Drosophila papers, but there are home-cage monitoring systems that allow continuous recording of mouse behavior over long times with high resolution. At the other end of the spectrum, there have been some long-term behaviour experiments done on worm behaviour with reasonably high time resolution (e.g Stern et al. 10.1016/j.cell.2017.10.041).

      The authors train a neural network to segment and track the larvae, however, little information is given on the training process and I don't think it would be possible to reproduce the model based on the description. More details of the network, hyperparameters, and training data would be required to evaluate it.

      The authors also state several times that larval identity is maintained throughout the recording, but this isn't quantified. It's not clear whether identity is maintained across collisions of two or more animals by the tracking algorithm or whether these collisions simply don't happen in their data because density is low.

      The environment is nominally isotropic, but once larvae have been crawling on the surface for hours, including periodic feeding, there will likely be multiple gradients the larvae may sense. This may not be observable in the data, but should perhaps be mentioned in the text.

      The authors show that the picking action results in a small but detectable increase in speed. The degree of perturbation overall depends on the picking frequency so some quantification of the inter-pick time interval would help to interpret whether this perturbation is relevant for a particular experiment. Is there a difference in excitation when larvae are picked successfully on the first try compared to when multiple tries or suction are required?

      From the reconstructed trajectory in Figure 4, this interval looks very long compared to speed increase after picking. When reconstructing the trajectory, how are the segments joined? Is it simply by resetting the xy position or also updating rotating to match the previous direction of travel? (I'm guessing the larva can rotate during transport?)

      The authors present a simple model in Figure 6 to illustrate the differences between individuals that can be hidden when looking at population distributions. However, the differences they show in the simulation don't seem relevant to the differences they observe in the experiments. Specifically, Fig. 6A and B show a contrast between individuals with similar mean speeds compared to individuals with different (but still unimodal) mean speeds. In contrast, the experimental data in Fig. D shows individual distributions that are quite similar but that are bimodal. So, there is indeed a difference between the individual distributions that is obscured in the population distribution, but is there evidence of larval personality types (line 444)? Similarly, the sentence beginning line 381 doesn't seem right either.

    1. Reviewer #1 (Public Review):

      This manuscript provides a structural analysis of bushy cells in the mouse cochlear nucleus. The analysis uses volume electron microscopy techniques to describe bushy cell-auditory nerve synapses and bushy cell dendrites. The analysis takes a morphological analysis of bushy cells to a new level, and the computational modeling is well done. The models are used to predict busy cell behavior, which leads to a major concern. The authors make reasonable assertions, but all of these need to be validated by electrophysiological studies before they can be treated as fact. Instead, they should be treated as predictions. For example, in the conclusions from the model section, that endbulb size does not strictly predict synaptic efficacy should be modified from an assertion to a prediction.

    2. Reviewer #2 (Public Review):

      This is an interesting manuscript in which the authors demonstrate the power of serial section reconstruction at the EM level of a volume within the anterior ventral cochlear nucleus (aVCN) containing bushy cells and their large afferent synapses - the endbulbs of Held. Integration of this information with compartmental modelling of the neuronal excitability is then used to make observations about the form and function of these neurons and their synaptic inputs. While this is technically impressive (in regards to both the structure and modelling) there are significant weaknesses because this integration makes massive assumptions and lacks a means of validation; for example, by checking that the results of the structural modelling recapitulate the single-cell physiology of the neuron(s) under study. This would require the integration of in vivo recorded data, which would not be possible (unless combined with a third high throughput method such as calcium imaging) and is well beyond the present study. The authors need to be more open about the limitations of their observations and their interpretations and focus on the key conclusions that they can glean from this impressive data set. The manuscript would be considerably improved by re-writing to focus the science on the most important results and provide clear declarations of limitations in interpretation.

    3. Reviewer #3 (Public Review):

      Bushy cells are one of the principal neurons in the cochlear nucleus that provide temporal information to higher auditory nuclei to compare sound signals from both ears. One prominent feature in the auditory processing of bushy cells is that they show enhanced temporal responses compared to the auditory nerve (AN) inputs, thus providing a better temporal representation of the acoustic signals. Another feature of the AN-bushy cell circuit is that AN fibers form large synapses termed "endbulbs" around the soma of bushy cells. Scientists have proposed that the temporal enhancement can be due to the coincidence detection of subthreshold convergent AN inputs, or a first-spike latency-based detection of convergent supra-threshold inputs. However, testing these hypotheses requires knowledge of the detailed anatomical arrangement of the AN inputs onto bushy cells. This paper provides a first look at the 3-D organizations of the pre- and postsynaptic structures of mouse bushy cells at a nanoscale resolution. Furthermore, the authors create a morphology-constrained biophysical model to examine how these structures may affect synaptic integration and auditory processing.

      The main finding of the paper is that the authors found two input motifs in the AN-bushy cell circuit: one with all small, subthreshold endbulb inputs (all < 180 um2), and the other with 1-2 large, suprathreshold endbulb inputs (> 180 um2) plus other smaller endbulb inputs. Using modeling, the authors argue that the former group correlates with a physiological phenotype of "coincidence detection", and the latter correlates with a phenotype termed "mixed-mode detection". "Coincidence detection" cells require the coincident firing of many subthreshold presynaptic inputs to evoke a postsynaptic spike; "mixed-mode" cells can either have postsynaptic spikes evoked by the largest input(s) alone, or by the coincident firing of small (plus large) inputs. Interestingly, the authors found that even though the large inputs alone can trigger spikes in the "mixed mode" cells, smaller inputs can further enhance the temporal precision of the spikes. The structural data are of very high quality and clearly show the endbulb inputs comprise various sizes. Whether these inputs are really supra/sub-threshold remains to be explored physiologically, but nevertheless, the model provides a hypothesis for the functional roles of the endbulb of different sizes.

      In addition to the finding of "two convergent motifs', the authors also report a first complete map of synaptic inputs to a single bushy cell, and structures that have not been observed before, such as synapses at axon-hillock and axon initial segment, dendritic "hub", "braided" dendrites, non-innervated dendrites, etc. These data, like the previous "two input motifs" observation, are also of very high quality and can be useful resources for the ultrastructural study of the bushy cells.

      Strengths:<br /> The strengths of this paper are that the authors obtained unprecedented high-resolution 3-D images of the AN-bushy cell circuit, and they implemented a biophysical model to simulate the neural processing of AN inputs based on these structural data. The 3-D reconstruction of the pre- (input organization) and post- (dendrites and axons) synaptic structures of bushy cells are of high quality, as exemplified by the high-resolution figures and animations. The biophysical modeling, although lacking comparison with in vivo physiological data due to the chosen species (mice), is also solid and well documented. The combination of high-resolution imaging and structure-based modeling, together with the detailed documentation, provides rich information for not only auditory scientists but non-auditory scientists who want to use similar techniques to explore neural circuits.

      Weaknesses:<br /> Despite the high quality of the data, the paper is marred by the species they chose: there are very few published in vivo single-unit results from mouse bushy cells, so it is hard to evaluate how well the model predictions fit the real-world data, and how the structural findings address the "fundamental questions" in physiology. If we look at data from other animals such as cats and gerbils, it is true that high-frequency (globular) bushy cells show envelope phase locking, but compared to ANs they are at best only moderately enhanced (gerbils: Frisina et al. 1990: Fig 7 and 10; cats: Joris and Yin 1998 Fig 4); the most prominent enhancement is actually to the temporal fine structures of low-frequency bushy cells (cells tuned to < 1 kHz), which mice lack. Furthermore, the temporal modulation transfer function (tMTF, i.e. the vector strengths vs modulation frequency plots in Fig 7O of the paper) of (globular) bushy cells are mostly low-pass filtered, with a cutoff frequency close to 1 kHz, and the highest vector strength rarely surpasses 0.9 (cats: Rhode 1994 Fig 9, 16, Rhode 2008 Fig 8G, Joris and Yin 1998 Fig 7; and there's one report from mice: Kopp-Scheinpflug et al 2003 Fig 8). Thus, the band-pass tMTFs tuned to 100-200 Hz with vector strengths > 0.9 or 0.95 in this paper (Fig 7O, Fig 8M) do not really match known physiology (in non-mouse species). Again, we know very little about in vivo physiology of mouse (globular) bushy cells and there is of course a possibility that responses in mice may be closer to the predictions of this paper. No rationale (e.g. use of molecular tools or in vitro physiology) is given why the authors focus on the mouse. It seems that the analyses provided here could as well have done on a species with good low-frequency hearing, which may have provided a much more interesting case for understanding the spectacular temporal transformation performed by bushy cells.

    4. Reviewer #4 (Public Review):

      The authors have collected an impressive array of physiological data and provided some beautiful 3D images of SBCs with dendrites. These are clearly strengths. The computational models for mechanisms of SBC responses, however, are made to fit what may be inadequate anatomical data. Instead of conclusions, perhaps they need to reword their discussions to refer to the anatomy as hypothetical substrates.

    1. Reviewer #1 (Public Review):

      Ichinose et al., utilize a mixture of cultured hippocampal neurons and non-neuronal cells to identify the role of the transmembrane protein teneurin-2 (TEN-2) in the formation of inhibitory synapses along the dendritic shaft. First, they identify distinct clusters of gephyrin that are either actin-rich, microtubule-rich or contain neither actin nor microtubules and find that TEN-2 is enriched in microtubule-rich gephyrin clusters. This leads the authors to hypothesize that TEN-2 recruits microtubules (MTs) through the plus end binding protein EB1 when successfully matched with a pre-synaptic partner, and perform a variety of experiments to test this hypothesis. The authors then extend this finding to state quite strongly throughout the paper, including in the title, that TEN-2 acts as a signpost for the unloading of cargo from motor proteins without providing any supporting evidence. They use previous work to justify this conclusion, but without actual experiments to back up the claim, it seems like a reach.

      The strength of the paper lies in the various lines of evidence that the authors employ to assess the role of TEN-2 in MT recruitment and synaptogenesis. They have also been very thorough in validating the expression and functionality of various knock-in constructs, knock-down vectors and antibodies that were generated during the study. However, there are some discrepancies in the findings that have not been addressed satisfactorily, as well as some instances where the data presented is not of sufficient quality to support the conclusions derived from them.<br /> 1. The emphasis placed on the clustering analysis presented in figure 1 and the two associated supplementary figures is puzzling, since the conclusion derived from the results presented would be that Neuroligin 2 (NLGN2) is the strongest candidate to test for a relationship to MT recruitment at inhibitory post synapses. Instead, the authors cite prior evidence to exclude NLGN2 from subsequent analysis and choose to focus on TEN2 instead.<br /> 2. It is difficult to reach the same conclusion as the authors from the images and intensity plot shown on Figure 2 E and F. While there seems to be an obvious reduction in expression levels between the TEN2N-L and TEN2TM constructs, neither seem to co-localize with EB1.<br /> 3. The authors mimic the activity of TEN-2 at the inhibitory post synapse in non-neuronal cells by immobilizing HA- tagged TEN constructs in COS-7 cells as a proxy for synaptic partner matching. Using this model, they find that by immobilizing TEN2N-L, which contains EB1 binding motifs, MTs are excluded from the cell periphery (Figure 3D). This contradicts their conclusion that MTs are recruited through EB1 by TEN-2 on synaptic partner matching. Later in the paper, when they use the same TEN2N-L construct as a dominant negative in neuronal cells, they find that MTs are recruited the membrane, even if TEN2N-L is not immobilized by synaptic partner matching (Figure 6C). Taken together, these findings call into question the sequence of events driven by TEN-2 during synaptogenesis.<br /> 4. It is unclear how the authors could conclude that TEN-2 is at the semi-periphery (?) of inhibitory post synapses from the STORM data that is presented in the paper. Figure 4D and 4F show comparisons of Bassoon and TEN-2 localization vs TEN-2 and gephyrin, but the image quality is not sufficient to adequately portray a strong distinction in the distance of center of mass, which is also only depicted for the TEN2-Gephyrin pair and not the TEN2-Bassoon pair in Figure 4J.<br /> 5. The authors do not satisfactorily explain why gephyrin appears to have completely disappeared in the TEN2N-L condition (Figure 6A), instead of appearing uniformly distributed as one would expect if MTs are indiscriminately recruited to the membrane by the dominant negative construct that remains unanchored.<br /> 6. In a similar critique to that of Figure 2E and F, the distinction that the authors wish to portray between the effect of TEN2TM and TEN2N-L constructs on EGFP-TEN-2 and MAP2 colocalization (Figure 6 E and F) appear to be driven by a difference in overall expression levels of EGFP-TEN2 rather that a true difference in localization of TEN-2 and MTs.

    2. Reviewer #2 (Public Review):

      Maturation of inhibitory synapses requires multiple vital biological steps including, i) translocation of cargos containing GABAARs and scaffolds (e.g. gephyrin) through microtubules (MTs), ii) exocytosis of inhibitory synapse proteins from cargo followed by the incorporation to the plasma membrane for lateral diffusion, and iii) incorporation of proteins to inhibitory synaptic sites where gephyrin and GABAARs are associated with actin. A number of studies have elucidated the molecular mechanisms for GABAARs and gephyrin translocation in each step. However, the molecular mechanisms underlying the transition between steps, particularly from exocytosis to lateral diffusion of inhibitory proteins, still need to be elucidated. This manuscript successfully characterizes three stages of inhibitory synapses during maturation, cluster1: an initial stage that receptors are being brought in and out by the MT system; cluster2: lateral diffusion stage; cluster 3: matured postsynapses anchored by gephyrin and actin, by quantifying the abundance of MAP2 or Actin in inhibitory synapse labeled by gephyrin. Importantly, the authors' findings suggest that TEN2, a trans-synaptic adhesion molecule that has two EB1 binding motifs, plays an important role in the transition from clusters 1 to 2, and inhibitory synapse maturation. The imaging results are impressive and compelling, these data will provide new insights into the mechanisms of protein transport during synapse development. However, the present study contains several loose ends preventing convincing conclusions. Most importantly, (1) it remains more TEN2 domain characterization on inhibitory synapse maturation, (2) further validation of the HA knock-in TEN2 mouse model is required, and (3) it requires additional physiology data that complement the authors' findings.

    3. Reviewer #3 (Public Review):

      In this paper, Ichinose et al. examine mechanisms that contribute to building inhibitory synapses through differential protein release from microtubules. They find that tenurin-2 plays a role in this process in cultured hippocampal neurons via EB1 using a variety of genetic and imaging methods. Overall, the experiments are generally designed well, but it is unclear whether their findings offer a significant advance. The experimental logic flow and rational difficult for readers to follow in the manuscript's current form.

      Strengths:<br /> 1) The experiments are generally well designed overall, and appropriate to the questions posed.<br /> 2) Several experimental methods are combined to validate key results.<br /> 3) Use of cutting-edge technologies (i.e. STORM imaging) to help answer key questions in the paper.

      Weakness:<br /> 1) Simplifying the text and story line would go a long way to ensure the study results are more effectively communicated. Additional specific suggestions are provided in the recommendations for the authors.<br /> 2) The introduction overall would benefit from simplification so that the reader is given only the information they need to know to understand the question at hand.<br /> 3) MT dynamics are important for paper results, but the background in the paper does not appropriately introduce this topic.<br /> 4) It is a bit unclear from the abstract and introduction how the findings of this paper have significantly advanced the field or taught something fundamentally new about how inhibitory synapses are regulated.<br /> 5) Figure 1 - Line 109, it is obscure why "it was found appropriate" to divide the data into three clusters. This section would better justified by starting with cellular functions and then basing the clusters on these functions.<br /> 6) The proteomic screen and candidate selection is not well justified and the logic steps for arriving at TEN2 are a bit weak. Again, less is more here.<br /> 7) Fig. 2 - The authors should consider whether EB1 overexpression would have functional consequences that alter the results and colocalization.<br /> 8) Fig. 3 - Is immobilization of COS cells using HA tag antibodies a relevant system for study of these questions?<br /> 9) Fig. 4 - The authors should confirm post-synaptic localization in vivo (brain).<br /> 10) Figure 4D-E - The way the STORM results are presented is confusing. The authors state is shows that TEN2 is postsynaptic but before this say that the Abs are the same size as the synaptic cleft so that the results cannot be considered conclusive. This issue should be resolved.<br /> 11) Figure 5 -The authors should examine the levels of gephyrin relative to the levels of knockdown given the knockdown variability.<br /> 12) Functional validation of a reduction in inhibition following TEN2 manipulation would elevate the paper.<br /> 13) Figure 6E - The expression levels of TEN2TM and TEN2NL are important to the outcome of these experiments. How did the authors ensure that the levels of two proteins were the same to begin with?

    1. Reviewer #1 (Public Review):

      Wu et al. sought to investigate the biological role of GPR110 in modulating hepatic lipid metabolism. The authors demonstrate a pathological role of GPR110 in promoting hepatic steatosis and generalized metabolic syndrome in a mouse model of diet-induced obesity. Furthermore, the authors identify enhanced SCD1 expression as an underlying mechanism promoting GPR110-induced metabolic dysfunction. Finally, the authors provide clinically relevant human data demonstrating a positive correlation between GPR110 expression and degree of hepatic steatosis. The strengths of this study include the rigorous design and execution of experiments, the utilization of gain and loss of function as well as pharmacological and genetic approaches, and the clinically relevant human data presented. The claims are supported by robust data. These findings have the potential to impact the field of metabolism in general, given their findings indicate targeting GPR110 can reverse diet induced obesity and metabolic syndrome. Only minor weaknesses were noted in regard to further interpretation of the data.

    2. Reviewer #2 (Public Review):

      In this manuscript, the authors have proposed that the suppression of hepatic GPR110, known as a tumorigenic gene, could improve non-alcoholic fatty liver disease (NALFD). With AAV-mediated GPR110 overexpression or a GalNAc-siGPR110 experiment, they have suggested that GPR110 could increase hepatic lipids through SCD1.

      Major comments<br /> 1. Although the authors claimed that GPR110 could enhance SCD1-mediated hepatic de novo lipogenesis, the level of GPR110 expression was decreased in obese mice (Figure 1E-F). However, it has been reported that the levels of de novo lipogenic genes, including SCD1, are upregulated in HFD-fed mice (PMID: 18249166, PMID: 31676768). Thus, they should show the levels of hepatic lipids and lipogenic gene expression, including SCD-1, in liver tissues from NCD vs. HFD-fed mice, which will provide insights between GPR110 level and hepatic lipogenic activity.

      2. In Figure 2, the authors have characterized metabolic phenotypes of hepatic GPR110 overexpression upon HFD, exhibiting significant phenotypes (including GTT, ITT, HOMA-IR, serum lipids, and hepatic lipid level). However, it is likely that these phenotypes could stem from increased body weight gain. Since they cannot explain how hepatic GPR110 overexpression could increase body weight, it is hard to conclude that the increased hepatic lipid level would be a direct consequence of GPR110 overexpression. Also, given the increased fat mass in GPR110 overexpressed mice, they should test whether GPR110 overexpression would affect adipose tissue. Along the same line, they have to carefully investigate the reason of increased body weight gain in GPR110 overexpressed mice (ex., food intake, and energy expenditure).

      3. GPR110 enhances hepatic lipogenesis via SCD1 expression (Figures 5 and 6). To verify whether GPR110 would specifically regulates SCD1 transcript, they have to provide the expression levels of other lipogenic genes, including Srebf1, Chrebp, Acaca, and Fasn. Also, measurement of de novo lipogenic activity using primary hepatocyte with GPR110 overexpression or knockdown would be valuable to affirm the authors' proposed model.

      4. In Figure 6, the author should provide the molecular mechanisms how GPR110 signaling could enhance SCD-1 transcription.

      5. Figure 9C shows the increased level of GPR110 with NAFLD severity. They should test whether the levels of hepatic GPR110 and SCD-1 might be elevated in a severe NAFLD mouse model. If it is the case, it would be better to show the beneficial effects of GPR110 suppression against NAFLD progression using a severe NAFLD (ex., NASH) mouse model.

    3. Reviewer #3 (Public Review):

      In this study, the authors examined the expression of GPR110 in a HFD-fed mouse model and validated their findings in human samples. They then performed both gain- and loss-of-function studies on the cellular and systemic metabolic effects of manipulating the levels of GPR110. They further demonstrated that SCD-1 was a downstream effector of GPR110, and the effects of GPR110 could be mediated by SCD-1. This study provides a novel target in NAFLD. Overall the data and analyses well performed and convincing. As the GPR110-SCD1-lipid metabolic phenotype axis is a central theme of the study, I would suggest that the authors further discuss the connection between GPR110 and SCD1, especially the persistent upregulation of SCD1 at late stage of HFD-fed mice (obese mouse model) when GPR110 is very low, for example, whether another regulator plays a more relevant role at this time point.

    1. Reviewer #1 (Public Review):

      The first defined that FAM76B inhibited the NF-κB-mediated inflammation by modulating translocation of hnRNPA2B1 to cytosol, where hnRNPA2B1 bound to IKK and released active NFkB that translocated into nuclear and initiated inflammation.

    2. Reviewer #2 (Public Review):

      This manuscript describes a study of a novel role of FAM76B in regulation of NF-kB-mediated inflammation, specially in neuroinflammation both in animal model and human brain disease. This study was logically designed and laid out and data from gene knockdown and knockout cell line and animals strongly support the note that FAM76B is involved in the neuroinflammatory diseases. This notion was further confirmed in patients with brain inflammatory diseases. Importantly, the authors further dissected the cellular molecular action of FAM76B in regulation of NF-kB pathway through binding to the hnRNPA2B1. However, it is still unclear how the FAM76B regulates/or affects the cytoplasmic translocation of hnRNPA2B1 in brain cells after a variety of inflammatory stimuli or injuries. Nonetheless, this study greatly enhances our understanding of the mechanisms of the brain inflammation and inflammation related brain degeneration.

    1. Reviewer #1 (Public Review):

      The authors have investigated the effect of aerobic exercise on the decline in cerebral blood flow and cognitive function in old mice. Using appropriately two-photon microscopy and optical coherence tomography they found that aerobic exercise restored capillary blood flow and oxygenation in the white matter more than in the grey matter in old female mice. Interestingly, this aerobic exercise also ameliorated cognitive performance in these mice. The data obtained strongly supports the hypothesis and supports the conclusion of the study. Nevertheless, it would be important to compare the effects of aerobic exercise in old mice to its effects in young animals. It will be also interesting to know if the protective effect of exercise is similar in male mice.

      This work brings new insights into the comprehension of the age-associated changes in cerebral microcirculation and in the protective effects of aerobic exercise.

    2. Reviewer #2 (Public Review):

      While aging is known to cause cerebral blood flow deficits, some studies suggested that exercise could reverse - at least partially - these deficits. In this study, the authors used technically-challenging techniques and approaches to test the hypothesis that 5 months of voluntary exercise reverses impairments in cerebrovascular function and cognition. Overall, I find the evidence for a favorable impact of exercise on microvascular perfusion and oxygenation convincing. The impact of exercise was most evident in the white matter and deep cortical tissues, which I believe to be a major finding of the study. The methods are very well-detailed and easy to follow. It is not clear, however, why the authors chose to study only one sex (female mice). This is an important consideration given that age-dependent hormonal changes could play a role in the findings. There are a few instances where it is unclear whether the number of vessels or animals were used for statistical analyses. It'd be very useful for the reader to understand why whisker stimulation led to a reduction in detected light intensity that reflects hyperemia as previously published by the authors (Sencan et al., 2022 JCBFM).

    3. Reviewer #3 (Public Review):

      The manuscript by Shin et al, "Aerobic exercise reverses aging-induced depth-dependent decline in cerebral microcirculation", addresses fundamental questions on the mechanism by which aerobic exercise can reverse several age-related dysfunctions in the cerebral vasculature. This work is solid as they use a wide range of complementary in vivo imaging modalities including two-photon fluorescent imaging, optical coherence tomography, and measurements of PO2 as well as behavioral tests. The experiments specifically examined region-specific differences in the young and aged vasculature and the response to aerobic exercise in superficial cortical areas and importantly in deeper white matter areas. This is a solid contribution because it provides additional understanding of age-related changes in the white matter microcirculation, a brain region where our understanding is incomplete. This work effectively sets the stage to further examine aging-related white matter degeneration, how aerobic exercise ameliorates the vascular decline in aging, and will potentially lead to novel interventions targeting the white matter.

    1. Reviewer #1 (Public Review):

      The manuscript by Huang, Li, et al. describes the identification of variants in the gene coding for p31 comet, a protein required for silencing the spindle assembly checkpoint or SAC, in women with recurrent pregnancy loss upon IVF. In three families mutations affecting splicing or expression of full-length protein were identified. The authors show that oocytes of the patients arrest in meiosis I, are most likely to fail to inactivate the SAC without a fully functional p31 comet. Indeed, the metaphase I arrest occurring in mouse oocytes upon overexpression of Mad2 can be rescued by overexpression of wild-type p31 comet, but not a truncated version. Injection of wt p31 comet into 6 human oocytes from one patient rescued the meiosis I arrest.

      Main points:

      The fact that inactivation of the SAC is required for anaphase I onset in human oocytes is not novel. Biallelic mutations of TRIP13 were shown to lead to the same phenotype (Zhang et al. Am J. Hum Gen., 2020).

      No new mechanistic insights are obtained.

      The authors propose a role for female fertility, however, also a male patient with a p31 comet variant is sterile.

      The fact that the C-terminus of p31 comet is required for interaction with Mad2 and hence, turning off the SAC, is already known.

    2. Reviewer #2 (Public Review):

      In this manuscript by Huang et al. the authors explore the genetic underpinnings that may cause human oocyte meiotic arrest. The meiotic arrest of oocytes can cause female infertility leading patients to seek treatment at IVF clinics to assist in having genetically related babies. However, because oocytes fail to develop to MII, oocytes from these patients cannot be fertilized, leaving no current options for genetically related babies for patients with this pathology. Huang et al identified 50 IVF patients with this phenotype, and after the whole exome sequence, 3 patients had mutations in a spindle assembly checkpoint regulator, Mad1bp1. This study describes these mutations in detail, shows how these mutations affect Mad1bp1 expression, evaluates gross function in mouse oocytes, and explores therapeutic treatment in human oocytes. Overall, this is an important translational study that adds to the growing body of literature that genetic mutations impact oocyte quality and fertility.

      In its current form, I find that the strengths exist in the analysis of the patients' genomes and pedigree information. This is unique data and is important for the field. The expression in oocytes, structure modeling, and conservation in evolution, while not essential for this study, add interesting information for the reader to consider. I sometimes find these distracting in manuscripts, but appreciate them here in this context. The conclusion using human oocytes to propose possible treatment takes the study to completion and is not an easy approach to carry out.

      I do find some weaknesses that weaken the conclusions. The conclusion described is that the SAC is not satisfied in oocytes from these patients. The authors attempt to show this by analysis of mouse oocytes using polar body extrusion and its timing as an assay. There could be many reasons contributing to arrest, therefore a singular assay is not ideal to justify the conclusions. While I do suspect the authors are correct, an intact SAC should be shown at the molecular level to fully justify this conclusion. There are many assays routinely performed in mouse oocytes that the authors can consider (check papers by authors from Wassmann, FitzHarris, and Schindler labs for example).

    1. Reviewer #1 (Public Review):

      This work reports an important demonstration of how to predict the mutational pathways to antimicrobial resistance (AMR) emergence, particularly in the enzyme DHFR (dihydrofolate reductase). Epistasis, or non-additive effects of mutations due to their background dependence, is a major confounding factor in the predictability of protein evolution, including proteins that confer antimicrobial resistance. In the first approach, they used the Rosetta to predict the mutant DHFR-drug binding affinity and the resulting selection coefficient, which then became inputs to a population genetics model. In the second approach, they use the observed clinical/environmental frequency of the variants to estimate the selection coefficient. Overall, this work is a compelling demonstration that a mechanistic model of the fitness landscape could recapitulate AMR evolution; however, considering that the number of mutations and pathways is small, a more compelling description of the robustness of the results and/or limitations of the model is needed.

      Major strengths:<br /> 1. This is a compelling multi-disciplinary work that combines a mechanistic fitness landscape of DHFR (previously articulated in literature and cited by the authors), Rosetta to determine the biophysical effects of mutations, and a population genetics model.<br /> 2. The study takes advantage of extensive data on the clinical/environmental prevalence of DHFR mutations.<br /> 3. Provides a careful review of the surrounding literature.

      Major weakness:<br /> 1. Considering that the number of mutations and pathways being recapitulated is rather small, I would suggest a more detailed description of the robustness of the results. For example:<br /> a. Please report the P-value for the correlation of the predicted DDG_{binding, theory} and DDG_{binding, experimental}. If interested in showing the correct assignment of mutational effects, perhaps use a contingency matrix to derive a P-value.<br /> b. Although the DDG_binding calculation in Rosetta seems to converge (Appendix figures 3 and 4), I do not think the DDG values before equilibration should be included in the final DDG estimate. In practice, there is a "burn in" number of runs where the force field optimizes the calculation to account for potential clashes in the structure, etc. This is particularly important since the starting structures are modeled from homology. Consequently, the distributions of DDG that include the equilibration runs are multimodal (Appendix figure 2), which means that calculating an average may be inappropriate.<br /> 2. The geographical areas over which the mutational pathways are independently estimated are not isolated, allowing for the potential that an AMR variant in one region arose due to "migration" from another area. For example, the S58R-S117N is the most frequent double mutant of PvDHFR in geographically proximate Southern/Southeastern Asia (Fig. 4). To a certain extent, similar mutational patterns occur for PfDHFR in Southern/Southeastern Asia (Fig. 3). Although accounting for mutant migration in the model may be beyond the scope of the study, a clear argument for the validity of the "isolated island" assumption is needed.

    2. Reviewer #2 (Public Review):

      In this work the authors use a simple biophysical model to predict evolutionary trajectories of resistance to pyrimethamine - inhibitor of PfDHFR from P. falciparum and PvDHFR from P. vivax - pathogens causing malaria which presents a worldwide health concern. The authors use a simple fitness model that posits that selection coefficient -relative change in fitness between WT and mutant strains is determined by the fraction of unbound (to antibiotic inhibitor) DHFR. The population genetics simulations use the Kimura formula which is applicable to low mutation high selection regime where populations are monoclonal. The authors use computational tool Rosetta Flex ddG to assess binding of the antibiotic ligand to WT and mutant protein and compare their predicted evolutionary trajectories with lab evolution and data on naturally evolved variants worldwide and find semi-quantitative agreement, albeit sith significant variation in detail.

      The paper is of potential interest as it presents one of the first (but not the first) attempts to compare evolutionary dynamics based on biophysics inspired fitness model with laboratory evolution and natural data for very important problem of emergence and fixation of antibiotic resistant alleles. As such it can be a useful starting point for more detailed and biophysical realistic models of evolution of resistance against anti-DHFR drugs.

    1. Reviewer #1 (Public Review):

      This work develops new and improved methods for tracking and quantifying yeast cells in time-lapse microscopy. Overall, the manuscript presents exceedingly clever solutions to many practical data analysis problems that arise in microfluidics, some of which may be useful in other image analysis settings.

      I find the manuscript is at times very dense and technical and is missing context for a general audience. Hard to know what are the most important contributions, and the authors assume the reader is familiar with many details of their previous work/field. Claims are made with little explanation, context or scientific logic.

    2. Reviewer #2 (Public Review):

      Microfluidics-assisted live-cell imaging is often the method of choice to gain insight into the growth behavior of single cells, in particular unicellular organisms with simple shapes. While growth rate measurements of symmetrically dividing and rod-shape organisms such as E.coli or fission yeast are simplified by their geometry, measurements of the common model organism budding yeast are more complicated due to growth in three dimensions and asymmetric 'budding'. As a consequence, analysis of live-cell imaging experiments typically still requires time-consuming manual work, in particular, to correct automated segmentation and tracking, assign mother-bud pairs, and determine the time point of cell division. In the present manuscript, Pietsch et al. aim to address this important issue by developing deep-learning-based analysis software named BABY for the automated extraction of growth rate measurements performed with microfluidic traps that are designed to keep mother cells, but quickly lose newborn daughters.

      To achieve this, Pietsch et al. introduce several innovative approaches. 1.) In contrast to previous deep-learning segmentation tools they allow 3D data (z-stacks) as inputs and allow for overlapping segmentation masks. 2.) By introducing 3 different object categories based on their size, they can take more specified approaches for each category and for the segmentation of overlapping objects 3.) By using cell edges and bud necks as additional predicted channels, they facilitate downstream post-processing of segmentation masks and mother-bud pairing, respectively. 4.) By using machine learning to predict tracking and mother-bud pairs from multiple features, they develop a novel approach to automate these steps. Using their automated analysis pipeline, the authors then study the growth behavior in different mutants and propose a novel mechanism in which growing buds are regulated by a combination of a 'sizer' and a 'timer' mechanism.

      This manuscript introduces exciting steps towards a fully automated analysis of bright-field microscopy data of growing yeast cells, which makes this manuscript an important contribution to the field. However, in part the quantitative reporting on the actual performance is not sufficient. For example, what is the actual overall success-rate in predicting mother-bud pairs? How accurately can cell cycle durations be predicted? This lack of information makes it hard to evaluate how appropriate using fully automated BABY actual is. In addition, the experiments supporting the major biological insight, i.e. the sizer-timer transition for bud growth are rather limited, and further experiments would be needed to strengthen this conclusion.

    3. Reviewer #3 (Public Review):

      In the work presented in "A label-free method to track individuals and lineages of budding cells", Pietsch et al. use multiple machine learning approaches to identify, delineate, and track yeast cells in microscopy images.

      I commend the authors for putting a lot of work into this manuscript and coming up with many new ideas to solve their problem of interest. However, throughout the manuscript, I felt that this manuscript does not work well as a 'methods' paper. Maybe it should have been a paper about the biology, which I find very interesting. My main reason for finding this manuscript not well-suited for a methods paper is that their approach as well as the goal are so specific that it may not be readily adopted by others. I would like to list the number of limitations and particularities of their set-up to support this conclusion:

      - The whole problem of small cells not being in focus in a single plane is to a large part due to the high ceiling of the authors' microfluidic chips (6 um according to Crane et al.). Other microfluidic chips have much lower ceilings, keeping cells essentially in 2D. If Pietsch et al. used a lower ceiling, small cells would presumably not be out of focus so frequently nor appear to overlap with other cells, and the usual single z-stack approach would suffice. (Another configuration in which cells appear to overlap is in wells, e.g., 96-well plates, which are similarly not ideal for imaging.) Thus, for the problem of interest to Pietsch et al., I would have used a different chip first and then seen what remains of the identification, segmentation, and tracking problem.

      - The method requires a number of z-stacks (although I read somewhere how many z-stacks the method needs, I now cannot find that information any more, which highlights a general problem with the presentation, which I will get to below). This means that the already large amount of data that needs to be acquired with regular 2D images now is multiplied by "n" for each z-stack. More importantly, initially, z-stacks have to be individually labeled for training the neural network. That is n times what other segmentation methods require. So, one would presumably only invest this amount of work if one really cared about the tiniest buds because that is, from what I understand, the main selling point of the method. But how many labs do care about this question and going about it in the exact same way as Pietsch et al.? For example, to just find the exact time a bud appears, most people could just extrapolate the size of a new bud in time to zero or simply use a fluorescent budneck marker. Somebody would have to want to measure the growth rates of the smallest buds without fluorescent labels, which the authors do in this present work. But unless someone wants to repeat this exact measurement, say, with other mutants, I do not see who else would invest a large amount of time and resources for this. Other quantities such as fluorescent protein levels cannot be measured with this approach anyway, i.e., by going through z-stacks with a widefield microscope. One would presumably have to use a confocal microscope.

      - Could the problem have been simplified by taking z-stacks but analyzing each as a regular 2D image with existing segmentation methods? If a new bud is detected in any of the z-stacks, it is counted as a new cell. This would allow one to use existing 2D training sets and methods and only add a few images of one's own, whether taken in a single z-stack or not. It would only involve tweaking or augmenting existing methods slightly.

      - While a 3D image needs to be fed to the neural network, ultimately, all measurements in this manuscript are 2D measurements, e.g., all growth rates are in units of um^2/h. (Somewhat unexpectedly, the authors use a Myo1-GFP construct to identify the budded phase of cells in Fig. 4, i.e., exactly what this method was designed to avoid.) Thus, the effort of going to 3D is only to make the identification of buds more accurate. So, we are not really dealing with a method that goes from 2D to 3D and reconstructs, for example, the shape of cells in 3D. So, while z-stacks go in, it is not 3D annotations that come out.

      - The authors may argue that they want to use their high-ceiling chips because they want to follow aging cells. Or, they may argue that indeed, this method is going to be used more widely because people want to study the growth rates of tiny buds in various mutants. However, then the limitation of their method to convex shapes or shapes that can be represented in cylindrical coordinates is a problem since old cells and many mutants can have strange shapes. In this way, the authors have gone a step back methodologically for reasons that I do not understand.

      - Given that the method is tailored to detecting small buds, I also do not understand why the authors do not use a higher magnification objective, e.g., a 100x objective instead of 60x? Maybe the problem becomes much easier that way?

      - It is unclear how well the tracking method generalizes for other configurations. Here, the tracking problem is somewhat special because there are only a few cell in and around the traps and frequently cells are washed away. For a method paper, the tracking method would need to be compared and contrasted with others for different kinds of experiments. Since tracking is in the title of the manuscript, it is presumably an important selling point of the manuscript.

      - The same applies to the segmentation problem. The traps in the authors' microfluidic chips only keep a small number of cells, avoiding problems that emerge when many cells of similar sizes abut.

    1. Reviewer #1 (Public Review):

      Extracellular vesicles (EVs) are emerging as important mediators of cell-to-cell signaling. In this paper the authors aim to demonstrate that Stranded at second (Sas), a Drosophila cell surface protein, binds to dArc1 and Ptp10D to mediate intercellular transport of dArc1 via EVs. dArc1 protein has been shown to form virus-like capsids that carry dArc1 mRNA from neurons to muscle, but little is known about this new intercellular communication pathway. Similarly, not much is known generally about how EVs are targeted to specific cell types, or how specific EV cargo can be delivered. Thus, this work is of interest to cell biologists and neuroscientists. However, the jumbled description of the results and general lack of rigor of experiments diminish the impact and interpretability of the conclusions. Moreover, almost all experiments rely on gain-of-function and over-expression of Sas, thus the relevance to normal physiological signaling is unclear.

      Major strengths:<br /> 1. The data showing that Sas is released into EVs and delivered to cells is strong.<br /> 2. The EM data showing Sas localization to EVs is clear.

      Major weaknesses:<br /> The description of the results omits some data in the figures and is not in a logical order. This made it hard to read and follow. There is also a lack of rigor and quantification in some experiments. Specifically:

      1. Figure 2: Description of dArc1 putative capsids is absent from the results section (2f,g) until describing fig 4 data (line 362). Given that there is no immuno-EM labeling of dArc1 protein, it is not clear if Sas and dArc1 are localized to the same EVs. Nor is it clear if the double membrane EVs are actually EVs that contain capsids. Overall, the EM data lacks quantification. How many EVs on average show Sas labeling? How many EVs have double membranes? The dense protein staining surrounding EVs seems unusual, is this due to artifact of the purification? EV kits are generally non-specific and isolate non-EV membranes, corroboration using ultracentrifugation or size exclusion chromatography methods would be beneficial. SAS-FL overexpression results in more EVs, which confounds subsequent experiments suggesting that Sas targets EVs to specific cell types/regions.

      2. Figure 3: There are no data showing the expression of Sas in SG cells using the GAL4 lines. Is this expression restricted to just SG cells? The results jump from a-b to f-g. c-e are out of order. The quantification in g should be broken into two and paired with the actual data (c-e, and f). It is not clear how the quantification in g was performed. How many WBs were analyzed? There seems to be a bubble in the first lane of f, which would preclude quantification. Why is d not quantified and there seems to be an overall increase in background staining in e that is not specific to discs. The source data files are not labelled and these data should be incorporated into annotated supplemental figures. Is transfer in a-b due to Ptp10D? How many WBs were quantified in g?

      3. Figure 4: C and d, IP data has no inputs for IPs, no sizing markers, and no IgG controls for antibody specificity. These data would also be more convincing if done with FL Sas and included co-Ips from cell lysates.

      4. In general, the WBs in the figures show very white backgrounds with high contrast, which suggests the images may have been manipulated. Total protein controls are also missing.

      5. Figure 5: Ashley et al (Cell 2018) showed that dArc1 mRNA transfer required the 3'UTR so it is puzzling that the authors used heterologous UTRs. The results using FISH on endogenous dArc1 mRNA are dramatic. The authors should show definitively that their probe does not pick up over-expressed dArc1.

      6. Many of the conclusions would be strengthened by the loss of function experiments, especially showing a requirement for Sas in dArc1 transfer.

    2. Reviewer #2 (Public Review):

      The manuscript addresses the important question of how EVs are targeted to their recipient cells once they are produced and released.

      The present manuscript contains 4 messages:<br /> First, it shows that the transmembrane protein Sas gets incorporated into EVs and that this protein binds to its receptor Ptp10D on target cells, thus targeting the EVs. Second, the manuscript shows that the Sas cytoplasmic domain ICD binds to dARC1 protein (and perhaps darc1 RNAs), which are incorporated into EVs where they form capsids, before being targeted to recipient cells. dARC1 is important for neuron development in flies! Interestingly the motif in the Sas ICD is conserved in mammalian APP that also binds ARC1, suggesting a conserved mechanism of targeting EVs in mammalian neural development. Third, exposure of target cells (ex vivo wing discs) to EVs positive to FL Sas leads to its increased targetting when the target cells also expressed Ptp10D and Numb, which are acting as Sas receptors in a synergetic manner. Fourth, dARC1 ORF expression in the EV-producing cells (SG) leads to the increased expression of dARC1 protein and mRNAs in the recipient cells in vivo (Trachea). Many techniques are used, including IEM, fly genetics, S2 cells, and Ips. It is broad, and well executed, and the questions are interesting.

      However, the manuscript should be strengthened. It is a lot of data and techniques but because there are so many messages in the paper, each needs more substances and controls.

      1: Use of more extensive fly genetics using specific Ptp10D LOF in wing discs and trachea (to show the converse of the GOF).<br /> Does Ptp10D acts as the MAIN receptor to FL Sas? Numb LOF, a combination of LOF and GOF?<br /> does Ptp10D GOF compensate for Numb and vice versa?

      2: What is the specificity for FL Sas? The expression of short Sas should not lead to its incorporation in EVs and their overnight addition should not lead to the same effect (Figure 3). This should be better investigated as short Sas is a good control for FL Sas.

      3: A better quantitative analysis should be provided. For instance, there is no quantitative data for Figure 5.

      4: All experiments are done with flies. There is no data on mammalian neurons in culture. This is missing. Exposure of neurons with SAS-positive EVs (or APP)

      5: Are the capsid reconstitution with purified dARC1 and 2 performed in the presence of darc1 rRNA? Any RNA (figure 2).

      6: The dAC1 increased expression in the target cells upon dARC1 increased production in SG(Figure 5) becomes an important part of the paper (and the model) but is not investigated!<br /> How does it work? Does the delivery of darc1 mRNAs packaged in capsids simply lead to more dARC1 translation? Is it proportional?<br /> OR is there also stimulation of darc1 transcription? Is there also an increase in the mRNA level (I cannot see the SG control of 5o (sage>+) supporting the authors' claim on line 562!).

      7: Most (all) experiments are performed with overexpression of FL Sas or ICD. Does endogenous Sas bind endogenous Ptp10D and dARC1? ICDs? Also full-length APP?

    3. Reviewer #3 (Public Review):

      Lee et al. identify the Stranded at second (Sas) cell surface protein as an extracellular vesicle (EV) component in Drosophila. They first show that different isoforms of Sas exhibit differential tissue distribution in vivo, with the EV-enriched full-length Sas isoform exhibiting distribution at distant sites away from its cells of origin. They show that Sas is present in EVs purified from Drosophila S2 cells, as assessed using exosome isolation kits and via immuno-electron microscopy. Their data suggest that Sas-bearing EVs preferentially target cells expressing Ptp10D, a receptor tyrosine phosphatase that is a known binding partner of Sas, both in the context of S2 cells and imaginal discs engineered to overexpress Ptp10D and the endocytosis regulatory protein Numb. Through immunoprecipitation (IP) of Sas from S2 cell EVs, as well as validation co-IPs and peptide binding assays, the authors found that Sas can interact with the dArc1 protein (i.e. the orthologue of mammalian Arc, which has the ability to form capsid-like structures) via a conserved protein motif of Sas. Finally, they show that Sas increases the transfer of dArc1 protein and mRNA from Sas-expressing cells to Ptp10D-enriched tissues in vivo. The authors conclude that Sas facilitates the delivery of dArc1 capsids that carry dArc1 mRNA to recipient cells that express Ptp10D.

      General Strengths: The in vivo and in vitro data conveying the selective targeting of the full-length Sas isoform to EVs, and the impact on the delivery of dArc1 to distant Ptp10D-expressing cells, are generally strong and supportive of the proposed model. The authors also show convincing data confirming the interaction of Sas with dArc1 by IP-MS and binding assays.

      General Weakness: It is not clear if the major biological function of the endogenous Sas-Ptp10D interaction is mediated via EVs. The inclusion of additional data evaluating dArc1 mRNA EV-mediated transfer to the trachea in Sas and/or Ptp10D null mutant flies would strongly enhance the paper and support the role of these proteins in tissue-specific EV targeting in vivo. Moreover, throughout the paper, there are several controls and quantifications missing that would be required in order to strengthen the general conclusions and proposed regulatory model. For instance, it is not clear to what extent Sas and dArc1 proteins are co-enriched within purified EV specimens. Immuno-EM studies or nanoparticle analysis strategies should be implemented to address this aspect. Several of the IF- and FISH-based labeling experiments lacked controls. Also, there are few if any quantifications provided as to the number of tissue specimens that were examined in the various assays as a basis for making specific conclusions.

    1. Reviewer #1 (Public Review):

      The authors of this manuscript address the question of whether vagal and sacral neural crest make distinct contributions to the enteric nervous system (ENS). The ENS regulates intestinal motility and many intestinal homeostatic functions; mutations in genes involved in ENS development lead to defects that can range from mild to catastrophic. The best studied of the ENS neuropathies is Hirschsprung disease, which is thought to result from failure of vagal neural crest cells to migrate properly into the distal intestine to differentiate into ENS neurons and glia. However, sacral neural crest cells are known to contribute to the distal ENS and have to migrate a considerably shorter distance. Thus, understanding whether there are distinct vagal and sacral contributions to the ENS provides insights into basic ENS biology as well as the basis of human disease. Previous transplantation and ablation studies have already revealed that vagal and sacral neural crest have differing ENS developmental potentials, although this has not been directly correlated with discrete cell types. Here the authors combine single cell RNA sequencing and a viral lineage tracing technique that is new to avians to gain insight into the different ENS cell types generated by vagal and sacral neural crest along the length of the intestine. They find that vagal and sacral neural crest exhibit distinct transcriptional profiles and contribute both similar and different progeny to the ENS. For example, both vagal and sacral crest contribute to progenitor cells, connective tissue and neurons, but most secretomotor neurons are vagal crest-derived whereas most adrenergic neurons and melanocytes in the distal intestine are sacral-crest derived. The authors also suggest a role of the local environment in determining the fate of vagal and sacral derivatives. The data presented in this manuscript provide a multitude of hypotheses about similarities and differences between vagal and sacral derived ENS cells. However, a shortcoming of the manuscript is that all of these hypotheses remain untested.

    2. Reviewer #2 (Public Review):

      The manuscript by Tang et al investigates the potential difference between the enteric nervous system derived from different axial regions of chicken embryos. By applying single cell RNA-sequencing (scRNA-seq) analysis of virally traced enteric cell populations, the authors conclude that vagal and sacral neural crest may contribute to different neural subtypes and non-neural cells in the sub-umbilical ENS. Confirming previous studies, their method also demonstrates the exact axial levels of the GI-tract populated by sacral neural crest. The analysis suggests that NPY/VIP+ neurons mainly arise from vagal neural crest in both the pre- and postumbilical ENS, while sacral neural crest mainly contribute with Th/Dbh/Ddc+ neurons. Sacral neural crest also appears to generate a greater proportion of schwann cell-like cells and melanocytes to the gut.

      While early studies in the chicken model (combined with quail) founded many of the key principles underlying the emergence of the ENS from different neural crest sources, the chicken model currently lags behind in the implementation of modern transcriptomic and neurophysiological approaches. This paper provides a long-saught comprehensive scRNA-seq datasets of the chicken ENS which is clearly lacking in the ENS field. The elegant viral delivery allows targeting of both vagal and sacral neural crest in the same embryo offering clear advantages to other commonly used model systems (including the mouse). However, analytical approaches are in the current form preliminary and not enough to draw firm biological conclusions. While the datasets are large (which is highly appreciated), they represent a relatively early stage of ENS development and possible differences between vagal and sacral-derived populations could partially be attributed to difference in maturity. Maturity will surely not explain the whole difference observed but needs to be factored into the interpretation. As scRNA-seq datasets from the mature chicken ENS are lacking (as well as detailed IHC-based neural classification system) the inference made in the paper between molecular classes and functional types are premature.

      Specific concerns:<br /> 1) Analysis of scRNA-sequenced sacral- versus vagal-derived ENS reveals clusters consistent with a non-ENS identity (endothelial, muscle, vascular and more). Previous studies in mouse using the neural crest tracing line Wnt1-Cre has not demonstrated such diverse progenies of neural crest from any region. An exception being a small population of mesenchymal-like cells (Ling and Sauka-Spengler, Nat Cell Biol. 2019; Zeisel et al., Cell 2018; Morarach et al., 2021; Soldatov et al., Science 2019). Therefore, the claimed broad potential of neural crest giving rise to diverse gut cell populations warrants more validating experiments.

      2) Several earlier studies have revealed that parts of the ENS is derived from neural crest that attach to nerve bundles, obtain a schwann cell precursor-like identity and thereafter migrate into the gut (Uesaka et al. J Neurosci 2015 and Espinosa-Medina et al, PNAS 2017). The current work in chicken needs to be interpretated in the light of these findings and the publications should be discussed in relevant sections of the introduction and discussion.<br /> 3) The analysis indicates the presence of melanocytes. It is not clear why they are part of the GI-tract preparations. Could they correspond to another cell type, with partially overlapping gene expression profile as melanocytes?

      4) As evident, the sacral- and vagal-derived ENS are not clonally related. To decipher differentiation paths and relations between clusters, individual analysis of the different datasets are needed. With only one UMAP representing the merged datasets combined with little information on markers, it is hard to evaluate the soundness of the conclusions regarding cell-identities of clusters and lineage differentiation.

      5) E10 is a relatively early stage in chicken ENS development. Around E7, the intestines do not contain differentiated neurons even. The relative high expression of Hes5 (marking mature enteric glia in the mouse; Morarach et al., 2021) in the vagal neural crest population might be explained by the more mature state of vagal versus sacral ENS. As also outlined below, Th/Dbh are known to be transiently expressed in the developing ENS why they could indicate the relative immaturity of sacral neural crest rather than differential neural identities. These issues need to be taken into account when interpreting biology from scRNA-seq data.

      6) Unlike the guineapig, and to some extent pig and murine ENS, the physiology of chicken enteric neurons has not been well characterized yet. Therefore, it is highly advisable to refrain from a nomenclature of clusters designating functions. Several key molecular markers are known to differ between murine, guineapig, rat and human systems. IPANs are a good example where differential expression is seen (SST in human but not mice; CGRP labels some IPANS in mouse, but not in guineapig, where Tac1 instead is expressed). IPANs are not defined in the chicken very well, and molecular markers found in other species may not be valid. Adrenergic and noradrenergic neurons have not been validated in the ENS (although, TH and Dbh have been observed in the especially in the submucosal ENS). Cholinergic neurons are also mentioned in the text, but do not appear in the figures as a defined group. Another reason to refrain from functional nomenclature is that a rather early stage is analysed in the present study, without possibilities to compare with scRNA-seq data from the mature chicken ENS (which was performed in Morarach et al, 2021 for the mouse). Recent data suggest that considerable differentiation may occur even in postmitotic neurons, and several markers are known to display a transient expression pattern (TH, DBH and NOS1; Baetge and Gershon 1990; Bergner et al., 2014; Morarach et al., 2021) why caution should be taken to infer neuronal identities to clusters.

      7) The immunohistochemical analysis (Figure 5,6) is an essential complementary addition and validation of scRNA-seq. However, it is very difficult to discern staining when magenda and red are combined to display co-expression.

      8) To give more information to the field and body of evidence for claims made, quantifications relating to the analysis in Figures 5 and 6 are warranted as well as an expanded set of marker genes that align with the scRNA-seq results.

      9) Correlations between genes and functions/neuron class are in many cases wrong (including Grm3, Gad1, Nts, Gfra3, Myo9d, Cck and more).

      10) Attempts to subcluster neuronal populations are needed (Figure 7). However, to understand the biology, it is important to address which cells are sacral versus vagal-derived. Additionally, related to previous comment, as the vagal and sacral neurons are not clonally related, it would be important to make separate analysis of neurons relating to each region.

    1. Reviewer #1 (Public Review):

      In this project, the authors used a single-cell RNA sequencing technique, created a cell atlas of normal and diseased human anterior cruciate ligaments of 49,356 cells from 8 patients, explored the variations of the cell subtypes' spatial distributions, and found their associations with ligamental degeneration. Using the single-cell RNA sequencing data, the authors identified fibroblast subsets unique to normal and diseased tissues, revealed two processes of acute and chronic disease outcome in ligamental degeneration and found immune cell and stromal cell subclusters changed the extracellular matrix in ligament and contributed to the disease. Combined with spatial transcriptome sequencing, they found the spatial distribution of immune and stromal cells associated with the disease and demonstrated cell-cell communications among endothelial cells, macrophages, and fibroblasts.

    2. Reviewer #2 (Public Review):

      In this study, Yang et al. used single-cell technology to construct the cell profiles of normal and pathological ligaments and identified the critical cell subpopulations and signaling pathways involved in ligament degeneration. The authors identified four major cell types: fibroblasts, endothelial cells, pericytes, and immune cells from four normal and four pathological human ligament samples. They further revealed the increased number of fibroblast subpopulations associated with ECM remodelling and inflammation in pathological ligaments. In addition, the authors further resolved the heterogeneity of endothelial and immune cells and identified an increase in pericyte subpopulations with muscle cell characteristics and macrophages in pathological ACL. Ligand-receptor interaction analysis revealed the involvement of FGF7 and TGFB signaling in interactions between pathological tendon subpopulations. Spatial transcriptome data analysis also validated the spatial proximity of disease-specific fibroblast subpopulations to endothelial and macrophages, suggesting their interactions in pathological ligaments. This study offers a comprehensive atlas of normal and pathological cells in human ligaments, providing valuable data for understanding the cellular composition of ligaments and screening for critical pathological targets. However, more in-depth analyses and experimental validation are needed to enhance the study.

      1) In this study, the authors performed deconvolution analysis between bulk RNA sequencing results and scRNA-seq results (L204-L208). However, the analysis of this section is not sufficiently in-depth and the authors failed to present the proportion of different cell subpopulations of the bulk sequencing samples to further increase the reliability of the results of the single cell data analysis.<br /> 2) In results 5, the authors should clearly describe whether the analysis is based only on pathological subpopulations of ligament cells or includes a mixture of normal and pathological subpopulations; the corresponding description should also be indicated in Figure 5. Besides, Although the authors claimed that "the TGF-β pathway was involved in many cell-cell interactions among fibroblasts subpopulations and macrophages", Figure 5C displayed that the CD8+NKT-like cells displayed the most TGFB signaling interactions with fibroblasts subpopulations.<br /> 3) In result 6, the authors performed spatial transcriptome sequencing, however, the sample numbers were relatively limited, with only one sample from each group; in addition, the results of this part failed to correlate and correspond well with the single-cell results. The subgroups labelled in L382 and L384 should be carefully checked. Besides, expression data of FGF7 and TGFB ligand and receptor molecules based on the spatial transcriptomes should be added to further confirm the critical signalling pathway in regulating the cellular interactions in pathological ACL.

    3. Reviewer #3 (Public Review):

      In this manuscript, Yang et al. claimed the creation of a single-cell atlas of the human anterior cruciate ligament (ACL) using scRNA-seq, spRNA-seq, and transcriptomic profiling. Upon analysis of about 25K cells from healthy and degenerated human ACL, the authors reported the existence of fibroblasts, endothelial cells, pericytes, and immune cells in healthy ACL. Their ratios altered in the degenerative ACL, featuring an increase in fibroblasts and immune cells, as demonstrated by the UMAP. Further characterization revealed the presence of subclusters in each of the four major types of cells. The evolution trajectory, spatial transcriptome, and signaling pathways that may contribute to biphasic ACL degeneration were also explored. These data are valuable, to some extent, in improving the current knowledge regarding ACL cellular heterogeneity, homeostasis, and ligamental degeneration. However, the abovementioned findings are purely derived from computational modeling; the authors haven't validated any of them experimentally in vitro and in vivo, particularly regarding whether there are multiple fibroblast subclusters in the ACL with distinct biology. The spatial transcriptomic analysis is also superficial, and few novel insights were generated. The reported work seems like a window show of fancy technologies rather than a hypothesis-driven investigation. Some figures were not clearly labeled, and figure legends were too brief to follow up the studies. Therefore, the significance of this work and its value as a cell atlas of ACL are compromised.

    1. Reviewer #1 (Public Review):

      It has been previously shown that defective autophagy and disorganized microtubule network contribute to the pathogenesis of Duchenne muscular dystrophy (DMD). The authors previously reported that nitrite oxide synthase 2 (NOX2) regulates these alterations. It was also shown that acetylated tubulin facilitates autophagosome-lysosome fusion and thus autophagy. In the present study, the authors showed that autophagy is differentially regulated by redox and acetylation modifications in dystrophic mdx mice. The ablation of Nox2 in mdx mice activated the autophagosome maturation but not its fusion with the lysosome. On the other hand, the inhibition of histone acetylase 6 (HDAC6) restored microtubule acetylation, promoted autophagosome-lysosome fusion, and improved muscle function in mdx mice. The strength of this paper is the combination of different approaches to decipher the mechanism, including the evaluation of the level and interaction of several proteins involved in the maturation of autophagosomes and in the fusion between autophagosomes and lysosomes.

      This study reveals an important molecular mechanism by which increasing microtubule acetylation improves autophagy and muscle function in dystrophic mice. This has a translational impact on several diseases in which autophagy is impaired. The improvement of autophagosome-lysosome fusion with HDAC6 inhibitor is supported by several data, but some parts merit further analysis:

      1) To add appropriate controls (e.g. without antibodies) to support protein-protein interaction for all co-immunoprecipitation assays.<br /> 2) The simple evaluation of the protein levels of p62 and LC3-II is not sufficient to claim autophagy improvement after HDAC6 inhibition. It would be good to evaluate the autophagic flux in vivo in all groups of mice (to treat the mice with or without autophagy inhibitor and evaluate whether the difference in the level of LC3-II between the two conditions is higher with HDAC6 inhibitor than without in the mdx mice).

    2. Reviewer #2 (Public Review):

      Agrawal et al. propose an interesting model in which the autophagy pathway in adult mouse skeletal muscle fibers is orchestrated by two independent mechanisms: a) the activity of the NADPH oxidase (Nox) 2 enzyme necessary for autophagosome biogenesis and maturation and b) the level of acetylation of the microtubule (MT) network more selectively responsible for the fusion of the autophagosomes to the lysosomes. Using the well-known mdx mouse, a model for Duchenne muscular dystrophy, the authors perform a quite impressive (but rather traditional) biochemical characterization of the autophagy pathway and found that biogenesis and maturation of the autophagosomes are impaired in mdx mice muscle fibers by means of altered expression of components of the class III phosphatidylinositol 3-kinase complex (PI3K) such as Beclin, VPS15 (both upregulated in mdx mice), ATG14L and VPS34 (both downregulated), and by the reduced expression of JNK and JIP-1, required for the formation of the heterodimer between Beclin and ATG14L-VPS34. In mdx mice, defective nucleation of the phagophore appears to be coupled to altered elongation and expansion as confirmed by decreased expression of WIPI-1, an early marker of autophagosome formation, required for the assembly of the ATG5-12 complex. Clearance of sequestered cytosolic components necessitates the fusion of the autophagosome with the lysosome, a process that the authors found impaired in mdx mice due to altered formation of the SNARE tertiary complex (STX17-SNAP29-VAMP8), as a result of the marked reduction of STX17 expression.

      In a previous work (Pal et al., Nat Commun 2014), the same group described the generation of an mdx-based mouse model where Nox2 activity was abolished by genetic ablation of the p47phox component. These mice presented with a better outcome in terms of dystrophic pathophysiology by means of reduced oxidative stress and improved autophagy. Further characterization of these mice in the present study reveals that in p47-/-/mdx mice abolishment of Nox2 activity restores autophagosome nucleation and maturation thanks to the increased expression of p-JNK, JIP-1 and improved stability of the Beclin-ATG14L complex, but no amelioration is observed on the formation of the SNARE tertiary complex indicating that the biogenesis of autophagosomes is dependent on Nox2 activity but not the fusion between autophagosomes and lysosomes. Given the existing body of evidence in non-muscle cells pointing at alpha-tubulin acetylation as a regulator of MT activity facilitating the fusion of autophagosomes to lysosomes, the authors thought to investigate the level of MT acetylation in mdx mice muscle fibers and found that acetylation is reduced but can be restored by inhibiting the HDAC6 enzyme via the FDA-approved, highly selective pharmacological inhibitor Tubastatin A (Tub A). Treatment of mdx mice at 3 weeks of age (before the onset of pathological manifestations) with Tub A not only restored the normal level of alpha-tubulin acetylation (without altering the organization and density of the MT network) but also curbed the intracellular redox status and improved the autophagic flux by stabilizing the SNARE tertiary complex. Interestingly, treatment of dystrophic mice with Tub A results in substantial improvement of the dystrophic phenotype as confirmed by a reduced level of apoptosis, diminished tissue inflammation, improved sarcolemma integrity, and superior force generation capacity in ex vivo experiments using the diaphragm and Extensor Digitorum Longus (EDL) muscle fibers of Tub A-treated mdx mice compared to untreated mdx and healthy counterparts.

      The in-depth characterization of the steps orchestrating the autophagy pathway in the mdx mouse model on the one hand, and the comprehensive evaluation of the phenotype of the mdx mice treated with the HDAC6 inhibitor Tubastatin A on the other, support the conclusions proposed by the authors. Nonetheless, some aspects deserve consideration.

      1) The effect of increased alpha-tubulin acetylation by means of genetic and pharmacological strategies (i.e., in vivo overexpression of alpha-tubulin acetyltransferase-aTAT1 and treatment with Tubacin or Tubastatin A, respectively) has been previously explored in isolated cardiomyocytes and skeletal muscle fibers and revealed that augmented MT acetylation, due to selective inhibition of HDAC6, increases cytoskeletal stiffness and favors Nox2 activation (Coleman et al., J Gen Physiol 2021).

      2) Altered organization and density of the MT network in mdx FDB muscle fibers with loss of vertical directionality is not a novelty as well and it has been reported by others (see Randazzo et al., Hum Mol Genet 2019), who also observed that overexpression of a single beta-tubulin (tubb6) in normal Flexor Digitorum Brevis (FDB) muscle fibers mimic the disruption to the MT network of mdx FDB fibers, increases the level of detyrosinated tubulin and increases Nox2 activity (through elevated expression of gp91phox). Conversely, downregulation of the same beta-tubulin restores normal MT organization in mdx FDB. Previous work from the authors (Loehr et al., eLife 2018) reported that in p47-/-/mdx mice MT organization in diaphragm muscle fibers is normalized and autophagy improved. Accordingly, it is puzzling that increased alpha-tubulin acetylation determines such a wide range of ameliorations in terms of physiological and morphological aspects in dystrophic skeletal muscle fibers treated with Tubastatin A whereas no improvement in the overall MT organization is observed, as reported by Agrawal and colleagues.

      3) Given that p47-/-/mdx mice present with levels of acetylated alpha-tubulin and HDAC6 expression comparable to mdx while showing significant improvement of the dystrophic phenotype despite partial rescue of the autophagic flux (as reported in Loehr et al., eLife 2018), it would have been of great interest to investigate the effect of HDAC6 inhibition in p47-/-/mdx mice as well.

    1. Reviewer #1 (Public Review):

      The purpose of this study was to investigate within the diverse Multiethnic Cohort (MEC) study on how COVID-19 impacted access to cancer screenings and treatment through a cross-sectional survey in this study population.

      Major strengths were leveraging existing participants in a cohort study that contained a diverse population. The MEC cohort participants have been studied since the 90's. The investigators used a well-designed survey and performed analysis on responses focused on cancer screening attendance. Weaknesses of this study are low response rates that make the results not generalizable to other populations, especially younger populations, and possible bias of specific types of individuals responding.

      This study found associations with racial/ethnic, age, comorbidities, and education to be key factors associated with cancer-related screening and healthcare seeking during the COVID-19 pandemic.

      Whether the associations observed by the investigators would remain over time is unknown, as health care seeking changed as the pandemic evolved and prevention tools (including mass testing and vaccination) became available. It is important to note that this is a snapshot in time, so while it is informative, it will be important to monitor whether certain groups/populations that may be at high risk for cancer may need to be targeted for early diagnosis and screening.

    1. Reviewer #1 (Public Review):

      This study provided evidence to interpret and understand the aging and developmental processes in children. The main strength of the study is it measures a set of biological age measures and a set of developmental measures, thus providing multi-faceted evidence to explain the associations between aging and development in children. The main weakness of this study is that how to measure and test the aging hypothesis of "a buildup of biological capital model" and "wear and tear" is not well-explained. Why the observed associations between biological age measures and developmental measures could support the aforementioned aging theories?

      1. Abstract - conclusion: The aging hypothesis of "a buildup of biological capital model" and "wear and tear" were mentioned in the conclusion without an explanation of these theories in the previous section. Readers who are not experts in the field may not understand the logic.<br /> 2. Result - Biological age marker performance: the correlation between transcriptome age and chronological age is very strong (r =0.94). I am afraid that very little age-independent information could be captured by the transcriptome age. Is it possible to down-regulate the age dependency of the transcriptome age in the training process?<br /> 3. The study population comes from several cohorts, which might influence the results. How the cohort effects were controlled for in the analyses?<br /> 4. Figure 3 only showed the number of p values. Can the author also provide the number of point estimates and 95% confidence intervals, perhaps in the supplemental table?

    2. Reviewer #2 (Public Review):

      The study had an especially relevant aim for aging research and utilized various data types in an especially interesting human population. Multi-omics perspective adds great value to the work. The researchers aimed to evaluate how different indicators of biological age (BA) behave in children during their developmental stage. In the analysis, relationships between indicators of BA, health risk factors, and developmental factors were assessed in cross-sectional data comprising children aged 5-12 years. The manuscript is well-written and easy to follow. The methodology is good. The authors succeeded to reach the aim in most parts.

      In the study, previously known and unknown biological age indicators were used. Known indicators included telomere length and Horvath's epigenetic age. Unknown (novel) indicators, transcriptomic and immunometabolic clocks, were developed in the present study and they showed a strong correlation with calendar age in this population, also in the validation data set. Although the transcriptomic and immunometabolic clocks have the potential of being true indicators of biological age, they are still lacking scientific evidence of being such indicators in adults. That is, their associations with age-related diseases and mortality are yet to be shown. Thus, the major remark of the study relates to the phrasing: these novel transcriptomic and immunometabolic clocks should be presented as BA indicator candidates waiting for the needed evidence.

    1. Reviewer #1 (Public Review):

      In the manuscript, titled "Comparative single-cell profiling reveals distinct cardiac resident macrophages essential for zebrafish heart regeneration," Wei et al. perform bulk and single-cell RNA-sequencing on uninjured and injured zebrafish hearts with or without prior macrophage depletion by clodronate. For the single-cell RNA sequencing, the authors sort macrophages and neutrophils prior to sequencing by using fluorescent reporters for each of the two lineages. The authors characterize the differential gene expression between injured and uninjured hearts with and without prior macrophage depletion. The single-cell analyses allow the characterization of nine discrete subpopulations of macrophages and two distinct neutrophil types. The manuscript is largely descriptive with lots of discussion of specific differentially expressed genes. The authors conclude that tissue-resident macrophages are important for heart regeneration through the remodeling of the microenvironment and by promoting revascularization. Circulating monocyte-derived macrophages cannot adequately replace the resident macrophages even after recovery from clodronate depletion.

      The manuscript presents a very large catalog of useful gene expression data and further characterizes the diversity of macrophages and neutrophils in the heart following injury. Although the conclusions that resident macrophages are important for regeneration and that circulating macrophages cannot adequately substitute for them are not particularly novel, this manuscript provides additional support for those ideas and extends that work by providing a wealth of gene expression data from the different macrophage sub-populations in the zebrafish and how they respond to and promote regeneration. The authors also present a nice analysis supporting the interactions of macrophages with neutrophils via comparing receptors and ligands (from gene expression data) on the two populations - this should be a useful resource.

    2. Reviewer #2 (Public Review):

      Wei et al. analysed the composition of immune cells, mostly macrophages, and neutrophils, in the context of zebrafish cardiac injury while utilizing clodronate liposomes (CL) to inhibit regeneration via alteration of the immune response. This work is a direct continuation of Shih-Lei et al. which compared the regenerative outcomes of zebrafish vs the non-cardiac regenerative medaka. In that work, the authors used CL to pre-deplete macrophages and showed significant effects on neutrophil clearance, revascularization, and cardiomyocyte proliferation. In this work, the authors used the same pre-depletion method to study the dynamics, composition, and transcriptomic state of macrophages and neutrophils, to overall assess the effect on cardiac regeneration. Using bulk RNA-seq at CL vs PBS treated hearts 7 and 21 days post cryo injury (dpci) a delayed\altered immune response was evident. Single-cell analysis at 1,3 and 7 dpci showed a wide range of immune populations in which most diverse are the macrophage populations. Pre-depletion using CL, altered the composition of immune cells resulting in the complete removal of a single resident macrophage population (M2) or dramatically reducing the overall numbers of other resident populations, while other populations were retained. Looking at the injury time course and distribution of macrophage populations, the authors identified several macrophage populations and neutrophil population 1 as pro-regenerative as their presence compared to CL-treated hearts correlates with regeneration. CL-treated hearts also show a marked sustained neutrophil retention suggesting that interaction with depleted macrophage populations is required for neutrophil clearance. As the marked reduction in populations 2 and 3 occurs after CL treatment, the authors tested whether early CL treatment (8 days or 1 month prior to injury) could reduce the non-recoverable populations and affect regenerative outcomes and indeed they observed a reduction in key genes characterizing M2 and M3 which caused marked reduction in revascularization, CM proliferation, neutrophil retention, and overall higher scaring of the heart.

      The findings of this paper could be broadly separated into the characterization of myeloid cells after injury and in non-regenerating animals and assessing the effects of early pre-depletion of macrophages on various cardiac functions involved in regeneration. Both parts draw conclusions that are supported by the facts however several questions remain to be clarified.

      1. In figures 2 and 3 the main claim is that the main resident macrophage populations, M2 and M3 are depleted and are largely unable to replenish after injury, similar to resident macrophages in mice 1. However, as the identification of this population is made solely using scRNA-seq, an alternative explanation would be that these cell populations do replenish but are sufficiently changed due to CL treatment (directly or indirectly) and thus would be a part of another cluster. To address this, we suggest:<br /> A. Run trajectory analysis to ascertain whether the different cell clusters are due to differentiating states of the cells<br /> B. Create a reporter line for M2 and M3 macrophages and assess whether they are indeed depleted or changing.

      2. One of the major findings of this paper is that some macrophage populations can persist throughout injury and promote the regenerative response. Considering that macrophages have a half-life of less than a day in tissue 2 (although could be different in zebrafish and in this population), we estimate that the resident populations should be proliferative. As there is only a single proliferating macrophage population (M5) we speculate that it is a combination of several populations which are clustered together due to the high expression of cell cycle genes. To verify whether the resident populations are proliferating we suggest:<br /> A. Perform cell-cycle scoring and regression (found in Seurat package) and assess whether after regressing out cell cycle genes there are contributions of M5 to other clusters.<br /> B. Perform EDU labelling experiments with cell cycle identifiers (staining for hbaa1, Timp4.3) and assess their proliferative dynamics.

      3. In connection to the previous point if indeed these resident macrophage populations are proliferative, even a smaller portion of remaining cells should be sufficient to partly replenish given sufficient time after CL 1. However as seen in Fig. 3B, the M2 population has a similar proportion of cells on days 1 and 3 after CL treatment and by day 7 it declines in numbers. Given that CL should not be present anymore, we expect this population to increase in numbers over time.

      4. In Figure 6 the authors show a reduction in mpeg+ population however a persistent, large population ({plus minus}70% of the original mpeg+) is retained. The authors suggest that this population is comprised of other, non-macrophage, cell types however as this method is the very core of the paper and the persistence of macrophages could alter our understanding of the results, it must be verified.

      Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nature Immunology 20, 29-39, doi:10.1038/s41590-018-0272-2 (2019).<br /> 2 Leuschner, F. et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med 209, 123-137, doi:10.1084/jem.20111009 (2012).

    3. Reviewer #3 (Public Review):

      Macrophages play an important role during heart regeneration. This has been shown in the mouse and zebrafish for example by treating the animals with clodronate liposomes to eliminate phagocytic cells.<br /> The manuscript follows up on a previous observation by the authors performing these experiments in the zebrafish (Lai et al eLife 2017). When comparing regenerative vs non-regenerative teleosts zebrafish resp Medaka they found that macrophages and neutrophils were the cell types more differentially responding in these two species to a cardiac injury.

      Here the authors anaylse in extenso neutrophil and macrophage populations using single-cell RNA-seq at different stages of regeneration. They perform FAC sorting of the two populations using specific reporter lines. They also assess the change in these populations upon clodronate treatment. They find that clodronate treatment affects the gene expression profiles of different subsets of macrophages and neutrophils as well as their abundance.

      They also show that chlodronate treatment performed several days before cryoinjury depleted macrophages from the heart but after injury overall macrophage number recovers. However, heart regeneration does not. Cardiomyocyte is the only parameter that is not affected, but vasculogenesis and scar resolution is impaired.

      The authors conclude that (1) there are different subsets of macrophages and neutrophils, (2) that they interact with each other during regeneration through specific ligand and receptor pairs, and (3) that a cardiac resident population rather than a circulating macrophage population is important for heart regeneration.

      The transcriptomic characterization of the two immune cell populations is very exhaustive and rigorous. No functional validation of subpopulation marker genes was performed, but the data as it stands will already be of great value to the community. The figure quality is outstanding.

    1. Reviewer #1 (Public Review):

      In the current work, the authors aimed to investigate the genetic and non-genetic factors that impact structural asymmetry.

      A major strength is the number of data samples included in the study to assess brain structural asymmetry. A consequence of the inclusion of many samples is then also the sample size. Given that the authors also work with longitudinal data, it would be nice to be able to appreciate the individual effects across time points, this is now a little unclear. A possible less well-developed approach is the genetic basis, as this was stated as the main question, here the investigations are not that deep and may only touch upon the question. Moreover, the association with cognition, handedness, sex, and ICV is somewhat interesting yet seems also a bit minimal to fully grasp its implications.

      To some extent, the aim of the study could still be written with more clarity. However, the authors have in part achieved their aims - assuming it is found a consensus on the brain asymmetry patterns in humans as is stated in the abstract. Overall the results support the conclusions, yet the strong interpretation of early life factors in particular is not empirically investigated as far as I gather.

      Overall this is a nice and thorough work on asymmetry that may inform further work on brain asymmetry, its genetic basis, development, environmentally induced change, and link to behavioural variation.

    1. Reviewer #1 (Public Review):

      This manuscript puts forward the concept that there is a specific time window during which YAP/TAZ driven transcription provides feedback for optimal endothelial cell adhesion, cytoskeletal organization and migration. The study follows up on previous elegant findings from this group and others which established the importance of YAP/TAZ-mediated transcription for persistent endothelial cell migration. The data presented here extends the concept at two levels: first, the data may explain why there are differences between experimental setups where YAP/TAZ activity are inhibited for prolonged times (e.g. cultures of YAP knockdown cells), versus experiments in which the transient inhibition of YAP/TAZ and (global) transcription affects endothelial cell dynamics prior to their equilibrium.

      All experiments are convincing, clearly visualized and quantified. I have some questions that the authors may address to strengthen this exciting new concept:

      • Point for more elaborate discussion: Apparently the timescale of negative feedback signals is conserved between endothelial cell migration in vitro (with human cells) and endothelial migration during the formation of ISVs in zebrafish. What do you think might be an explanation for such conserved timescales? Are there certain processes within cytoskeletal tension build up that require this quantity of time to establish? Or does it relate to the time that is needed to begin to express the YAP/TAZ target genes that mediate feedback?<br /> • Do you expect different timescales for slower endothelial migratory processes (e.g. for instance during fin vascular regeneration which takes days) ?<br /> • Is the ~4hrs and 8hrs feedback time window a general property or does it differ between specific endothelial cell types? In the veins the endothelial cells generate less stress fibers and adhesions compared to in the arteries. Does this mean that there might be a difference in the feedback time window, or does that mean that certain endothelial cell types may not have such YAP/TAZ-controlled feedback system?<br /> • The experiments are based on perturbations to prove that transcriptional feedback is needed for endothelial migration. What would happen if the feedback systems is always switched on? An experiment to add might be to analyse the responsiveness of endothelial cells expressing constitutively active YAP/TAZ.<br /> • To investigate the role of YAP-mediated transcription in an accurate time-dependent manner the authors may consider using the recently developed optogenetic YAP translocation tool: https://doi.org/10.15252/embr.202154401

    2. Reviewer #2 (Public Review):

      Here the effect of overall transcription blockade, and then specifically depletion of YAP/TAZ transcription factors was tested on cytoskeletal responses, starting from a previous paper showing YAP/TAZ-mediated effects on the cytoskeleton and cell behaviors. Here, primary endothelial cells were assessed on substrates of different stiffness and parameters such as migration, cell spreading, and focal adhesion number/length were tested upon transcriptional manipulation. Zebrafish subjected to similar manipulations were also assessed during the phase of intersegmental vessel elongation. The conclusion was that there is a feedback loop of 4 hours that is important for the effects of mechanical changes to be translated into transcriptional changes that then permanently affect the cytoskeleton.

      The idea is intriguing, but it is not clear how the feedback actually works, so it is difficult to determine if the events needed could occur within 4 hrs. Specifically, it is not clear what gene changes initiated by YAP/TAZ translocation eventually lead to changes in Rho signaling and contractility. Much of the evidence to support the model is preliminary. Some of the data is consistent with the model, but alternative explanations of the data are not excluded. The fish washout data is quite interesting and does support the model. It is unclear how some of the in vitro data supports the model and excludes alternatives.

      Major strengths: The combination of in vitro and in vivo assessment provides evidence for timing in physiologically relevant contexts, and rigorous quantification of outputs is provided. The idea of defining temporal aspects of the system is quite interesting.

      Major weaknesses: The evidence for a "loop" is not strong; rather, most of the data can also be interpreted as a linear increase in effect with time once a threshold is reached. Washout experiments are key to setting up a time window, yet these experiments are presented only for the fish model. A major technical challenge is that siRNA experiments take time to achieve depletion status, making precise timing of events on short time scales problematic. Also, Actinomycin D blocks most transcription so exposure for hours likely leads to secondary and tertiary effects and perhaps effects on viability. No RNA profiling is presented to validate proposed transcriptional changes.

    3. Reviewer #3 (Public Review):

      The authors examined mechanotransductive feedback dynamics that govern endothelial cell motility and vascular morphogenesis. They investigated endothelial cell morphology, migration speed, cell shape, cytoskeletal and focal adhesion maturation in human derived ECFC. To substantiate their in vitro data set, they imaged intersegmental vessel development in zebrafish embryos treated with various inhibitors of translation and acto-myosin remodelling . They conclude that the transcriptional regulators, YAP and TAZ, are activated by mechanical cues to transcriptionally limit cytoskeletal and focal adhesion maturation, forming a conserved mechanotransductive feedback loop that mediates endothelial cell motility. Mechanistically, YAP and TAZ induced transcriptional suppression of myosin II activity to maintain dynamic cytoskeletal equilibria. Such transcriptional feedback loop may be necessary for persistent endothelial cell migration and vascular morphogenesis. The authors addressed an interesting aspect of vascular development and I have some comments and suggestions that are listed below.

      Comments:

      The authors used ECFC - endothelial colony forming cells (circulating endothelial cells that activate in response to vascular injury).

      Q: did the authors characterize these cells and made sure that they are truly endothelial cells - for example examine specific endothelial markers, arterial-venous identity markers & Notch signalling status, overall morphology etc prior to the start of the experiment. How were ECFC isolated from human individuals, are these "healthy" volunteers - any underlying CVD risk factors, cells from one patient or from pooled samples, what injury where these humans exposed to trigger the release of the ECPFs into the circulation, etc. The materials & methods on ECFC should be expanded.

      The authors suggest that loss of YAP/TAZ phenocopies actinomycin-D inhibition - "both transcription inhibition and YAP/TAZ depletion impaired polarization, and induced robust ventral stress fiber formation and peripheral focal adhesion maturation". However, the cell size of actinomycin-D treated cells (Fig. 1B, top right panel), differs from the endothelial cell size upon siYAP/TAZ (Fig. 1E, top right panel) - and vinculin staining seems more pronounced in actinomyocin-D treated cells (B, bottom right) when compared to siYAP/TAZ group. Cell shape is defined by acto-myosin tension.

      Q: besides Fraction of focal adhesion >1um; focal adhesion number did the authors measure additional parameters related to cytoskeleton remodelling / focal adhesions that can substantiate their statement on similarity between loss of YAP/TAZ and actinomycin-D treatment. Would it be possible to make a more specific genetic intervention (besides YAP/TAZ) interfering with the focal adhesion pathway as opposed to the broad spectrum inhibitor actinomyocin-D.<br /> Q: does the actinomycin-D treatment affect responsiveness to Vegf? induce apoptosis or reduce survival of the ECFC?<br /> Q: Which mechanism links ECM stiffness with endothelial surface area in the authors scenario. In zebrafish, activity of endothelial guanine exchange factor Trio specifically at endothelial cell junctions (Klems, Nat Comms, 2020) and endoglin in response to hemodynamic factors (Siekmann, Nat Cell Biol 2017) have been show to control EC shape/surface area - do these factors play a role in the scenario proposed by the authors.<br /> Q: the authors report that EC migrate faster on stiff substrate, and concomitantly these cells have a larger surface area. What is the physiological rationale behind these observations. Did the authors observe such behaviors in their zebrafish ISV model? How do these observation integrate with the tip - stalk cell shuffling model (Jakobsson&Gerhardt, Nat Cell Biol, 2011) and Notch activity in developing ISVs.

      The authors examined the formation of arterial intersegmental vessels in the trunk of developing zebrafish embryos in vivo. They used a variety of pharmacological inhibitors of transcription and acto-myosin remodelling and linked the observed morphological changes in ISV morphogenesis with changes in endothelial cell motility.<br /> Q: reduced formation and dorsal extension of ISVs may have several reasons, including reduced EC migration and proliferation. The Tg(fli1a:EGFP) reporter however is not the most suitable line to monitor migration of individual endothelial cells. Can the authors repeat the experiments in Tg(fli1a:nEGFP); Tg(kdrl:HRAS-mCherry) double transgenics to visualise movement-migration of the individual endothelial cells and EC proliferation events, in the different treatment regimes.<br /> ISV formation is furthermore affected by Notch signalling status and a series of (repulsive) guidance cues.<br /> Q: Does de novo blockade of gene expression with Actinomycin D affect Notch signalling status, expression of PlexinD - sFlt1, netrin1 or arterial-venous identify genes.

      Remark: the authors may want to consider using the Tg(fli1:LIFEACT-GFP) reporter for in vivo imaging of actin remodelling events.

      Remark: the authors report "As with broad transcription inhibition, in situ depletion of YAP and TAZ by RNAi arrested cell motility, illustrated here by live-migration sparklines over 10 hours: siControl: , siYAP/TAZ: (25 μm scale-bar: -)". Can the authors make a separate figure panel for this, how many cells were measured?<br /> Remark: in the wash-out experiments, exposure to the inhibitors is not the same in the different scenarios - could it be that the longer exposure time induces "toxic" side effect that cannot be "washed out" when compared to the short treatment regimes?

    1. Reviewer #1 (Public Review):

      The authors set out to develop an organoid model of the junction between early telencephalic and ocular tissues to model RGC development and pathfinding in a human model. The authors have succeeded in developing a robust model of optic stalk(OS) and optic disc(OD) tissue with innervating retinal ganglion cells. The OS and OD have a robust pattern with distinct developmental and functional borders that allow for a distinct pathway for pathfinding RGC neurites.

      This study falls short on a thorough analysis of their single cell transcriptomics (scRNAseq). From the scRNAseq it is unclear the quality and quantity of the targeted cell types that exist in the model. A comparative analysis of the scRNAseq profiles of their cell-types with existing organoid protocols, to determine a technical improvement, or with fetal tissue, to determine fidelity to target cells, would greatly improve the description of this model and determine its utility. This is especially necessary for the RGCs developed in this protocol as they recommend this as an improved model to study RGCs.

      Future work targeting RGC neurite outgrowth mechanisms will be exciting.

    2. Reviewer #2 (Public Review):

      The study by Liu et al. reports on the establishment and characterization of telencephalon eye structures that spontaneously form from human pluripotent stem cells. The reported structures are generated from embryonic cysts that self-form concentric zones (centroids) of telencephalic-like cells surrounded by ocular cell types. Interestingly, the cells in the outer zone of these concentric structures give rise to retinal ganglion cells (RGCs) based on the expression of several markers, and their neuronal morphology and electrophysiological activity. Single-cell analysis of these brain-eye centroids provides detailed transcriptomic information on the different cell types within them. The single-cell analysis led to the identification of a unique cell-surface marker (CNTN2) for the human ganglion cells. Use of this marker allowed the team to isolate the stem cell-derived RGCs.

      Overall, the manuscript describes a method for generating self-forming structures of brain-eye lineages that mimic some of the early patterning events, possibly including the guidance cues that direct axonal growth of the RGCs. There are previous reports on brain-eye organoids with optic nerve-like connectivity; thus, the novel aspect of this study is the self-formation capacity of the centroids, including neurons with some RGC features. Notably, the manuscript further reports on cell-surface markers and an approach to generating and isolating human RGCs.

    1. Todd Henry in his book The Accidental Creative: How to be Brilliant at a Moment's Notice (Portfolio/Penguin, 2011) uses the acronym FRESH for the elements of "creative rhythm": Focus, Relationships, Energy, Stimuli, Hours. His advice about note taking comes in a small section of the chapter on Stimuli. He recommends using notebooks with indexes, including a Stimuli index. He says, "Whenever you come across stimuli that you think would make good candidates for your Stimulus Queue, record them in the index in the front of your notebook." And "Without regular review, the practice of note taking is fairly useless." And "Over time you will begin to see patterns in your thoughts and preferences, and will likely gain at least a few ideas each week that otherwise would have been overlooked." Since Todd describes essentially the same effect as @Will but without mentioning a ZK, this "magic" or "power" seems to be a general feature of reviewing ideas or stimuli for creative ideation, not specific to a ZK. (@Will acknowledged this when he said, "Using the ZK method is one way of formalizing the continued review of ideas", not the only way.)

      via Andy

      Andy indicates that this review functionality isn't specific to zettelkasten, but it still sits in the framework of note taking. Given this, are there really "other" ways available?

    1. Reviewer #3 (Public Review):

      This study focuses on defining the specific importance of HSP90 isoforms in stress-resistance. Specifically, addressing the importance of the two HSP90 isoforms alpha and beta in adapting cells to chronic stress. Noting that chronic stresses of different types can induce increases of cellular size, the authors investigated the role of HSP90a/b in this process. Intriguingly, they found that KO of either of these isoforms did not influence chronic stress-dependent increases of cell size. However, they did find that HSF1 plays an important role in this process through undefined mechanisms. The authors go on to show that this increase in cell size appears to be correlated with enhanced protein synthesis during conditions of stress, which allow cells to maintain protein density in the enlarged cell. Intriguingly, this correlation is disrupted in HSP90a/b KO cells, where cell size increases, but there is a deficiency in recovery of protein synthesis following the initial insult. This appears to involve sustained ISR signaling that does not resolve in HSP90-deficient cells. Using a number of different compounds that increase (e.g., CDKi) or inhibit (e.g., rapamycin) cell size changes, the authors demonstrate that protection against chronic stress correlates with cell size and protein density, linking cell expansion to stress resistance.

      Overall, this is an observational study that heavily relies on correlation to define a proposed stress responsive signaling mechanism termed the 'rewiring stress response' to explain the coordinated increase in cell size and protein translation in protection against chronic stress.

      Due to the reliance on correlation, there remains many questions unanswered related to this work. For example. What is the specific role for HSP90a/b in regulating protein translation during chronic stress through the ISR or related pathways? The authors indicate that the induction of the eIF2a phosphatase GADD34 is not impacted in HSP90-deficient cells, so what role does HSP90 have in this process. Is HSP90 required for proper folding of GADD34? Would you see similar effects in protein translation recovery if other ISR activators are used in HSP90-deficient cells? Addressing this central unanswered question that would significantly enhance the current study. While the authors are undoubtedly pursuing this in subsequent studies, it is difficult to fully gauge the impact of this work without more clarity on that point specifically.

      Along the same lines, another critical unanswered question is 'Are similar effects observed in non-dividing cells?' Does chronic stress lead to increases of size and regulation of protein translation in primary cell models that are not undergoing division.

      Ultimately, this is an interesting study that does a good job of establishing correlations between increases in cell size and protein translation, but does not get to the really intriguing questions related to this coordination. As this study is extended through either revisions to this manuscript or subsequent papers, the importance of this rewiring stress response in the context of cellular stress and pathologic conditions (e.g., age-associated disease) will become increasing apparent.

    2. Reviewer #1 (Public Review):

      The manuscript describes that cultured mammalian cells adapt to chronic stress by increasing their size and protein translation through Hsp90. The authors extensively use Hsp90 knockout cells and mass spectrometry to provide solid evidence that chronic heat shock response is accompanied by cell size changes and stress resistance in large cells. The major strength of the work is the authors ability to document the heat shock response in detail, while the main weakness is that the cell size changes appear not to be quantitative making it difficult to assess how much the cell density is changed in chronic stress. Nevertheless, the increased stress resistance of large cells is conceptually important and provides one potential explanation why cells need to control their size. This work adds to our understanding of how cellular stress is managed, and while stress responses have been observed previously in relation to cell size, this work provides evidence for increased stress resistance in larger cells.

    3. Reviewer #2 (Public Review):

      The paper by Maiti et al. reporting a highly interesting, previously un-noticed, phenomenon of cell size increase as part of the response to chronic proteotoxic stresses, such as heat shock, which the authors term "rewiring stress response". Furthermore, they establish that it is mediated via HSF1, and, strikingly, necessitates a certain threshold levels of HSP90. Dwelling deeper into the underlying mechanisms, they find that HSP90 help scale protein synthesis with the increased cell sizes, and when diminished, this scaling is impaired, and also cell viability in chronic stress is also compromised. These findings correspond with a previous study by this group on the lethality of HSP90 deficient mice, and moreover, have implications to our understanding of cellular adaptation to stress, and generate interesting hypotheses about the possible links of this mechanism to the impairments of the ability to cope with stress during aging and senescence.

      This is an excellent study, with highly novel and important findings, which illuminate a new phenomenon related to cellular adaptation to chronic stress. I have only one major concern, about some technical aspects, specifically over-crowding effects, which could confound the results, which should be answered by the authors. Other than that, further details which I think are pertinent to the study most likely already exist in the experiments performed, and most could be answered with additional simple experiments and by further analyses of the proteomics data which has already been performed, but which results are not sufficiently shown in detail.

    1. Reviewer #2 (Public Review):

      This study proposed the AG fibroblast-neutrophil-ILC3 axis as a mechanism contributing to pathological inflammation in periodontitis. However, the immune response in the vivo is very complex. It is difficult to determine which is the cause and which is the result. This study explores the relevant issue from one dimension, which is of great significance for a deeper understanding of the pathogenesis of periodontitis. It should be fully discussed.

      1) Many host cells participate in immune responses, such as gingival epithelial cells. AG fibroblast is not the only cell involved in the immune response, and the weight of its role needs to be clarified. So the expression in the conclusion should be appropriate.

      2) This study cannot directly answer the issue of the relationship between periodontitis and systemic diseases.

    2. Reviewer #1 (Public Review):

      In this article, the authors found a distinct fibroblast subpopulation named AG fibroblasts, which are capable of regulating myeloid cells, T cells and ILCs, and proposed that AG fibroblasts function as a previously unrecognized surveillant to orchestrate chronic gingival inflammation in periodontitis. Generally speaking, this article is innovative and interesting, however, there are some problems that need to be addressed to improve the quality of the manuscript.

      Results:

      1) It is recommended to add HE staining and immunohistochemistry staining to observe the inflammation, tissue damage, and repair status from 0 to 7 days, so that readers can understand cell phenotype changes corresponding to the periodontitis stage. The observation index can include inflammation and vascular related indicators.

      2) Figure 1A-1D can be placed in the supplementary figure.

      3) I suggest the authors to put the detection of the existence of AG fibroblasts before exploring its relationship with other types of cells.

      4) The layout of the picture should be closely related to the topic of the article. It is recommended to readjust the layout of the picture. Figure 1 should be the detection of AG cells and their proportion changes from 0 to 7 days. In other figures, the authors can separately describe the proportion changes of myeloid cells, T cells and ILCs, and explored the association between AG fibroblasts and these cell types.

      Methods:

      It is recommended to separately list the statistical methods section. The statistical method used in the article should be one-way ANOVA.

    1. Reviewer #1 (Public Review):

      Overall, I find the work performed by the authors very interesting. However, the authors have not always included literature that seems relevant to their study. For instance, I do not understand why two papers Dunican et al 2013 and Dunican et al 2015, which provide important insight into Lsh/HELLS function in mouse, frog and fish were not cited. It is also important that the authors are specific about what is known and in particular about what is not known about CDCA7 function in DNA methylation regulation. Unless I am mistaken, there is currently only one study (Velasco et al 2018) investigating the effect of CDCA7 disruption on DNA methylation levels (in ICF3 patient lymphoblastoid cell lines) on a genome-wide scale (Illumina 450K arrays). Unoki et al 2019 report that CDCA7 and HELLS gene knockout in human HEK293T cells moderately and extremely reduces DNA methylation levels at pericentromeric satellite-2 and centromeric alpha-satellite repeats, respectively. No other loci were investigated, and it is therefore not known whether a CDCA7-associated maintenance methylation phenotype extends beyond (peri)centromeric satellites. Thijssen et al performed siRNA-mediated knockdown experiments in mouse embryonic fibroblasts (differentiated cells) and showed that lower levels of Zbtb24, Cdca7 and Hells protein correlate with reduced minor satellite repeat methylation, thereby implicating these factors in mouse minor satellite repeat DNA methylation maintenance. Furthermore, studies that demonstrate a HELLS-CDCA7 interaction are currently limited to Xenopus egg extract (Jenness et al 2018) and the human HEK293 cell line (Unoki et al 2019). Whether such an interaction exists in any other organism and is of relevance to DNA methylation mechanisms remains to be determined. Therefore, in my opinion, the conclusion that "Our co-evolution analysis suggests that DNA methylation-related functionalities of CDCA7 and HELLS are inherited from LECA" should be softened, as the evidence for this scenario is not very compelling and seems premature in the absence of molecular data from more species.

      The authors used BLAST searches to characterize the evolutionary conservation of CDCA7 family proteins in vertebrates. From Figure 2A, it seems that they identify a LEDGF binding motif in CDCA7/JPO1. Is this correct and if yes, could you please elaborate and show this result? This is interesting and important to clarify because previous literature (Tesina et al 2015) reports a LEDGF binding motif only in CDCA7L/JPO2.

      To provide evidence for a potential evolutionary co-selection of CDCA7, HELLS and the DNA methyltransferases (DNMTs) the authors performed CoPAP analysis. Throughout the manuscript, it is unclear to me what the authors mean when referring to "DNMT3". In the Material and Methods section, the authors mention that human DNMT3A was used in BLAST searches to identify proteins with DNA methyltransferase domains. Does this mean that "DNMT3" should be DNMT3A? And if yes, should "DNMT3" be corrected to "DNMT3A"? Is there a reason that "DNMT3A" was chosen for the BLAST searches?

      CoPAP analysis revealed that CDCA7 and HELLS are dynamically lost in the Hymenoptera clade and either co-occurs with DNMT3 or DNMT1/UHRF1 loss, which seems important. Unfortunately, the authors do not provide sufficient information in their figures or supplementary data about what is already known regarding DNA methylation levels in the different Hymenoptera species to further consider a potential impact of this observation. What is "the DNA methylation status" of all these organisms? This information cannot be easily retrieved from Table S2. A clearer presentation of what is actually known already would improve this paragraph.

      Furthermore, A. thaliana DDM1, and mouse and human Lsh/Hells are known to preferably promote DNA methylation at satellite repeats, transposable elements and repetitive regions of the genome. On the other hand, DNA methylation in insects and other invertebrates occurs in genic rather than intergenic regions and transposable elements (e.g. Bewick et al 2017; Werren JH PlosGenetics 2013). It would be helpful to elaborate on these differences.

    2. Reviewer #2 (Public Review):

      In this manuscript, Funabiki and colleagues investigated the co-evolution of DNA methylation and nucleosome remolding in eukaryotes. This study is motivated by several observations: (1) despite being ancestrally derived, many eukaryotes lost DNA methylation and/or DNA methyltransferases; (2) over many genomic loci, the establishment and maintenance of DNA methylation relies on a conserved nucleosome remodeling complex composed of CDCA7 and HELLS; (3) it remains unknown if/how this functional link influenced the evolution of DNA methylation. The authors hypothesize that if CDCA7-HELLS function was required for DNA methylation in the last eukaryote common ancestor, this should be accompanied by signatures of co-evolution during eukaryote radiation.

      To test this hypothesis, they first set out to investigate the presence/absence of putative functional orthologs of CDCA7, HELLS and DNMTs across major eukaryotic clades. They succeed in identifying homologs of these genes in all clades spanning 180 species. To annotate putative functional orthologs, they use similarity over key functional domains and residues such as ICF related mutations for CDCA7 and SNF2 domains for HELLS. Using established eukaryote phylogenies, the authors conclude that the CDCA7-HELLS-DNMT axis arose in the last common ancestor to all eukaryotes. Importantly, they found recurrent loss events of CDCA7-HELLS-DNMT in at least 40 eukaryotic species, most of them lacking DNA methylation.

      Having identified these factors, they successfully identify signatures of co-evolution between DNMTs, CDCA7 and HELLS using CoPAP analysis - a probabilistic model inferring the likelihood of interactions between genes given a set of presence/absence patterns. As a control, such interactions are not detected with other remodelers or chromatin modifying pathways also found across eukaryotes. Expanding on this analysis, the authors found that CDCA7 was more likely to be lost in species without DNA methylation.

      In conclusion, the authors suggest that the CDCA7-HELLS-DNMT axis is ancestral in eukaryotes and raise the hypothesis that CDCA7 becomes quickly dispensable upon the loss of DNA methylation and/or that CDCA7 might be the first step toward the switch from DNA methylation-based genome regulation to other modes.

      The data and analyses reported are significant and solid. However, using more refined phylogenetic approaches could have strengthened the orthologous relationships presented. Overall, this work is a conceptual advance in our understanding of the evolutionary coupling between nucleosome remolding and DNA methylation. It also provides a useful resource to study the early origins of DNA methylation related molecular process. Finally, it brings forward the interesting hypothesis that since eukaryotes are faced with the challenge of performing DNA methylation in the context of nucleosome packed DNA, loosing factors such as CDCA7-HELLS likely led to recurrent innovations in chromatin-based genome regulation.

      Strengths:

      - The hypothesis linking nucleosome remodeling and the evolution of DNA methylation.<br /> - Deep mapping of DNA methylation related process in eukaryotes.<br /> - Identification and evolutionary trajectories of novel homologs/orthologs of CDCA7.<br /> - Identification of CDCA7-HELLS-DNMT co-evolution across eukaryotes.

      Weaknesses:

      - Orthology assignment based on protein similarity.<br /> - No statistical support for the topologies of gene/proteins trees (figure S1, S3, S4, S6) which could have strengthened the hypothesis of shared ancestry.

    1. Reviewer #1 (Public Review):

      The manuscript focused on roles of a key fatty-acid synthesis enzyme, acetyl-coA-carboxylase 1 (ACC1), in the metabolism, gene regulation and homeostasis of invariant natural killer T (NKT_ cells and impact on these T cells' roles during asthma pathogenesis. The authors presented data showing that the acetyl-coA-carboxylase 1 enzyme regulates the expression of PPARg then the function of NKT cells including the secretion of Th2-type cytokines to impact on asthma pathogenesis. The results are clearcut and data were logically presented.

      Major concerns:

      1. This study heavily relied on the CD4-CreACC1fl/fl mice. While using of a-GalCer stimulation and Ja18KO mice mitigated the concern, it is still a major concern that at least some of the phenotype were due to the effect on conventional CD4 T cells. For example, the deletion of ACC1 gene seems also decreased the numbers of conventional CD4 T cells (Fig. 2D, Fig. S1D). Previously there were reports showing ACC1 gene in conventional CD4 T cells also plays a role in lung inflammation (Nakajima et al., J. Exp. Med. 218, 2021). If the authors believe the phenotype observed was mainly due to iNKT cells, rather than conventional CD4 T cells, a compare/contrast of the two studies should be discussed to explain or reconcile the results.

      2. The overall significance of the manuscript is related to the potential clinical suppression of ACC1 in human asthma patients. However, the authors only showed the elevated ACC1 genes in these patients, not even in vitro data demonstrating that suppression of ACC1 genes in the iNKT cells from patients could have potential therapeutic effect or suppression of the relevant cytokines.

      3. The authors report that a-GalCer administration can induce the AHR, however, in the cited paper (Hachem et al., Eur J. Immunol. 35, 2793, 2005), iNKT cell activation seems to have the opposite effect to inhibit AHR. Did the authors mean to cite different papers?

    2. Reviewer #2 (Public Review):

      In this study the authors sought to investigate how the metabolic state of iNKT cells impacts their potential pathological role in allergic asthma. The authors used two mouse models, OVA and HDM-induced asthma, and assessed genes in glycolysis, TCA, B-oxidation and FAS. They found that acetyl-coA-carboxylase 1 (ACC1) was highly expressed by lung iNKT cells and that ACC1 deficient mice failed to develop OVA-induced and HDM-induced asthma. Importantly, when they performed bone marrow chimera studies, when mice that lacked iNKT cells were given ACC1 deficient iNKT cells, the mice did not develop asthma, in contrast to mice given wildtype NKT cells. In addition, these observed effects were specific to NKT cells, not classic CD4 T cells. Mechanistically, iNKT cell that lack AAC1 had decreased expression of fatty acid-binding proteins (FABPs) and peroxisome proliferator-activated receptor (PPAR)γ, but increased glycolytic capacity and increased cell death. Moreover, the authors were able to reverse the phenotype with the addition of a PPARg agonist. When the authors examined iNKT cells in patient samples, they observed higher levels of ACC1 and PPARG levels, compared to healthy donors and non-allergic-asthma patients.

    1. Reviewer #1 (Public Review):

      In the study by Venkat et al. the authors expand the current knowledge of allosteric diversity in the human kinome by c-terminal splicing variants using as a paradigm DCLK1. In this work, the authors provide evolutionary and some mechanistic evidence about how c-terminal isoform specific variants generated by alternative splicing can regulate catalytic activity by means of coupling specific phosphorylation sites to dynamical and conformational changes controlling active site and substrate pocket occupancy, as well as interfering with protein-protein interacting interfaces that altogether provides evidence of c-terminal isoform specific regulation of the catalytic activity in protein kinases.

      The paper is overall well written, the rationale and the fundamental questions are clear and well explained, the evolutionary and MD analyses are very detailed and well explained. The methodology applied in terms of the biochemical and biophysical tools falls a bit short in some places and some comments and suggestions are given in this respect. If the authors could monitor somehow protein auto-phosphorylation as a functional readout would be very useful by means of using phospho-specific antibodies to monitor activity. Overall I think this is a study that brings some new aspects and concepts that are important for the protein kinase field, in particular the allosteric regulation of the catalytic core by c-terminal segments, and how evolutionary cues generate more sophisticated mechanisms of allosteric control in protein kinases. However a revision would be recommended.

    1. Reviewer #1 (Public Review):

      Original review:

      This manuscript by Walker et. al. explores the interplay between the global regulators HapR (the QS master high cell density (HDC) regulator) and CRP. Using ChIP-Seq, the authors find that at several sites, the HapR and CRP binding sites overlap. A detailed exploration of the murPQ promoter finds that CRP binding promotes HapR binding, which leads to repression of murPQ. The authors have a comprehensive set of experiments that paints a nice story providing a mechanistic explanation for converging global regulation. I did feel there are some weak points though, in particular the lack of integration of previously identified transcription start sites, the lack of replication (at least replication presented in the manuscript) for many figures, some oddities in the growth curve, and not reexamining their HapR/CRP cooperative binding model in vivo using ChIP-Seq.

      Review of revised version:

      This revised manuscript by Walker et. al. addresses some of the editorial points and conceptual discussion, but in general, most of my suggestions (as the previous reviewer #1) for additional experimentation or addition were not addressed as discussed below. Therefore, my overall review has not changed.

      1) For example, in point 1, the suggested analysis was not performed because it is not trivial. My reason for making this suggestion is that the original manuscript was limited to Vibrio cholerae, and the impact of the manuscript would increase if the findings here were demonstrated to be more broadly applicable. I expect papers published in eLife to have such broad applicability. But no changes were made to the manuscript in this regard. The revised version is still limited to only Vibrio cholerae.

      2) For point 2, the activity of FLAG-tag luxO could have been simply validated in a complementation assay. Yes, they demonstrated DNA binding, but that is not the only activity of LuxO.

      3) For point 7, the transcriptional fusions were not explored at different times or different media, which is also something that was hinted at by other reviewers. In regard to exploring expression at different time points, this seems particularly relevant for QS regulated genes.

      4) For point 13, the authors express that doing an additional CHIP-Seq is outside of the scope of this manuscript. Perhaps that is the case, but the point of the comment is to validate the in vitro binding results with an in vivo binding assay. A targeted CHIP-Seq approach specifically analyzing the promoters where cooperative binding was observed in vitro could have addressed this point.

    2. Reviewer #2 (Public Review):

      This manuscript by Walker et al describes an elegant study that synergizes our knowledge of virulence gene regulation of Vibrio cholerae. The work brings a new element of regulation for CRP, notably that CRP and the high density regulator HapR co-occupy the same site on the DNA but modeling predicts they occupy different faces of the DNA. The DNA binding and structural modeling work is nicely conducted and data of co-occupation are convincing. The work seeks to integrate the findings into our current state of knowledge of HapR and CRP regulated genes at the transition from the environment and infection. The strength of the paper is the nice ChIP-seq analysis and the structural modeling and the integration of their work with other studies. The weakness is that it is not clear how representative these data are of multiple hapR/CRP binding sites or how the work integrates as a whole with the entire transcriptome that would include genes discovered by others. Overall this is a solid work that provides an understanding of integrated gene regulation in response to multiple environmental cues.

    1. Reviewer #1 (Public Review):

      "MAGIC" was introduced by the Rong Li lab in a Nature letters article in 2017. This manuscript is an extension of this original work and uses a genome wide screen the Baker's yeast to decipher which cellular pathways influence MAGIC. Overall, this manuscript is a logical extension of the 2017 study, however the manuscript is challenging to follow, complicated by the data often being discussed out of sequence. Although the manuscripts makes claims of a mechanism being pinpointed, there are many gaps and the true mechanisms of how the factors identified in the screen influence MAGIC is not clear. A key issue is that there are many assumptions drawn on previous literature, but central aspects of the mechanisms being proposed are not adequately shown.

      Key comments:

      [1] Reasoning and pipelines presented in the first two sections of the results are disordered and do not follow figure order. In some instances, the background to experimental analyses such as detailing the generation of spGFP constructs in the YKO mutant library, or validation of Snf1 activation are mentioned after respective results are discussed. This needs to be fixed.<br /> [2] In general there is a lack of data to support microscopy data and supporting quantification analysis. The validity of this data could be significantly strengthened with accompanying western blots showing accumulation of a given constructs in mitochondrial sub compartments (as was the case in the labs original paper in 2017).<br /> [3] Much of the mechanisms proposed relies on the Snf1 activation. This is however not shown, but assumed to be taking place. Given that this activation is central to the mechanism proposed this should be explicitly shown here - for example survey the phosophorylation status of the protein.

    2. Reviewer #2 (Public Review):

      Work of Rong Li´s lab, published in Nature 2017 (Ruan et al, 2017), led the authors to suggest that the mitochondrial protein import machinery removes misfolded/aggregated proteins from the cytosol and transports them to the mitochondrial matrix, where they are degraded by Pim1, the yeast Lon protease. The process was named mitochondria as guardian in cytosol (MAGIC).

      The mechanism by which MAGIC selects proteins lacking mitochondrial targeting information, and the mechanism which allows misfolded proteins to cross the mitochondrial membranes remained, however, enigmatic. Up to my knowledge, additional support of MAGIC has not been published. Due to that, MAGIC is briefly mentioned in relevant reviews (it is a very interesting possibility!), however, the process is mentioned as a "proposal" (Andreasson et al, 2019) or is referred to require "further investigation to define its relevance for cellular protein homeostasis (proteostasis)" (Pfanner et al, 2019).

      Rong Li´s lab now presents a follow-up story. As in the original Nature paper, the major findings are based on in vivo localization studies in yeast. The authors employ an aggregation prone, artificial luciferase construct (FlucSM), in a classical split-GFP assay: GFP1-10 is targeted to the matrix of mitochondria by fusion with the mitochondrial protein Grx5, while GFP11 is fused to FlucSM, lacking mitochondrial targeting information. In addition the authors perform a genetic screen, based on a similar assay, however, using the cytosolic misfolding-prone protein Lsg1 as a read-out.

      My major concern about the manuscript is that it does not provide additional information which helps to understand how specifically aggregated cytosolic proteins, lacking a mitochondrial targeting signal could be imported into mitochondria. As it stands, I am not convinced that the observed FlucSM-/Lsg1-GFP signals presented in this study originate from FlucSM-/Lsg1-GFP localized inside of the mitochondrial matrix. The conclusions drawn by the authors in the current manuscript, however, rely on this single approach.

      In the 2017 paper the authors state: "... we speculate that protein aggregates engaged with mitochondria via interaction with import receptors such as Tom70, leading to import of aggregate proteins followed by degradation by mitochondrial proteases such as Pim1." Based on the new data shown in this manuscript the authors now conclude "that MP (misfolded protein) import does not use Tom70/Tom71 as obligatory receptors." The new data presented do not provide a conclusive alternative. More experiments are required to draw a conclusion.<br /> In my view: to confirm that MAGIC does indeed result in import of aggregated cytosolic proteins into the mitochondrial matrix, a second, independent approach is needed. My suggestion is to isolate mitochondria from a strain expressing FlucSM-GFP and perform protease protection assays, which are well established to demonstrate matrix localization of mitochondrial proteins. In case the authors are not equipped to do these experiments I feel that a collaboration with one of the excellent mitochondrial labs in the US might help the MAGIC pathway to become established.

    3. Reviewer #3 (Public Review):

      In this study, Wang et al extend on their previous finding of a novel quality control pathway, the MAGIC pathway. This pathway allows misfolded cytosolic proteins to become imported into mitochondria and there they are degraded by the LON protease. Using a screen, they identify Snf1 as a player that regulates MAGIC. Snf1 inhibits mitochondrial protein import via the transcription factor Hap4 via an unknown pathway. This allows cells to adapt to metabolic changes, upon high glucose levels, misfolded proteins an become imported and degraded, while during low glucose growth conditions, import of these proteins is prevented, and instead import of mitochondrial proteins is preferred.

      This is a nice and well-structured manuscript reporting on important findings about a regulatory mechanism of a quality control pathway. The findings are obtained by a combination of mostly fluorescent protein-based assays. Findings from these assays support the claims well.

      While this study convincingly describes the mechanisms of a mitochondria-associated import pathway using mainly model substrates, my major concern is that the physiological relevance of this pathway remains unclear: what are endogenous substrates of the pathway, to which extend are they imported and degraded, i.e. how much does MAGIC contribute to overall misfolded protein removal (none of the experiments reports quantitative "flux" information). Lastly, it remains unclear by which mechanism Snf1 impacts on MAGIC or whether it is "only" about being outcompeted by mitochondrial precursors.

    1. Joint Public Review:

      Smirnova et al. present a cryo-EM structure of human SIRT6 bound to a nucleosome as well as the results from molecular dynamics simulations. The results show that the combined conformational flexibilities of SIRT6 and the N-terminal tail of histone H3 limit the residues with access to the active site, partially explaining the substrate specificity of this sirtuin-class histone deacetylase. The cryo-EM analysis in its current form is incomplete, lacking aspects of validation such as angular distribution information and other standard measurements of the quality of the reconstruction. Biochemical validation of the structural findings is inadequate, relying primarily on previous publications. Importantly, two other groups have recently published cryo-EM structures of SIRT6:nucleosome complexes. This manuscript by Smirnova et al., therefore, confirms and complements these previous findings, with the addition of some novel insights into the role of structural flexibility in substrate selection.

    1. Reviewer #1 (Public Review):

      Gehr and colleagues used an elegant method, using neuropixels probes, to study retinal input integration by mouse superior collicular cells in vivo. Compared to a previous report of the same group, they opto-tagged inhibitory neurons and defined the differential integration onto each group. Through these experiments, the author concluded that overall, there is no clear difference between the retina connectivity to excitatory and inhibitory superior colliculus neurons. The exception to that rule is that excitatory neurons might be driven slightly stronger than inhibitory ones. Technically, this work is performed at a high level, and the plots are beautifully conceived, but I have doubts if the interpretation given by the authors is solid. I will elaborate below.

      Some thoughts about the interpretation of the results.

      My main concern is the "survivor bias" of this work, which can lead to skewed conclusions. From the data set acquired, 305 connections were measured, 1/3 inhibitory and 2/3 excitatory. These connections arise from 83 RGC onto 124 RGC (I'm interpreting the axis of Fig.2 C). Here it is worth mentioning that different RGC types have different axonal diameters (Perge et al., 2009). Here the diameter is also related to the way cells relay information (max frequencies, for example). It is possible that thicker axons are easier to measure, given the larger potential changes would likely occur, and thus, selectively being picked up by the neuropixels probe. If this is the case, we would have a clear case of "survival bias", which should be tested and discussed. One way to determine if the response properties of axonal termini are from an unbiased sample is to make a rough functional characterization as generally performed (see Baden et al. 2006). This is fundamental since all other conclusions are based on unbiased sampling.

      One aspect that is not clear to me is to measure of connectivity strength in Figure 2. Here it seems that connectivity strength is directly correlated with the baseline firing rate of the SC neuron (see example plots). If this is a general case, the synaptic strength can be assumed but would only differ in strength due to the excitability of the postsynaptic cell. This should be tested by plotting the correlation coefficient analysis against the baseline firing rate.

      My third concern is the assessment of functional similarity in Fig. 3. It is not clear to me why the similarity value was taken by the arithmetic mean. For example, even if the responses are identical for one connected pair that exclusively responds either to the ON or OFF sparse noise, the maximal value can only be 0.67. Perhaps I misunderstood something. Secondly, correlations in natural(istic) movies can differ dramatically depending on the frame rate that the movie was acquired and the way it is displayed to the animal. What looks natural to us will elicit several artifacts at a retinal level, e.g., due to big jumps between frames (no direction-selective response) or overall little modulation (large spatial correlations). I would rather opt for uniform stimuli, as suggested previously. Of course, these are also approximations but can be easily reproduced by different labs and are not subjected to the intricacies of the detailed naturalistic stimulus used.

      Fourth. It is important to control the proportion of inhibitory cells activated optogenetically across the recording probe. Currently, it is not possible to assess if there are false negatives. One way of controlling for this would be to show that the number of inhibitory interneurons doesn't vary across the probe.

      Fifth. In Fig. 4, the ISI had a minimal bound of 5 ms. Why? This would cap the firing rate at 200Hz, but we know that RGC in explants can fire at higher frequencies for evoked responses. I would set a lower bound since it should come naturally from the after-depolarization block. Another aspect that remains unclear is to what extent the paired-spike ratio depends on the baseline firing rate. This would change the interpretation from the particular synaptic connection to the intrinsic properties of the cell and is plausible since the bassline firing rate varies tremendously. One related analysis would be to plot the change of PSR depending on the ISI. It would be intuitive to make a scatter plot for all paired spikes of all recorded neurons (separated into inhibitory and excitatory) of ISI vs. PSR.

      Panel 4E is confusing to me. Here what is plotted is efficacy 1st against PSR (which is efficacy 2nd/efficacy 1st). Given that you have a linear relation between efficacy 1st and efficacy 2nd (panel 4C), you are essentially re-plotting the same information, which should necessarily have a hyperbolic relationship: [ f(x) = y/x ]. Thus, fitting this with a linear function makes no sense and it has to be decaying if efficacy 2nd > efficacy1st as shown in 4C.

      Finally, in Figure 5, the perspective is inverted, and the spike correlations are seen from the perspective of SC neurons. Here it would also be good to plot the cumulative histograms and not look at the averages. Regarding the similarity index and use of natural stats, please see my previous comments. Also, would it be possible to plot the contribution v/s the firing rate with the baseline firing rate with no stimulation or full-field stimulation? This is important since naturalistic movies have too many correlations and dependencies that make this plot difficult to interpret.

      Overall, the paper only speaks from excitatory and inhibitory differences in the introduction and results. However, it is known that there are three clear morphologically distinct classes of excitatory neurons (wide-field, narrow-field, and stellate). This topic is touched in the discussion but not directly in the context of these results. Smaller cells might likely be driven much stronger. Wide-field cells would likely not be driven by one RGC input only and will probably integrate from many more cells than 6.

    2. Reviewer #2 (Public Review):

      This study follows up on a previous study by the group (Sibille et al Nature Communications 2022) in which high density Neuropixel probes were inserted tangentially through the superficial layers of the superior colliculus (SC) to record the activity of retinocollicular axons and postsynaptic collicular neurons in anesthetized mice. By correlating spike patterns, connected pairs could be identified which allowed the authors to demonstrate that functionally similar retinal axon-SC neuron pairs were strongly connected.

      In the current study, the authors use similar techniques in vGAT-ChR2 mice and add a fiber optic to identify light-activated GABAergic and non-light-activated nonGABAergic neurons. Using their previously verified techniques to identify connected pairs, within regions of optogenetic activation they identified 214 connected pairs of retinal axons and nonGABAergic neurons and 91 pairs of connected retinal axons and GABAergic neurons. The main conclusion is that retinal activity contributed more to the activity of postsynaptic nonGABAergic SC neurons than to the activity of postsynaptic GABAergic SC neurons.

      The study is very well done. The figures are well laid out and clearly establish the conclusions. My main comments are related to the comparison to other circuits and further questions that might be addressed in the SC.

      It is stated several times that the superior colliculus and the visual cortex are the two major brain areas for visual processing and these areas are compared throughout the manuscript. However, since both the dorsal lateral geniculate nucleus (dLGN) and SC include similar synaptic motifs, including triadic arrangements of retinal boutons with GABAergic and nonGABAergic neurons, it might be more relevant to compare and contrast retinal convergence and other features in these structures.

      The GABAergic and nonGABAergic neurons showed a wide range of firing rates. It might be interesting to sort the cells by firing rates to see if they exhibit different properties. For example, since the SC contains both GABAergic interneurons and projection neurons it would be interesting to examine whether GABAergic neurons with higher firing rates exhibit narrower spikes, similar to cortical fast spiking interneurons. Similarly, it might be of interest to sort the neurons by their receptive field sizes since this is associated with different SC neuron types.

      The recording techniques allowed for the identification of the distance between connected retinocollicular fibers and postsynaptic neurons. It might also be interesting to compare the properties of connected pairs recorded at dorsal versus ventral locations since neurons with different genetic identities and response properties are located in different dorsal/ventral locations (e.g. Liu et al. Neuron 2023). Also, regarding the strength of connections, previous electron microscopy studies have shown that the retinocollicular terminals differ in density and size in the dorsal/ventral dimension (e.g Carter et al JCN 1991).

      Was optogenetic activation of GABAergic neurons ever paired with visual activation? It would be interesting to examine the receptive fields of the nonGABAergic neurons before and after activation of the GABAergic neurons (as in Gale and Murphy J Neurosci 2016).

    3. Reviewer #3 (Public Review):

      This study performs in vivo recordings of neurons in the mouse superior colliculus and their afferents from the retina, retinal ganglion cells (RGCs). Building on a preparation they previously published, this study adds the use of optogenetic identification of inhibitory neurons (aka optotagging) to compare RGC connectivity to excitatory and inhibitory neurons in SC. Using this approach, the authors characterize connection probability, strength, and response correlation between RGCs and their target neurons in SC, finding several differences from what is observed in the retina-thalamus-visual cortex pathway. As such, this may be a useful dataset for efforts to understand retinocollicular connectivity and computations.

    1. Reviewer #1 (Public Review):

      Segas et al. present a novel solution to an upper-limb control problem which is often neglected by academia. The problem the authors are trying to solve is how to control the multiple degrees of freedom of the lower arm to enable grasp in people with transhumeral limb loss. The proposed solution is a neural network based approach which uses information from the position of the arm along with contextual information which defines the position and orientation of the target in space. Experimental work is presented, based on virtual simulations and a telerobotic proof of concept.

      The strength of this paper is that it proposes a method of control for people with transhumeral limb loss which does not rely upon additional surgical intervention to enable grasping objects in the local environment. A challenge the work faces is that it can be argued that a great many problems in upper limb prosthesis control can be solved given precise knowledge of the object to be grasped, its relative position in 3D space and its orientation. It is difficult to know how directly results obtained in a virtual environment will translate to real world impact. Some of the comparisons made in the paper are to physical systems which attempt to solve the same problem. It is important to note that real world prosthesis control introduces numerous challenges which do not exist in virtual spaces or in teleoperation robotics.

      The authors claim that the movement times obtained using their virtual system, and a teleoperation proof of concept demonstration, are comparable to natural movement times. The speed of movements obtained and presented are easier to understand by viewing the supplementary materials prior to reading the paper. The position of the upper arm and a given target are used as input to a classifier, which determines the positions of the lower arm, wrist and the end effector. The state of the virtual shoulder in the pick and place task is quite dynamic and includes humeral rotations which would be challenging to engineer in a real physical prosthesis above the elbow. Another question related to the pick and place task used is whether or not there are cases where both the pick position and the place position can be reached via the same, or very similar, shoulder positions? i.e. with the shoulder flexion-extension and abduction-adduction remaining fixed, can the ANN use the remaining five joint angles to solve the movement problem with little to no participant input, simply based on the new target position? If this was the case, movements times in the virtual space would present a very different distribution to natural movements, while the mean values could be similar. The arguments made in the paper could be supported by including individual participant data showing distributions of movement times and the distances travelled by the end effector where real movements are compared to those made by an ANN.

      In the proposed approach users control where the hand is in space via the shoulder. The position of the upper arm and a given target are used as input to a classifier, which determines the positions of the lower arm, wrist and the effector. The supplementary materials suggest the output of the classifier occurs instantaneously, in that from the start of the trial the user can explore the 3D space associated with the shoulder in order to reach the object. When the object is reached a visual indicator appears. In a virtual space this feedback will allow rapid exploration of different end effector positions which may contribute to the movement times presented. In a real world application, movement of a distal end-effector via the shoulder is not to be as graceful and a speed accuracy trade off would be necessary to ensure objects are grasped, rather than knocked or moved.

      Another aspect of the movement times presented which is of note, although it is not necessarily incorrect, is that the virtual prosthesis performance is close too perfect. In that, at the start of each trial period, either pick or place, the ANN appears to have already selected the position of the five joints it controls, leaving the user to position the upper arm such that the end effector reaches the target. This type of classification is achievable given a single object type to grasp and a limited number of orientations, however scaling this approach to work robustly in a real world environment will necessitate solving a number of challenges in machine learning and in particular computer vision which are not trivial in nature. On this topic, it is also important to note that, while very elegant, the teleoperation proof of concept of movement based control does not seem to feature a similar range of object distance from the user as the virtual environment. This would have been interesting to see and I look forward to seeing further real world demonstrations in the authors future work.

    2. Reviewer #2 (Public Review):

      Segas et al motivate their work by indicating that none of the existing myoelectric solution for people with trans-humeral limb difference offer four active degrees of freedom, namely forearm flexion/extension, forearm supination/pronation, wrist flexion/extension, and wrist radial/ulnar deviation. These degrees of freedom are essential for positioning the prosthesis in the correct plan in the space before a grasp can be selected. They offer a controller based on the movement of the stump.

      The proposed solution is elegant for what it is trying to achieve in a laboratory setting. Using a simple neural network to estimate the arm position is an interesting approach, despite the limitations/challenges that the approach suffers from, namely, the availability of prosthetic hardware that offers such functionality, information about the target and the noise in estimation if computer vision methods are used. Segas et al indicate these challenges in the manuscript, although they could also briefly discuss how they foresee the method could be expanded to enable a grasp command beyond the proximity between the end-point and the target. Indeed, it would be interesting to see how these methods can be generalise to more than one grasp.

      One bit of the results that is missing in the paper is the results during the familiarisation block. If the methods in "intuitive" I would have thought no familiarisation would be needed. Do participants show any sign of motor adaptation during the familiarisation block?

      In Supplementary Videos 3 and 4, how would the authors explain the jerky movement of the virtual arm while the stump is stationary? How would be possible to distinguish the relative importance of the target information versus body posture in the estimation of the arm position? This does not seem to be easy/clear to address beyond looking at the weights in the neural network.

      I am intrigued by how the Generic ANN model has been trained, i.e. with the use of the forward kinematics to remap the measurement. I would have taught an easier approach would have been to create an Own model with the native arm of the person with the limb loss, as all your participants are unilateral (as per Table 1). Alternatively, one would have assumed that your common model from all participants would just need to be 'recalibrated' to a few examples of the data from people with limb difference, i.e. few shot calibration methods.

    3. Reviewer #3 (Public Review):

      This work provides a new approach to simultaneously control elbow and wrist degrees of freedom using movement based inputs, and demonstrate performance in a virtual reality environment. The work is also demonstrated using a proof-of-concept physical system. This control algorithm is in contrast to prior approaches which electrophysiological signals, such as EMG, which do have limitations as described by the authors. In this work, the movements of proximal joints (eg shoulder), which generally remain under voluntary control after limb amputation, are used as input to neural networks to predict limb orientation. The results are tested by several participants within a virtual environment, and preliminary demonstrated using a physical device, albeit without it being physically attached to the user.

      Strengths:<br /> Overall, the work has several interesting aspects. Perhaps the most interesting aspect of the work is that the approach worked well without requiring user calibration, meaning that users could use pre-trained networks to complete the tasks as requested. This could provide important benefits, and if successfully incorporated into a physical prosthesis allow the user to focus on completing functional tasks immediately. The work was also tested with a reasonable number of subjects, including those with limb-loss. Even with the limitations (see below) the approach could be used to help complete meaningful functional activities of daily living that require semi-consistent movements, such as feeding and grooming.

      Weaknesses:<br /> While interesting, the work does have several limitations. In this reviewer's opinion, main limitations are: the number of 'movements' or tasks that would be required to train a controller that generalized across more tasks and limb-postures. The authors did a nice job spanning the workspace, but the unconstrained nature of reaches could make restoring additional activities problematic. This remains to be tested.

      The weight of a device attached to a user will impact the shoulder movements that can be reliably generated. Testing with a physical prosthesis will need to ensure that the full desired workspace can be obtained when the limb is attached, and if not, then a procedure to scale inputs will need to be refined.

      The reliance on target position is a complicating factor in deploying this technology. It would be interesting to see what performance may be achieved by simply using the input target positions to the controller and exclude the joint angles from the tracking devices (eg train with the target positions as input to the network to predict the desired angles).

      Treating the humeral rotation degree of freedom is tricky, but for some subjects, such as those with OI, this would not be as large of an issue. Otherwise, the device would be constructed that allowed this movement.

      Overall, this is an interesting preliminary study with some interesting aspects. Care must be taken to systematically evaluate the method to ensure clinical impact.

    1. Reviewer #1 (Public Review):

      In this study, Drougard et al. examined the consequences of an acute high fat diet (HFD) on microglia in mice. 3-day HFD influenced the regulation of systemic glucose homeostasis in a microglia-dependent and independent manner, as determined using microglial depletion with PLX5622. 3-day HFD increased microglial membrane potential and the levels of palmitate and stearate in cerebrospinal fluid in vivo. Using confocal imaging, respirometry and stable isotope-assisted tracing in primary microglial cultures, the authors suggest an increase in mitochondrial fission and metabolic remodelling occurs when exposed to palmitate, which increases the release of glutamate, succinate and itaconate that may alter neuronal metabolism. This acute microglial metabolic response following acute HFD is subsequently linked to improved higher cognitive function (learning and memory) in a microglia and DRP1-dependent manner.

      Strengths:<br /> Overall, this study is interesting and novel in linking acute high fat diet to changes in microglia and improved learning and memory in mice. The role for microglia and DRP1 in regulating glucose homeostasis and memory in vivo appears to be supported by the data.

      Weaknesses:<br /> The authors suggest that utilisation of palmitate by microglia following HFD is the driver of the acute metabolic changes and that the release of microglial-derived lactate, succinate, glutamate and itaconate are causally linked to improvements in learning and memory.<br /> A major weakness is that the authors provide no mechanistic link between beta-oxidation of palmitate (or other fatty acids) in microglia and the observed systemic metabolic and memory phenotypes in vivo. Pharmacological inhibition of CPT1a could be considered or CPT1a-deficient microglia.

      Another major weakness is that the authors also suggest that 3-day HFD microglial response (increase membrane potential) is likely driven by palmitate-induced increases in itaconate feedforward inhibition of complex II/SDH. Whilst this is an interesting hypothesis, the in vitro metabolic characterisation is not entirely convincing. The authors suggest that acute palmitate appears to rapidly compromise or saturate complex II activity. Succinate is a membrane impermeable dicarboxylate. It can enter cells via MCT transporters at acidic pH. It is not clear that I) Succinate is taken up into microglia, II) If the succinate used was pH neutral sodium succinate or succinic acid, and III) If the observed changes are due to succinate oxidation, changes in pH or activation of the succinate receptor SUCNR1 on microglia. In the absence of these succinate treatments, there are no alterations in mitochondrial respiration or membrane potential following palmitate treatment, which does not support this hypothesis. Intracellular itaconate measurements and quantification are lacking and IRG1 expression is not assessed. There also appears to be more labelled itaconate in neuronal cultures from control (BSA) microglia conditioned media, which is not discussed. What is the total level of itaconate in neurons from these conditioned media experiments? No evidence is provided that the in vivo response is dependent on IRG1, the mitochondrial enzyme responsible for itaconate synthesis, or itaconate. To causally link IRG1/itaconate, IRG1-deficient mice could be used in future work.

      While microglial DRP1 is causally implicated the role of palmitate is not convincing. Mitochondrial morphology changes are subtle including TOMM20 and DRP1 staining and co-localization - additional supporting data should be provided. Electron microscopy of mitochondrial structure would provide more detailed insight to morphology changes. Western blot of fission-associated proteins Drp1, phospho-Drp1 (S616), MFF and MiD49/51. Higher magnification and quality confocal imaging of DRP1/TOMM20. Drp1 recruitment to mitochondrial membranes can be assessed using subcellular fractionation. No characterisation of primary microglia from DRP1-knockout mice is performed with palmitate treatment. Authors demonstrate an increase in both stearate and palmitate in CSF following 3-day HFD. Only palmitate was tested in the regulation of microglial responses, but it may be more informative to test stearate and palmitate combined.

    2. Reviewer #2 (Public Review):

      The study "A rapid microglial metabolic response controls metabolism and improves memory" by Drougard et al. provides evidence that short-term HFD has a beneficial effect on spatial and learning memory through microglial metabolic reprogramming. The manuscript is well-written and the statistics were properly performed with all the data. However, there are concerns regarding the interpretation of the data, particularly the gap between the in vivo observations and the in vitro mechanistic studies.

      In the PLX-5622 microglial depletion study, it is unclear what happened to the body weight, food intake, and day-night behavior of these mice compared to the vehicle control mice. It is important to address the innate immunity-dependent physiology affected by a long period of microglial depletion in the brain (also macrophages in the periphery). Furthermore, it would be beneficial to validate the images presented in Fig.1F by providing iba1 staining in chow diet-fed mice with or without PLX-5622 for 7-10 days. Additionally, high-quality images, with equal DAPI staining and comparable anatomical level, should be provided in both chow diet-fed mice and HFD-fed mice with or without PLX-5622 in the same region of hypothalamus or hippocampus. These are critical evidences for this project, and it is suggested that the authors provide more data on the general physiology of these mice, at least regarding body weight and food intake.

      It is also unclear whether the microglia shown in Fig.3A were isolated from mice 4 weeks after Tamoxifen injection. It is suggested that the authors provide more evidence, such as additional images or primary microglia culture, to demonstrate that the mitochondria had more fusion upon drp1 KO. It is recommended to use mito-tracker green/red to stain live microglia and provide good resolution images.

      Regarding the data presented in Fig.5A, it is suggested that the authors profile the metabolomics of the microglial conditioned media (and provide the methods on how this conditioned media was collected) to determine whether there was already abundant lactate in the media. Any glucose-derived metabolites, e.g. lactate, are probably more preferred by neurons as energy substrates than glucose, especially in embryonic neurons (which are ready to use lactate in newborn brain).<br /> Finally, it is important to address whether PLX-5622 affects learning and spatial memory in chow diet-fed animals. Following the findings shown in Fig 5J and 5K, the authors should confirm these by any morphological studies on synapse, e.g. by synaptophysin staining or ultrastructure EM study in the area shown in Fig 5I.

    3. Reviewer #3 (Public Review):

      Drougard et al. explore microglial detection of a switch to high-fat diet and a subsequent metabolic response that benefits memory. The findings are both surprising and novel in the context of acute high-fat intake, with convincing evidence of increased CSF palmitate after 3 days of HFD. While the authors demonstrate compelling signs of microglial activation in multiple brain regions and unique metabolite release in tracing studies, they should address the following areas prior to acceptance of this manuscript.

      Major Points:<br /> 1. It appears that the authors perform key metabolic assays in vitro/ex vivo using primary microglia from either neonatal or adult mice, which should be more clearly delineated especially for the 13C-palmitate tracing. In the case of experiments using primary microglia derived from mixed glial cultures stimulated with M-CSF, this system relies on neonatal mice. This is understandable given the greater potential yield from neonatal mice, but the metabolic state and energetic demands of neonatal and adult microglia differ as their functional roles change across the lifespan. The authors should either show that the metabolic pathways they implicate in neonatal microglia are also representative of adult microglia or perform additional experiments using microglia pooled from adult mice, especially because they link metabolites derived from neonatal microglia (presumably not under the effects of acute HFD) to improved performance in behavioral assays that utilize adult mice.

      2. The authors demonstrate that 3 days of HFD increases circulating palmitate by CSF metabolomics and that microglia can readily metabolize palmitate, but the causal link between palmitate metabolism specifically by microglia and improved performance in behavioral paradigms remains unclear. A previous body of research, alluded to by the authors, suggests that astrocyte shuttling of lactate to neurons improves long-term and spatial memory. The authors should account for palmitate that also could be derived from astrocyte secretion into CSF, and the relative contribution compared to microglia-derived palmitate. Specifically, although microglia can metabolize the palmitate in circulation, there is no direct evidence that the palmitate from the HFD is directly shuttled to microglia and not, for example, to astrocytes (which also express CX3CR1). Thus, the Barnes Maze results could be attributed to multiple cell types. Furthermore, the evidence provided in Figure 5J is insufficient to claim a microglia-dependent mechanism without showing data from mice on HFD with and without microglia depletion (analogous to the third and fourth bars in panel K).

      3. Given the emphasis on improved cognitive function, there is minimal discussion of the actual behavioral outcomes in both the results and discussion sections. The data that HFD-treated animals outperform controls should be presented in more detail both in the figure and in the text. For example, data from all days/trials of the Barnes Maze should be shown, including the day(s) HFD mice outperform controls. Furthermore, the authors should either cite additional literature or provide experimental evidence supporting the notion that microglia release of TCA-associated substrates into the extracellular milieu after HFD specifically benefits neuronal function cellularly or regionally in the brain, which could translate to improved performance in classical behavioral paradigms. The single reference included is a bit obscure, given the study found that increased lactate enhances fear memory which is a neural circuit not studied in the current manuscript. Are there no additional studies on more relevant metabolites (e.g., itaconate, succinate)?

      Minor Points:<br /> 1. In Figure 5J the latency to find the hole was noticeably higher (mean around 150s) than the latency in panel K (mean around 100s for controls, and 60s for Drp1MGWT on HFD). This suggests high variability between experiments using this modified version of the Barnes Maze, despite the authors' assertion that a "standard" Barnes Maze was employed and the results were reproducible at multiple institutions. Why do Drp1MGWT mice on control diet find the escape hole significantly faster than WT mice on control diet in panel J? Given the emphasis on cognitive improvement following acute HFD as a novel finding, the authors should explain this discrepancy.

      2. The authors highlight in the graphical abstract and again in Figure 4A the formation of lipid droplets following palmitate exposure as evidence of that microglia can process fatty acids. They later suggest that a lack of substantial induction of lipid droplet accumulation suggests that microglia are metabolically wired to release carbon substrates to neighboring cells. Clarification as to the role of lipid droplet formation/accumulation in explaining the results would eliminate any possible confusion.

      3. In many bar graphs showing relatively modest effects, it would be helpful to use symbols to also show the distribution of sample and animal replicates (especially behavioral paradigms).

    1. Reviewer #2 (Public Review):

      Breast cancer is the most common malignant tumor in women. One of subtypes in breast cancer is so called triple-negative breast cancer (TNBC), which represents the most difficult subtype to treat and cure in the clinic. Chemotherapy drugs including epirubicin and cisplatin are widely used for TNBC treatment. However, drug resistance remains as a challenge in the clinic. The authors uncovered a molecular pathway involved in chemotherapy drug resistance, and molecular players in this pathway represent as potential drug targets to overcome drug resistance. The experiments are well designed and the conclusions drawn mostly were supported by the data. The findings have potential to be translated into the clinic.

  2. May 2023
    1. Reviewer #1 (Public Review):

      In this manuscript by Douglas et al, the investigative team seeks to identify Staphylococcus aureus genes (and associated polymorphisms) that confer altered susceptibility to human serum, with the hypothesis that such genes might contribute to the propensity of a strain to cause bacteremia, invasive disease, and/or death. Using an innovative GWAS-like approach applied to a bank of over 300 well-characterized clinical S. aureus isolates, the authors discover SNPs in seven different staphylococcal genes that confer increased survival in the setting of serum exposure. The authors then mainly focus on one gene, tcaA, and illustrate a potential mechanism whereby modification of peptidoglycan structure and WTA display leads to altered susceptibility to serum, serum-derived antimicrobial compounds, and antibiotics. One particularly significant finding is that the identified tcaA SNP is significantly associated with patient mortality, in that patients infected with the SNP bearing isolate are less likely to die from infection. It is therefore hypothesized that this SNP represents an adaptive mutation that promotes serum survival while decreasing virulence and host mortality. In a murine model of infection, the strain bearing the WT allele of tcaA is significantly more virulent than the tcaA mutant, suggesting that the role of tcaA in bacteremia is infection-phase dependent.

      This manuscript has many strengths. The triangulation of genomic analysis, patient outcomes data, and in vitro and in vivo mechanistic testing adds to the significance of the findings in terms of human disease. Testing the impact of mutating tcaA in multiple staphylococcal lineages and backgrounds also increases the rigor of the study. The identification of bacterial loci that impact susceptibility to both host antimicrobial compounds and commonly used antibiotics is also a strength of this work, given the evolutionary and treatment implications for such genes.

      One moderate weakness is that the impact of the identified SNP in tcaA is only tested in some of the assays, whereas the majority of the testing is performed with a whole gene knockout. In some cases this results in more speculative conclusions that will require further testing to validate. All in all, this is an exciting manuscript that will be of interest to the broader research communities focused on staphylococcal pathogenesis, bacterial evolution, and host-pathogen interactions, as well as to clinicians who care for patients with invasive staphylococcal infection.

    2. Reviewer #2 (Public Review):

      The authors embarked on a study to identify SNPs in clinical isolates of S. aureus that influence sensitivity to serum killing. Through a phenotypic screen of 300 previously sequenced S. aureus bacteremia (SAB) isolates, they identified ~40 SNPs causing altered serum survival. The remainder of the study focuses of tcaA, a gene with unknown function. They show that when tcaA is disrupted, it results in increased resistance to glycopeptides and antimicrobial components of human serum.

      They perform an elegant series of experiments demonstrating how a tcaA knockout is more resistant to killing by whole serum. arachadonic acid, LL-37 and HNP-1. They provide compelling evidence that in the absence of tcaA resistance to arachidonic acid is mediated through release of wall teichoic acids from the cell wall, which acts as a decoy and sequesters the fatty acid.

      Similarly, they suggest that resistance to cationic antimicrobial peptides is through alteration of the net charge of the cell wall due to loss of negatively charged WTAs based on reduced cytochrome C binding.

      They continue to show that tcaA is induced in the presence of human serum, which causes increased resistance to the glycopeptide teichplanin.

      They propose that tcaA disruption causes altered cell wall structure based on morphologic changes on TEM and increased sensitivity to lysostaphin and increased autolysis via triton x-100 assay.

      Finally, they propose that tcaA influences mortality in SAB based on raw differences in 30-day morality. Interestingly they do decreased fitness during murine bacteremia model compared to wild-type.

      The strengths of this manuscript are that it is well written and the identification of SNPs leading to altered serum killing is convincing and valuable data. The mechanism for tcaA-mediated resistance to arachadonic acid and AMPs is compelling and novel. The murine infection data demonstrating that tcaA mutants exhibit reduced virulence is important data.

      The weakness of this manuscript mainly concerns the proposed mechanism that tcaA mutants show reduced peptidoglycan crosslinking. This conclusion is based on qualitative TEM images and increased sensitivity to lysostaphyin/autolysis. While these data are suggestive. it is difficult to draw such a conclusion without analysis of the cell wall by LC-MS.

      Overall, I think this is a good submission and the majority of their conclusions are supported by the data. The mechanism behind the clinically relevant tcaA mutation is important, given its known role in glycopeptide resistance and therefore likely clinical outcomes. This manuscript would benefit from the inclusion of some additional experiments to help support their finding.

    3. Reviewer #3 (Public Review):

      In this manuscript by Douglas et al., the authors used a functional genomics approach to understand how Staphylococcus aureus survives in the bloodstream to cause bacteraemia. They identified seven novel genes that affect serum survival. The study focused on tcaA, a gene associated with resistance to the antibiotic teicoplanin and is activated when exposed to serum and plays a role in producing a critical virulence factor called wall teichoic acids (WTA) in the cell envelope. This protein affects the bacteria's sensitivity to cell wall attacking agents, human defense fatty acids, and antibiotics, as well as autolytic activity and lysostaphin sensitivity. The data in this study suggested that TcaA play a role in the ligation or retention of WTA within the cell wall. However, more work is needed to clarify that part. Interestingly, despite making the bacteria more vulnerable to serum killing, tcaA contributes to S. aureus virulence by altering the cell wall architecture, as demonstrated by the wild type strain outcompeting the tcaA mutant in a Mouse Co-infection model. The study raises an important point that TcaA in S. aureus may represent a system balancing two scenarios: it makes the bacteria more susceptible to serum killing, potentially limiting bacteraemia and providing long-term benefits between hosts; however, once established in the bloodstream, the bacteria survive and thrive, causing successful bacteraemia, as per the short-sighted evolution of virulence hypothesis. This duality highlights the complex interplay between within-host and between-host fitness in bacterial evolution. I strongly suggest creating a graphical abstract to illustrate the complex relationship between within-host and between-host fitness scenarios involving TcaA. Having this visual representation in the discussion will enhance comprehension and provide a concise summary of the complex system for the reader.

      In this manuscript, the authors achieved their aims, and the results support their conclusions. This work will be important for understanding this complex system and for developing novel therapeutics and vaccines for S. aureus.

    1. Reviewer #1 (Public Review):

      Using an immobilised metal affinity chromatography (IMAC)-based assay coupled with Western blot immunodetection analysis, SbtB, the regulatory protein for SbtA activity, is shown in itself to be regulated by the local adenylate energy charge (AEC), with inhibitory binding of SbtB to SbtA disfavoured at high ATP:ADP ratios. Such conditions are expected to be encountered during steady-state photosynthesis with the associated cellular demand for Ci and SbtA activity.

      By homology with ATP-binding PII proteins, ATP is proposed to interact with a loop region of SbtB, changing its conformation on binding and inhibiting the formation of the (inactive) SbtA:SbtB complex. On the basis of this, the authors propose that SbtB acts an AEC-sensing 'curfew' protein for SbtA activity, tuning bicarbonate import by this protein for situations when carbon fixation would be physiologically (and energetically) advantageous. As SbtA is a HCO3-/Na+ symporter, Na+ homeostasis would also be controlled by regulation of this transporter.

      The IMAC assay used to monitor SbtA:SbtB complex stability as a function of AEC seems robust, is relatively straightforward and may be of interest to other researchers investigating adenylate-sensing protein reaction partners (with the usual caveats on extrapolating in vitro results to living systems, as noted by the authors).

      In this study, SbtA regulation was also investigated in vivo in a Synechococcus HCO3- transporter knockout mutant via measurement of labelled HCO3- uptake and overall photosynthetic performance (MIMS-monitored O2 evolution as a function of PAR). Here, SbtB was inferred to regulate SbtA activity during the induction of photosynthesis (i.e. at low ATP:ADP) and not when photosynthesis was fully activated and in a steady-state condition. SbtA inactivation on a light-dark transition was also demonstrated in vivo irrespective of the presence SbtB, indicative of additional regulatory pathways affecting the activity of this transporter. These conclusions seem to be well-supported by the presented data.

    2. Reviewer #2 (Public Review):

      Inorganic carbon (Ci) uptake by autotrophic organisms is often the rate-limiting process in overall photosynthetic productivity. Aquatic autotrophs including the cyanobacteria have evolved elaborate and metabolically expensive, yet very efficient CO2 concentrating mechanisms (CCMs) to over-come this limitation. The work examines the regulation of SbtA, which is a high affinity sodium dependent symporter. Current evidence suggests that this SbtA is highly regulated both at the transcriptional and post-transcriptional levels. For example, the sbtA gene is transcriptionally upregulated under conditions of inorganic carbon limitation and the transport activity of the expressed SbtA protein is apparently regulated allosterically by multiple factors, including those exerted by the binding of the small trimeric protein, SbtB. SbtB is a PII-type regulator that conditionally binds to the cytoplasmic face of the trimeric SbtA to form a hetero-complex apparently inactivating SbtA to which it is bound. The factors affecting this interaction remains to be clarified, but it is already clear that there is considerable complexity that needs to be unraveled since as with other PII proteins, multiple effector molecules act as ligands.

      Using a novel protein-protein interaction assay combined with physiological analysis of various mutants, the authors present new information on the regulation of SbtA from Cyanobium sp. PCC7001 and Synechococcus elongatus PCC7942. Because of their novelty, additional validation may be important to establish their validity, yet they do appear to be robust overall..The work builds on earlier studies indicating negative regulation of SbtA and helps clarify other work, including detailed analysis of the orthologous, albeit somewhat more complex protein from Synechocystis PCC6803. The key significance of the present findings is that the energy charge of the adenylate system, a ubiquitous metabolic control mechanism in the biological world, is the prime and perhaps overriding regulatory parameter governing of SbtA activity. Based on this a model for the diurnal control transporter activity was proposed based on energy charge.

    3. Reviewer #3 (Public Review):

      The regulation of transporters in many physiological systems is poorly known. Here, Forster and colleagues describe how activity of an inorganic carbon transporter, SbtA, in the bacterial carbon concentrating mechanism is regulated by the PII protein SbtB. Although there is now significant structural knowledge of the system and many potential SbtB-regulating small molecule effectors are known, Forster and colleagues clarify, how the adenylate charge in the cell, rather than any single metabolite, is the important regulatory effector. This is critical for the endogenous function, as the cyanobacterial host undergoes dramatic changes in adenylate charge over the course of a diurnal cycle and this result explains how the channel is regulated to efficiently function in CO2 assimilation. The manuscript is generally clear and the data generally supportive of the conclusions as written. However, there are several instances where additional clarification and/or experiments are needed to confirm the major findings of the paper.

    1. Reviewer #1 (Public Review):

      Here, Ensinck et al. investigated the composition of the yeast mRNA m6A methyltransferase complex required for meiosis. This complex was known to contain three proteins but is much more complex in mammals, insects, and plants. Through IP-MS analysis, they identified three more proteins Kar4, Ygl036w, and Dyn2. Of these, Kar4 and Ygl036w are homologous to Mettl14 and Virma, respectively, and, like the previously described factors, are essential for m6A deposition, mating, and binding of the reader Pho92 to mRNA during meiosis by evidence acquired with appropriate methodology. Dyn2 is a novel factor not described for any m6A complex and is not essential for m6A deposition, mating, and binding of the reader Pho92 to mRNA during meiosis.

      In addition, detailed analysis of the Slz1 revealed homology to the mammalian factor m6A complex member ZC3H13 to comprise a conserved complex of five proteins, Mettl3, Mettl14, Mum2/WTAP, Virma, and Slz/ZC3H13. When co-expressed in insect cells, they co-purify stoichiometrically, and the presence of Mum2 as a dimer is also indicated, as shown for WTAP.

      Complementary to these data, they show that the stability of the individual complex members is affected in mutants supporting that they are stabilized through complex formation.<br /> Furthermore, the authors then show that kar4 has additional roles in mating that are separable from its role through the m6A complex in meiosis.<br /> The authors employ appropriate methodology throughout to address their aims and present convincing evidence for their claims. The evidence presented here reinforces that the m6A complex is evolutionary and highly conserved, with a broad scope for its functional analysis in humans and model organisms.

    2. Reviewer #2 (Public Review):

      N6-methyladenosine (m6A), the most abundant mRNA modification, is deposited by the m6A methyltransferase complexes (MTC). While MTC in mammals/flies/plants consists of at least six subunits, yeast MTC was known to contain only three proteins. Ensinck, Maman, et al. revisited this question using a proteomic approach and uncovered three new yeast MTC components, Kar4/Ygl036w/Dyn2. By applying sequence and structure comparisons, they identified Kar4, Ygl036w, and Slz1 as homologs of the mammalian METTL14, VIRMA. ZC3H13, respectively. While these proteins are essential for m6A deposition, the dynein light chain protein, Dyn2, is not involved in mRNA methylation. Interestingly, while mammalian and fly MTCs are configured as MAC (METTL3 and METTL14), and MACOM (other subunits) complexes, yeast MTC subunits appear to have different configurations. Finally, Kar4 has a different role as a transcription regulator in mating, which is not mediated by other MTC members. These data establish an important framework for the yeast MTC and also provide novel insights for those studying m6A deposition.

    1. Reviewer #1 (Public Review):

      The current study was designed to test the hypothesis that neural circuit plasticity during adolescence can be targeted to restore cortical function under conditions of developmental disruptions that are relevant to psychiatric disorders. Specifically, the authors targeted the mesofrontal cortical dopamine system in 2 genetic mouse models of schizophrenia and performed optical recordings in combination with behavior and chemogenetic manipulations. Major findings and strengths include that stimulation of frontal dopaminergic projections in a limited adolescent time window can stably reverse defects in cortical neuronal activity and cognitive control in adulthood in 2 genetic mouse models of psychiatric disorders. While the precise postsynaptic mechanisms underlying the positive impact of adolescent mesofrontal dopamine stimulation were not address, another strength of this study is that the authors performed key manipulations using age and dose/intensity as dependent variables to show that the level of neural circuit activation during adolescence follows an inverted U-shape pattern. Collectively, this is a well-design study with many strengths and novel findings that are likely to positively impact a widespread of disciplines within the biological psychiatry and neuroscience field.

    2. Reviewer #2 (Public Review):

      The manuscript by Mastwal and colleagues explores how transient adolescent stimulation of ventral midbrain neurons that project to the frontal cortex may help to improve performance on certain memory tasks. The manuscript provides an interesting set of observations that DREADD-based activation over only 3 days during adolescence provides a fast-acting and long-lasting improvement in performance on Y-maze spontaneous alternation as well as aspects of neuronal function as assessed using in vivo imaging methods. While interesting, there are several weaknesses. First and foremost, it is not clear that the effects the authors are observing are mediated by dopamine. It has been clearly documented that the DAT-Cre line provides a better representation of midbrain dopamine cells in the mouse, particularly near the midline of the ventral midbrain (Lammel et al., Neuron 2015). This is precisely where the cells that project to the frontal cortex are located. Therefore, the selection of TH-Cre is problematic. It is very likely that the authors are labeling a substantial number of non-dopaminergic cells.

    3. Reviewer #3 (Public Review):

      In this manuscript, the authors use behavior, calcium imaging, and circuit modulation (DREADDs etc) to assess dopamine regulation of prefrontal cortical circuits in the mouse. The authors have previously established that activation of dopamine inputs to prefrontal cortex during adolescence can drive increases in mPFC DA bouton number and enhanced mPFC activity in WT mice. Here the authors use two mouse models - one with a reporter replacing the Arc gene, and another with knockout of the schizophrenia-associated gene Disc1, both of which are thought to have reduced prefrontal cortical activity. First they trained mice on a Y-maze and showed impaired performance in the Arc knockout. Then they demonstrated selective disruption of neuronal firing with calcium imaging at the time of the decision in the task. The Arc mice were found to have reduced dopamine bouton density, and adolescent activation of the DA neurons corrected this as well as the PFC firing and the behavior. Similar data were shown in the Disc1 KO. The data are well controlled and the authors use a number of leading edge methods.

    1. Reviewer #1 (Public Review):

      The authors aimed to contrast the effects of pharmacologically enhanced catecholamine and acetylcholine levels versus the effects of voluntary spatial attention on decision making in a standard spatial cueing paradigm. Meticulously reported, the authors show that atomoxetine, a norepinephrine reuptake inhibitor, and cue validity both enhance model-based evidence accumulation rate, but have several distinct effects on EEG signatures of pre-stimulus cortical excitability, evoked sensory EEG potentials and perceptual evidence accumulation. The results are based on a reasonable sample size (N=28) and state-of-the art modeling and EEG methods.

      Although the authors draw a few partial conclusions that are not fully supported by the data (see below), I think that the authors' EEG findings provide sufficient support for the overall conclusion that "selective attention and neuromodulatory systems shape perception largely independently and in qualitatively different ways". This is an important conclusion because neuromodulatory systems and selective spatial attention are both known to regulate the neural gain of task-relevant single neurons and neural networks. Apparently, these effects on neural gain affect decision making in dissociable ways.

      The effects of donepezil, a cholinesterase inhibitor, were generally less strong than those of atomoxetine, and in various analyses went in the opposite direction. The authors fairly conclude that more work is necessary to determine the effects of cholinergic neuromodulation on perceptual decision making.

      1) I believe that the following partial conclusions are not fully supported by the data:

      a) In the results section on page 6, the authors conclude that "Attention and ATX both enhanced the rate of evidence accumulation towards a decision threshold, whereas cholinergic effects were negligible." I believe "negligible" is wrong here: the corresponding effects of donepezil had p-values of .09 (effect of donepezil on drift rate), .07 (effect of donepezil on the cue validity effect on drift rate) and .09 (effect of donepezil on non-decision time), and were all in the same direction as the effects of atomoxetine, and would presumably have been significant with a somewhat larger sample size. I would say the effects of donepezil were "in the same direction but less robust" (or at the very least "less robust") instead of "negligible".

      b) "In the results section on page 8, the authors conclude that "Summarizing, we show that drug condition and cue validity both affect the CPP, but they do so by affecting different features of this component (i.e. peak amplitude and slope, respectively)."<br /> This conclusion is a bit problematic for two reasons. First, drug condition had a significant effect not only on peak amplitude but also on slope. Second, cue validity had a significant effect not only on slope but also on peak amplitude. It may well be that some effects were more significant than others, but I think this does not warrant the authors' conclusion.

      c) In the discussion section on page 11, the authors conclude that "First, although both attention and catecholaminergic enhancement affected centro-parietal decision signals in the EEG related to evidence accumulation (O'Connell et al., 2012; Twomey et al., 2015), attention mainly affected the build-up rate (slope) whereas ATX increased the amplitude of the CPP component (Figure 3D-F)."<br /> As I wrote above, I believe it is not correct that "attention mainly affected the build-up rate or slope", given that the effect of cue-validity on CPP slope was also significant. Also, while the authors' data do support the conclusion that ATX increased the amplitude and not the slope of the CPP component, a previous study in humans found the opposite: ATX increased the slope but did not affect the peak amplitude of the CPP (Loughnane et al 2019, JoCN, https://pubmed.ncbi.nlm.nih.gov/30883291/). Although the authors cite this study (as from 2018 instead of 2019), they do not draw attention to this important discrepancy between the two studies. I encourage the authors to dedicate some discussion to these conflicting findings.

      2) On page 12 and page 14 the authors suggest a selective effect of ATX on *tonic* catecholamine activity, but to my knowledge the exact effects of ATX on phasic vs. tonic catecholamine activity are unknown. Although microdialysis studies have shown that a single dose of atomoxetine increases catecholamine concentrations in rodents, it is unknown whether this reflects an increase in tonic and/or phasic activity, due to the limited temporal resolution of microanalysis. Thus, atomoxetine may affect tonic and/or phasic catecholamine activity, and which of these two effects dominates is still unknown, I think.

    2. Reviewer #2 (Public Review):

      The authors attempt to show distinct contributions of selective attention and neuromodulators (both cholinergic and catecholaminergic) during a spatial attention task. To do this, they had participants perform a Posner cueing task using random dot motion stimuli, with a typical 80/20 split of valid to invalidly cued trials. In addition, they designed a within-subjects paradigm wherein participants took placebo (PLA), Donepezil (DNP), or Atomoxetine (ATX). Both behaviour and EEG measures were taken in order to investigate the interaction or lack thereof of Drug and Cue factors with respect to these measures, and relative timing of EEG differences to derive potential neuromechanistic similarities/differences. In this context, an interaction of Drug and Cue factors (e.g. faster valid vs invalid RTs in ATX vs PLA) might indicate a role of that neuromodulator in the mechanisms of spatial attention. This is in fact not what they found, rather most findings pointed towards a lack of interaction of Drug and Cue, hence the central thesis of the paper of distinct contributions of neuromodulator and selective attention.

      Strengths:<br /> - The experimental design is well done, especially the blinding of the drug taken in each session. However, it is an important caveat to any results that participants were obviously aware they had taken an active drug in ATX condition (Supp Info).<br /> - The analyses are in general quite solidly performed, with most analysis choices relating to behaviour and EEG making sense, albeit with exceptions below.<br /> - The research question and how it relates to the experiment is very interesting, and the question worthy of consideration.

      Weaknesses:<br /> - The main weakness of the paper lies in the strength of evidence provided, and how the results tally with each other. To begin with, there are a lot of significance tests performed here, increasing the chances of false positives. Multiple comparison testing is only performed across time in the EEG results, and not across post-hoc comparisons throughout the paper. In and of itself, it does not invalidate any result per se, but it does colour the interpretation of any results of weak significance, of which there are quite a few. For example, the effect of Drug on d' and subsequent post-hoc comparisons, also effect of ATX on CPP amplitude and others.<br /> - The lack of an overall RT effect of Drug leaves any DDM result a little underwhelming. How do these results tally? One potential avenue for lack of RT effect in ATX condition is increased drift rate but also increased non-decision time, working against each other. However, it may be difficult to validate these results theoretically.<br /> - There is an interaction between ATX and Cue in terms of drift rate, this goes against the main thesis of the paper of distinct and non-interacting contributions of neuromodulators and attention. This finding is then ignored. There is also a greater EDAN later for ATX compared to PLA later in the results, which would also indicate interaction of neuromodulators and attention but this is also somewhat ignored.<br /> - The CPP results are somewhat unclear. Although there is an effect of ATX on drift rate algorithmically, there is no effect of ATX on CPP slope. On the other hand, even though there is no effect of DNP on drift rate, there is an effect of DNP on CPP slope. Perhaps one may say that the effect of DNP on drift rate trended towards significance, but overall the combination of effects here is a little unconvincing. In addition, there is an effect of ATX on CPP amplitude, but how does this tally with behaviour? Would you expect greater CPP amplitude to lead to faster or slower RTs? The authors do recognise this discrepancy in the Discussion, but discount it by saying the relationship between algorithmic and CPP parameters in terms of DDM is unclear, which undermines the reasoning behind the CPP analyses (and especially the one correlating CPP slope with DDM drift rate).<br /> - The posterior component effects are problematic. The main issue is the lack of clarification of and justification for the choice of posterior component. The analysis is introduced in the context of the target selection signal the N2pc/N2c, but the component which follows is defined relative to Cue, albeit post-target. Thus this analysis tells us the effect of Cue on early posterior (possibly) visual ERP components, but it is not related to target selection as it is pooled across target/distractor. Even if we ignore this, the results themselves wrt Drug lack context. There is a trending lower amplitude for ATX at later latencies at temporo-parietal electrodes, and more positive for DNP, relative to PLA. Is this what one would expect given behaviour? This is where the issue of correct component identification becomes critical in order to inform any priors on expected ERP results given behaviour.

      Given the issues above; mainly a) weak statistical evidence, b) contradictory behavioural and EEG evidence, and c) lack of theoretical background to inform priors on what to expect from the EEG results in order to develop a coherent narrative, I would say that what remains is moderate/incomplete evidence towards the thesis of the paper. This work is however a very fruitful effort at approaching the research question as to whether there is an interaction of neuromodulators and spatial attention. I commend the authors on a transparent and rigorous analysis of the current data.

    1. Reviewer #2 (Public Review):

      In this study, the authors explore the structure/function of the DCLK kinases, most specifically DCLK1 as it is the most studied to date. Recently, the C-terminal domain has garnered attention as it was found to regulate the kinase domain, however, the different isoforms retain additional amino acid sequences with as-yet-undefined functions. The authors provide an evolutionary and biochemical characterization of these regions and provide evidence for some functionality for these additional C-terminal sequences. While these experiments are informative they do require that the protein is soluble and not membrane-bound as has been suggested to be important for functionality in other studies. Still, this is a major contribution to understanding the structure/function of these proteins that will be important in future experimental designs.

    1. Reviewer #1 (Public Review):

      Ruby et al. have investigated patterns of age-specific mortality in the exceptionally long-lived naked mole-rat (NMR), under captive conditions. The authors first visited this topic five years previously with an unprecedently large data set and concluded that naked mole-rats are 'non-aging': because analyses of their survival did not detect an increasing mortality hazard with age. This result has obvious applied interest in humans because of its implications for maintaining health into later life. One criticism directed at this previous work was that a limited number 'old-aged' individuals in their data set (individuals in what might be expected to be the latter half of the life course) reduced the power with which to detect an age-related increase in mortality - or to convincingly demonstrate its absence. The current study revisits this topic with a larger sample across the life course. The authors also provide additional analyses that explore various predictors of mortality, including breeding status, body weight and colony size, and now also make direct comparisons to mortality patterns in other species of African mole-rat from the Fukomys clade (which share many convergent social and life history features). I found the analyses of Fukomys mortality particularly illuminating. However, while these additional analyses provide some useful context and can generate interesting discussion points about ageing patterns in an extremely unusual species, the principal issue at hand whether the absence of Gompertzian mortality in NMR is a robust pattern.

      In this respect, a major limitation of the current study is that only 11% of the animals (n = 755) had died at the point of its conclusion- the remaining 89% being right-censored (n = 6138). This means that, as in the previous analysis, there are still relatively small numbers of individuals that have died in the older age classes (see Fig 1 for the high level of right-censoring between 15-20 years and the low numbers of deaths after this point, also Supp 1 for the raw data): the part of the life course where one would predict mortality rates to increase from an evolutionary perspective. Thus, while the authors claim very generally that the "demographic data has doubled", this in no way reflects whether the new data is informative to the question at hand, which relies on an ability to estimate death rates in older individuals accurately. If one looks more closely at the numbers which do matter, then one can see that the number of deaths in the data set has shifted from 447 in the former treatment (Ruby et al. 2018) to 755 currently, but that the number of later-stage deaths remains somewhat modest (and that this is probably reflected in the large confidence intervals for the mortality hazards at this time). I therefore remain unconvinced that the current study can rule out an exponential increase in hazard in older individuals.

      The authors have also not provided any statistical evidence that the mortality hazard changes with age (or not), instead relying on visual comparisons of aggregated data. This is a fundamental problem and demands a more thorough treatment that compares survival models with different shape profiles. If anything, it seems that the hazard rate is declining with age - see Figures 1B & 2C, and while this may strengthen the authors argument if supported statistically, I would still wonder whether the higher mortality in early life - say 6 months to 3 years of age - is a consequence of the costs of early life development and that this is not a useful baseline against which to compare 'adult' mortality. It would also not overcome the data limitations identified above.

      An additional concern is that the paper is selective in its presentation of previous work, with the authors focussing on results which support their main interpretations and glossing over those that don't. For example, the study refers to the fact that NMRs are resistant to various age-related diseases and do not show many age-related declines in physiology. Yet, while this argument of negligible senescence might hold generally, the literature contains various reports of later life declines in NMR physiology (Andziak et al. 2006; Edrey et al., 2011). Referring to work from your own group, Braude et al. (2021) write "several typical mammalian age-related lesions of muscles, bone, heart, liver, and eye, including sarcopenia, osteoarthritis, a decline in articular cartilage thickness of the condyles, lipofuscin accumulation in several organs, eye cataracts, and kidney fibrosis have been described in naked mole-rats older than 26 years (Edrey et al., 2011)". A more balanced treatment of physiology in extremely old individuals would prove constructive.

      Another way in which the study fails to fully represent the literature is with respect to the divergence in ageing rates between breeders and non-breeders. This pattern has proved seductive for various mole-rat researchers because of its similarities to social insects and the suggestion that it is reproduction itself which delays ageing. While this is a clear possibility with some empirical support, it is important to also consider the question from the other way: which is to ask why non-breeders die at higher rates than breeders. For other cooperative breeders such as meerkats, the answer is clear: dominant, breeding individuals evict subordinates and once evicted from the group, the chances that these individuals will survive plummets (e.g. Cram et al. 2028). Is it possible that a similar form of dominance control might contribute the shorter life span of non-breeders in captivity? You reference Toor et al. (2020) elsewhere and this is relevant here again.<br /> Captivity also prevents non-breeders from dispersing when they would otherwise ordinarily do so (Braude 2000): is it possible that this also affects their mortality in captivity? Perhaps not being able to disperse induces chronic stress (see for example the discussion in Novikov et al. 2015). The idea that breeders show a lower intrinsic rate of aging is attractive, but many factors could contribute to this and alternatives should be considered unless they can be strongly refuted.

      Lastly, it would be very beneficial to have more information on how individuals become breeders in the captive population/s. For the purposes of the analyses, individuals have been categorised as a breeder or a non-breeder based on whether they bred or not at some point in their life (i.e., they are a "breeder" for their whole life for the purposes of the Kaplan Meier curves and the estimation of mortality hazards). I think it is therefore important to rule out the possibility that only high-quality individuals become breeders and that this is what drives the contrast in breeder and non-breeder mortality. In short, is it the case that most breeders are created through the random pairing of a male and a female? Or do new breeders inherit the position once the old queen dies? The latter could lead to breeders being of generally higher quality, which might affect their mortality hazard independently of status.

      Overall, I think that the authors can confidently conclude that any onset of actuarial senescence is heavily delayed in naked mole-rats, but the main conclusion that naked mole-rats "defy Gompertzian mortality" is based on inadequate evidence. It seems very possible that the inability to detect an increasing mortality hazard in such a long-lived species arises from data limitations. The central finding of the study should therefore be viewed very critically.

      Refs:<br /> Anziak et al. (2006) Aging Cell 5:463-471.<br /> Braude et al. (2021) Biological Reviews 96: 376-293.<br /> Cram et al. (2018) Current Biology 28: 1-6.<br /> Edrey et al. (2011) ILAR Journal 52:41-53.<br /> Novikov et al. (2015) Biogerontology 16: 723-732.<br /> Toor et al. (2020) Animal Behaviour 168: 45-58.

    2. Reviewer #2 (Public Review):

      Ruby et al. investigated whether demographic aging was absent in the naked-mole rat (Heterocephalus glaber); an exceptionally long-lived small mammal that appears to challenge Gompertzian patterns of increased mortality hazard with age. In particular, this study replicates a previous one in which the authors show that the mortality hazard does not increase with age as it is expected for mammals, especially small ones. The main motivation of this replication is to address the current controversy surrounding the "perpetual neoteny" reported by the authors. The study also extends to the exploration of the role of social factors on the observed patterns in mortality hazard across age and to a meta-analysis comparing mortality hazards across species of mole-rats which highlights the unique pattern of demographic aging (or the absence of) in naked mole-rats. This study is of broad interest to readers in the field of demography, aging, and life history evolution. The key claims of the manuscript state that naked-mole rats avoid an increase in mortality hazard as they age. Although this work raises new evolutionary questions concerning the unexpected gradual (or fully absent) increase versus Gompertzian increase in hazard among mammals, I also identified weaknesses that I discuss below.

      Strengths:<br /> Sample sizes - The sample sizes across analyses are vast and the data curation described demonstrates careful thought during the data analysis processes.

      Social factors - The analysis testing associations between body mass (as proxy for dominance) and colony size (as proxy for social competition) are novel and provide insights into potential evolutionary drivers for the observed lack of increase in mortality hazard.

      Across species comparison - The analysis using Fukomys mole-rats offered a novel phylogenetic comparison of the mortality hazard across age and raises new evolutionary questions concerning the unexpected gradual versus Gompertzian increase in hazard. This study encourages new ones exploring alternative life histories among mammals.

      Weaknesses:<br /> Censored data - A significant number of individuals remained alive (~50%) at the end of the study, and thus I wonder how much can the authors say about increased hazard if the individuals have not reach old ages. Maybe the individuals do live long and show increased hazard are very old ages.

      Independence between studies - The study provides the replication of a prior study using the same captive population, but I understand that many observations are not independent across studies given repeated measurements. Although this provides reliability, I wonder how independent the conclusions are. This represents a weakness to me because we still do not know whether this is a unique evolutionary trait of this particular captive population. If this is the case, I agree this makes the population a great model for aging studies but do the authors findings have further implications across populations or species? I wonder if populations raised under different conditions would present similar patterns of mortality hazard across age.

      Analysis - Another weakness concerns the analysis used. Authors make the claims that social hierarchy may affect mortality hazards and decide to explore associations between body mass and hazard. I wonder if a Cox regression model is more appropriate for the available continuous data, relative to a Kaplan-Meir method. A Cox regression will allow the authors to control for several continuous variables simultaneously, without the limitation of categorical assumptions. A Cox model could also be extended to time-varying covariates allowing for the hazard to change over time (if that is the case). If the authors understand that their approach is equivalent, I suggest a discussion on it. This also applies to the analysis on colony size.

      In summary, I see value in this study. There is vast evidence for the penalty of becoming old among mammals. Thus, studies like this one reporting novel patterns are of high impact. I agree that such findings must be replicated and validated. I also see a lot of potential for the use of the available data for more extensive meta-analyses comparing life histories across social mammals or across species with similar use of habitat (underground). Such analyses may allow the authors to move beyond descriptions and discuss why such life history traits may have evolved. Yet, I am not sure how much novelty this study brings, relative to prior studies. It seems the authors may need more than 5 years to allow their individuals to reach older ages.

    3. Reviewer #3 (Public Review):

      As a follow up from a manuscript previously published (Ruby et al. 2018), the authors use basic survival analysis methods to estimate hazard rates on an extended dataset of naked mole rats. They conclude that naked mole rats do not show the common exponential increase in mortality that has been typified in most mammals.

      In fact, this species has attracted great interest due to their extreme longevity, and the physiological mechanisms that have been associated with slower aging. As the authors show, this species shows unprecedented longevity, particularly considering their body size and phylogenetic location.

      However, the data available and the methods used cannot support the conclusion of an absence of increase in mortality for adults. As the authors show, the survivorship curves, calculated using Kaplan-Meier estimators, do not reach below values of 0.5. In short, nothing can be said about hazard rates after the age of median life expectancy. What the authors show is that, up to a certain age (when at least 50% of the individuals are still alive), the hazard rate is relatively constant. Beyond that age, the authors cannot draw any conclusions.

      In addition, here is a summary of the methodological limitations I could find based on their limited description: 1) their survivorships do not go below 0.5 and thus cannot make any statements about actuarial senescence; 2) ignoring this last, to test whether the hazards follow a Gompertz mortality it would be more appropriate to use maximum likelihood and test alternative models (e.g., exponential, Siler), and not visually as they show in fig 1; 3) they seem to be confusing left-censoring with left-truncation; 4) given the left-truncation, they should be using product limit estimators and not Kaplan-Meier estimators (which they might, but it's not possible to know based on the limited description of the methods); 5) their treatment of the effects of colony size, breeding status, and body weight should be at least by means of a proportional hazards, not a simple visual inspection on arbitrary age intervals.

      In light of these limitations, I would rank the significance of the study as not more than useful, and the strength of evidence inadequate. Still, and as I've stated above, this species is of great interest for ageing research, and the extensive work that the authors have done maintaining this captive colony is to be commended.

    1. Reviewer #3 (Public Review):

      Fission yeast is an important model organism and studies on fission yeast have provided many key insights into the understanding of genes and biological pathways. However, even in such a well-studied model organism, there are still many genes without known functions.

      In this work, the authors took advantage of the availability of genome-wide fission yeast deletion mutants to systematically analyze the mutant phenotypes under 131 different conditions. This effort generated a genotype-phenotype dataset larger than the currently curated genotype-phenotype dataset, which is derived from studies over many decades by hundreds of fission yeast laboratories. The authors used the dataset to construct gene clusters that provide functional clues for many genes without previously known functions, including ones conserved in humans. This rich resource will surely be highly useful to the fission yeast community and beyond.

      In addition, the authors also used machine learning to generate functional predictions of fission yeast genes and yield novel understandings, which are validated by experimental analysis of new ageing-related genes.

      Overall, this study provides unprecedented and highly valuable resources for understanding fission yeast gene functions.

    2. Reviewer #1 (Public Review):

      In this manuscript, the authors aimed to provide information about the likely function of uncharacterised genes in fission yeast. The authors highlight the bias in the literature to well-studied genes/proteins and the fact that the functions of many proteins that are conserved from yeast to humans remain unknown. Initial functional characterisation could provide the impetus for researchers to dedicate time and resources to detailed investigations of protein function. The authors subject the fission yeast deletion set to a battery of perturbations (drug treatments etc) and measured the resultant colony size. In total, 131 conditions were analysed for nearly 3,500 mutants, representing a rich dataset. Clustering analysis was then used to identify common phenotype patterns and thereby infer protein functions using a "guilt by association approach. To assign potential GO terms to uncharacterised proteins, the authors developed a new computational approach (NET-FF) which combined two previous approaches, which they validated against curated annotations on the S. pombe database Pombase. Finally, the authors chose a group of genes which their analysis predicted to be involved in cellular ageing for experimental validation, cross-validating a priority unstudied novel gene (SPAC23C4.09c) to be involved in this process. Overall, the functional analysis performed in this manuscript is rigorous, thorough and incorporates some novel approaches leading to new insights and predicted protein functions. It will be an important resource for the fission yeast community.

    3. Reviewer #2 (Public Review):

      This manuscript describes colony-growth phenotypes to measure the fitness of deletion mutants for 3509 non-essential S. pombe genes in 131 conditions. 3492 mutants, including 124 mutants of 'priority unstudied' proteins conserved in humans, providing varied functional clues.

      Phenotype-correlation networks provide evidence for the roles of poorly characterized proteins through guilt by association with known proteins. Gene Ontology (GO) terms were predicted using machine learning methods that take advantage of protein-network and protein-homology data.

      Integrated analyses produced 1,675 novel GO predictions for 783 genes, including 47 predictions for 23 priority unstudied proteins. Experimental validation for genes involved in cellular ageing were obtained.

      A method called NET-FF, which combines network embeddings and protein homology data to predict GO annotations, was developed. The authors demonstrate NET-FF predicts GO terms better than random and compare the information content of the predicted terms with the PomBase GO annotations. The phenotypic data was used to filter the GO annotation predictions made by NET-FF and then explore specific biological examples supported by both datasets

      This is a very impressive and rich resource of phenotypic data and it will be particularly useful for the S. pombe research community and generally useful for the functional characterization of highly conserved eukaryotic genes. Overall, the analysis is powerful and sound.

    1. Reviewer #2 (Public Review):

      This paper is an attempt to extend or augment muscle synergy and motor primitive ideas with task measures. The authors idea is to use information metrics (mutual information, co-information) in 'synergy' creation including task information directly. My reading of the paper is that the framework proposed radically moves from attempts to be analytic in terms of physiology and compositionality with physiological bases, instead into more descriptive ML frameworks that may not support physiological work easily.

      This approach is very different from the notions of physiological compositional elements as muscle synergies and motor primitives, and to me seems to really be striving to identify task relevant coordinative couplings. This is a meta problem for more classical analyses. Classical analyses seek compositional elements stable across tasks. These elements may then be explored in causal experiments and generative simulations of coupling and control strategies. The present work does not convince me that the joint 'meta' analysis proposed with task information added is not unmoored from physiology and causal modeling in some important ways. It also neglects publications and methods that might be inconvenient to the new framework.

      Information based separation has been used in muscle synergy analyses using infomax ICA, which is information not variance based at core. Though linear mixing of sources is assumed, minimized mutual information is the basis.

      Physiological causal testing of synergy ideas is neglected in the literature reviews in the paper. Although these are in animal work, the clear connection of muscle synergy choices and analyses to physiology is important, and needs to be managed in the new methods proposed. Is any correspondence assumed? Possible?

      Questions and concerns with the framework as an overall tool:

      First, muscle based motor information sources have influences on different time scales in the task mechanics. Analyses of synergies in the methods proposed will be very much dependent on the number and quality of task variables included and how these are managed. Standardizing and comparing among labs, tasks sets and instrumentation differences is not well enough considered as a problem in this new proposed method toolset, at least in my reading. Will replication, and testing across groups ever be truly feasible in this framework? Muscle based motor information sources have influences on different time scales in the task mechanics. Kinematic analyses, dynamic analyses and force plate analyses of the same task may provide task variables that alter the results in the proposed framework it seems.

      Second, there is a sampling problem in all synergy analyses. We cannot record all muscles or all task parameters. Examining synergies across multiple tasks seeks 'stationary' compositionality. Including task specific elements may or may not reinforce or give increased coordinative precision to the stationary compositionality.<br /> To me the new methods proposed seem partly orthogonal to the ideas of stable compositionality. The 'synergies' obtained will likely differ, and are more likely to be coordinative control groupings of recurrent task and muscle motifs (based on instrumentation) which may or may not relate to core compositionality in physiology. Is there any expectation that the framework should relate to core compositionality and physiology. This is not clear in the paper as written.

      It would be useful to explore the approach with a range of neuromechanical models and controllers and simulated data to explore the issues I am raising and convince readers that this analysis framework adds clarity rather than dissolving the generalizability and interpretability of analyses in terms of underlying causal mechanisms.

      The authors need to better frame their work in relation to causal analyses if they are claiming links to muscle synergies analyses and claim extension/refinement. Alternatively, these may not be linked, and instead parallel approaches exploring different hypotheses and goals using different organizational data descriptors.<br /> To me this appears a data science tool that may not help any reductionist efforts and leads into less interpretable descriptions of motor control. Not invalid, but sufficiently different that common term use muddies the water.

    2. Reviewer #1 (Public Review):

      The proposed study provides an innovative framework for the identification of muscle synergies taking into account their task relevance. State-of-the-art techniques for extracting muscle interactions use unsupervised machine-learning algorithms applied to the envelopes of the electromyographic signals without taking into account the information related to the task being performed. In this work, the authors suggest including the task parameters in extracting muscle synergies using a network information framework previously proposed. This allows the identification of muscle interactions that are relevant, irrelevant, or redundant to the parameters of the task executed.

      The proposed framework is a powerful tool to understand and identify muscle interactions for specific task parameters and it may be used to improve man-machine interfaces for the control of prostheses and robotic exoskeletons.

      With respect to the network information framework recently published, this work added an important part to estimate the relevance of specific muscle interactions to the parameters of the task executed. However, the authors should better explain what is the added value of this contribution with respect to the previous one, also in terms of computational methods.

      In general, the method proposed relies on several hyperparameters and cost functions that have been optimized for the specific datasets. A sensitivity analysis should be performed, varying these parameters and reporting the performance of the framework.

      It is not clear how the well-known phenomenon of cross-talk during the recording of electromyographic muscle activity may affect the performance of the proposed technique and how it may bias the overall outcomes of the framework.

    3. Reviewer #3 (Public Review):

      In this study, the authors developed and tested a novel framework for extracting muscle synergies. The approach aims at removing some limitations and constrains typical of previous approaches used in the field. In particular, the authors propose a mathematical formulation that removes constrains of linearity and couple the synergies to their motor outcome, supporting the concept of functional synergies and distinguishing the task-related performance related to each synergy. While some concepts behind this work were already introduced in recent work in the field, the methodology provided here encapsulates all these features in an original formulation providing a step forward with respect to the currently available algorithms. The authors also successfully demonstrated the applicability of their method to previously available datasets of multi-joint movements.

      Preliminary results positively support the scientific soundness of the presented approach and its potential. The added values of the method should be documented more in future work to understand how the presented formulation relates to previous approaches and what novel insights can be achieved in practical scenarios and confirm/exploit the potential of the theoretical findings.

      Strengths:

      This work proposes a novel framework that addresses physiologically non-verified hypothesis of standard muscle synergy methods: it removes restrictive model assumptions (e.g. linearity, same mixing coefficients) and the reliance on variance-accounted-for (VAF) metrics.

      The method is solid and achieves the prescribed objectives at a computational level and in preliminary laboratory data.

      A toolbox is available for testing the methods on a larger scale.

      The paper is well written and shows a high level of innovation, original content and analysis

      Weaknesses:

      Task performance variables could be specified in more quantitative definition in future work (e.g.: articular angles rather than a generic starting point- end point).

      The paper does not show a comparison with previous approaches (e.g.: NMF) or recently developed approaches (such as MMF).

      A discussion of the likely impact of the work on the field, and the utility of the methods and data to the community.

      In this work, the effort of the authors aimed at developing the field is clear. It is fundamental to develop novel frameworks for synergy extraction and use them to make them more interpretable and applicable to real scenarios, as well as more adherent to recent findings achieved in motor control and neuroscience that are not reflected in the standard models. At the same time, muscle synergies are being used more and more in research but their impact in practical scenarios is still limited, probably because synergies have rarely been analyzed in a functional context. This paper shows a very in-depth analysis and a novel framework to interpret data that links to the task space from a functional perspective. I also found that the results on the datasets are very well commented but could expand more to show why using this framework is advantageous.

      There are some key points for discussion that follow from this paper which can be described more, maybe in future work, and that might contribute to major developments in the field, including:

      The understanding of how the separation between relevant (redundant and synergistic) and irrelevant synergies impact on synergy analysis in practical works;

      Interpreting how different synergistic organizations described in this work allows to better describe data from real scenarios (e.g.: motor recovery of patients after neurological diseases);

      Discussing in detail how the presented findings compare with standard algorithms such as NMF to determine the added value provided with this approach;

      Describe how redundant synergies reflect real neural organization and - if their "existence" is confirmed - how they contribute to redesign the concept of muscle synergies and of modular/synergistic control in general.

    1. Reviewer #1 (Public Review):

      This is a well-written manuscript, aiming to seek experimental evidence to establish anatomical and functional connectivity between the cerebellum and the nucleus accumbens (NAc). The authors combined anatomical, neural tracing, and electrophysiological approaches with electrical stimulation and optogenetics and provided a novel and solid set of data supporting the existence of disynaptic connections between the cerebellum and the NAc. The results are convincing and the main conclusion is supported by the data. Overall, this was a well-conceived project, and the experiments were conducted carefully, though some gaps remain to be filled. The knowledge generated from this manuscript will build a foundation for further research focusing on the interaction between cerebellum and limbic system as well as the role of such interaction in controlling motivated behavior.

      Overall, this is a well-conceived project. The experiments were conducted carefully. The results support the conclusion of the existence of disynaptic circuits from the cerebellum to the NAc.

    1. Reviewer #3 (Public Review):

      The authors present a pipeline for generating strain-specific genome-scale metabolic models for bacteria using Klebsiella spp. as the demonstrative data. The proposed improvement of performance and accuracy in this process holds great value. However, the demonstrated evidence, justification, and validation methods require further discussion.

      Apart from the claim to quickly and accurately produce strain-specific models, the manuscript highlights the need to create pan-metabolic models from manually curated models, which are relatively time-consuming and can only be done with well-established organisms. Therefore, claims to speed up the process are redundant.

      The justification and evaluation of the generated models are inadequate and one-dimensional. The authors only focus on statistics such as the number of reactions and genes in the models, which does not accurately depict the completeness of the model.

      Furthermore, the authors solely compare their results with the performance of the previously published CraveMe packages, and the results do not clearly demonstrate the superior performance of the Bactabolize tool that they developed.

      The authors have not provided evidence or discussion on the accuracy of any metabolic fluxes, which are considered to be crucial for reconstructing metabolic models. Additionally, the authors have not mentioned the importance of non-growth associated maintenance and the criticality of biomass composition analysis, both of which significantly determine the fluxes in the system.

      Overall, the work holds potential for direct application in certain specific aims and fields. However, the cryptic details and critical points of the justification regarding the completeness of the models require further discussion. A detailed discussion on the importance of manually curated models and the potential future direction of incorporating machine learning into the process would significantly enhance the quality of the manuscript.

    2. Reviewer #2 (Public Review):

      The authors present a computational tool for high-throughput generation of bacterial strain-specific metabolic models. The study seems interesting. However, I have the following concerns.

      1. In the results section "description of Bactabolize", the authors present technical details on how to generate a metabolic model. For the input and output, please provide concrete examples to show the functionality of Bactabolize.

      2. KpSC pan-metabolic reference model is provided. Are they required as input for Bactabolize? Are the gene, metabolite information open accessible by users?

      3. To generate metabolic models, the authors present comparison results with other methods. However, the authors only present the numbers in genes, metabolites and substrates. Since the interactions between gene, metabolite, and substrate are also critical, if possible, please provide the coverage details about these interactions. Venn diagram is recommended to compare these coverage differences.

      4. Are quality control and gap-filling needed to be processed when constructing a new metabolic model?

      5. Are there any visualization results to check the status of the generated draft model?

    3. Reviewer #1 (Public Review):

      In this work, Vezina et al. present Bactabolize, a rapid reconstruction tool for the generation of strain-specific metabolic models. Similar to other reconstruction pipelines such as CarveMe, Bactabolize builds a strain-specific draft reconstruction and subsequently gap-fills it. The model can afterwards be used to predict growth in any defined medium the user specifies. The authors constructed a pan-model of the Klebsiella pneumoniae species complex (KpSC) and used it as input for Bactabolize to construct a genome-sale reconstruction of K. pneumoniae KPPR1. They compared the generated reconstruction with a reconstruction built through CarveMe as well as a manually curated reconstruction for the same strain. They then compared predictions of carbon, nitrogen, phosphor, and sulfur sources and found that the Bactabolize reconstruction had the overall highest accuracy. Finally, they built draft reconstructions for 10 clinical isolates of K. pneumoniae and evaluated their predictive performance. Overall, this is a useful tool, the data is well-presented, and the paper is well-written. However, the predictions are only compared with two existing reconstruction tools though more have been recently published.

    1. Joint Public Review:

      The manuscript by Lolicato and colleagues characterizes the role of FGF2 dimerization in the unconventional secretion of this signaling molecule using a combination of cell-based and in vitro assays. FGF2 is secreted from the cell via an unconventional mechanism because it lacks a signal sequence. Previous studies by the same group have established a compelling model in which FGF2 forms an oligomer in a PIP2-dependent manner at the plasma membrane, which drives its translocation to the cell exterior. The same group also identified two cysteine residues (C77 and C95) critical for FGF2 oligomerization and secretion.

      In this study, the authors analyzed the impact of single cysteine to alanine substitution on the oligomerization and secretion of FGF2. They found that C95 but not C77 is required for PIP2-dependent membrane binding, FGF2 oligomerization, and secretion. On the other hand, C77 regulates the interaction of FGF2 with the plasma membrane Na, K-ATPase, which is thought to enhance the FGF2-PIP2 interaction. Using a set of bi-functional crosslinkers, the authors were able to capture an FGF2 homo-dimer whose formation is dependent on C95.

      They propose that FGF2 forms a disulfide-bridged dimer via C95, the building block for FGF2 oligomerization in the plasma membrane.

      While most experiments were carefully designed and the data are of high quality, a few issues need further clarification.

      A significant concern is a need for more direct evidence for the proposed disulfide-bridged FGF2 dimer in the cytoplasm despite multiple assays highlighting the critical role of C95 in FGF2 oligomerization and secretion. The crosslinking experiments only suggest that C95 is close to another C95 in crosslinked FGF2 dimers. Given that the reducing cytosolic environment does not usually support disulfide bond formation and that no electron acceptor has been identified to support this unusual model, the reviewers feel that the authors should consider an alternative and more plausible explanation for their observations, which is that the C95A mutation disrupts the dimerization interface. This is actually the author's explanation for why the C77A FGF2 mutant fails to bind Na, K-ATPase. For these reasons, the reviewers feel it is an overstatement to claim that FGF2 forms a disulfide dimer in the cytoplasm.

      Furthermore, the authors propose that FGF2 dimers can assemble into a transient higher-order FGF2 oligomer to form a toroidal pore for protein secretion. This is supported by a computational simulation study, which suggests that FGF2 dimers exhibit a higher affinity for PI(4,5)P2 than monomers. However, the model would be much stronger if the authors could provide additional experimental validation.

      Additionally, the authors propose that C95-dependent FGF2 dimerization may generate a signaling module. They cited a few structure papers on page 9 (Plotnikov et al., 1999; Plotnikov et al., 2000; Schlessinger et al., 2000), suggesting that the FGF2 dimer reported here may be the primary signaling unit. However, this statement may mislead the reader, as it has been clearly stated in these papers that FGF2 does not form a dimer directly. Instead, heparin facilitates the dimerization of the FGF receptor, which results in the recruitment of two FGF2 molecules.

    1. Reviewer #1 (Public Review):

      This fascinating paper by A.L. Schneider et al. describes voyAGEr, a shiny-based interface for easy exploration of the GTEx dataset by non- or novice programmers. Importantly, voyAGEr is open source and available from github, which could greatly accelerate additional development and further uses of this interesting tool.

      The authors developed a pipeline for modeling age-related changes in gene expression in the GTEx data called ShARP-LM, fitting a linear model for age, sex, and age&sex interaction terms. This pipeline underlies the later analyses that can be applied within voyAGEr. These analyses are labeled by tissue so that users can easily begin a query based on a tissue or a gene of possible interest.

      voyAGEr implements many kinds of interesting R-based tools such as pathway overrepresentation analysis and gene co-expression module analysis, in a way that makes these approaches accessible to non-bioinformaticist aging researchers.

      As the tidal wave of publicly available large, high-dimensional datasets such as transcriptomes continues to grow exponentially, the usefulness of tools such as voyAGEr will only increase. While test users may be able to imagine features or refinements they wish were already present, due to the open source approach they or anyone else including but not limited to the present authors can implement additional features in the future. I look forward to using this tool and to staying abreast of its future development.

      Overall, this study describes a new tool of interest to the field. The manuscript is clearly written overall. The figures and supplementary information are all clear and all add to the manuscript.

    2. Reviewer #2 (Public Review):

      The purpose of this study is to develop a tool that serves as a starting point for investigating and uncovering genes and pathways associated with aging. The tool utilizes information from the GTEx public database, which contains post-mortem human data. It focuses on identifying age-related gene expression changes across different age range, biological sexes, and medical histories, with a focus on specific tissues.

      Additionally, the authors envision the platform as continuously evolving, with ongoing development and expansion to include new data and features, ensuring it remains a cutting-edge resource for researchers studying aging.

      # Strengths<br /> voyAGEr presents a tool for exploring gene expression changes across multiple tissues in the context of aging. One of the main strengths of the tool is its intuitive and user-friendly interface, which allows for easy navigation and exploration of gene expression patterns for biologists. Users can explore changes in gene expression of single genes across multiple tissues, enabling them to identify genes of interest that can be further investigated.

      A particularly noteworthy strength of the tool is its ability to show tissue-specific gene expression patterns. This feature is essential for elucidating the paradigm of tissue-specific asynchronous aging and provides a unique and valuable resource for the aging community.

      Overall, the tool offers an entry point for further investigation of genes involved in aging, and its ability to show tissue-specific gene expression patterns provides a unique and valuable resource for the scientific community.

      Lastly, the tool is accompanied by a clear and thorough tutorial that explains each of its functionalities and provides examples. The authors also acknowledge the limitations of the statistical inference tests used in the tool, which adds to its overall transparency.

      # Weaknesses

      ## Underlying data analysis<br /> In this tool/resource paper, it is crucial that the data used is up-to-date to provide the most comprehensive and relevant information to users. However, the authors utilized GTEx v7, which is an outdated (2016) version of the dataset. It is worth noting that GTEx v8 includes over 940 individuals, representing a 35% increase in individuals, and a 50% increase in the total number of samples. The authors should check the newer versions of GTEx and update the data.

      The authors did not address any correction for batch effects or RNA integrity numbers, which are known to affect transcriptome profiles. For instance, our analysis of GTEx v8 Cortex tissue revealed that after filtering out lowly expressed genes, in the same way authors did, PC1 (which accounts for 24% of the variation) had a Spearman's correlation value of 0.48 (p<6.1e-16) with RNA integrity number.

      The data analyzed in the GTEx dataset is not filtered or corrected for the cause of death, which can range from violent and sudden deaths to slow deaths or cases requiring a ventilator. As a result, the data may not accurately represent healthy aging profiles but rather reflect changes in the transcriptome specific to certain diseases due to the age-related increase in disease risk. While the authors do acknowledge this limitation in the discussion, stating that it is not a healthy cohort and disease-specific analysis is not feasible due to the limited number of samples, it would be useful for users to have the option to analyze only cases of fast death, excluding ventilator cases and deaths due to disease. This is typically how GTEx data is utilized in aging studies. Alternatively, the authors should consider including the "cause of death" variable in the model.

      The age distribution varies across tissues which may impact the results of the study. The authors' claim that age distribution does not affect the outcomes is inconclusive. Since the study aims to provide cross-tissue analysis, it is important to note that differing age distributions across tissues can influence the overall results. To address this, the authors should conduct downsampling to different age distributions across tissues and evaluate the level of tissue-specific or common changes that remain after the distributions are made similar.

      The GTEx resource is extremely valuable, however, it comes with challenges. GTEx contains tissue samples from the same individuals across different tissues, resulting in varying degrees of overlap in sample origin across tissues as not all tissues are collected for all individuals. This could affect the similar/different patterns observed across tissues. As this tool is meant for broader use by the community, it is crucial for the authors to either rule out this possibility by conducting a cross-tissue comparison using a non-parametric model that accounts for the dependency between samples from the same individual, or to provide information on the degree of similarity between samples so that the users can keep this possibility in mind when using the tool for hypothesis generation.

      ## Visualisation and analysis platform<br /> The authors aimed to create an open-source and ever-evolving resource that could be adapted and improved with new functionality. However, this goal was only partially achieved. Although the code for the web app is open source, crucial components such as the statistical tests or the linear model are not included in the repository, limiting the tool's customizability and adaptability.

      Furthermore, the authors' choice of visualization platform (R shiny) may not be the best fit for extensibility and open-source collaboration, as it lacks modularity. A more suitable alternative could be production-oriented platforms such as Flask or FastAPI.

      To facilitate collaboration and improve the tool's adaptability, data resulting from the pre-processing pipeline should be made publicly available. This would make it easier for others to contribute and extend the tool's functionality, ultimately enhancing its value for the scientific community.

    3. Reviewer #3 (Public Review):

      In their manuscript, Schneider et al. aim to develop voyAGEr, a web-based tool that enables the exploration of gene expression changes over age in a tissue- and sex-specific manner. The authors achieved this goal by calculating the significance of gene expression alterations within a sliding window, using their unique algorithm, Shifting Age Range Pipeline for Linear Modelling (ShARP-LM), as well as tissue-level summaries that calculated the significance of the proportion of differentially expressed genes by the windows and calculated enrichments of pathways for showing biological relevance. Furthermore, the authors examined the enrichment of cell types, pathways, and diseases by defining the co-expressed gene modules in four selected tissues. The voyAGEr was developed as a discovery tool, providing researchers with easy access to the vast amount of transcriptome data from the GTEx project. Overall, the research design is unique and well-performed, with interesting results that provide useful resources for the field of human genetics of aging. I have a few questions and comments, which I hope the authors can address.

      1. In the gene-centric analyses section of the result, to improve this manuscript and database, linear regression tests accounting for the entire range of age should be added. The authors' algorithm, ShARP-LM, tests locally within a 16-year window which makes it has lower power than the linear regression test with the whole ages. I suspect that the power reduction is strongly affected in the younger age range since a larger number of GTEx donors are enriched in old age. By adding the results from the lm tests, readers would gain more insight and evidence into how significantly their interest genes change with age.<br /> 2. In line with the ShARP-LM test results, it is not clear which criterion was used to define the significant genes and the following enrichment analyses. I assume that the criterion is P < 0.05, but it should be clearly noted. Additionally, the authors should apply adjusted p-values for multiple-test correction. The ideal criterion is an adjusted P < 0.05. However, if none or only a handful of genes were found to be significant, the authors could relax the criteria, such as using a regular P < 0.01 or 0.05.<br /> 3. In the gene-centric analyses section, authors should provide a full list of donor conditions and a summary table of conditions as supplementary.<br /> 4. The tissue-specific assessment section has poor sub-titles. Every title has to contain information.<br /> 5. I have an issue understanding the meaning of NES from GSEA in the tissue-specific assessment section. The authors performed GSEA for the DEGs against the background genes ordered by t-statistics (from positive to negative) calculated from the linear model. I understand the p-value was two-tailed, which means that both positive and negative NES are meaningful as they represent up-regulated expression direction (positive coefficient) and down-regulated expression direction (negative coefficient) with age, respectively, within a window. However, in the GSEA section of Methods, authors were not fully elaborate on this directionality but stated, "The NES for each pathway was used in subsequent analyses as a metric of its over- or down-representation in the Peak". The authors should clearly elaborate on how to interpret the NES from their results.<br /> 6. In the Modules of co-expressed genes section, the authors did not explain how or why they selected the four tissues: brain, skeletal muscle, heart (left ventricle), and whole blood. This should be elaborated on.<br /> 7. In the modules of the co-expressed genes section, the authors did not provide an explanation of the "diseases-manual" sub-tab of the "Pathway" tab of the voyAGEr tool. It would be helpful for readers to understand how the candidate disease list was prepared and what the results represent.

    1. Reviewer #1 (Public Review):

      This study by Sokač et al. entitled "GENIUS: GEnome traNsformatIon and spatial representation of mUltiomicS data" presents an integrative multi-omics approach which maps several genomic data sources onto an image structure on which established deep-learning methods are trained with the purpose of classifying samples by their metastatic disease progression signatures. Using published samples from the Cancer Genome Atlas the authors characterize the classification performance of their method which only seems to yield results when mapped onto one out of four tested image-layouts.

      Major recommendations:

      - In its current form, GENIUS analysis is neither computationally reproducible nor are the presented scripts on GitHub generic enough for varied applications with other data. The GENIUS GitHub repository provides a collection of analysis scripts and not a finished software solution (e.g. command line tool or other user interface) (the presented scripts do not even suffice for a software prototype). In detail, the README on their GitHub repository is largely incomplete and reads analogous to an incomplete and poorly documented analysis script and is far from serving as a manual for a generic software solution (this claim was made in the manuscript). The authors should invest substantially into adding more details on how data can be retrieved (with example code) from the cited databases and how such data should then be curated alongside the input genome to generically create the "genomic image". In addition, when looking at the source code, parameter configurations for training and running various modules of GENIUS were hard-coded into the source code and users would have to manually change them in the source code rather than as command line flags in the software call. Furthermore, file paths to the local machine of the author are hard-coded in the source code, suggesting that images are sourced from a local folder and won't work when other users wish to replicate the analysis with other data. I would strongly recommend building a comprehensive command line tool where parameter and threshold configurations can be generically altered by the user via command line flags. A comprehensive manual would need to be provided to ensure that users can easily run GENIUS with other types of input data (since this is the claim of the manuscript). Overall, due to the lack of documentation and hard-coded local-machine folder paths it was impossible to computationally reproduce this study or run GENIUS in general.

      - In the Introduction the authors write: "To correct for such multiple hypothesis testing, drastic adjustments of p-values are often applied which ultimately leads to the rejection of all but the most significant results, likely eliminating a large number of weaker but true associations.". While this is surely true for any method attempting to separate noise from signal, their argument fails to substantiate how their data transformation will solve this issue. Data transformation and projection onto an image for deep-learning processing will only shift the noise-to-signal evaluation process to the postprocessing steps and won't "magically" solve it during training. In addition, multiple-testing correction is usually done based on one particular data source (e.g. expression data), while their approach claims to integrate five very different genomic data sources with different levels and structures of technical noise. How are these applications comparable and how is the training procedure able to account for these different structures of technical noise? Please provide sufficient evidence for making this claim (especially in the postprocessing steps after classification).

      - I didn't find any computational benchmark of GENIUS. What are the computational run times, hardware requirements (e.g. memory usage) etc that a user will have to deal with when running an analogous experiment, but with different input data sources? What kind of hardware is required GPUs/CPUs/Cluster?

      - A general comment about the Methods section: Models, training, and validation are very vaguely described and the source code on GitHub is very poorly documented so that parameter choices, model validation, test and validation frameworks and parameter choices are neither clear nor reproducible. Please provide a sufficient mathematical definition of the models, thresholds, training and testing frameworks.

      - In chapter "Latent representation of genome" the authors write: "After successful model training, we extracted the latent representations of each genome and performed the Uniform Manifold Approximation and Projection (UMAP) of the data. The UMAP projected latent representations into two dimensions which could then be visualized. In order to avoid modeling noise, this step was used to address model accuracy and inspect if the model is distinguishing between variables of interest.". In the recent light of criticism when using the first two dimensions of UMAP projections with omics data, what is the evidence in support of the author's claim that model accuracy can be quantified with such a 2D UMAP projection? How is 'model accuracy' objectively quantified in this visual projection?

      - In the same paragraph "Latent representation of genome" the authors write: "We observed that all training scenarios successfully utilized genome images to make predictions with the exception of Age and randomized cancer type (negative control), where the model performed poorly (Figure 2B).". Did I understand correctly that all negative controls performed poorly? How can the authors make any claims if the controls fail? In general, I was missing sufficient controls for any of their claims, but openly stating that even the most rudimentary controls fail to deliver sufficient signals raises substantial issues with their approach. A clarification would substantially improve this chapter combined with further controls.

    2. Reviewer #2 (Public Review):

      In this manuscript, Birkbak and colleagues use a novel approach to transform multi-omics datasets in images and apply Deep Learning methods for image analysis. Interestingly they find that the spatial representation of genes on chromosomes and the order of chromosomes based on 3D contacts leads to best performance. This supports that both 1D proximity and 3D proximity could be important for predicting different phenotypes. I appreciate that the code is made available as a github repository. The authors use their method to investigate different cancers and identify novel genes potentially involved in these cancers. Overall, I found this study important for the field.

      The major points of this manuscript could be grouped in three parts:

      1. While the authors have provided validation for their model, it is not always clear that best approaches have been used.<br /> a. In the methods there is no mention of a validation dataset. I would like to see the authors training on a cancer from one cohort and predict on the same cancer from a different cohort. This will convince the reader that their model can generalise. They do something along those lines for the bladder cancer, but no performance is reported. At the very least they should withhold a percentage of the data for validation. Maybe train on 100 and validate on the remaining 300 samples. They might have already done something along these lines, but it was not clear from the methods.<br /> b. It was not clear how they used "randomised cancer types as the negative control". Why not use normal tissue data or matched controls?<br /> c. If Figure 2B, the authors claim they have used cross validation. Maybe I missed it, but what sort of cross validation did they use?<br /> 2. Potential improvement to the method<br /> a. It is very encouraging the use of HiC data, but the authors used a very coarse approach to integrate it (by computing the chromosome order based on interaction score). We know that genes that are located far away on the same chromosome can interact more in 3D space than genes that are relatively close in 1D space. Did the authors consider this aspect? Why not group genes based on them being located in the same TAD?<br /> b. Authors claim that "given that methylation negatively correlates with gene expression, these were considered together". This is clearly not always the case. See for example https://genomebiology.biomedcentral.com/articles/10.1186/s13059-022-02728-5. What would happen if they were not considered together?<br /> 3. Interesting results that were not explained.<br /> a. In Figure 3A methylation seems to be the most important omics data, but in 3B, mutations and expression are dominating. The authors need to explain why this is the case.

    1. Reviewer #1 (Public Review):

      Gametocytes are erythrocytic sexual stages of the malaria-causing parasite Plasmodium, and are essential for parasite transmission and reproduction in the mosquito vector. In this study, Murata et al investigated the mechanisms of gene regulation in female gametocytes in the rodent malaria model parasite Plasmodium berghei. According to current views, gene regulation in Plasmodium parasites is dominated by the family of AP2 transcription factors (TFs), such as the AP2-G TF, which drives sexual commitment. The same authors previously identified one AP2 TF, called AP2-FG, as an essential TF mediating differentiation of female gametocytes. Here, they identified a novel protein, called PFG (for partner of AP2-FG), which cooperates with AP2-FG to regulate a subset of female gametocyte genes.

      PFG was identified among AP2-G targets, but possesses no known DNA binding or other characterized domain. The authors show that PFG-knockout P. berghei parasites can form male and female gametocytes yet cannot transmit to mosquitoes, due to a defect in female gametocyte development. Using RNA-seq, they show that many female-specific genes are down-regulated in PFG(-)parasites. Chromatin immunoprecipitation combined with DNA sequencing (ChIP-seq) revealed that PFG colocalizes with AP2-FG on a ten-base motif that is enriched upstream of female-specific genes. Importantly, the ChIP-seq profile of PFG is unchanged in the absence of AP2-FG, suggesting that PFG binds to DNA independently of AP2-FG. Mutation of the ten-base motif in one target gene using CRISPR-Cas9 demonstrates that this motif is required for PFG localization at the gene locus. The data also show that binding of AP2-FG is affected in the absence of PFG, with disruption of AP2-FG interaction with the ten-base motif, but conservation of AP2-FG binding to distinct five-base motifs. Using a recombinant AP2 domain from AP2-FG, the authors demonstrate that the AP2 domain of AP2-FG binds to the five-base motifs. Using CRISPR they show that disruption of the five-base motifs in the genome abrogates AP2-FG binding, and using a reporter expression system they confirm that these motifs act as a cis-activating promoter element.

      Through the analysis of target genes based on the presence of the ten- versus five-base motifs, the authors propose a model where AP2-FG can function in two forms, associated or not with PFG, and acting on the ten- or five-base motifs, respectively, to regulate distinct gene subsets during development of female gametocyte development.

      The paper is very well written, with a clear narrative, and the work is very well performed, relying on robust molecular approaches. Generally the conclusions and the model proposed by the authors are well supported by the data. Nevertheless, the study as it stands raises a number of questions. First, it is unclear how the authors selected PFG as a candidate protein as the protein lacks any known DNA binding or regulatory domain. Detailing the reasoning that led to the identification of PFG would make the entire study more appealing. While the data convincingly show that PFG and AP2-FG cooperate to regulate the expression of a subset of female-specific genes, the paper does not show whether the two proteins actually interact with each other to form a complex. Finally, how PFG binds to DNA and whether the protein has transactivating activity remains elusive, as the protein apparently possesses no known DNA-binding or activating domain. These points could be discussed in more detail in the manuscript and/or be the subject of follow up studies.

      In summary, this work reveals the essential role of a Plasmodium protein with no known DNA binding or regulatory domain, illustrating that unknown facets remain to be uncovered in this fascinating pathogen.

    2. Reviewer #2 (Public Review):

      Murata et al have characterized a new transcription activator termed PFG, which regulates gene expression in female gametocytes. The authors show solid evidence that PFG is a partner of the previously described transcription factor AP2-FG and describe three sets of genes: genes activated by PFG or AP2-FG alone and genes activated by the complex. The authors also show differential binding to the target DNA sequences by AP2-FG to either a 10bp, if in a complex with PFG or a 5bp motif if alone. In all, this is a useful study which further elucidates the underlying regulatory network that drives development of sexual stages and ultimately transmission to mosquitoes. The data presented are clear and solid and the conclusions drawn are mostly supported by the results shown. However, in the absence of evidence of physical interaction, it remains unclear if AP2-FG and PFG actually interact directly or as part of the same complex.

    3. Reviewer #3 (Public Review):

      This study is well designed and executed and provides new and important insights into the role of two TFs during the maturation of female gametocytes and fertilization in the mosquito midgut. However, it would benefit from a more thorough characterization of the phenotype to understand at which step of development these factors are required.

      The gene at the center of this study (PBANKA_0902300) was identified in an earlier genetic screen by Russell et al. as being a female specific gene with essential role in transmission and named Fd2 (for female-defective 2). Since this name entered the literature first and is equally descriptive, the Fd2 name should be used instead of PFG to maintain clarity and avoid unnecessary confusion.

      This study is well designed and executed and provides new and important insights into the role of two TFs during the maturation of female gametocytes and fertilization in the mosquito midgut. However, it would benefit from a more thorough characterization of the phenotype to understand at which step of development these factors are required.

      The gene at the center of this study (PBANKA_0902300) was identified in an earlier genetic screen by Russell et al. as being a female specific gene with essential role in transmission and named Fd2 (for female-defective 2). Since this name entered the literature first and is equally descriptive, the Fd2 name should be used instead of PFG to maintain clarity and avoid unnecessary confusion.

    1. Reviewer #1 (Public Review):

      Thermogenic adipocyte activity associate with cardiometabolic health in humans, but decline with age. Identifying the underlying mechanisms of this decline is therefore highly important.

      To address this task, Holman and co-authors investigated the effects of two major determinants of thermogenic activity: cold, which induce thermogenic de novo differentiation as well as conversion of dormant thermogenic inguinal adipocytes: and aging, which strongly reduce thermogenic activity. The authors study young and middle-aged mice at thermoneutrality and following cold exposure.

      Using linage tracing, the authors conclude that the older group produce less thermogenic adipocytes from progenitor differentiation. However, they found no differences between thermogenic differentiation capacity between the age groups when progenitors are isolated and differentiated in vitro. This finding is consistent with previous findings in humans, demonstrating that progenitor cells derived from dormant perirenal brown fat of humans differentiate into thermogenic adipocytes in vitro. Taken together, this underscores that age-related changes in the microenvironment rather than autonomous alterations in the ASPCs explain the age related decline in thermogenic capacity, This is an important finding in terms of identifying new approaches to switch dormant adipocytes into an active thermogenic phenotype.

      To gain insight into the age-related changes, the authors use single cell and single nuclei RNA sequencing mapping of their two age groups, comparing thermoneutral and cold conditions between the two groups. Interestingly, where the literature previously demonstrated that de novo lipogenesis (DNL) occurs in relation to thermogenic activation, the authors show that DNL in fact is activated in a white adipocyte cell type, whereas the beige thermogenic adipocytes form a separate cluster.

      Considering recent findings, that adipose tissue contains several subtypes of ASPCs and adipocytes, mapping the changes at single cell resolution following cold intervention provides an important contribution to the field, in particular as an older group with limited thermogenic adaptation is analyzed in parallel with a younger, more responsive group. This model also allowed for detection of microenvironment as a determining factor of thermogenic response.

      The use of only two time points (young and middle-aged) along the aging continuum limits the conclusions that can be made on aging as the only driver of the observed differences between the groups. It should for example be noted that the older mice had higher weights and larger fat depots, thus the phenotype is complex and this should be taken into consideration when interpreting the data.

      In conclusion, this study provides an important resource for further studies on how to reactivate dormant thermogenic fat and potentially improve metabolic health.

    2. Reviewer #2 (Public Review):

      This manuscript focused on why aging leads to decreased beiging of white adipose tissue. The authors used an inducible lineage tracing system and provided in vivo evidence that de novo beige adipogenesis from Pdgfra+ adipocyte progenitor cells is blocked during early aging in subcutaneous fat. Single-cell RNA sequencing of adipocyte progenitor cells and in vitro assays showed that these cells have similar beige adipogenic capacities in vitro. Single-cell nucleus RNA sequencing of mature adipocytes indicated that aged mice have more Npr3 high-expressing adipocytes in the subcutaneous fat from aged mice. Meanwhile, adipocytes from aged mice have significantly lower expression of genes involved in de novo lipogenesis, which may contribute to the declined beige adipogenesis.

      The mechanism that leads to age-related impairment of white adipose tissue beiging is not very clear. The finding that Pdgfra+ adipocyte progenitor cells contribute to beige adipogenesis is novel and interesting. It is more intriguing that the aging process represses Pdgfra+ adipocyte progenitor cells from differentiating into beige adipocytes during cold stimulation. Mature adipocytes that have high de novo lipogenesis activity may support beige adipogenesis is also novel and worth further pursuing. The study was carried out with a nice experimental design, and the authors provided sufficient data to support the major conclusions. I only have a few comments that could potentially improve the manuscript.

      1. It is interesting that after three days of cold exposure, aged mice also have much fewer beige adipocytes. Is de novo adipogenesis involved at this early stage? Or does the previous beige adipocyte that acquired white morphology have a better "reactivation" in young mice? It would be nice if the author could discuss the possibilities.<br /> 2. Is the absolute number of Pdgfra+ cells decreased in aged mice? It would be nice to include quantifications of the percentage of tomato+ beige adipocytes in total tomato+ cells to reflect the adipogenic rate.

    1. Reviewer #1 (Public Review):

      Despite numerous studies on quinidine therapies for epilepsies associated with GOF mutant variants of Slack, there is no consensus on its utility due to contradictory results. In this study Yuan et al. investigated the role of different sodium selective ion channels on the sensitization of Slack to quinidine block. The study employed electrophysiological approaches, FRET studies, genetically modified proteins and biochemistry to demonstrate that Nav1.6 N- and C-tail interacts with Slack's C-terminus and significantly increases Slack sensitivity to quinidine blockade in vitro and in vivo. This finding inspired the authors to investigate whether they could rescue Slack GOF mutant variants by simply disrupting the interaction between Slack and Nav1.6. They find that the isolated C-terminus of Slack can reduce the current amplitude of Slack GOF mutant variants co-expressed with Nav1.6 in HEK cells and prevent Slack induced seizures in mouse models of epilepsy. This study adds to the growing list of channels that are modulated by protein-protein interactions, and is of great value for future therapeutic strategies.

      I have a few comments with regard to how Nav1.6 sensitize Slack to block by quinidine.

      It is not clear to me if the Slack induced current amplitude varies depending on the specific Nav subtype. To this end, it would be valuable to test if Slack open probability is affected by the presence of specific Nav subtypes. Nav induced differences in Slack current amplitude and open probability could explain why individual Nav subtypes show varied ability to sensitize Slack to quinidine blockade.

      It has previously been shown that INaP (persistent sodium current) is important for inducing Slack currents. Here the authors show that INaT (transient sodium current) of Nav1.6 is necessary for the sensitization of Slack to quinidine block whereas INaP surprisingly has no effect. The authors then show that the N-tail together with C-tail of Nav1.6 can induce same effect on Slack as full-length Nav1.6 in presence of high intracellular concentrations of sodium. However, it is not clear to me how the isolated N- and C-tail of Nav1.6 can induce sensitization of Slack to quinidine by interacting with C-terminus of Slack, while sensitization also is dependent on INaT. The authors speculate on different slack open conformation, but one could speculate if there is a missing link, such as an un-identified additional interacting protein that causes the coupling.

    2. Reviewer #2 (Public Review):

      This is a very interesting paper about the coupling of Slack and Nav1.6 and the insight this brings to the effects of quinidine to treat some epilepsy syndromes.

      Slack is a sodium-activated potassium channel that is important to hyperpolarization of neurons after an action potential. Slack is encoded by KNCT1 which has mutations in some epilepsy syndromes. These types of epilepsy are treated with quinidine but this is an atypical antiseizure drug, not used for other types of epilepsy. For sufficient sodium to activate Slack, Slack needs to be close to a channel that allows robust sodium entry, like Nav channels or AMPA receptors. but more mechanistic information is not available. Of particular interest to the authors is what allows quinidine to be effective in reducing Slack.

      In the manuscript, the authors show that Nav, not AMPA receptors, are responsible for Slack's sensitization to quinidine blockade, at least in cultured neurons (HeK293, primary cortical neurons). Most of the paper focuses on the evidence that Nav1.6 promotes Slack sensitivity to quinidine.

      The paper is very well written although there are reservations about the use of non-neuronal cells or cultured primary neurons rather than a more intact system. I also have questions about the figures. Finally, riluzole is not a selective drug, so the limitations of this drug should be discussed. On a minor point, the authors use the term in vivo but there are no in vivo experiments.

    3. Reviewer #3 (Public Review):

      Yuan et al., set out to examine the role of functional and structural interaction between Slac and NaVs on the Slack sensitivity to quinidine. Through pharmacological and genetic means they identify NaV1.6 as the privileged NaV isoform in sensitizing Slac to quinidine. Through biochemical assays, they then determine that the C-terminus of Slack physically interacts with the N- and C-termini of NaV1.6. Using the information gleaned from the in vitro experiments the authors then show that virally-mediated transduction of Slack's C-terminus lessens the extent of SlackG269S-induced seizures. These data uncover a previously unrecognized interaction between a sodium and a potassium channel, which contributes to the latter's sensitivity to quinidine.

      The conclusions of this paper are mostly well supported by data, but some aspects of functional and structural studies in vivo as well as physically interaction need to be clarified and extended.

      1) Immunolabeling of the hippocampus CA1 suggests sodium channels as well as Slac colocalization with AnkG (Fig 3A). Proximity ligation assay for NaV1.6 and Slac or a super-resolution microscopy approach would be needed to increase confidence in the presented colocalization results. Furthermore, coimmunoprecipitation studies on the membrane fraction would bolster the functional relevance of NaV1.6-Slac interaction on the cell surface.

      2) Although hippocampal slices from Scn8a+/- were used for studies in Fig. S8, it is not clear whether Scn8a-/- or Scn8a+/- tissue was used in other studies (Fig 1J & 1K). It will be important to clarify whether genetic manipulation of NaV1.6 expression (Fig. 1K) has an impact on sodium-activated potassium current, level of surface Slac expression, or that of NaV1.6 near Slac.

      3) Did the epilepsy-related Slac mutations have an impact on NaV1.6-mediated sodium current?

      4) Showing the impact of quinidine on persistent sodium current in neurons and on NaV1.6-expressing cells would further increase confidence in the role of persistent sodium current on sensitivity of Slac to quinidine.

    1. Reviewer #1 (Public Review):

      With genephys, the author provides a generative model of brain responses to stimulation. This generative model allows mimicking of specific parameters of a brain response at the sensor level, to test the impact of those parameters on critical analytic methods utilized on real M/EEG data. Specifically, they compare the decoding output for differently set parameters to the decoding pattern observed in a classical passive viewing study in terms of the resulting temporal generalization matrix (TGM). They identify that the correspondence between the mimicked and the experimental TGM depends on an oscillatory component that spans multiple channels, frequencies, and latencies of response; and an additive, slower response with a specific (cross-frequency) relation to the phase of the oscillatory, faster component.

      A strength of the article is that it considers the complexity of neural data that contributes to the findings obtained in stimulation experiments. An additional strength is the provision of a Python package that allows scientists to explore the potential contribution of different aspects of neural signals to obtained experimental data and thereby to potentially test their theoretical assumptions critical parameters that contribute to their experimental data.

      A weakness of the paper is that the power of the model is illustrated for only one specific set of parameters, added in a stepwise manner and the comparison to on specific empirical TGM, assumed to be prototypical; And that this comparison remains descriptive. (That is could a different selection of parameters lead to similar results and is there TGM data which matches these settings less well.) It further remained unclear to me, which implications may be drawn from the generative model, following from the capacities to mimic this specific TGM (i) for more complex cases, such as the comparison between experimental conditions, and (ii) about the complex nature of neural processes involved.

      Towards this end, I would appreciate (i) a more profound explanation of the conclusions that can be drawn from this specific showcase, including potential limitations, as well as wider considerations of how scientists may empower the generative model to (ii) understand their experimental data better and (iii) which added value the model may have in understanding the nature of underlying brain mechanism (rather than a mere technical characterization of sensor data).

    2. Reviewer #2 (Public Review):

      This paper introduces a new model that aims to explain the generators of temporal decoding matrices (TGMs) in terms of underlying signal properties. This is important because TGMs are regularly used to investigate neural mechanisms underlying cognitive processes, but their interpretation in terms of underlying signals often remains unclear. Furthermore, neural signals are often variant over different instances of stimulation despite behaviour being relatively stable. The author aims to tackle these concerns by developing a generative model of electrophysiological data and then showing how different parameterizations can explain different features of TGMs. The developed technique is able to capture empirical observations in terms of fundamental signal properties. Specifically, the model shows that complexity is necessary in terms of spatial configuration, frequencies and latencies to obtain a TGM that is comparable to empirical data.

      The major strength of the paper is that the novel technique has the potential to further our understanding of the generators of electrophysiological signals which are an important way to understand brain function. Furthermore, the used techniques are state-of-the-art and the developed model is publicly shared in open source code.

      On the other hand, the results of comparisons between simulations and real data are not always clear for an inexperienced reader. For example, the comparisons are qualitative rather than quantitative, making it hard to draw firm conclusions. Relatedly, it is unclear whether the chosen parameterizations are the only/best ones to generate the observed patterns or whether others are possible. In the case of the latter, it is unclear what we can actually conclude about underlying signal generators. It would have been different if the model was directly fitted to empirical data, maybe of different cognitive conditions. Finally, the neurobiological interpretation of different signal properties is not discussed. Therefore, taken together, in its currently presented form, it is unclear how this method could be used exactly to further our understanding of the brain.

    1. Reviewer #1 (Public Review):

      The paper by Dongsheng Xiao, Yuhao Yan and Timothy H Murphy presents a timely approach to record neuronal activity at multiple temporal and spatial scales. Such approaches are at the forefront of system neuroscience and a few examples include, among others, fMRI alongside electrophysiology (Logothetis et al, 2021. Nature) or widefield calcium imaging (Lake et al, 2020. Nat Meth) , or functional ultrasound imaging and multi unit recording (Claron et al, 2023 Cell Reports), The method presented here combines "low resolution" (i.e. cortical regions) widefield calcium imaging across most of the dorsal portions of the murine cortex combined with electrical recording of single neurons in specific cortical and subcortical locations (as a matter of fact, this later components can be used everywhere in the murine brain).

      The method presented here is straightforward to implement and very well documented. Examples of novel insights that this approach can generate are well presented and demonstrate the strength of the presented approach, some aspects of the analysis require clarification.

      For example, the author reveal Spike-Triggered average cortical activation Maps (STMs) linked to the activity of single neurons (Figs 4 and 5) This allows to directly asses the functional connectivity between cortical and sub-cortical areas. It nevertheless unclear what is the stability of the established relationships. The nature of the "recordings" in Fig 4. is unclear. It looks like these are imaging sessions on the same day, the length of these recordings as well as the interval between them is not stated. It will be fundamental to build a metric to compare STMs variability across sessions/recordings/days; a root-mean-square from an average map across all recordings could provide a starting point.

      Also with respect to the STMs analysis, the data-driven choice of 10 clusters might need a bit more explorations. While the silhouette clustering accuracy peaks at 10 (Fig 5A), this metrics comes without a confidence intervals making it difficult to know if a difference of less than 10% (i.e. 11 or 13 clusters) should be deemed different. Maybe a bootstrapping approach could be used here to build such confidence intervals. Another approach to reach the number of cluster to use could be based on "consensus" between different partitioning algorithms (e.g. Strehl, A. & Ghosh, J. itions. J. Mach. Learn. Res. 3, 583-617 (2001). A much stronger argument should be provided to use the 0.3 correlation cutoff value which seems to be arbitrarily low. The main point here is that the authors should show that their conclusions hold within a range of parameter values (number of clusters and correlation threshold).

    2. Reviewer #2 (Public Review):

      The article presents 'Mesotrode,' a technique that integrates chronic widefield calcium imaging and electrophysiology recordings using tetrodes in head-fixed mice. This approach allows recording the activity of a few single neurons in multiple cortical/subcortical structures, in which the tetrodes are implanted, in combination with widefield imaging of dorsal cortex activity on the mesoscale level, albeit without cellular resolution. The authors claim that Mesotrode can be used to sample different combinations of cortico-subcortical networks over prolonged periods of time, up to 60 days post-implantation. The results demonstrate that the activity of neurons recorded from distinct cortical and subcortical structures are coupled to diverse but segregated cortical functional maps, suggesting that neurons of different origins participate in distinct cortico-subcortical pathways. The study also extends the capability of Mesotrode by conducting electrophysiological recordings from the facial motor nerve. It demonstrates that facial nerve spiking is functionally associated with several cortical areas( PTA, RSP, and M2), and optogenetic inhibition of the PTA area significantly reduced the facial movement of the mice.

      Studying the relationship between widefield cortical activity patterns and the activity of individual neurons in cortical and subcortical areas is very important, and Murphy's lab has been a pioneer in the field. However, the choice of low-yield recording methods (tetrode) instead of more high-yield recording techniques, such as silicon probes, makes the approach presented in this study somewhat less appealing. Also, the authors claim that a tetrode-based approach can allow chronic recordings of single neural activity over days - a topic that is very controversial. In terms of results, I was under the impression that most of the conclusions presented in the bulk of the paper ( Figures 1-5) are very similar to what previous work from Murphy's lab and other labs has shown using acute preparation. In this respect, the paper can benefit from a more in-depth analysis of the heterogeneity of single-neuron functional coupling. The last part of the facial nerve recording is interesting (Figure 6), but I think it can be integrated better into the rest of the paper.

    1. Reviewer #1 (Public Review):

      In this study, Hoops et al. showed that Netrin-1 and UNC5c can guide dopaminergic innervation from nucleus accumbens to cortex during adolescence in rodent models. They found that these dopamine axons project to the prefrontal cortex in a Netrin-1 dependent manner and knocking down Netrin-1 disrupted motor and learning behaviors in mice. Furthermroe, the authors used hamsters, a seasonal model that is affected by the length of daylight, to demonstrate that the guidance of dopamine axons is mediated by the environmental factor such as daytime length and in sex dependent manner. While this study highlighted the important roles of two neurodevelopmental markers, netrin-1 and UNC5C, in the projection of dopaminergic azons in the adolescence/adult brain, the major weakness is that the data are quite superficial and do not establish any definitive evidence to support the causal relationship between the expression of netrin-1 and UNC5C in the projection of dopaminergic axons remain unclear.<br /> Below are several major concerns regarding the data presented in this manuscript:

      1. Despite the well-established role of Netrin-1 and UNC5C axon guidance during embryonic commissural axons, it remains unclear which cell type(s) express Netrin-1 or UNC5C in the dopaminergic axons and their targets. For instance, the data in Figure 1F-G and Figure 2 are quite confusing. Does Netrin-1 or UNC5C express in all cell types or only dopamine-positive neurons in these two mouse models? It will also be important to provide quantitative assessments of UNC5C expression in dopaminergic axons at different ages.

      2. Figure 1 used shRNA to knockdown Netrin-1 in the Septum and these mice were subjected to behavioral testing. These results, again, are not supported by any valid data that the knockdown approach actually worked in dopaminergic axons. It is also unclear whether knocking down Netrin-1 in the septum will re-route dopaminergic axons or lead to cell death in the dopaminergic neurons in the substantia nigra pars compacta?

      3. Another issue with Figure1J. It is unclear whether the viruses were injected into a WT mouse model or into a Cre-mouse model driven by a promoter specifically expresses in dorsal peduncular cortex? The authors should provide evidence that Netrin-1 mRNA and proteins are indeed significantly reduced. The authors should address the anatomic results of the area of virus diffusion to confirm the virus specifically infected the cells in dorsal peduncular cortex.

      4. The authors need to provide information regarding the efficiency and duration of knocking down. For instance, in Figure 1K, the mice were tested after 53 days post injection, can the virus activity in the brain last for such a long time?

      5. In Figure 1N-Q, silencing Netrin-1 results in less DA axons targeting to infralimbic cortex, but why the Netrin-1 knocking down mice revealed the improved behavior?

      6. What is the effect of knocking down UNC5C on dopamine axons guidance to the cortex?

      7. In Figures 2-4, the authors only showed the amount of DA axons and UNC5C in NAcc. However, it remains unclear whether these experiments also impact the projections of dopaminergic axons to other brain regions, critical for the behavioral phenotypes. What about other brain regions such as prefrontal cortex? Do the projection of DA axons and UNC5c level in cortex have similar pattern to those in NAcc?

      8. Can overexpression of UNC5c or Netrin-1 in male winter hamsters mimic the observations in summer hamsters? Or overexpression of UNC5c in female summer hamsters to mimic the winter hamster? This would be helpful to confirm the causal role of UNC5C in guiding DA axons during adolescence.

      9. The entire study relied on using tyrosine hydroxylase (TH) as a marker for dopaminergic axons. However, the expression of TH (either by IHC or IF) can be influenced by other environmental factors, that could alter the expression of TH at the cellular level.

      10. Are Netrin-1/UNC5C the only signal guiding dopamine axon during adolescence? Are there other neuronal circuits involved in this process?

      11. Finally, despite the authors' claim that the dopaminergic axon project is sensitive to the duration of daylight in the hamster, they never provided definitive evidence to support this hypothesis.

    2. Reviewer #2 (Public Review):

      In this manuscript, Hoops et al., using two different model systems, identified key developmental changes in Netrin-1 and UNC5C signaling that correspond to behavioral changes and are sensitive to environmental factors that affect the timing of development. They found that Netrin-1 expression is highest in regions of the striatum and cortex where TH+ axons are travelling, and that knocking down Netrin-1 reduces TH+ varicosities in mPFC and reduces impulsive behaviors in a Go-No-Go test. Further, they show that the onset of Unc5 expression is sexually dimorphic in mice, and that in Siberian hamsters, environmental effects on development are also sexually dimorophic. This study addresses an important question using approaches that link molecular, circuit and behavioral changes. Understanding developmental trajectories of adolescence, and how they can be impacted by environmental factors, is an understudied area of neuroscience that is highly relevant to understanding the onset of mental health disorders. I appreciated the inclusion of replication cohorts within the study.

    3. Reviewer #3 (Public Review):

      This study from the Flores group aims at understanding neuronal circuit changes during adolescence which is an ill-defined, transitional period involving dramatic changes in behavior and anatomy. They focus on DA innervation of the prefrontal cortex, and their interaction with the guidance cue Netrin-1. They propose DA axons in the PFC increase in the postnatal period, and their density is reduced in a Netrin 1 knockdown, suggesting that Netrin abets the development of this mesocortical pathway. In such mice impulsivity gauged by a go-no go task is reduced. They then provide some evidence that Unc5c is developmentally regulated in DA axons. Finally they use an interesting hamster model, to study the effect of light hours on mesocortical innervation, and make some interesting observations about the timing of innervation and Unc5c expression, and the fact that females housed in winter day length conditions display an accelerated innervation of the prefrontal cortex. While this work is novel and on an interesting, understudied topic, several aspects need to be further consolidated, to make it more persuasive.

      Main comments<br /> 1. Fig 1 A and B don't appear to be the same section level.<br /> 2. Fig 1C. It is not clear that these axons are crossing from the shell of the NAC.<br /> 3. Fig 1. Measuring width of the bundle is an odd way to measure DA axon numbers. First the width could be changing during adult for various reasons including change in brain size. Second, I wouldn't consider these axons in a traditional bundle. Third, could DA axon counts be provided, rather than these proxy measures.<br /> 4. TH in the cortex could also be of noradrenergic origin. This needs to be ruled out to score DA axons<br /> 5. Netrin staining should be provided with NeuN + DAPI; its not clear these are all cell bodies. An in situ of Netrin would help as well.<br /> 6. The Netrin knockdown needs validation. How strong was the knockdown etc?<br /> 7. If the conclusion that knocking down Netrin in cortex decreases DA innervation of the IL, how can that be reconciled with Netrin-Unc repulsion.<br /> 8. The behavioral phenotype in Fig 1 is interesting, but its not clear if its related to DA axons/signaling. IN general, no evidence in this paper is provided for the role of DA in the adolescent behaviors described.<br /> 9. Fig2 - boxes should be drawn on the NAc diagram to indicate sampled regions. Some quantification of Unc5c would be useful. Also, some validation of the Unc5c antibody would be nice.<br /> 10. "In adolescence, dopamine neurons begin to express the repulsive Netrin-1 receptor UNC5C, and reduction in UNC5C expression appears to cause growth of mesolimbic dopamine axons to the prefrontal cortex".....This is confusing. Figure 2 shows a developmental increase in UNc5c not a decrease. So when is the "reduction in Unc5c expression" occurring?<br /> 11. In Fig 3, a statistical comparison should be made between summer male and winter male, to justify the conclusions that the winter males have delayed DA innervation.<br /> 12. Should axon length also be measured here (Fig 3)? It is not clear why the authors have switched to varicosity density. Also, a box should be drawn in the NAC cartoon to indicate the region that was sampled.<br /> 13. In Fig 3, Unc5c should be quantified to bolster the interesting finding that Unc5c expression dynamics are different between summer and winter hamsters. Unc5c mRNA experiments would also be important to see if similar changes are observed at the transcript level.<br /> 14. Fig 4. The peak in exploratory behavior in winter females is counterintuitive and needs to be better discussed. IN general, the light dark behavior seems quite variable.

    1. Reviewer #1 (Public Review):

      This paper describes the development and initial validation of an approach-avoidance task and its relationship to anxiety. The task is a two-armed bandit where one choice is 'safer' - has no probability of punishment, delivered as an aversive sound, but also lower probability of reward - and the other choice involves a reward-punishment conflict. The authors fit a computational model of reinforcement learning to this task and found that self-reported state anxiety during the task was related to a greater likelihood of choosing the safe stimulus when the other (conflict) stimulus had a higher likelihood of punishment. Computationally, this was represented by a smaller value for the ratio of reward to punishment sensitivity in people with higher task-induced anxiety. They replicated this finding, but not another finding that this behavior was related to a measure of psychopathology (experiential avoidance), in a second sample. They also tested test-retest reliability in a sub-sample tested twice, one week apart and found that some aspects of task behavior had acceptable levels of reliability. The introduction makes a strong appeal to back-translation and computational validity, but many aspects of the rationale for this task need to be strengthened or better explained. The task design is clever and most methods are solid - it is encouraging to see attempts to validate tasks as they are developed. There are a few methodological questions and interpretation issues, but they do not affect the overall findings. The lack of replicated effects with psychopathology may mean that this task is better suited to assess state anxiety, or to serve as a foundation for additional task development.

    2. Reviewer #2 (Public Review):

      Summary:<br /> The authors develop a computational approach-avoidance-conflict (AAC) task, designed to overcome limitations of existing offer based AAC tasks. The task incorporated likelihoods of receiving rewards/ punishments that would be learned by the participants to ensure computational validity and estimated model parameters related to reward/punishment and task induced anxiety. Two independent samples of online participants were tested. In both samples participants who experienced greater task induced anxiety avoided choices associated with greater probability of punishment. Computational modelling revealed that this effect was explained by greater individual sensitivities to punishment relative to rewards.

      Strengths:<br /> Large internet-based samples, with discovery sample (n = 369), pre-registered replication sample (n = 629) and test-retest sub group (n = 57). Extensive compliance measures (e.g. audio checks) seek to improve adherence.

      There is a great need for RL tasks that model threatening outcomes rather than simply loss of reward. The main model parameters show strong effects and the additional indices with task based anxiety are a useful extension. Associations were broadly replicated across samples. Fair to excellent reliability of model parameters is encouraging and badly needed for behavioral tasks of threat sensitivity.

      The task seems to have lower approach bias than some other AAC tasks in the literature. Although this was inferred by looking at Fig 2 (it doesn't seem to drop below 46%) and Fig 3d seems to show quite a strong approach bias when using a reward/punishment sensitivity index. It would be good to confirm some overall stats on % of trials approached/avoided overall.

      Weaknesses:<br /> The negative reliability of punishment learning rate is concerning as this is an important outcome.

      The Kendall's tau values underlying task induced anxiety and safety reference/ various indices are very weak (all < 0.1), as are the mediation effects (all beta < 0.01). This should be highlighted as a limitation, although the interaction with P(punishment|conflict) does explain some of this.

      The inclusion of only one level of reward (and punishment) limits the ecological validity of the sensitivity indices.

      Appraisal and impact:<br /> Overall this is a very strong paper, describing a novel task that could help move the field of RL forward to take account of threat processing more fully. The large sample size with discovery, replication and test-retest gives confidence in the findings. The task has good ecological validity and associations with task-based anxiety and clinical self-report demonstrate clinical relevance. The authors could give further context but test-retest of the punishment learning parameter is the only real concern. Overall this task provides an exciting new probe of reward/threat that could be used in mechanistic disease models.

    3. Reviewer #3 (Public Review):

      This study investigated cognitive mechanisms underlying approach-avoidance behavior using a novel reinforcement learning task and computational modelling. Participants could select a risky "conflict" option (latent, fluctuating probabilities of monetary reward and/or unpleasant sound [punishment]) or a safe option (separate, generally lower probability of reward). Overall, participant choices were skewed towards more rewarded options, but were also repelled by increasing probability of punishment. Individual patterns of behavior were well-captured by a reinforcement learning model that included parameters for reward and punishment sensitivity, and learning rates for reward and punishment. This is a nice replication of existing findings suggesting reward and punishment have opposing effects on behavior through dissociated sensitivity to reward versus punishment.

      Interestingly, avoidance of the conflict option was predicted by self-reported task-induced anxiety. This effect of anxiety was mediated by the difference in modelled sensitivity to reward versus punishment (relative sensitivity). Importantly, when a subset of participants were retested over 1 week later, most behavioral tendencies and model parameters were recapitulated, suggesting the task may capture stable traits relevant to approach-avoidance decision-making.

      However, interpretation of these findings are severely undermined by the fact that the aversiveness of the auditory punisher was largely determined by participants, with the far-reaching impacts of this not being accounted for in any of the analyses. The manipulation check to confirm participants did not mute their sound is highly commendable, but the thresholding of punisher volume to "loud but comfortable" at the outset of the task leaves substantial scope for variability in the punisher delivered to participants. Indeed, participants' ratings of the unpleasantness of the punishment was moderate and highly variable (M = 31.7 out of 50, SD = 12.8 [distribution unreported]). Despite having this rating, it is not incorporated into analyses. It is possible that the key finding of relationships between task-induced anxiety, reward-punishment sensitivity and avoidance are driven by differences in the punisher experienced; a louder punisher is more unpleasant, driving greater task-induced anxiety, model-derived punishment sensitivity, and avoidance (and vice versa). This issue can also explain the counterintuitive findings from re-tested participants; lower/negatively correlated task-induced anxiety and punishment-related cognitive parameters may have been due to participants adjusting their sound settings to make the task less aversive (retest punisher rating not reported). It can therefore be argued that the task may not actually capture meaningful cognitive/motivational traits and their effects on decision-making, but instead spurious differences in punisher intensity.

      This undercuts the proposed significance of this task as a translational tool for understanding anxiety and avoidance. More information about ratings of punisher unpleasantness and its relationship to task behavior, anxiety and cognitive parameters would be valuable for interpreting findings. It would also be of interest whether the same results were observed if the aversiveness of the punisher was titrated prior to the task.

      Although the procedure and findings reported here remain valuable to the field, claims of novelty including its translational potential are perhaps overstated. This study complements and sits within a much broader literature that investigates roles for aversion and cognitive traits in approach-avoidance decisions. This includes numerous studies that apply reinforcement learning models to behavior in two-choice tasks with latent probabilities of reward and punishment (e.g., see doi: 10.1001/jamapsychiatry.2022.0051), as well as other translationally-relevant paradigms (e.g., doi: 10.3389/fpsyg.2014.00203, 10.7554/eLife.69594, etc).

    1. Reviewer #1 (Public Review):

      Sensory neurons of the mechanosensory bristles on the head of the fly project to the sub esophageal ganglion (SEZ). In this manuscript, the authors have built on a large body of previous work to comprehensively classify and quantify the head bristles. They broadly identify the nerves that various bristles use to project to the SEZ and describe their region-specific innervation in the SEZ. They use dye-fills, clonal labelling, and electron microscopic reconstructions to describe in detail the phenomenon of somatotopy - conserved peripheral representations within the central brain - within the innervation of these neurons. In the process they develop novel tools to access subsets of these neurons. They use these to demostrate that groups of bristles in different parts of the head control different aspects of the grooming sequence.

    2. Reviewer #2 (Public Review):

      The authors combine genetic tools, dye fills and connectome analysis techniques to generate a "first-of-its-kind", near complete, synaptic resolution map of the head bristle neurons of Drosophila. While some of the BMN anatomy was already known based on previous work by the authors and other researchers, this is the first time a near complete map has been created for the head BMNs at electron microscopy resolution.

      Strengths:<br /> 1. The authors cleverly use techniques that allow moving back and forth between periphery (head bristle location) and brain, as well as moving between light microscopy and electron microscopy data. This allows them to first characterize the pathways taken by different head BMNs to project to the brain and also characterize anatomical differences among individual neurons at the level of morphology and connectivity.<br /> 2. The work is very comprehensive and results in a near complete map of all head BMNs.<br /> 3. Authors also complement this anatomical characterization with a first-level functional analysis using optogenetic activation of BMNs that results in expected directed grooming behavior.

      Weaknesses:<br /> 1. The clustering analysis is compelling but cluster numbers seem to be arbitrarily chosen instead of by using some informed metrics.<br /> 2. It could help provide context if authors revealed some of the important downstream pathways that could explain optogenetics behavioral phenotypes and previously shown hierarchical organization of grooming sequences.<br /> 3. In contrast to the rigorous quantitative analysis of the anatomical data, the behavioral data is analyzed using much more subjective methods. While I do not think it is necessary to perform a rigorous analysis of behaviors in this anatomy focused manuscript, the conclusions based on behavioral analysis should be treated as speculative in the current form e.g. calling "nodding + backward walking" as an avoidance response is not justified as it currently stands. Strong optogenetic activation could lead to sudden postural changes that due to purely biomechanical constraints could lead to a couple of backward steps as seen in the example videos. Moreover since the quantification is manual, it is not clear what the analyst interprets as backward walking or nodding. Interpretation is also concerning because controls show backward walking (although in fewer instances based on subjective quantification).

      Summary:<br /> The authors end up generating a near-complete map of head BMNs that will serve as a long-standing resource to the Drosophila research community. This will directly shape future experiments aimed at modeling or functionally analyzing the head grooming circuit to understand how somatotopy guides behaviors.

    3. Reviewer #3 (Public Review):

      Eichler et al. set out to map the locations of the mechanosensory bristles on the fly head, examine the axonal morphology of the bristle mechanosensory neurons (BMNs) that innervate them, and match these to electron microscopy reconstructions of the same BMNs in a previously published EM volume of the female adult fly brain. They used BMN synaptic connectivity information to create clusters of BMNs that they show occupy different regions of the subesophageal zone brain region and use optogenetic activation of subsets of BMNs to support the claim that the morphological projections and connectivity of defined groups of BMNs are consistent with the parallel model for behavioral sequence generation.

      The authors have beautifully cataloged the mechanosensory bristles and the projection paths and patterns of the corresponding BMN axons in the brain using detailed and painstaking methods. The result is a neuroanatomy resource that will be an important community resource. To match BMNs reconstructed in an electron microscopy volume of the adult fly brain, the authors matched clustered reconstructed BMNs with light-level BMN classes using a variety of methods, but evidence for matching is only summarized and not demonstrated in a way that allows the reader to evaluate the strength of the evidence. The authors then switch from morphology-based categorization to non-BMN connectivity as a clustering method, which they claim demonstrates that BMNs form a somatotopic map in the brain. This map is not easily appreciated, and although contralateral projections in some populations are clear, the distinct projection zones that are mentioned by the authors are not readily apparent. Because of the extensive morphological overlap between connectivity-based clusters, it is not clear that small projection differences at the projection level are what determines the post-synaptic connectivity of a given BMN cluster or their functional role during behavior. The claim the somatotopic organization of BMN projections is preserved among their postsynaptic partners to form parallel sensory pathways is not supported by the result that different connectivity clusters still have high cosine similarity in a number of cases (i.e. Clusters 1 and 3, or Clusters 1 and 2). Finally, the authors use tools that were generated during the light-level characterization of BMN projections to show that specifically activating BMNs that innervate different areas of the head triggers different grooming behaviors. In one case, activation of a single population of sensory bristles (lnOm) triggers two different behaviors, both eye and dorsal head grooming. This result does not seem consistent with the parallel model, which suggests that these behaviors should be mutually exclusive and rely on parallel downstream circuitry.

      This work will have a positive impact on the field by contributing a complete accounting of the mechanosensory bristles of the fruit fly head, describing the brain projection patterns of the BMNs that innervate them, and linking them to BMN sensory projections in an electron microscopy volume of the adult fly brain. It will also have a positive impact on the field by providing genetic tools to help functionally subdivide the contributions of different BMN populations to circuit computations and behavior. This contribution will pave the way for further mechanistic study of central circuits that subserve grooming circuits.

    1. Reviewer #1 (Public Review):

      This important study reveals the structure of human STEAP2 for the first time and suggests the electron transport pathway, but some questions remain regarding the interpretation of the in vitro electron transport experiments, the lack of available redox couples, and potential alternative hypotheses that would if addressed, strengthen the claims in the manuscript.

      Strengths

      One of the clear strengths of the manuscript that stands out is the determination of the structure of human STEAP2. The structures of some other homologs are known, but STEAP2's structure was not, and STEAP2 seems to have an unusually low activity towards certain metal chelates. The approach of producing the human STEAP2 in insect cells with the supplementation of cofactor biogenesis components nicely results in cofactor-replete protein. The structure of STEAP2 reveals a domain-swapped trimer, with the NADPH-binding domain of the neighboring protomer within electron-transport distance of the FAD-heme axis. The FAD has an interesting and somewhat unusual extended conformation and abuts a Leu residue that may regulate electron transport. Another strength of the manuscript is the demonstration that STEAP1, which does not have the internal NADPH binding domain, can interact modestly and shuttle electrons to the heme in STEAP1 through FAD. These experiments nicely expand information on the function of STEAP1 and provide a structural basis for electron transport in STEAP2.

      Weaknesses

      A major weakness in the manuscript lies with the kinetics data and how the data, as presented, are unclear to the reader regarding their impact and their connection to the purported electron transport scheme. While multiple sets of data are reported, the analysis in all cases is simply the reduction of a hexacoordinate heme and its related spectra and kinetic parameters. In most cases, it's unclear to the reader which part of the electron pathway is being tested in which experiment. Simple diagrams would be helpful in each case. However, it's also unclear if all of the potential order of addition experiments were actually performed; i.e., flavin but no NADPH; NADPH but no flavin; flavin before NADPH; flavin after NADPH, etc. As there are multiple permutations that should be tested to demonstrate the electron transport pathway, presenting the data in a way that makes it clear to the reader is challenging. Particularly missing are the determined redox potentials of the hemes in both STEAP1 and STEAP2. Could differences in these heme redox potentials be drivers of the difference in metal reduction rates? Also, the text indicates that STEAP2 does not show a reduction rate dependence on the [Fe3+-NTA], but Figure 1A shows a difference in rates dependent on [Fe3+-NTA], and the shape of the reduction curve also changes based on [Fe3+-NTA]. This discrepancy should be rectified.

      A second major weakness is the lack of any verification of the relevance of the STEAP2 oligomerization to its in vivo function. Is the same domain-swapped trimer known to exist in vivo? If the protein were prepared in other detergents, is the oligomerization preserved? It is alluded to in the text that another STEAP protein is also a trimer. Was this oligomerization verified in vivo? Could this oligomerization be disrupted to impede or abrogate electron transport to underscore the oligomerization relevance? This point is germane, as it would further suggest that the domain-swapped trimer observed in the STEAP2 cryo-EM structure is physiologically relevant, especially given how far the distance between the NADPH and the FAD would otherwise be to support electron transport.

      Beyond these two areas in which the manuscript could be improved there are a couple of minor considerations. First, the modest resolution of the STEAP2 structure prevents assigning the states of NADP+/NADPH and FAD/FADH2 with confidence. An orthogonal measure would be useful for modeling the accurate states in the structure. Finally, the BLI b5R/STEAP1 binding/unbinding fits seem somewhat poor, especially at high concentrations of b5R in the dissociation regime, which likely influences the derived value of Kd. A different fitting equilibrium might yield better agreement between the experimental and theoretical results. Moreover, whether this binding strength is influenced by the reduction state of the NADPH would be helpful in understanding and contextualizing the weak binding affinity.

    2. Reviewer #2 (Public Review):

      The manuscript provides new insight into a family of human enzymes. It demonstrates that STEAP2 can reduce iron and STEAP1 can be promiscuous regarding the source of electron donors that it can use. The quality of the kinetics experiment and the structural analysis is excellent. I am less enthusiastic about the interpretation of data and the take-home message that the manuscript intends to deliver. Above all, the work combines data on STEAP2 and STEAP1 and it remains unclear which questions are ultimately addressed. A second critical point is about the interpretation of the experiment demonstrating that STEAP1 can be reduced by cytochrome b5 reductase. The abstract states that "We show that STEAP1 can form an electron transfer chain with cytochrome b5 reductase" whereas the main text discusses the data by suggesting that "we speculate that FAD on b5R may partially dissociate to straddle between the two proteins". The two statements seem to be partly contradictory. Cytochrome b5 reductases do not easily release FAD but rather directly donate electrons to heme-protein acceptors (PMID: 36441026). According to the methods section, no FAD was added to the reaction mix used for the cytochrome b5 reductase experiment. Overall, the data seem to indicate that the reductase might reduce the heme of STEAP1 directly. Would it be possible to check whether FAD addition affects the kinetics of the process? And to perform a control experiment to check that NAD(P)H does not directly reduce the heme of STEAP1 (though unlikely)? A final point concerns the "slow Fe3+-NTA reduction by STEAP2". The reaction is not that slow as the initial phase is 2 per second. The reaction does not show dependence on the substrate concentration suggesting "poor substrate binding". I am not convinced by this interpretation. Poor substrate binding would give rise to substrate dependency as saturation would not be achieved. A possible interpretation could be that substrate binding is instead tight and the enzyme is saturated by the substrate. Can it be that the reaction is limited by non-productive substrate-binding and/or by interconversions between active and non-active conformations?

    3. Reviewer #3 (Public Review):

      The six-transmembrane epithelial antigen of the prostate (STEAP) family comprises four members in metazoans. STEAP1 was identified as integral membrane protein highly upregulated on the plasma membrane of prostate cancer cells (PMID: 10588738), and it later became evident that other STEAP proteins are also over expressed in cancers, making STEAPs potential therapeutic targets (PMID: 22804687). Functionally, STEAP2-4 are ferric and cupric reductases that are important for maintaining cellular metal uptake (PMIDs: 16227996, 16609065). The cellular function of STEAP1 remains unknown, as it cannot function as an independent metalloreductase. In the last years, structural and functional data have revealed that STEAPs form trimeric assemblies and that they transport electrons from intracellular NADPH, through membrane bound FAD and heme cofactors, to extracellular metal ions (PMIDs: 23733181, 26205815, 30337524). In addition, numerous studies (including a previous study from the senior authors) have provided strong implications for a potential metalloreductase function of STEAP1 (PMIDs: 27792302, 32409586).

      This new study by Chen et al. aims to further characterize the previously established electron transport chain in STEAPs in high molecular detail through a variety of assays. This is a well-performed, highly specialized study that provides some useful extra insights into the established mechanism of electron transport in STEAP proteins. The authors first perform a detailed spectroscopic analysis of Fe3+-NTA reduction by STEAP2 and STEAP1, confirming that both purified proteins are capable of reducing metal ions. A cryo-EM structure of STEAP2 is also presented. It is then established that STEAP1 can receive electrons from cytochrome b5 reductase, and the authors provide experimental evidence that the flavin in STEAP proteins becomes diffusible.

      The specific aims of the study are clear, but it is not always obvious why certain experiments are performed only on STEAP2, on STEAP1, or on both isoforms. A better justification of the performed experiments through connecting paragraphs and proper referencing of the literature would improve readability of the manuscript. Experimentally, the conclusions are appropriate and mostly consistent with the experimental data, although one important finding can benefit from further clarification. Namely, the observation that STEAP1 can form an electron transfer chain with cytochrome b5 reductase in vitro is an exciting finding, but its physiological relevance remains to be validated. The metalloreductase activity of STEAP1 in vitro has been described previously by the authors and by others (PMIDs: 27792302, 32409586). However, when over expressed in HEK cells, STEAP1 by itself does not display metal ion reductase activity (PMID: 16609065), and it was also found that STEAP1 over expression does not impact iron uptake and reduction in Ewing's sarcoma (cancer) cells (PMID: 22080479). Therefore, the physiological relevance of metal ion reduction by STEAP1 remains controversial. The current work establishes an electron transfer chain between STEAP1 and cytochrome b5 reductase in vitro with purified proteins. However, the conformation of this metalloreductase activity of the STEAP1-cytochrome b5 complex will be required in a cell line to prove that the two proteins indeed form a physiological relevant complex and that the results are not just an in vitro artefact from using high concentrations of purified proteins.

      The work will be interesting for scientists working within the STEAP field. However, some of the presented data are redundant with previous findings, moderating the study's impact. For instance, the new structural insights into STEAP2 are limited because the structure is virtually identical to the published structures of STEAP4 and STEAP1 (PMIDs: 30337524, 32409586), which is not surprising because of the high sequence similarity between the STEAP isoforms. Moreover, the authors provide experimental evidence to prove the previous hypothesis (PMID: 30337524) that the flavin in STEAP proteins becomes diffusible, but the molecular arrangement of a STEAP protein, in which the flavin interacts with NADPH, remains unknown. Based on the manuscript title, I would also expect the in-depth characterization of STEAP1/STEAP2 hetero trimers (first identified by the authors), but this is only briefly mentioned. When taken together, this study by Chen et al. strengthens and supports previously published biochemical and structural data on STEAP proteins, without revealing many prominent conceptual advances.

    1. Reviewer #1 (Public Review):

      This study aims to identify the existence of hedonic feeding and to distinguish it from homeostatic feeding, in Drosophila. The authors use direct observation of feeding events, a novel automated feeding event detector, inventive behavioral assays, and genetics to separate out the ways that the Drosophila interacts with food. Using two choice assays, the authors find an increased duration of interactions with high-concentration sugars under conditions of expected satiety, which is considered to be hedonic feeding.

      The technical advances in the measurement of animal interactions with food will help advance the understanding of feeding behavior and motivational states. The correlation of specific types of food interactions across satiation state, sex, and circadian time will help drive forward the understanding of the scope of an animal's goals with feeding, and likely their relation between species and eating disorders. The assessment of mushroom body circuitry in a type of food interaction is helpful for understanding the coding of feeding control in the brain.

      The bulk of the feeding data presented in the manuscript are from the interactions of individual flies with a source of liquid food, where interaction is defined as 'physical contact of a specific duration.' Although the assay they use allows for measurements to be made at high temporal resolution, the authors include some data showing that solid food consumption follows the same trend.

    2. Reviewer #2 (Public Review):

      Weaver et al. used video analysis of flies that were feeding in their previously developed FLIC assay to begin to dissect the mechanisms of feeding. FLIC or Fly Liquid Interaction Counter records electrical signals that are generated when a fly touches a liquid food substrate with its legs or proboscis or both. Using video data of the liquid food interactions in the FLIC assay allowed the authors to precisely identify what a fly is doing in the feeding chamber and what the relationship is between the flies' behavior and the electrical signal recorded in the assay. This analysis produced the first detailed behavioral profile of feeding flies and allowed the authors to categorize different types of feeding in the FLIC assay, from tasting food (using their legs) to fast and long feeding bouts (using their proboscis).

      After establishing what FLIC signals correspond to the different types of feeding, they used these signals to examine the food choices of starved and sated flies when presented with a sugar-rich (2% sucrose) or protein-rich (2% yeast + 1% sucrose) liquid food source. To represent hedonic feeding, they also presented flies with a choice between super sweet (20% sucrose) food or protein-rich (2% yeast + 1% sucrose) liquid food. Although fully fed flies show no difference in the number of times they visit either food choice, the flies spend more time feeding during their visits on 20% sucrose food than they do on regular sugar and on the yeast food source, suggesting that 20% sucrose is a more pleasurable food source. To make sure this was not due to the higher caloric content of 20% sucrose, they also offered flies food with the same sweetness as 20% sucrose (2% sucrose + 18% arabinose) but without caloric content and food with the same caloric content but the sweetness of 2% sucrose (2% sucrose + 18% sorbitol). This experiment showed that sweetness was the driver for the longer feeding bouts, confirming that sweeter food is apparently perceived as more pleasurable. They also looked at the effect of starving flies on the hedonic drive and found that starvation increases the time spent feeding on pleasurable food, consistent with findings in mammals that homeostatic feeding affects the hedonic drive.

      To begin dissecting circuits underlying hedonic drive, the authors used CaMPARI expression in all neurons. CaMPARI is a green fluorescent reporter that turns red in the presence of Ca2+ (a measure of neuronal activity) and UV exposure. Fully fed flies in the super sweet food choice condition showed more red fluorescence in the mushroom bodies. Inhibiting a subset of these neurons acutely shows that horizontal lobes are required for the increased duration of feeding bouts on super sweet food. These lobes are innervated by a cluster of DA neurons and inhibiting them also blocks the increased super sweet feeding times.

      The data in the paper largely support the conclusions. The application of this tool to distinguish between homeostatic and hedonic feeding is innovative and very compelling. As proof of the principle of the strength of their paradigm, the authors identify a distinct brain circuit involved in hedonic feeding. The methods established in the paper make a deeper understanding of feeding mechanisms possible at both a genetic and brain circuit level.

    1. Reviewer #1 (Public Review):

      The authors use a combination of crop modeling and field experiments to argue that drought during seedling establishment likely severely impacts the yield of pearl millet, an important but understudied cereal crop, and that rapid seedling root elongation could play a major role in mitigating this. They further argue that this trait has a strong genetic basis and that major polymorphisms in candidate genes can be identified using standard methods from modern genetics and genomics. Finally, they use homology with the model plant Arabidopsis thaliana to argue that the function of one putatively causal gene is to regulate root cell elongation.

      The major strength of this paper is that it convincingly demonstrates how modern methods from plant breeding and model organisms can be combined to address questions of great practical importance in important but poorly understood crops. The notion that it is possible to connect single-locus polymorphism and cellular biology to drought tolerance and crop yield in pearl millet is not a trivial one.

      The weakness is obvious: while the argument made is convincing, it must be recognized that the strength of the evidence is by no means of the level expected in a model organism. Conclusions could easily be wrong, and there is no direct evidence that regulatory variation in PgGRXC9 leads to higher crop yield via cell elongation and seedling drought tolerance. However, generating such evidence in a poorly studied crop would be a monumental undertaking, and should probably not be the priority of people working on pearl millet!

      The utility of this work is that it suggests that it is practicable to gain valuable insight into crop adaptation by clever use of modern methods from a variety of sources.

    2. Reviewer #2 (Public Review):

      Carla de la Fuente et al., utilize a diversity of approaches to understand which plant traits contribute to the stress resilience of pearl millet in the Sahelian desert environment. By comparing data resulting from crop modeling of pearl millet growth and meteorological data from a span of 20 years, the authors clearly determined that early season drought resilience is contributed by accelerated growth of the seedling primary root, which confirms a hypothesis generated in a previous study, Passot et al., 2016. To determine the genetic basis for this trait, they performed a combination of GWAS, QTL analysis, and RNA sequencing and identified a previously unannotated coding sequence of a glutaredoxin C9-like protein, PgGRXC9, as the strongest candidate. Phenotypic analysis using a mutant of the closest Arabidopsis homolog AtROXY19 suggests the broad conservation of this pathway. Comparisons between the transcript of PgGRXC9 by in situ hybridization (this work) and AtROXY19 pattern expression (Belin et al., 2014) support the hypothesis that this pathway acts in the elongation zone of the root. Additional analysis of cell production and elongation rates in root apex in both pearl millet and A. thaliana suggests that PgGRXC9 specifically regulates primary root through the promotion of cell elongation. While several studies have established the connection between redox status of cells and root growth, the current study represents an important contribution to the field because of the agricultural importance of the plant studied, and the connection made between this developmental trait and stress resilience in a specific and stressful environmental context of the Sahelian desert.

      While the study presents a compelling narrative that is based on a diverse range of approaches, some aspects require further refinement to be fully convincing.

      First, while it is appreciated that working with pearl millet presents certain technical challenges regarding genetic characterization, and the authors have done outstanding work by combing the power of GWAS and QTL mapping to reproducibly identify genetic loci associated with root growth, the related work in Arabidopsis is not fully substantiated. In particular, only one mutant allele was utilized to test the function of this gene in root growth. The lack of a second characterized allele or evidence of genetic complementation makes it difficult to definitively contribute the root developmental defects to the characterized mutation in ROXY19.

      The role of redox status in contributing to root growth differences between accessions was not directly tested here. The manuscript is not able to mechanistically link the molecular function of ROXY19 to the change in root growth rate, however, this limitation of the study was not clearly described in the text.

      The authors state the use of cell elongation rate (Morris and Silk, 1992) as a parameter to estimate the difference in root growth between contrasted pearl millet lines and A. thaliana roxy19 mutant versus wild type; however, there are inconsistencies in what data are presented. First, in Figure 2E, regarding the comparison between different genotypes of pearl millet lines, they use the parameter of maximum cell length but when authors compare cell elongation between A. thaliana genotypes, in Figure 4D, they use the elongation rate parameter. Second, while the cell elongation rate is based exclusively on the cell length data of the "elongation only" zone (Morris and Silk, 1992), the authors profile the cell length in the whole root apex, from the quiescent center to the beginning of the differentiation zone and it is not clear how they discriminate between each developmental zone and what data was used to estimate elongation rate.

    1. Reviewer #1 (Public Review):

      Specifically controlling the level of proteins in bacteria is an important tool for many aspects of microbiology, from basic research to protein production. While there are several established methods for regulating transcription or translation of proteins with light, optogenetic protein degradation has so far not been established in bacteria. In this paper, the authors present a degradation sequence, which they name "LOVtag", based on iLID, a modified version of the blue-light-responsive LOV2 domain of Avena sativa phototropin I (AsLOV2). The authors reasoned that by removing the three C-terminal amino acids of iLID, the modified protein ends in "-E-A-A", similar to the "-L-A-A" C-terminus of the widely used SsrA degradation tag. The authors further speculated that, given the light-induced unfolding of the C-terminal domain of iLID and similar proteins, the "-E-A-A" C-terminus would become more accessible and, in turn, the protein would be more efficiently degraded in blue light than in the dark.

      Indeed, several tested proteins tagged with the "LOVtag" show clearly lower cellular levels in blue light than in the dark. While the system works efficiently with mCherry (10-20x lower levels upon illumination), the effect is rather modest (2-3x lower levels) in most other cases. Accordingly, the authors propose to use their system in combination with other light-controlled expression systems and provide data validating this approach. Unfortunately, despite the claim that the "LOVtag" should work faster than optogenetic systems controlling transcription or translation of protein, the degradation kinetics are not consistently shown; in the one case where this is done, the response time and overall efficiency are similar or slightly worse than for EL222, an optogenetic expression system.

      The manuscript and the figures are generally very well-composed and follow a clear structure. The schematics nicely explain the underlying principles. However, limitations of the method in its main proposed area of use, protein production, should be highlighted more clearly, e.g., (i) the need to attach a C-terminal tag of considerable size to the protein of interest, (ii) the limited efficiency (slightly less efficient and slower than EL222, a light-dependent transcriptional control mechanism), and (iii) the incompletely understood prerequisites for its application. In addition, several important controls and measurements of the characteristics of the systems, such as the degradation kinetics, would need to be shown to allow a comparison of the system with established approaches. The current version also contains several minor mistakes in the figures.

    2. Reviewer #2 (Public Review):

      In this manuscript the authors present and characterize LOVtag, a modified version of the blue-light sensitive AsLOV2 protein, which functions as a light-inducible degron in Escherichia coli. Light has been shown to be a powerful inducer in biological systems as it is often orthogonal and can be controlled in both space and time. Many optogenetic systems target regulation of transcription, however in this manuscript the authors target protein degradation to control protein levels in bacteria. This is an important advance in bacteria, as inducible protein degradation systems in bacteria have lagged behind eukaryotic systems due to protein targeting in bacteria being primarily dependent on primary amino acid sequence and thus more difficult to engineer. In this manuscript, the authors exploit the fact that the J-alpha helix of AsLOV2, which unwinds into a disordered domain in response to blue light, contains an E-A-A amino acid sequence which is very similar to the C-terminal L-A-A sequence in the SsrA tag which is targeted by the unfoldases ClpA and ClpX. They truncate AsLOV2 to create AsLOV2(543) and combine this truncation with a mutation that stabilizes the dark state to generate AsLOV2*(543) which, when fused to the C-terminus of mCherry, confers light-induced degradation. The authors do not verify the mechanism of degradation due to LOVtag, but evidence from deletion mutants contained in the supplemental material hints that there is a ClpA dominated mechanism. They demonstrate modularity of this LOVtag by using it to degrade the LacI repressor, CRISPRa activation through degradation of MCP-SoxS, and the AcrB protein which is part of the AcrAB-TolC multidrug efflux pump. In all cases, measurement of the effect of the LOVtag is indirect as the authors measure reduction in LacI repression, reduction in CRISPRa activation, and drug resistance rather than directly measuring protein levels. Nevertheless the evidence is convincing, although seemingly less effective than in the case of mCherry degradation, although it is hard to compare due to the different endpoints being measured. The authors further modify LOVtag to contain a known photocycle mutation that slows its reversion time in the dark, so that LOVtag is more sensitive to short pulses of light which could be useful in low light conditions or for very light sensitive organisms. They also demonstrate that combining LOVtag with a blue-light transcriptional repression system (EL222) can decrease protein levels an additional 269-fold (relative to 15-fold with LOVtag alone). Finally, the authors apply LOVtag to a metabolic engineering task, namely reducing expression of octanoic acid by regulating the enzyme CpFatB1, an acyl-ACP thioesterase. The authors show that tagging CpFatB1 with LOVtag allows light induced reduction in octanoic acid titer over a 24 hour fermentation. In particular, by comparing control of CpFatB1 with EL222 transcriptional repression alone, LOVtag, or both the authors show that light-induced protein degradation is more effective than light-induced transcriptional repression. The authors suggest that this is because transcriptional repression is not effective when cells are at stationary phase (and thus there is no protein dilution due to cell division), however it is not clear from the available data that the cells were in stationary phase during light exposure. Overall, the authors have generated a modular, light-activated degron tag for use in Escherichia coli that is likely to be a useful tool in the synthetic biology and metabolic engineering toolkit.

    3. Reviewer #3 (Public Review):

      The authors present the mechanism, validation, and modular application of LOVtag, a light-responsive protein degradation tag that is processed by the native degradosome of Escherichia coli. Upon exposure to blue light, the c-terminal alpha helix unfolds, essentially marking the protein for degradation. The authors demonstrate the engineered tag is modular across multiple complex regulatory systems, which shows its potential widespread use throughout the synthetic biology field. The step-by-step rational design of identifying the protein that was most dark-stabilized as well as most light-responsive for degradation, was useful in terms of understanding the key components of this system. The most compelling data shows that the engineered LOVTag can be fused to multiple proteins and achieve light-based degradation, without affecting the original function of the fused protein; however, results are not benchmarked against similar degradation tagging and optogenetic control constructs. Creating fusion proteins that do not alter either of the original functions, is often difficult to achieve, and the novelty of this should be expanded upon to drive further impact.

    1. Joint Public Review:

      The manuscript presented by Pabba et al. studied chromatin dynamics throughout the cell cycle. The authors used fluorescence signals and patterns of GFP-PCNA (GFP tagged proliferating cell nuclear antigen) and CY3-dUTP (which labels newly synthesized DNA but not the DNA template) to determine cell cycle stages in asynchronized HeLa (Kyoto) cells and track movements of chromatin domains. PCNA binds to replication forks and form replication foci during the S phase. The major conclusions are: (1) Labeled chromatin domains were more mobile in G1/G2 relative to the S-phase. (2) Restricted chromatin motion occurred at sites in proximity to DNA replication sites. (3) Chromatin motion was restricted by the loading of replisomes, independent of DNA synthesis. This work is based on previous work published in 2015, entitled "4D Visualization of replication foci in mammalian cells corresponding to individual replicons," in which the labeling method was demonstrated to be sound. Although interesting, reduced chromatin mobility in S relative to G1 phase is not new to the field. The genome in HeLa cells is greatly abnormal with heterogeneous aneuploidy, which makes quantification complicated and weakens the conclusions.

    1. Reviewer #1 (Public Review):

      She et al studied the evolution of gene expression reaction norms when individuals colonise a new environment that exposes them to physiologically challenging conditions. Their objective was to test the "plasticity first" hypothesis, which suggest that traits that are already plastic (their value changes when facing a new environment compared to the original environment) facilitates the colonisation of novel environments, which, if true, would be predicted to result in the evolution of gene expression values that are similar in the population that colonised the new environment and evolved under these particular selection pressures. To test this prediction, they studied gene expression in cardiac and muscle tissues in individuals originating from three conditions: lowland individuals in their natural environment (ancestral state), lowland individuals exposed to hypoxia (the plastic response state), and a highland population facing hypoxia for several generations (the coloniser state). They classified gene expression patterns as maladaptive or adaptive in lowland individuals responding to short term hypoxia by classifying gene expression patterns using genes that differed between the ancestral state (lowland) and colonised state (highland). Genes expressed in the same direction in lowland individuals facing hypoxia (the plastic state) as what is found in the colonised state are defined as adaptative, while genes with the opposite expression pattern were labelled as maladaptive, using the assumption that the colonised state must represent the result of natural selection. Furthermore, genes could be classified as representing reversion plasticity when the expression pattern differed between the plasticity and colonised states and as reinforcement when they were in the same direction (for example more expressed in the plastic state and the colonised state than in the ancestral state). They found that more genes had a plastic expression pattern that was labelled as maladaptive than adaptive. Therefore, some of the genes have an expression pattern in accordance with what would be predicted based on the plasticity-first hypothesis, while others do not.

      As pointed out by the authors themselves, the fact that temperature was not included as a variable, which would make the experimental design much more complex, misses the opportunity to more accurately reflect the environmental conditions that the colonizer individuals face at high altitude. Also pointed out by the authors, the acclimation experiment in hypoxia lasted 4 weeks. It is possible that longer term effects would be identifiable in gene expression in the lowland individuals facing hypoxia on a longer time scale. Furthermore, a sample size of 3 or 4 individuals per group depending on the tissue for wild individuals may miss some of the natural variation present in these populations. Stating that they have a n=7 for the plastic stage and n= 14 for the ancestral and colonized stages refers to the total number of tissue samples and not the number of individuals, according to supplementary table 1. Finally, I could not find a statement indicating that the lowland individuals placed in hypoxia (plastic stage) were from the same population as the lowland individuals for which transcriptomic data was already available, used as the "ancestral state" group (which themselves seem to come from 3 populations Qinghuangdao, Beijing, and Tianjin, according to supplementary table 2) nor if they were sampled in the same time of year (pre reproduction, during breeding, after, or if they were juveniles, proportion of males or females, etc). These two aspects could affect both gene expression (through neutral or adaptive genetic variation among lowland populations that can affect gene expression, or environmental effects other than hypoxia that differ in these populations' environments or because of their sexes or age). This could potentially also affect the FST analysis done by the authors, which they use to claim that strong selective pressure acted on the expression level of some of the genes in the colonised group.

      Impact of the work<br /> There has been work showing that populations adapted to high altitude environments show changes in their hypoxia response that differs from the short-term acclimation response of lowland population of the same species. For example, in humans, see Erzurum et al. 2007 and Peng et al. 2017, where they show that the hypoxia response cascade, which starts with the gene HIF (Hypoxia-Inducible Factor) and includes the EPO gene, which codes for erythropoietin, which in turns activates the production of red blood cell, is LESS activated in high altitude individuals compared to the activation level in lowland individuals (which gives it its name). The present work adds to this body of knowledge showing that the short-term response to hypoxia and the long term one can affect different pathways and that acclimation/plasticity does not always predict what physiological traits will evolve in populations that colonize these environments over many generations and additional selection pressure (UV exposure, temperature, nutrient availability).

      Altogether, this work provides new information on the evolution of reaction norms of genes associated with the physiological response to one of the main environmental variables that affects almost all animals, oxygen availability. It also provides an interesting model system to study this type of question further in a natural population of homeotherms.

      Erzurum, S. C., S. Ghosh, A. J. Janocha, W. Xu, S. Bauer, N. S. Bryan, J. Tejero et al. "Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans." Proceedings of the National Academy of Sciences 104, no. 45 (2007): 17593-17598.

      Peng, Y., C. Cui, Y. He, Ouzhuluobu, H. Zhang, D. Yang, Q. Zhang, Bianbazhuoma, L. Yang, Y. He, et al. 2017. Down-regulation of EPAS1 transcription and genetic adaptation of Tibetans to high-altitude hypoxia. Molecular biology and evolution 34:818-830.

    2. Reviewer #2 (Public Review):

      This is a well-written paper using gene expression in tree sparrow as model traits to distinguish between genetic effects that either reinforce or reverse initial plastic response to environmental changes. Tree sparrow tissues (cardiac and flight muscle) collected in lowland populations subject to hypoxia treatment were profiled for gene expression and compared with previously collected data in 1) highland birds; 2) lowland birds under normal condition to test for differences in directions of changes between initial plastic response and subsequent colonized response.

      The question is an important and interesting one but I have several major concerns on experimental design and interpretations.

      1) The datasets consist of two sources of data. The hypoxia treated birds collected from the current study and highland and lowland birds in their respective native environment from a previous study. This creates a complete confounding between the hypoxia treatment and experimental batches that it is impossible to draw any conclusions. The sample size is relatively small. Basically correlation among tens of thousands of genes was computed based on merely 12 or 9 samples.

      2) Genes are classified into two classes (reversion and reinforcement) based on arbitrarily chosen thresholds. More "reversion" genes are found and this was taken as evidence reversal is more prominent. However, a trivial explanation is that genes must be expressed within a certain range and those plastic changes simply have more space to reverse direction rather than having any biological reason to do so.

      3) The correlation between plastic change and evolved divergence is an artifact due to the definitions of adaptive versus maladaptive changes. For example, the definition of adaptive changes requires that plastic change and evolved divergence are in the same direction (Figure 3a), so the positive correlation was a result of this selection (Figure 3d).

    1. Reviewer #1 (Public Review):

      In this paper, authors used IL-33KO and ILC2KO mice to generate evidence for pregnancy specific enrichment of ILC2s and their unique molecular signatures. They documented that uterine ILC2s are distinct from the ILC2s residing in lung and lymph nodes. They have provided solid evidence that although litter size did not change, but fetuses from ILC2KO mice showed growth restriction. In the absence of ILC2s, LPS injections lead to increased abortion rates and fetal loss suggesting the critical role of ILC2s in protection against infection induced pathology. Most of the results presented in the paper support the conclusion, but in some instances the evidence is indirect. Some clarifications on experimental interpretations are required as below.

      • The immunohistology experiments revealed that IL-33 predominately co-localizes with ILC2 in the myometrium, but the staining appears to be diffused throughout the myometrium. It is difficult to pinpoint ILC2 specific IL-33 colocalization. Is the decidual expression of IL-33 largely restricted to ILC2s? Also, IL-33 is produced by a variety of other cell types including endothelial cells, which is difficult to ascertain from the images in Fig 1.<br /> • Authors report that ILC2s are responsible for fetal growth restriction (FGR) noted in the ILC2 KO mice. They attribute FGR to utero-placental abnormalities but the experimental evidence, including spiral arterial remodelling and glucose transporter gene expression are indirect. Is there any compensation from other cell types such as macrophages in the absence of ILC2s as they reported increased dendritic cells, neutrophils, and macrophages in ILC2KO mice. Clarify whether IL-33 levels were consistent between WT and ILC2KO mice. How do these other increased numbers of macrophages, DCs and neutrophils fit in the FGR context besides gene expression changes they captured in DCs and macrophages.<br /> • They captured spiral arterial wall to lumen ratio alterations in ILC2KO mice suggesting sub-optimal vascular changes in ILC2KO mice. They did not find any changes in the uNK cells or IFN-production between WT and ILC2KO. What would be the mechanistic link between ILC2 and spiral arterial vascular changes. They indirectly link it to the IL1B gene expression.<br /> • In the LPS induced abortion in ILC2 KO mice experiments, how do they reconcile the predominant role of macrophages and LPS induced TNF-a in the pathology? They did not find any differences in the gene expression in the LPS induced signature cytokine, TNF-a despite increased numbers of macrophages in ILC2 KO mice. Clarification is required on whether these inflammatory alterations that they captured directly linked to utero-placental insufficiency between WT and ILC2KO. The type 2 cytokines were barely detectable in ILC2KO mice, which likely predispose them for utero-placental alterations.

    2. Reviewer #2 (Public Review):

      Balmas et al., continue the previous work from multiple groups that suggested the implication of uterine ILC2s and signals that activate them, i.e., IL-33/ST2 axis, in healthy and complicated pregnancies and move forward to understand further their role. The authors leverage available and appropriate tools to address more specifically the role of ILC2s during pregnancy and endotoxin-induced abortion, namely mouse models of selective ILC2 deficiency (Roraflox/floxIl7raCre/wt) and transcriptomic analysis of the immune response.

      The authors demonstrate, and therewith confirm findings by Bartemes et al. (2018), that ILC2 reside in the mouse uterus, depend on IL-33 and expand during pregnancy. Moreover, they show the Il33 expression by CD45- cells of the uterine stroma. What remains unclear is the kinetics of Il33 expression and ILC2 expansion upon gestation and whether the local ILC2 population expands or arrives from the periphery.

      Lack of maternal ILC2, in a mouse genetic model, resulted, as expected, in the absence of uILC2 but also in lighter fetuses at term, similar to the phenotype observed in the absence of maternal IL-33. It would be interesting to understand whether the effect of the IL-33 signaling is a direct ILC2 mediated effect, as for example by using the ST2flox/flox mice. Do the fetuses catch up in weight with their WT controls during weaning time? Do they have any long-term cognitive/behavioral impairment?<br /> The authors showcase the impairment in the remodeling of uterine wall vessels in dams lacking ILC2. It remains to be verified whether this is dependent on IL-33 and whether it is a direct effect of ILC2 or ILC2-dependent infiltration of eosinophils. Further, the absence of ILC2 is accompanied by an increase in Il1b in the uterine tissue suggesting that uILC2 contribute to the uterine microenvironment.

      The authors perform RNA sequencing analysis on the bulk samples of uterine ILC2, where uILC2 cluster separately from corresponding lung and LN cells and are featured with higher expression of typical ILC2 markers. Somewhat odd, the authors report on the Foxp3/FoxP3 expression among uILC2, however the staining is not very bright and a Treg control as well as biological negative control should be provided. Moreover, FoxP3 is also not expressed among intestinal ILC2 with regulatory function (Wang et al. 2017). I suggest this data panel to be re-evaluated. A scRNA-Seq analysis would probably be more comprehensive in this case, but might be beyond the scope of this publication.

      Absence of uILC2 results in the increased numbers of DCs, macrophages and neutrophils in the uterus, an impact which is not visible in the spleen, which is why the authors argue that this is a uterus-restricted phenomenon, although perturbances in the large intestine and lungs could be expected. Moreover, it remains to be investigated whether these effects are restricted to mid-term pregnancy or preserved until term.

      Upon establishing the role of uILC2 in maintaining healthy pregnancy, the authors demonstrate a role for uILC2 in endotoxin-mimicked bacterial infection and abortion. An impressive set of data demonstrate that dams that lack uILC2 have a significantly higher fetus resorption rate than WT dams upon LPS challenge. It remains to be understood whether this phenotype is also dependent on IL-33. Finally, mechanistically, using a somewhat reductionist in vitro model, the authors suggest a protective feedback mechanism between type 2-secreting uILC2 and IL-1b-expressing DCs. This is an interesting concept that still needs a formal confirmation in vivo. Are uILC2 also subjected to plasticity upon IL-1b treatment (Ohne et al. 2016)?

      In conclusion, the authors provide a well-conceived study that will be useful for reproductive and tissue immunologists. The data are collected using validated models and methodology and analyzed in a solid manner and can be used as a starting point for further mechanistic studies, assessing the protective potential of uILC2 in pregnancy during infections.

    3. Reviewer #3 (Public Review):

      The authors show that ILC2s seem to be important during pregnancy to achieve an optimal fetal growth. This is an important finding to the field and provides ILC2s with new roles distinct from parasite protection and allergy inducers. However, the fetal weight restriction phenotype does not seem very striking. Moreover, the mechanism by which ILC2s promote homeostasis in pregnancy are not well shown. The data shown in Figure 3 is overall a bit confusing and does not lead the reader to the conclusions stated in the text. Figure 4 conclusions are not very informative. The authors also show that ILC2s are protective to fetal loss during LPS infection. Again, the means by which ILC2s could be doing so are not well presented and the supporting data not fully convincing. Throughout the manuscript, the authors present quantitative data as fold change, expressing data in fold change is not as clear as showing actual numbers of cells for each group. Moreover, they should show the flow cytometry plots and gating strategy for all their FACS analysis.

    1. Reviewer #1 (Public Review):

      In this study Guss and colleagues identify a requirement of the ECM component Perlecan for the maintenance of neuronal structures. The authors convincingly demonstrate that the absence of Perlecan (in the entire organism) causes a severe perturbation of the ECM-based neural lamella, a support structure surrounding axon bundles and, to a lesser extent, the neuromuscular junction (NMJ). Likely because of these ECM perturbations, axons and even entire nerve bundles break at sites prior to the innervation of the peripheral muscles. Within hemisegments all affected motoneurons show signs of degeneration and synapses are retracted (degenerate). Through targeted genetic approaches in combination with immunohistochemical and electrophysiological approaches the authors aim to elucidate cell specific requirements of Perlecan. Interestingly, knock down of Perlecan in single tissues but also in combinations of tissues (neurons, glia and muscles) was not sufficient to recapitulate the phenotypes observed after ubiquitous knock down. Similarly, a rescue of these phenotypes via motoneuron expression in null mutants was not successful.

      The authors very convincingly demonstrate that in the absence of Perlecan synaptic terminals degenerate and that axon and neural lamella morphology and structure is perturbed. All processes were analyzed using multiple and complementary approaches including live-imaging and electrophysiology. The precise correlation of these phenotypes and especially the careful classification into degenerated and non-affected NMJs revealed that the cause for all phenotypes is likely the disruption of the neural lamella that - through thus far unknown mechanisms - cause axonal breakage and subsequently synaptic retractions.

      This study highlights the importance of the ECM to maintain neuronal structures, however, the precise source of Perlecan and the precise cause of axonal breakage remains still unresolved.

      Further rescue experiments would be necessary to resolve the source of Perlecan. This requires a first demonstration that a rescue is possible with the available tools using a ubiquitous-expression analogous to the RNAi-experiments.<br /> In addition, a careful longitudinal analysis of the integrity of individual axons (e.g. MN1 or MN4) combined with an ECM analysis may provide insights into the place and cause of the axonal breakages that are likely causal for all other observed phenotypes. As pointed out in the discussion a disruption of the blood-brain barrier at specific (?) vulnerable sites seems currently the most reasonable explanation for the observed effects. Surprisingly, the authors did not observe any rescue effect after the inhibition of Wallarian degeneration mechanisms highlighting that the cellular mechanisms underlying these two forms of degeneration in which axons are disrupted may be different.

    2. Reviewer #3 (Public Review):

      The manuscript by Guss et al. characterizes an extracellular matrix protein, Perlecan (trol), in maintaining axon and synapse stability in motor neurons through its function in maintaining the neural lamella's integrity in Drosophila. Using a combination of immunostaining and protein labeling with fluorescent tags, the authors find that perlecan localizes to the neural lamella. When perlecan is deleted, the authors identify a synapse retraction phenotype as the subsequent result of axon damage. They further suggest that this axon instability is the result of loss of perlecan causing a disruption in the neural lamella, due to the mislocalization of neural lamella protein, Collagen IV (Vkg). Moreover, they find that perlecan acts independently of previously characterized interactions with the wnt signaling and Wallerian degradation pathways, however important controls for these negative results are lacking.

      The manuscript offers an interesting and important role for perlecan in motor neuron axon maintenance. However, the experiments attempting to elucidate the mechanism of action of this protein require further validation and clarification.

    1. Reviewer #1 (Public Review):

      We conclude that this descriptive study has some strengths but additionally, we propose several ways in which to increase its potential impact and to strengthen some of the claims. This study describes the remodeling of Merkel cells and their innervating sensory axons in the skin. By using transgenic mouse lines in which these cells were genetically fluorescently labeled, the authors performed a series of analyses mostly focusing on the number and location of Merkel cells and the sensory axons that innervate them.

      One of the major strengths of the study is the establishment of intravital imaging techniques to investigate the dynamic simultaneous behavior of Merkel cells and their innervation during homeostasis and hair regeneration. However, how the findings integrate into the existing knowledge of skin development is unfortunately only partially addressed.

      To the best of our understanding, a few technical limitations of the study define its major weaknesses: First, Merkel cell loss is dramatic and it's unclear whether this reduction is part of a developmentally controlled reduction in cell number, or whether additional cells are expected to be integrated into the system. Longer windows of imaging might help here. Second, the depilation agent might be too aggressive and lead to cell death and thus better controls might be suggested. Similarly, ablating Merkal cells throughout development might cause developmental issues that might mask the proposed homeostasis analyses. A controlled adult specific ablation might be suggested. Finally, the TrkC based transgenic mouse is expected to be heterozygous - could that be an issue? Either better controls, or a textual addressing of this topic are advised.

      All in all, we think this study has the potential to establish a high resolution description of Merkel cells - sensory axon dynamic interactions. We hope that the authors will be encouraged to improve the paper based on our comments, something that will likely improve its potential significance and impact.

    2. Reviewer #2 (Public Review):

      Clary et al. utilized 2-photon intravital imaging techniques to investigate the dynamic behavior of Merkel cells and their innervation during homeostasis and hair regeneration. The authors demonstrated that both Merkel cells (Atoh1-GFP) and the branched axons (TrkC) innervating them undergo significant plasticity and remodeling during homeostasis. Merkel cells were added, removed, and relocated, while axons showed growth and regression. By taking advantage of live imaging, the authors identified two different ways in which Merkel cells interact with axons: creating the stable kylikes and the previously undescribed dynamic Bouton structure. Using live imaging and extensive quantification tools, the authors thoroughly characterized Merkel cell and axon plasticity. They found that Merkel cell plasticity is associated with the hair cycle, while axon plasticity is not. Moreover, newly generated Merkel cells have a short lifespan. By comparing the survival of afferents associated with Merkel cells to empty ones and analyzing Atoh1 cKO, the authors concluded that Merkel cells have a stabilizing effect on axon terminals.

      Strengths:

      The authors developed an intravital imaging system that enables the simultaneous tracking of both Merkel cells and axon branches. Live imaging, combined with numerous quantification tools, enabled an in-depth characterization of the different behaviors and dynamic nature of Merkel cells, axon branches, and their interaction. The authors' approach has the particular strength of allowing for the comparison of the dynamic behavior of axons associated with Merkel cells to those not innervating Merkel cells within the same touch dome, as well as describing a Bouton structure as a novel morphology mediating Merkel cell and nerve interaction.

      Weaknesses:

      Although the authors provide an in-depth analysis of Merkel cell dynamics and its association with hair growth, these concepts have been previously reported by the authors and others. Therefore, the extent of novel concepts and scientific advances should be better explained.

      The authors suggest that Merkel cell association is a stabilizing factor on innervated axon branches by comparing branch plasticity between branches connected to Merkel cells and empty ones and using Atoh cKO. While the first set of experiments are compelling and provide interesting observations, additional experimental models, such as Merkel cell ablation in adults, may better strengthen the authors' claims. The authors currently use K14-Cre;Atoh1 cKO to support their observations. However, the absence of Merkel cell development in this model, might also lead to developmental defects in nerve patterning (absence of target organ) leading to the phenotype observed by the authors.

      Finally, the authors use intravital imaging to describe the Bouton structure and dynamic. Though very interesting there is not enough data to support authors claim for interaction between axon and Merkel cells through the Bouton structure. The paper can benefit from additional functional analysis of this structure.

    3. Reviewer #3 (Public Review):

      This study documents the dynamics of Merkel cells and their axonal afferents during the hair growth cycle. Methodologically, the study is impressive-using two transgenic lines and repeated 2-photon imaging allowed the researchers to monitor Merkel cells and afferent axons over the course of weeks. These exciting tools and methods will enable future studies of these cell interactions. The manuscript is well written, the figures are clear and appealing, the statistical analyses are rigorous and appropriate, and potentially confounding issues (e.g., damage caused by 2-photon imaging or hair removal) were thoughtfully considered and controlled for. The clear and rigorously analyzed findings make the conclusions well justified. The impact of this study could be enhanced with further experiments that provide more functional characterization of boutons and kylikes, and that characterize axonal dynamics in Atoh mutants lacking Merkel cells.

    4. Reviewer #4 (Public Review):

      In this manuscript, Clary and colleagues use two-photon imaging to visualize the dynamics of Merkel cells and their innervating sensory axons using a combination of transgenic lines, where these parts of the mechanosensory organs of the skin are labelled with distinct fluorescent proteins. It is noteworthy that this study does not stand alone, but should be compared to prior published work cited by the authors, such as Wright et al., Developmental Biology 422 (2017) 4-13.

      The study demonstrates a comparably high degree of remodelling, with a large fraction of Merkel cells (50% in three weeks) and a similar fraction of elaborated (cup-like) axons endings disappearing. It appears by timing and correlation that changes in Merkel cells can clearly drive axonal remodelling, while axons can still remodel even if the Merkel cells remain stable by the parameters measured here. Moreover, changes in Merkel cells partially relate to the hair growth cycle.

      The imaging approach chosen is straightforward and clearly suited in principle to reveal the dynamism of the studied cellular structures. To co-visualize two synaptic partners in a vertebrate sensory organ in vivo - while not unprecedented - certainly remains quite challenging, and represents a strength of the paper. Similarly, understanding how stable structures in the nervous system are under homeostatic (rather than developmental) conditions, remains an understudied topic. I also found some of the correlative analysis in the later parts of the study quite interesting, albeit not always straightforward to interpret.

      My central concern is the very high disappearance rate of Merkel cells. This, in my view is not compatible with a steady state situation in an adult animal - and not with the prior literature (especially the similar study by Wright et al. cited above). Obviously, if this rate were to continue, Merkel cells would all be lost in early adulthood in mice. Whether this is the case in the specific anatomical location was not examined in the study - but it would also imply that the study really addresses a dynamic developmental remodelling situation and should be written up accordingly. I am more suspicious of the depilation agent (plus the shaving). As Wright et al. already show that shaving causes some changes in Merkel cell dynamics (but, as far as I can tell, did not chemically depilate), I would not be surprised that we see an artificially high remodelling rate. Such skin treatment-related biology is probably less relevant in the context of neurobiology (albeit probably quite interesting to other audiences). So, my recommendation to the authors would be to invest some energy to find out, what causes the swift Merkel cell loss.

      Another technical point that warrants discussion is the axonal labelling - first, I do not find the innervation patterns always easy to discern in the images provided, so I am not always sure how reliable this part is. Any artefact here creates the impression of dynamics, as during in vivo imaging stability is more reassuring than change. There are many ways not to see or recognize something, while there are few options to explain by an artefact why something did not change. Additionally, it might be good to explicitly mention that the TrkC mice are knock-in/knock-out (this is how I understood the JAX entry) - so the observations were made under reduced TrkC expression. It would help to explain, why this cannot affect axonal dynamics or Merkel cell-axon interactions.

      Overall, while I feel that the authors performed an interesting in vivo imaging study, I think technical aspects make it difficult to conclude with confidence, whether we are watching a normal and physiological process here or dynamics that are induced by specific interventions. While these interventions might represent conditions that can occur also outside the laboratory, it would be important to clarify how the reader should contextualize this study.

    1. Reviewer #1 (Public Review):

      In the manuscript, the authors tried to explore the molecular alterations of adipose tissue and skeletal muscle in PCOS by global proteomic and phosphorylation site analysis. In the study, the samples are valuable, while there are no repeats for MS and there are no functional studies for the indicted proteins, phosphorylation sites. The authors achieved their aims to some extent, but not enough.

    2. Reviewer #2 (Public Review):

      This study provides the proteomic and phosphoproteomics data for our understanding of the molecular alterations in adipose tissue and skeletal muscle from women with PCOS. This work is useful for understanding of the characteristics of PCOS, as it may provide potential targets and strategies for the future treatment of PCOS. While the manuscript presents interesting findings on omics and phenotypic research, the lack of in-depth mechanistic exploration limits its potential impact.

      The study primarily presents findings from omics and phenotypic research, but fails to provide a thorough investigation into the underlying mechanisms driving the observed results. Without a thorough elucidation of the mechanistic underpinnings, the significance and novelty of the study are compromised.

    1. Reviewer #2 (Public Review):

      In this study, Isoe and team produced an atlas of the telencephalon of the adult medaka fish with which they better defined pallial and subpallial regions, characterized the expression of neurotransmitters, and performed clonal analysis to address their organization and maintenance during the continuous neurogenesis. They show that pallial anatomical regions are formed by independent clonal units. Furthermore, the authors demonstrate that pallial compartments exhibit region-specific chromatin landscapes, suggesting that gene expression is differentially regulated. Specifically, synaptic genes have a distinct chromatin landscape and expression in one of the regions of the dorsal pallium, the Dd2. Using the region-specific RNA expression and chromatin accessibility data they have generated; the authors propose several transcription factors as candidate regulators of Dd2 specification. Lastly, the authors use the enrichment of transcription factor binding motifs to establish homology between medaka and human telencephalon, aiming to describe an evolutionary origin for the Dd2 region.

      Overall, the study carefully describes diverse aspects of neurogenesis in the telencephalon of the adult medaka fish. As such, the manuscript has the potential to contribute insights to the understanding of circuits and neurogenesis in teleosts and the medaka fish, as well as the evolution of cellular heterogeneity and organization of the telencephalon. Furthermore, the atlas, if easily accessible to the broader community, could be a substantial resource to researchers interested in medaka and teleosts neuroscience. However, there are some conceptual and technical concerns that should be addressed to strengthen this work.

      Improving the atlas: The different interpretations of the imaging data generated remain isolated or fragmented and could be better integrated to describe anatomical, connectivity, and ontogeny differences through pallial and subpallial regions.<br /> Molecular differences across regions and species: Differential gene expression and chromatin accessibility throughout regions should be better and more deeply characterized and presented, exhibiting more region-specific features, and leading to a better description of candidate transcription factors that could differentially regulate regional gene expression. The comparison between medaka fish and human telencephalon regions would benefit from a more extensive molecular analysis. Comparison of gene expression and accessible regions could expand the analysis together with TF-binding motif enrichment.<br /> Lineage tracing: The authors claim that the functional compartmentalization of the pallium relies on different cell lineages, which also mostly share connectivity patterns and, at least to some extent, expression patterns. It would be interesting to see how homogenous these lineages are at the molecular level and whether their compartmentalization is retained when neurons reach maturity.

    2. Reviewer #1 (Public Review):

      In the present study, Yasuko Isoe, Ryohei Nakamura & colleagues follow a lineage analysis study aiming at identifying the clonal organization of the dorsal telencephalon. The authors use the teleost fish medaka to conduct their experiments since it displays a clearly delineated dorsal pallium. After identifying the clonal units that constitute the dorsal telencephalon, they analyze the epigenetic landscape in each unit. The authors identify then differential open chromatin patterns that they relate to functional aspects of each unit, and additionally, use the epigenetic landscape to infer the identity of transcription factors operating as putative regulators. Overall, the study consists of an impressive amount of data that shed light on the organization of a central brain region in vertebrates.

      The findings in the manuscript are organized into two main sections: lineage analysis and epigenetic organization. The authors combine genetic tools with laser dissections of specific clones and ATAC-seq and RNA-seq analysis in multiple samples, an approach that is very elegant and follows high technical standards. For lineage analysis, the authors used a basic, but appropriate, tool to induce and follow clones generated in early embryos, with the side note that lineages are followed using a non-ubiquitous promoter so that the authors restrict their analysis to neural progenitors. My overall impression is that the authors have collected a massive amount of high-quality data, which unfortunately is not properly integrated or discussed in the manuscript. There is only a superficial effort in incorporating the two main findings, which contrasts with the depth of acquired data.

      The observation of clonal sectors in the pallium is a great finding that deserves a more detailed analysis in terms of their developmental and evolutionary origin: How may progenitors are used to set up the entire pallium? What is the smallest clone that contributes to it? Is there any laterality bias in the clonal architecture? Is the clonal architecture exclusive for progenitors or does it extend to neurons as well? How has the clonal architecture impacted the morphological diversity of the pallium among teleosts? What are possible evolutionary paths to explain this phenomenon? The authors' discussion on this point circles around one concept, illustrated in the following sentence: " (The clonal architecture) ... possibly explains how the difference in diversity between the pallium and subpallium has emerged: the subpallium is conserved because cells belong to various clonal units intertwined with each other, which has constrained their modification during evolution; whereas the pallium is diverse because of the modular nature of the clonal units which allows for the emergence of diversity". This is the concept that I have the most problems with. The authors' reason that a more defined clonal structure (pallium) makes a system more prone to evolutionary novelties, while a region where clones intermingle (subpallium) is more rigid and therefore more conserved between species.  Is there experimental data that backs up this statement in any other systems? If there is, I urge the authors to share these here. If this is just a speculation, then the argument would benefit from an explanation of how this clonal organization allows for evolutionary novelty. Would it happen by the appearance of more clones at the early stages of development? The authors leave this central point untouched even when discussing the evolutionary origin of the pallium in teleosts.

      Having shown the clonal architecture of the pallium and conducted a detailed epigenetic analysis in clones, the authors could also speculate on what is special about this type of organisation. Particularly, how they envision that cells belonging to the same clone inherit a common epigenetic landscape that will define their function later on. There is little analysis of the cellular organization of each clone, mainly because the authors labeled only a subset of the real, genetic clone. The authors present images of entire brains and optical horizontal and transverse sections, which largely sustain their claims for a clonal organization. The difference in the clonal arrangements between the Dld and the Vd is clear, but the authors could provide a higher-resolution image of some clones in the telencephalon to get an idea of the cellular composition of the regions they use for their analysis. What is the extent of non-GFP cells in the regions they use for RNAseq and ATACseq? From the images shown it is very difficult to realize whether all cells in the clonal sector do indeed belong to the clone.

    3. Reviewer #3 (Public Review):

      In this manuscript, the authors characterized the clonal composition in the medaka pallium and found the dorsal pallium region to be a compartment constituting repeatedly identifiable clonal units. By performing ATAC-seq on the clonal units as well as RNA-seq on different subregions of the pallium, the dorsal pallium was further identified as a unique region with open chromatin regions with regulatory elements enriched for synapse-related genes. Further experimental and bioinformatic evidence supports the region's putative function of synapse generation, with similar TF-binding motifs to homologous brain regions in human. Although the "uniqueness" of the dorsal pallium might be a coincidence of the timing of clonal tracing, the conclusions in the manuscript are largely supported by experimental evidence. The study showcases an elegant model of how anatomical, molecular, and functional diversity arises in a previously under-characterized brain region. The enriched genes in Dd2 are an interesting candidate for future investigation, and the function of the dorsal pallium of teleost fish is of general interest for studies of brain evolution.

    1. Reviewer #1 (Public Review):

      Holzinger et al. investigated potential antimicrobial compounds for cystic fibrosis (CF) infection with similarity to a host-derived antimicrobial, bactericidal permeability-increasing protein (BPI). Human BPI (huBPI) is neutralised by anti-BPI antibodies, rendering it ineffective at eradicating Pseudomonas aeruginosa infection in a large proportion of people with cystic fibrosis. BPI produced by mice (muBPI), scorpionfish (scoBPI), and oysters (oyBPI) was evaluated on their anti-inflammatory, bactericidal, and immunogenic potency. The authors showed that each BPI orthologue evaded recognition by anti-BPI. The cationic BPI orthologues also reduced bacterial burden in vitro, reducing the expression of proinflammatory cytokines (IL-6 and TNF) and significantly decreasing cell culture density in the laboratory and multidrug-resistant P. aeruginosa strains. ScoBPI was the most potent, with greater anti-inflammatory and bactericidal activity than huBPI and all other orthologues.

      This study investigates the action of BPI orthologues as potential CF antimicrobials. While scoBPI appears significantly more effective as an anti-inflammatory and bactericidal agent compared to huBPI, the orthologue has not been tested in environments that model the CF lung environment. The authors describe the cationic BPI as binding to the LPS via electrostatic interaction. This interaction could be limited in vivo, as anionic extracellular DNA, cationic metal ions and polyamines, and other charged substances may impede interaction. Further, delivery of scoBPI to the infection site may be detrimentally impacted, due to the viscous mucous in the lungs and the biofilm mode of growth of P. aeruginosa. The discussion of the study could be improved by describing important considerations for future development. These could include in vitro testing against P. aeruginosa biofilms in relevant sputum-mimicking media, and in vivo validation in Galleria mellonella, and CF and non-CF mouse models.

      Overall, the authors present an interesting study that provides a compelling basis for a potential novel antimicrobial for CF chronic airway infection. The authors' claims are well supported by their data, which they present in a clear, logical manner. To build on these findings, the authors could test scoBPI in models that recapitulate core factors of the CF environment.

    2. Reviewer #2 (Public Review):

      Human bactericidal/permeability-increasing protein (huBPI) is known to have in vitro antibacterial activity against Pa, but in vivo, its antibacterial activity is significantly lowered due to binding by autoantibodies called BPI-ANCA. The authors of this study hypothesized that non-human BPIs would escape neutralization by intrinsic BPI-ANCA and retain full antibacterial activity against Pa. Through bioinformatic analysis, the authors anticipated that scorpion BPI (scoBPI) has enough similarity with huBPI to retain antimicrobial activity while escaping recognition by BPI-ANCA. This hypothesis is supported by the following observations: 1) scoBPI fails to capture any BPI-ANCA, 2) scoBPI prevents E. coli- and Pa-LPS dependent inflammatory responses like huBPI and 3) scoBPI exhibits remarkable antimicrobial activity against MDR-Pa in the nanomolar range. Antimicrobial activity of scoBPI was also demonstrated against E. coli suggesting a conserved mechanism of activity against Gram-negative bacteria. The authors use immobilization methods to demonstrate that scoBPI does not bind BPI-ANCA, but a drawback of this method is that some molecular interactions may be disrupted due to immobilization. Moreover, any inhibitory effects of BPI-ANCA on scoBPI activity in the bactericidal assays were not explored. Regardless, the results of this study clearly support their original hypothesis. These findings have broad implications in identifying novel chemotherapies to treat drug-resistant Gram-negative bacterial infections.

    1. Reviewer #1 (Public Review):

      In this paper, the authors use patch-clamp recordings of immature (4w and 5w) and mature granule cells (GC) in hippocampal slices to study stimulus-response properties at different cell ages. First analyzing spike trains generated by a fluctuating stimulus, they show that the reliability of spiking responses increases with cell age. They then fit a Spike Response Model (SRM), a type of GLM that translates inputs to membrane potential and then membrane potential to spikes. Using this model they compare the model parameters from different cells. Time constants for the input-voltage filter are faster for the mDGCs than the 4w, with 5w intermediate, and time constants across all cells appear to be faster when reliability is higher. They analyze stimulus reconstruction and stimulus-response information using the recordings and then extend this to pseudo-populations to test how heterogeneous properties contribute to coding efficacy. They find that mixed pools of neurons, including cells of multiple ages, decode stimuli more accurately.

      Overall, this is a cleverly designed study with sound methodology. A major contribution of the paper is demonstrating with precise, quantitative methods how a degree of heterogeneity that naturally arises in neural populations may be beneficial to decoding the stimulus, despite the fact that some of the heterogeneity arises from variability in single cells. This is an intriguing result showing how neural coding and decoding may actually benefit from heterogeneous response properties rather than only be hindered by variation.

      The paper has a couple of weaknesses. First, it is difficult to assess how meaningful the effects that the authors measure are. For example, is a 3% improvement in decoding (Fig. 4H) with mixed populations of GCs substantial? A second issue not currently addressed in the paper is the relative roles of age-dependent variability and within-group variability: how much of the improvement in stimulus decoding/information encoding is achieved by heterogeneity across model parameters that appears in each age group? Further analyses and clarifications in this vein are suggested.

    2. Reviewer #2 (Public Review):

      The paper by Arribas et al. examines the coding properties of adult-born granule cells in the hippocampus at both single cell and network level. To address this question, the authors combine electrophysiology and modeling. The main findings are:<br /> - Noisy stimulus patterns produce unreliable spiking in adult-born granule cells, but more reliable responses in mature granule cells.<br /> - Analysis of spike patterns with a spike response model (SRM) demonstrates that adult-born and mature GCs show different coding properties.<br /> - Whereas mature GCs are better decoders on the single cell level, heterogeneous networks comprised of both mature and adult-born cells are better encoders at the network level.

      Based on these results, the authors conclude that granule cell heterogeneity confers enhanced encoding capabilities to the dentate gyrus network.

      Although the manuscript contains interesting ideas and initial data, several major points need to be addressed.

      Major points:<br /> 1. The authors use and noisy stimulation paradigm to activate granule cells at a relatively high frequency. However, in the intact network in vivo, granule cells fire much more sparsely. Furthermore, granule cells often fire in bursts. How these properties affect the coding properties of granule cells proposed in the present paper remains unclear. At the very least, this point needs to be better discussed.

      2. The authors induce spiking in granule cells by injection of current waveforms. However, in the intact network, neurons are activated by synaptic conductances. As current and conductance have been shown to affect spike output differently, controls with conductance stimuli need to be provided. Dynamic clamp is not a miracle anymore these days.

      3. The greedy procedure is a good idea, but there are several issues with its implementation. First, it is unclear how the results depend on the starting value. What we end up with the same mixed network if we would start with adult-born cells? Second, the size of the greedy network is very small. It is unclear whether the main conclusion holds in larger networks, up to the level of biological network size (1 million). Finally, the fraction of adult-born granule cells in the optimal network comes out very large. This is different from the biological network, where clearly four or five-week-old granule cells cannot represent the majority. Much more work is needed to address these issues.

      4. Likewise, the idea of dynamic pattern separation seems quite nice. However, the authors focus on the differences between mixed and pure networks, which are extremely small. Furthermore, the correlation coefficients of "low", "medium", and "high" correlation groups are chosen completely arbitrarily. A correlation coefficient of 0.99, considered low here, would seem extremely high in other contexts. Whether dynamic pattern separation is possible over a wider range of input correlation coefficients is unclear (see O'Reilly and McClelland, 1995, Hippocampus, for a possible relationship). Finally, aren't code expansion and lateral inhibition the key mechanisms underlying pattern separation? None of these potential mechanisms are incorporated here.

      5. A main conclusion of the paper is that while mature GCs are better decoders on the single cell level, heterogeneity in mixtures improves coding in neuronal networks. However, this seems to be true only for r^2 as a readout criterion (Fig. 4F). For information, the result is less clear (Fig. 4G). The results must be discussed in a more objective way. Furthermore, intuitive explanations for this paradoxical observation are not provided. Saying that "this is an interesting open question for future work" is not enough.

      6. The authors ignore possible differences in the output of mature and adult-born granule cells in their thinking. If mature and adult-born granule cells had different outputs, this could affect their contributions to the code (either positively or negatively). At the very least, this possibility should be discussed.

    3. Reviewer #3 (Public Review):

      This is a highly interesting paper that comprehensively investigates the electrophysiological properties of granule cells in the dentate gyrus at different developmental stages. Using state-of-the-art in vitro electrophysiological techniques, the authors record granule cell responses to fluctuating current injections to study how they encode stimuli. The authors find that while immature granule cells produce less reliable stimulus responses and worse stimulus representations than mature cells (8wks and older), cell populations containing neurons of mixed ages improve overall stimulus reconstruction. These data suggest that the cellular diversity contributed by immature granule cells could be beneficial for transmitting distinct properties of stimuli with rich temporal structure, potentially improving the cellular process of pattern separation.<br /> Major strengths of the paper lie in the precise age determination of immature neurons in Ascl1-CreERT2-Tom mice, recordings of immature neurons, which are rare in in vivo and in vitro studies, precise control over cell-intrinsic properties by blocking excitatory and inhibitory inputs in vitro, and characterization of encoding properties using a spike response model (SRM).

      The conclusions drawn are supported by the data, and the results are likely of great interest to a specialist community of hippocampal electrophysiologists.

    1. Reviewer #1 (Public Review):

      This manuscript by Toshima et al. describes a study of the organization of traffic in the endomembrane system of the budding yeast Saccharomyces cerevisiae. The authors address the relation between endocytosis and the Golgi (TGN: a collection of maturing membrane elements derived from the trans-Golgi). The study builds on a previous article by the group of Benjamin Glick. In that study (Day et al., 2018), it was postulated that the TGN is the first destination for yeast endocytic traffic after internalization from the plasma membrane. Additionally, Day et al. had shown that endocytic recycling traffic towards the plasma membrane departs from the TGN as well. Therefore, early endosome and recycling endosome compartments would be identical to the TGN or contained within it. Here, Toshima et al. use super-resolution confocal live imaging microscopy (SCLIM) to refine a model of endocytic pathway organization. This powerful imaging technology allows them to show that out of two partially overlapping TGN markers, namely Tlg2 and Sec7, the syntaxin Tlg2 correlates better with the arrival of fluorescently labeled endocytic cargo than alternative TGN marker Sec7. Building on this main finding, the authors conclude that a specific part of the TGN (an "independent sub-compartment") functions as the early endosome. Further experiments in mutants for GGA clathrin adaptors, required for departure of endocytic cargo from the TGN to the Rab5-positive prevacuolar endosome, show again that endocytosed cargo accumulation correlates better with Tlg2 than with Sec7. Furthermore, in GGA mutants the overlap between Tlg2 and Sec7 is decreased, suggesting that GGA is required for maturation of this Tlg2 sub-compartment.

      The study is well conducted and its main conclusion that a Tlg2 subregion within the TGN functions as the early endosome seems well supported by the superb live imaging and the analysis of GGA mutants.

      Although a technical feat in live superresolution imaging, this single kind of data (moving, shape-shifting blobs of fluorescently-labeled proteins) does not totally fill with meaning the terms "compartment", "sub-compartment", or "independent sub-compartment". This, I think, is the main limitation of the study. Are these compartments or sub-compartments individuated membrane elements, collections of vesicles, regions of the same cisterna or saccule? For this, electron microscopy would be needed.

    2. Reviewer #2 (Public Review):

      In this manuscript Toshima et al document the use of sophisticated microscopy - with powerful spatial and time resolution - to image markers of the yeast endosomal system.

      The initial work documented in this paper does a good job of defining the compartment endocytic cargoes internalise to. This is convincingly shown to be a compartment that is not marked by Sec7 but is instead a distinct (sub)compartment marked by the SNARE protein Tlg2. This agrees with many previous studies, (including biochemical experiments and microscopy of cargoes in a series of membrane trafficking mutants) but has different conclusions to another study (Day et al 2018 - Developmental Cell). Although the microscopy techniques used in the two studies are different, the yeast system and many of the reporters (FP tagged Tlg1, Sec7, Vps21 and fluorescently labelled mating factor) are the same. The Day et al study is suitably referenced throughout the manuscript but as to why the authors have come to fundamentally different answers about endocytic cargoes internalising to a Sec7+ compartment, is not discussed.

      The work goes on to show endocytic carriers (marked by Abp1) and endocytic cargoes like fluorescently labelled mating factor internalise to the Tlg2+ compartment. The forward trafficking of these molecules is then observed to transit to a later endosome compartment labelled by Vps21. The super-resolution and time lapse imaging, sometimes even using 3 colours - is of very high quality and fully support the model presented at the end of the paper for this trafficking itinerary. Trafficking mutants are also used (such as a defective allele of arp3 and deletion of VPS21 / YPT52 GTPases) to interrupt trafficking routes and define the pathways followed by endocytosed mating factor.

      The endocytic trafficking from Tlg2+ to Vps21 compartments is shown to be defective in mutants lacking GGA adaptors (gga1∆ gga2∆), with cargoes accumulating in the Tlg2+ compartment and other clathrin adaptor mutants not causing this defect. This research avenue also reveals that the GGA proteins are required to maintain the distinct Tlg2 sub compartment.

      The final section of the paper uses the same tools to analyse the localisation of the recycling v-SNARE protein Snc1. This is arguably the most important set of experiments in the paper, not only is Snc1 a putative v-SNARE that functionally interacts with Tlg2, but this cargo, unlike pheromone, allows the investigation of recycling back to the PM from TGN/endosomes. However, the authors do not comment on the fact that Snc1 does not localise to the plasma membrane in either experiments using different microscopy techniques (Figure 5A + 5B), calling into question whether the recycling pathway is operating properly or that the FP-tagged machinery has disrupted processing? The steady state localisation of Snc1 in WT cells only looks normal in Supplemental figure, this discrepancy should be discussed or addressed.

    3. Reviewer #3 (Public Review):

      The manuscript by JY Toshima et al. is an excellent and important study that demonstrates very clearly the existence of an endosomal compartment in yeast, distinct from the trans-Golgi network, to which endocytic vesicles fuse upon internalization. They show that this compartment is enriched in the SNARE protein Tlg2, a yeast homologue of syntaxin, and is segregated from the Golgi-localized Sec7-containing compartment, indicating that the organization of the endocytic system in yeast is similar to that of animal cells. Furthermore, they demonstrate the trafficking machinery required for maturation of this compartment, and that it is also a station on the pathway back to the plasma membrane. Because there have been conflicting reports in the literature as to the existence of an endosomal compartment in yeast distinct from the trans-Golgi network, this paper is of great importance for the cell biology community.

      Major strengths of this study are the cutting-edge imaging technology used, and the careful, quantitative analyses carried out. The authors use a super-resolution live cell imaging approach that allows them to discriminate to a high resolution different compartments and membrane domains of highly dynamic yeast organelles, and to follow an internalizing cargo over time. With their manuscript, they have provided a full set of movies, along with quantifications, to support their conclusions.

      The authors use fluorescent-protein-labelled endocytic cargo (alpha-factor) and florescent-protein-labelled compartment markers, assaying them in high resolution and super-resolution live cell imaging microscopy systems. In this way, they are able to follow trafficking of cargo through compartments in real time. The authors first demonstrate that the alpha-factor cargo substantially colocalized with the SNARE protein Tlg2, a marker of early endosomes, but very little with Sec7. They also show that Tlg2 marks a sub-compartment distinct from the Sec7 compartment, but adjacent to it. Furthermore, they demonstrate using super-resolution microscopy and triple color 4D imaging that endocytosed alpha-factor cargo structures make contact with the Tlg2 compartment, adjacent to the Sec7 compartment, then disappear, supporting the conclusion that endocytic vesicles first fuse with the Tlg2 compartment. Next the authors show that alpha factor is transported from the Tlg2 compartment to the Vps21 compartment, a process that requires the GGA adaptors Gga1 and Gga2. Finally, the authors show that recycling of the endocytic R-SNARE Snc1 also occurs by passage through the Tlg2 compartment.

      The use of mutants that affect different stages of endosomal trafficking is a strength of the manuscript, as it allows elucidation of the mechanism of transport through successive compartments. Importantly, using a gga1-delta gga2-delta mutant, the authors demonstrate convincingly that the GGA adaptors Gga1 and Gga2 are required for alpha factor transport from the Tlg2 compartment to the Vps21 compartment.

      Throughout this study, the authors use fluorescent protein-labelled cargo and compartment markers (EGFP, mCherry, iRFP), but don't explicitly state to what extent these fusion proteins are functional compared to the endogenous proteins. They could cite previous publications or their results describing the functionality of the fusion proteins used.

    1. Reviewer #1 (Public Review):

      Luu et al. have developed a genome-edited African elite rice variety, Komboka. The work was initiated in response to the outbreak in Eastern Africa by Xanthomonas oryzae strains that are phylogenetically related to Asian strains and carry TALes, similar to strains from China, possessing an expanded repertoire of TALes compared to those in endemic strains. As these emerging strains contain TALe targeting SWEET11a, as well as that suppressing Xa1, pthXo1, and iTALes, the authors have generated edited lines targeting promoter regions of SWEET11a, 13 and 14 in African elite rice variety, Komboka. The same team has previously generated genome-edited lines targeting the promoter regions of SWEET11a, 13, and 14 in varieties Kitaake, IR64, and Ciherang-Sub1. Bacterial blight outbreaks and emerging pathogen lineages remain to be a threat to rice production. Thus, efforts in targeting pathogen weaknesses to generate genome-edited varieties possessing broad-spectrum resistance are required. The survey, collection of isolates, and strain characterization studies on >800 strains are commendable. This study has taken advantage of this ongoing collection to stay ahead in the arms race to deploy broad-spectrum resistance in an elite rice variety using TALe targets.

      Overall conclusions presented here are supported to some extent; however, I have listed some of my comments and concerns below.

      1. Data in supplementary table 2 suggests that Komboka is still a moderately resistant variety under field conditions in Africa, with a disease severity scale of 2 i.e. 4-6% disease severity, compared to other varieties having a disease severity scale of 5. Thus, I am not convinced that emerging strains are of concern on the Komboka variety under field conditions, thus, question the justification of Komboka being a choice for editing to tackle emerging strains.

      2. Is Xa4 from Komboka related to Xa4_Teqing? The breakdown of Xa4T was due to the mutant allele of avrXa4 in virulent Xoo CR6. But this breakdown was accompanied by a fitness penalty and residual QTL had a significant residual effect on virulent strains. Would this be why Komboka carrying Xa1 (Xa45(t) and Xa4 under field conditions still showed moderate resistance? But Xoo strains showed susceptibility in leaf clipping assays.

      3. I felt a bit of a disconnect in sections on phenotypic assays confirming the virulence profile of strains on Komboka and then understanding mechanisms underlying virulence since the same strains used in path data were not the ones mentioned in WGS and TALe analysis, leaving the readers with the only one strain to support the hypothesis of the basis for higher disease severity on Komboka due to new TALes, pthXo1, and iTALe. Do authors have pathogenicity data for African strains T19, Dak16, and Xoo3-1 that grouped with endemic African strains on Komboka? Authors present data on CIX4457, 4458, and 4462 being virulent on Komboka, and show that they cluster with Asian strains. However, in the tree, 4462 is the only one shown to be closely related to Chinese strains. Where are 4457 and 4458 placed? Do 4457 and 4458 also contain pthXo1 and iTALe? Authors could also provide path data for 4506/4509 that they included in TALe figure and in the phylogenetic tree.

      4. The authors present pathogenicity data on EBE-edited T0, T1, and T2 lines of Komboka which are promising against the Tanzanian strains carrying new TALes. The cas9/cpf1 system developed here to target multiple EBEs will be a valuable contribution to the scientific community. What are the agronomic characteristics of these edited lines? As the edited lines have not been tested against a diversity panel of Asian and African strains, I would be skeptical of the choice of the term "broad-spectrum" yet.<br /> Regardless of my comment earlier on Komboka being moderately resistant under field conditions and thus a questionable choice for EBE-editing here, the genome-edited lines in any variety imparting resistance to bacterial blight remain to be a valuable contribution to managing disease outbreaks.

      5. As this manuscript utilizes the diversity of African strains to generate edited lines, it would be good to make diagnostics and path data for 833 strains available to the scientific community (instead of select strains as indicated in the supplementary table), especially for the fact stated here in the manuscript about scarce data on Xoo in Africa and the goal of systematic comparison of the pathogen population.

    2. Reviewer #2 (Public Review):

      This study describes the emergence of virulent strains of the rice bacterial blight pathogen Xanthomonas oryze pv. oryzae in the Morogoro rice-growing region in Tanzania. The aims of the study were to describe the virulence features of the emerging population, as compared to previous bacterial blight outbreaks in Africa, and generate an elite rice variety that is resistant to both pathogen populations. To achieve these aims, the authors characterized the genetic basis of the virulence of these new strains by sequencing the genomes of three representative strains and phenotyping using excellent genetic resources for identifying the susceptibility gene targets of this pathogen in rice. They then used two rounds of hybrid CRISPR-Cas9/Cpf1 to successfully edit six targets of the pathogen in an East African rice variety, which conferred resistance to all strains tested.

      The strengths of this paper are the systematic analysis of the virulence of emerging pathogen strains relative to strains from previous outbreaks and the successful creation of edited lines that will form the basis for continued efforts to gain regulatory approval for the introduction of resistant rice in East Africa. The creation of the edited line is a substantial and important contribution, indeed, the authors include strains collected in 2021 and include disease severity data from 2022 in the supplementary data, illustrating the urgent need for solutions.

      The weaknesses of the study are largely related to the quick turnaround between data collection and manuscript submission.<br /> (1) Different strains are used for different experimental work and sequence analysis, making relationships between different parts of the work unclear and also more challenging for the reader to follow because of changing strain designations. CIX4457, CIX4458, and CIX4462 were virulent on rice near-isogenic-lines, CIX4457 and CIX4505 were used for identifying SWEET targets and phenotyping edited lines, while whole genome sequencing was conducted with CIX4462, CIX4506, CIX4509.<br /> (2) Disease survey results from 2022 are listed in Supplementary Table 2, but it is challenging for the reader to summarize across many lines of data, which appear to represent individual samples.<br /> (3) The focus of the editing is Komboka but bacterial blight in 2022 was mostly on other varieties. It would be helpful to have more context on this variety and what has prevented adoption by the growers in the Morogoro region to date.

    3. Reviewer #3 (Public Review):

      One key finding of this work is the identification of Xanthomonas oryzae pv. oryzae (Xoo) strains in Africa, based on their genomes sequence and their TALE repertoires, have high similarity with Asian strains. Asian Xoo strains typically overcome NLR-mediated recognition of TALEs in rice by so-called iTALEs. Moreover, some Asian strains contain a TALE resembling PthXo1, a TALE protein that was shown to overcome xa5 resistance.

      The authors now found that some of the newly identified African strains have iTALEs and PthXo1-like TALEs. Such newly evolved African strains were found to be fully virulent on the African rice elite variety Komboka, which is resistant to a broad panel of African Xoo strains.

      Previous studies have shown that TALEs bind to effector binding elements (EBEs) present in promoters of rice SWEET genes to promote disease. Work from the lab of the authors and other labs has shown that TALEs can no longer promote the disease if matching EBEs are changed or deleted by CRISPR or TALEN-mediated mutagenesis. In fact, pioneering work by Bing Yang, one of the authors of this article published about ten years ago a Nature Biotechnology article where he showed that rice plants with mutated EBEs are resistant to Xoo. Recently, a combined effort of the Yang and Frommer labs resulted in two further Nature Biotechnology publications (2019), in which they described along with other useful tools rice lines where multiple EBEs were mutagenized in parallel and that provide broad spectrum resistance.

      The work under review describes now CRISPR mutagenesis of an African elite cultivar resulting in a line that mediates resistance to Asian and newly evolved African strains.

      Overall, the work is technically sound. Yet, the approach that has been described - mutagenesis of multiple EBEs - has been used before and is a routine procedure for labs that are focused on such undertakings. While such approaches do not provide new insights for fundamental research, they nevertheless are certainly important and useful in translational research, as demonstrated here.

    1. Reviewer #1 (Public Review):

      This study used intersectional genetic approaches to stimulate a specific brainstem region while recording swallow/laryngeal motor responses. These results, coupled with histology, demonstrate that the PiCo region of the IRt mediates swallow/laryngeal behaviors, and their coordination with breathing. The data were gathered using solid methods and difficult electrophysiological techniques. This study and its findings are interesting and relevant. The analysis (and/or the presentation of the analysis) is incomplete, as there are analyses that need to be added to the manuscript. The interpretation of the data is mostly valid, but there are claims that are too speculative and are not well-supported by the results. The introduction and discussion would benefit from more citations and a deeper exploration of how this study relates to other work - especially a thorough accounting of and comparison to other studies concerning putative swallow gates.

      General/major concerns:

      • The field of respiratory control is far from unified regarding the role of PiCo in breathing or any other laryngeal behaviors. If anything, the current consensus does not support the triple-oscillator hypothesis (in which PiCo is one of 3 essential respiratory oscillators). The name "PiCo", short for "post-inspiratory complex", suggests a function that has not been well-supported by data - it is a putative post-inspiratory complex, at best. I suggest putting this area in context with other discussions i.e. IRt (such as in Toor et al., 2019) or Dhingra et al. 2020 showed broad activation of many brainstem sites at the post-I period (including pons, BotC, NTS)

      • Did you perform control experiments in which the opto stimulations were done on animals without the genetic channels (for example, WT or uncrossed ChAT-ires-cre, etc.), or in mice with the genetic channels that weren't crossed (uncrossed Ai32 mice)? If so, please include. If not, why?

      • How do you know that your opto activations simulate physiological activation? First, the intensive optical activation at the stim site does not occur in those neurons naturally. Doing a natural (water) stim for comparison is good, but it cannot necessarily be directly compared to the opto stim. The water stim would activate many other brainstem regions in addition to PiCo. A caveat is that opto PiCo stim =/= water stim (in terms of underlying mechanisms) should be included. Second, in looking at the differences between water vs opto swallows in Table S2: it appears that the ChAT animals (S2A) have something weaker than a swallow with opto stim. For the Vglut2 and ChAT/Vglut2 (S2B&C), the opto swallows also aren't as "strong" as the water swallows (the X and EMG amplitudes are smaller). The interpretation/discussion attributes this to the lack of sensory input during opto stim, but does not mention the strong possibility that there is a difference in central mechanisms occurring. It also seems to be dismissed with the characterization of the swallow as "all-or-none" (see note on Fig 3 results).

      • The writing needs extensive copy editing to improve clarity and precision, and to fix errors.

      • Results/Fig 1: What proportion had no/other motor response (non-swallow, non-laryngeal) to the opto stim? I can extrapolate by subtraction, but it would be nice to see the "no/other response" on the plot.

      • The explanation of genetics is too spread out and confusing. There needs to be more detail about all the genetic tools used, using the standard language for such tools, in one spot. Please also provide a clear explanation of what those tools accomplish. Include a figure if necessary. Pick a conventional designator/abbreviation for the different strains, define them in the methods and in the first paragraph of the results section, and use those abbreviations throughout. I think that using ChAT as an abbreviation for your ChAT-ires-cre x Ai32 mice is confusing because it makes it sound like you're talking about the enzyme rather than the specific strain/neurons. Saying "ChAT stimulated swallows... swallows evoked by water or ChAT" makes it sound like the enzyme choline acetyltransferase itself is stimulating swallow. As is convention, pick a more precise abbreviation like ChAT-cre/Ai32 or ChAT:Ai32 or ChAT-ChR2 or ChAT/EYFP. This goes for the other strains as well.

      • For Fig S2C&D, why does it say mCherry? Isn't it tdTomato? Is it just an anti-ChAT antibody and then the tdTomato Ai65 is only labeling Vglut2? I don't see this in the methods section.

      • I also don't see methods for all the staining in Fig S3. The photomicrograph says Vglut2-cre Ai6, but there's no mention of Ai6 anywhere else. Which mice are these? Did you cross Vglut2-cre with an Ai6 reporter mouse? How can you image an Ai6 mouse (which I assume expresses ZsGreen? and that you excited at 488?) and a 488 anti-goat in the same section (that's the only secondary listed in the methods that would work with your goat anti-ChAT)? Is there an error in listing the fluorophores in the methods? Please give more details on the microscopy including which filters were used for the triple staining.

      • Regarding the staining: I would expect the staining/maps in for the 2 different ChAT/Vglut2 intersectional strains to be similar (Fig 5A/B and S2C/D). The photomicrographs look very different to me, while the heat maps (this goes for all the heat maps in the paper) have barely distinguishable differences. In Fig 5, the staining looks much stronger than in Fig S2C. Why does it look like there are so many more transfected neurons in Fig 5A2 than there are red neurons in the corresponding panel Fig S2C2? And for Fig 5A4 and Fig S2C44? The plot and results text for Fig 5 says the avg number of neurons was 123+¬11. The plot for Fig S2D says 112+¬15, but the results text says 242+¬12 (not sure which is the correct number).

      • The results text for Fig S2C also says the staining is "similar to the previous ChAT staining...", which I assume refers to S2A/B. The plot and results text for Fig S2B reports 403+¬39 neurons, while S2D is either 112 or 242 (not sure?). The plots have different Y scales, which should be changed to be the same. But why do the photomicrographs and the heat maps look so similar? I would expect far fewer neurons to be stained in the intersectional mice (Fig 5 and Fig S2C/D) than in the ChAT staining (Fig S2A/B). I am having trouble reconciling the different presentations/quantifications and making sense of the data in these histology figures.

      • How can you distinguish PiCo from non-PiCo in the histology, especially in the ChAT-only staining? It seems that you have arbitrarily defined the PiCo region, and only counted neurons within that very constrained area. I can see stained neurons in the area immediately outside of PiCo, and I'd like to see lower-magnification images that show the staining distribution in a broader region surrounding PiCo as well, especially in the rest of the reticular formation.

      • Similarly, how can you be sure you're stereotaxically targeting PiCo precisely (600um in diameter?) with your opto fiber (200um in diameter). Wouldn't small variations in anatomy put the fiber outside the tiny PiCo area?

      • Please put N's and stats results in Table S1 for both swallow and laryngeal activity. I took what I assume to be the Ns (10, 11, and 4) and did some stats like the ones you presented for the laryngeal duration. The differences between vagus duration for 40 and 200 ms pulse durations are all significant for each strain, by my calculations. Also, I think there must be an error in the orange swallow plot in Fig 3A. The orange dots don't correspond to the table values. I plotted all the Table S1 values for each strain. Each line looks similar to the blue laryngeal activation plot in Fig 3A. The slopes of the Vglut2 were less than the other strains, and the slopes for the swallow behavior were less than the laryngeal behavior for all strains. Otherwise, they all look similar. Please double-check your values/stats to address these discrepancies. If it is indeed true that the stim pulse duration affects swallow duration, revise the interpretations and manuscript accordingly.

      • Please add more details on stats in general, including the specific tests that were performed, F values and degrees of freedom, etc.

      • How do you know that you're not just activating motoneurons in the NA when you stimulate your ChAT animals, especially given the results in Fig 1B? In this case, the phase-specific results could be explained by inhibitory inputs (during inspiration) to motoneurons in the region of the opto stim.

      • While the study from Toor et al is cited, there needs to be a much more thorough discussion of how their findings relate to the current study. They demonstrated that PiCo isn't necessary for the apneic portion of swallow. Inhibiting this region also didn't affect TI. PiCo cannot be the sole source of post-I timing, and the evidence overwhelmingly favors the major involvement of other regions such as the pons. They also showed that inhibition of all neurons (not just ChAT/Vglut) in the PiCo region suppresses post-I activity in eupnea. This suppression was overcome by the increased respiratory drive during hypoxia.

      • This study has not demonstrated some of the things that are depicted in Fig 7 and included in the discussion. While swallow can inhibit inspiration, there are many mechanisms by which this can happen other than a direct inhibitory connection from the DGS to PreBotC. You cite Sun et al., 2011 findings of "a group of neurons that inhibits inspiration" during SLN stim, but don't mention that it is the BotC and that the paper shows that swallow apnea is dependent on BotC. That is also supported by the Toor study. I don't understand how post-I (aka E) can be discussed without discussion of the BotC - this is a glaring omission.

      • Why is it necessary for PiCo to innervate the cNTS? That is true if the conjecture that PiCo gates swallowing is true, as the cNTS is the only known region for central swallow gating. However, PiCo could influence afferent input to the NTS less directly, and therefore not function as a gating hub per se. The experimental evidence does not warrant the claim that PiCo gates swallowing. The definition of a swallow gate(s) is a topic of much debate and no conclusive experimental evidence has emerged for swallow gating regions to exist anywhere except in the NTS. The current study's evidence also does not meet the criteria necessary to conclusively call PiCo a swallow gate. The authors should soften this claim and language throughout the manuscript.<br /> It is also unclear that PiCo acts directly on the swallow pattern generator to gate swallowing. It is not just "conceivable that the gating mechanism involves" the pons, but nearly certain. Swallow gating by respiratory activity may not be able to be ascribed to one particular location. At a minimum, it likely involves the NTS/DSG, pons, and possibly IRt (inclusive of PiCo). The authors are correct that "further studies are necessary to understand the interaction between PiCo and the pontine respiratory group on the gating swallow and other airway protective behaviors." This is why it shouldn't be stated that "this small brainstem microcircuits acts as a central gating mechanism for airway protective behaviors."<br /> PiCo is likely part of the VSG (and thus the swallow pattern generator). PiCo, as part of the IRt/VSG could indeed be surveilling afferent information and providing output that affects swallow or other laryngeal activation and the coordination of these behaviors with breathing. However, this is not the responsibility of PiCo alone. This role is likely shared by other parts of the SPG, and may require distributed SPG network participation to be functional. If one were to stim other regions of the distributed SPG, similar results might be expected. When Toor et al silenced the PiCo area (and locations that lie at least lightly beyond the borders of what the present study defines as PiCo), stim-evoked fictive swallows were greatly suppressed. However, swallow-related apnea was unaffected. This supports the role of PiCo as a premotor relay for swallow motor activation, but not as the site that terminates inspiration. Therefore, it cannot be called a gate.

      • Similarly, Fig 7 does not accurately depict things that are already well-supported by evidence. PiCo should be included as part of the swallow pattern generator (VSG), not as a separate entity acting on it. The BotC and pons are glaring omissions. This study has not demonstrated the labeled inhibitory connection from DSG to PreBotC. The legend states speculations as fact and needs to be dialed way back to either include statements with solid experimental evidence or to clearly mark things as putative/speculative.

      • The discussion of expiratory laryngeal motoneurons needs to be expanded and integrated better into the discussion of swallow, post-I, and other laryngeal motor activation. Why can't PiCo just be premotor to ELMs?

      • Concerning the discussion of "PiCo's influence as a gate for airway protective behaviors is blurred...": The incomplete swallow motor sequence didn't seem super different in timing or duration compared to the fully transfected animals (comparing plots from Fig 6 to Fig S1, and Table S2 to Table S3. The values for swallow durations (XII and X) for each group for water and opto seem within similar ranges, as do the differences between water & opto-evoked swallows between strains. While the motor pattern is distinctive from the normal swallow, with laryngeal activity rather than submental activity leading, one might not even be able to call that a swallow. Is it evidence against a classic all-or-nothing swallow behavior any more than the graded swallow results from (fully transfected) Table S1?

      • Please expand on this point and put it into context with others' results: "This brings into question whether this is the first evidence against the classic dogma of swallow as an "all or nothing" behavior, and/or whether this is an indication that activating the cholinergic/glutamatergic neurons in PiCo is not only gating the SPG, but is actually involved in assembling the swallow motor pattern itself."

    2. Reviewer #2 (Public Review):

      The study "Postinspiratory complex acts as a gating mechanism regulating swallow-breathing coordination and other laryngeal behaviors" by Huff et al., provides additional insight into the role of the recently discovered postinspiratory complex during swallow-breathing coordination. The authors used optogenetics in mice to show that activation of the PiCo during inspiration or at the start of post-inspiration can evoke swallowing. At later stages of expiration, PiCo activation activates undefined laryngeal activities. The analysis of respiratory phase reset leads to the conclusion that the PiCo is important for central gating of swallow. In conclusion, the authors claim that swallow-breathing coordination depends on a defined microcircuit compromising the PiCo and the pre-Botzinger complex.

    3. Reviewer #3 (Public Review):

      Huff et.al further characterise the anatomy and function of a population of excitatory medullary neurons, the Post-inspiratory Complex (PiCo), which they first described in 2016 as the origin of the laryngeal adduction that occurs in the post-inspiratory phase of quiet breathing. They propose an additional role for the glutamatergic and cholinergic PiCo interneurons in coordinating swallowing and protective airway reflexes with breathing, a critical function of the central respiratory apparatus, the neural mechanics of which have remained enigmatic. Using single allelic and intersectional allelic recombinase transgenic approaches, Huff et al. selectively excited choline acetyltransferase (ChAT) and vesicular glutamate transporter-2 (VGluT2) expressing neurons in the intermediate reticular nucleus of anesthetised mice using an optogenetic approach, evoking a stereotyped swallowing motor pattern (indistinguishable from a water-induced swallow) during the early phase of the breathing cycle (within the first 10% of the cycle) or tonic laryngeal adduction (which tracked tetanically with stimulus length) during the later phase of the breathing cycle (after 70% of the cycle).

      They further refine the anatomical demarcation of the PiCo using a combination of ChAT immunohistochemistry and an intersectional transgenic strategy by which fluorescent reporter expression (tdTomato) is regulated by a combinatorial flippase and cre recombinase-dependent cassette in triple allelic mice (Vglut2-ires2-FLPO; ChAT-ires-cre; Ai65).

      Lastly, they demonstrate that the PiCo is anatomically positioned to influence the induction of swallowing through a series of neuroanatomical experiments in which the retrograde tracer Cholera Toxin B (CTB) was transported from the proposed location of the putative swallowing pattern generator within the caudal nucleus of the solitary tract (NTS) to glutamatergic ChAT neurons located within the PiCo.

      Methods and Results<br /> The experimental approach is appropriate and at the cutting edge for the field: advanced neuroscience techniques for neuronal stimulation (virally driven opsin expression within a genetically intersecting subset of neurons) applied within a sophisticated in vivo preparation in the anaesthetized mouse with electrophysiological recordings from functionally discrete respiratory and swallowing muscles. This approach permits selective stimulation of target cell types and simultaneous assessment of gain-of-function on multiple respiratory and swallowing outputs. This intersectional method ensures PiCo activation occurs in isolation from surrounding glutamatergic IRt interneurons, which serve a diverse range of homeostatic and locomotor functions, and immediately adjacent cholinergic laryngeal motor neurons within the nucleus ambiguous (seen by some as a limitation of the original study that first described the PiCo and its roll in post-I rhythm generation Anderson et al., 2016 Nature 536, 76-80). These experiments are technically demanding and have been expertly performed.

      The supplemental tracing experiments are of a lower standard. CTB is a robust retrograde tracer with some inherent limitations, paramount of which is the inadvertent labelling of neurons whose axons pass through the site of tracer deposition, commonly leading to false positives. In the context of labelling promiscuity by CTB, the small number of PiCo neurons labelled from the NTS (maybe 5 or 6 at most in an optical plane that features 20 or more PiCo neurons) is a concern. Even assuming that only a small subset of PiCo neurons makes this connection with the presumed swallowing CPG within the cNTS, interpretation is not helped by the low contrast of the tracer labelling (relative to the background) and the poor quality of the image itself. The connection the authors are trying to demonstrate between PiCo and the cNTS could be solidified using anterograde tracing data the authors should already have at hand (i.e. EYFP labelling driven by the con-fon AAV vectors from PiCo neurons (shown in Fig5), which should robustly label any projections to the cNTS).

      The retrograde labelling from laryngeal muscles seems unnecessary: the laryngeal motor pool is well established (within the nAmb and ventral medulla), and it would be unprecedented for a population of glutamatergic neurons to form direct connections with muscles (beyond the sensory pool).

      The authors support their claim that PiCo neurons gate laryngeal activity with breathing through the demonstration that selective activation of glutamatergic and cholinergic PiCo neurons is sufficient to drive oral/pharyngeal/laryngeal motor responses under anaesthesia and that such responses are qualitatively shaped by the phase of the respiratory cycle within which stimulation occurs. Optical stimulation within the first 10% of the respiratory cycle was sufficient to evoke a complete, stereotyped swallow that reset the breathing cycle, while stimuli within the later 70% of the cycle, evoked discharge of the laryngeal muscles in a stimulus length-dependent manner. Induced swallows were qualitatively indistinguishable from naturalistic swallow induced by the introduction of water into the oral cavity. The authors note that a detailed interpretation of induced laryngeal activity is probably beyond the technical limits of their recordings, but they speculate that this activity may represent the laryngeal adductor reflex. This seems like a reasonable conclusion.

      The authors propose a model whereby the PiCo impinges upon the swallowing CPG (itself a poorly resolved structure) to explain their physiological data. The anatomical data presented in this study (retrograde transport of CTB from cNTS to PiCo) are insufficient to support this claim. As suggested above, complementary, high-quality, anterograde tracing data demonstrating connectivity between these structures as well as other brain regions would help to support this claim and broaden the impact of the study.

      This study proposes that the PiCo in addition to serving as the site of generation of the post-I rhythm also gates swallowing and respiration. The scope of the study is small, and limited to the subfields of swallowing and respiratory neuroscience, however, this is an important basic biological question within these fields. The basic biological mechanisms that link these two behaviors, breathing and swallowing, are elusive and are critical in understanding how the brain achieves robust regulation of motor patterning of the aerodigestive tract, a mechanism that prevents aspiration of food and drink during ingestion. This study pushes the PiCo as a key candidate and supports this claim with solid functional data. A more comprehensive study demonstrating the necessity of the PiCo for swallow/breathing coordination through loss of function experiments (inhibitory optogenetics applied in the same transgenic context) along with robust connectivity data would solidify this claim.

    1. Reviewer #1 (Public Review):

      This paper explores the potential regulatory role of a previously unstudied phosphorylation site in the Src kinase SH3 domain. The data presented conclusively demonstrate that a phosphomimetic mutation of this site, src90E, causes an elevation in Src kinase activity, changes the structure of the Src catalytic domain as determined with a FRET sensor, disrupts certain SH3 domain interactions, causes changes in kinase intracellular dynamicity, and promotes cell invasiveness. Based on the behavior of the phosphomimetic mutant, the idea that constitutive phosphorylation of Y90 could have all of these effects is well-supported by the data. However, in wild-type cells or cells transformed by activated forms of Src, there is no constitutive phosphorylation of this site. Therefore, the question remains whether Y90 phosphorylation occurs to any significant extent in cells, and the data suggesting that it could do so is limited. It also remains to be conclusively established whether Y90 phosphorylation occurs via autophosphorylation.

      Major comments:

      1. Y90 was identified as a site of phosphorylation in Luo et al. It would be helpful if more information were provided about its significance relative to other sites identified in that study. Was it detected in non-transformed cells? Was it a major site? How does it relate to Y416 in abundance? The reference to the identification of the site in a different study from the White lab is made in the discussion but not in the introduction (this should be corrected). How abundant was it that study? A fuller description of its detection would strengthen the rationale for this study. Any additional phosphoproteomics studies that identified it should also be included.

      2. Related to point 1, is there evidence from the literature indicating a significant site of phosphorylation in Src has been overlooked? Or, was this site only identified because of the recent advances in MS technology and increased sensitivity of this methodology? An introduction to these points would also enhance the rationale for the study.

      3. The explanation of the MS experiment designed to show that Y90 phosphorylation happens in cells is insufficient in the text. It is not clear why the SYF cells were not used and not clear why the FRET sensor constructs were used. It is also not clear whether or how the proteins were purified before MS analysis. Also, rather than showing the MS data as a relative level, it would be preferable to provide the number of spectra obtained for each peptide/phosphopeptide and compare this also to Y416. A fuller comparison between the phosphorylation of Y90 to that of Y416 is necessary in order to place the potential Y90-mediated phosphoregulation in context.

      4. I would like to see conclusive evidence that Y90 phosphorylation is due to autophosphorylation. This would involve relatively simple experiments. As one possibility, an IP kinase assay followed by immunoblotting with a site-specific antibody or MS or other types of phosphopeptide visualization/identification.

      5. A few other mutations would be interesting to examine in both kinase and transformation assays for comparison to the mutants that were: Y527F Y416F; Y527F Y416F Y90E. The first is a low activity control and the second is for understanding whether Y90E could overcome the lack of Y416 phosphorylation.

      5. I recommend that the results are discussed in a more circumspect manner. The results presented in Figure 7 on the double mutant, Y527F Y90F, suggest that phosphorylation of Y90 is not a very significant component of Src kinase regulation, at least in these biological contexts. That Y90 phosphorylation isn't a major regulatory factor does not diminish the value of the work describing Y90 phosphorylation. However, it does alter the interpretations. I encourage a more conservative discussion of its importance and a broader discussion of why it isn't a major site of Src phosphorylation, particularly if it is due to autophosphorylation.

    2. Reviewer #2 (Public Review):

      The manuscript "Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase" describes efforts to understand how phosphorylation of tyrosine (Y90) in the SH3 domain of Src affects the activity and function of this multi-domain kinase. The authors find that an Src variant containing a phospho-mimetic mutation (Glu) at position 90 demonstrates elevated activation levels in lysates and cells (Figure 1) and adopts a less compact autoinhibited conformation within the context of a SrcFRET biosensor in lysates (Figures 3A, 3B). A series of pulldown experiments with an isolated SH3 domain (Figure 2A, 2B) or full-length Src (Figure 2C, 2D) that contain the phospho-mimetic Y90E mutation demonstrates that phosphorylation of Tyr90 would likely disrupt the interaction of Src's SH3 domain with intermolecular binding partners and the linker that couples SH2 domain/C-tail binding to autoinhibition, which provides a mechanistic basis for the observed elevated kinase activity of Src Y90E. By performing a series of imaging experiments with a SrcFRET biosensor, the authors show that the Y90E mutation does not show enhanced localization at focal adhesions like a hyperactivated Src mutant (Y527F) that contains a non-phosphorylatable C-tail (Figure 4A). However, using ImFCS combined with TIRF microscopy (Figure 4B), the authors demonstrate that Src Y90E shows similarly reduced mobility (relative to the WT SrcFRET biosensor) at the plasma membrane (especially at focal adhesions) as Src Y527F. Consistent with the elevated kinase activity of Src Y90E, the authors go on to demonstrate that the Src Y90E variant shows an ability to transform fibroblasts-at levels that are intermediate between wild-type Src and the hyperactive Src mutant Y527F (Figure 5). Similarly, Src Y90E confers an intermediate level (between wild-type Src and Src Y527F) of invasiveness and ability to form spheroids. Together, these comprehensive experiments with a Y90 phospho-mimetic strongly support a model where phosphorylation of Src's SH3 domain at Tyr90 would lead to a more intramolecularly disengaged SH3 regulatory domain and enhanced kinase activity in cells.

      Most of the conclusions in this paper are well supported by solid data, but confidence in several assays would be higher if additional technical detail or controls were provided and the biological significance of these findings would be higher if the role that Y90 phosphorylation plays in Src regulation and function were better delineated.

      1) The kinase activity assays in Figures 1C,1D, and 7A need to be scaled to the Src variant levels present in the lysate (quantification of relative Src levels is not provided).

      2) More details are required for the experiments quantifying Y90 phosphorylation levels in Figure 3C. The experimental states that equal amounts of IP'd proteins were used for these analyses but there are no details on how this was confirmed. In addition, the experimental states that normalized intensities were used for your quantifying the Y90 phospho-peptide but no details are provided on how normalization was performed (the legend states that a base peptide was used but it is unclear what this means).

      3) A key question is whether Y90 phosphorylation serves a regulatory role in Src's cellular activity and, if so, what is the regulatory network that mediates this phospho-event. Using a mass spectrometry readout with three Src variants (wild type vs. Y527F vs. E381G) that possess differing kinase activities, the authors demonstrate that Y90 phosphorylation levels correlate to Src's kinase activity (Figure 3C), which they suggest is an indication that this residue is an autophosphorylation site (or phosphorylated by another Src family kinase). However, as Src's kinase activity correlates with SH3 domain disengagement (which leads to a more accessible Y90), it is also entirely possible that another tyrosine kinase is responsible for this phosphorylation event. More importantly, it is unclear under which signaling regime Y90 phosphorylation would play a significant regulatory role. This phospho-event was observed in a previous phospho-proteomic study but it is unclear whether the phosphorylation levels of this site occur high enough stoichiometry to modulate the intracellular function of Src and whether there is a regulatory signaling network that influences Y90 phosphorylation levels.

    3. Reviewer #3 (Public Review):

      The relevance of Y90 phosphorylation as a regulatory mechanism is shown by the comparison of Src kinase activity, transforming potential, cell invasiveness, and lateral diffusion in membranes. Mechanistically, Y90E mutation affects the opening of the structure, estimated from FRET experiments, and the phosphorylation status of the three main downstream signaling pathways.

      The effect of the Y90E mutation is very clear, although its description as "phosphomimicking" is, in my opinion, not accurate. Glutamic acid has a negative charge but is significantly different from phosphotyrosine. Maybe other polar mutants (lysine, glutamine...) would have a similar destabilizing effect on hydrophobic interactions. Erpel 1995 showed some effects of the Y90A mutants.

      The effect of tyrosine phosphorylation on the SH3 domain of proteins having the conserved ALYDY motif supports the proposed role, although the evidence for in vivo Y90 phosphorylation in c-Src is scarce. The possible autophosphorylation of Y90 is suggested but the evidence is not very strong and does not rule out other kinases, especially some downstream of Src itself -as already suggested by the authors.

      The authors suggest that the perturbation of Y90 reduces the interaction with the connector domain. This is a reasonable explanation, supported by the opening of the structure, but additional effects may exist: The SH3 hydrophobic region including Y90 is also the binding site for the myristoyl group (Le Roux et al. iScience, 12, 194-203) and mutations in the SH3 RT loop significantly affected lipid binding. This could contribute to the observed reduced diffusion in the lipid bilayer.

    1. Reviewer #1 (Public Review):

      This manuscript reports the results of a clever chemogenetic manipulation study designed to probe how stimulation (excitation and inhibition) of D1-expressing spiny projection neurons in the striatum (direct pathway) influences hemodynamic characteristics of local and global regions in the brain in mice. Stimulating in the dorsal caudate, the authors found alteration of the local hemodynamic BOLD responses in adjacent areas of the striatum, regions of the thalamus known to project back to the striatum, and more unimodal cortical regions. The authors also observed a decrease in functional connectivity between several cortical regions and the striatum with direct pathway excitation, and the opposite effect with direct pathway inhibition. Put together the results begin to paint a picture of the macroscopic signatures of direct pathway stimulation (and inhibition) that could be used to help infer global BOLD patterns in task-related experiments.

      Overall, this appears to be a timely study. The rise of papers using chemo/optogenetic methods to probe the underlying mechanisms of the BOLD response is crucial for the neuroimaging field to continue moving forward. The methods are, for the most part, rigorous and clear. There are, however, a few open issues that require addressing in order for readers to reach the same conclusion as the authors.

      MAJOR CONCERNS

      1. Classifier as an evaluation method.

      The authors largely rely on a support vector machine (SVM) classifier to predict whether BOLD dynamics within atlas-defined regions reflect stimulation-on or stimulation-off windows. While in one way this is a conservative method for evaluating stimulation effects in the resting BOLD fluctuations, the authors largely report their findings as accuracies of the classifier. Figures 3-5 largely only report model accuracy effects, but we get no sense as to what exactly is happening to the BOLD dynamics in each region. The autocorrelation analysis (Fig. 6) somewhat tries to get at this, but only for a subset of regions and the results are largely unclear (see comment below). As a result, a key goal of the study is left largely unaddressed for the reader: i.e. how do intra-region BOLD dynamics change with direct pathway stimulation? The study needs more effort put into this descriptive level of analysis to complement the rigorous classifier analysis.

      Also, the classifier method itself seems highly parameterized. The hctsa method returns 7702 features for each time series. It is unclear exactly how many were in the final set used to run the classification, but even if half of the features were removed, it would still make the classification problem highly overparameterized (e.g., 23 and 25 observations against thousands of features for the excitation and inhibition classifiers respectively). Assuming the authors used cross-validation correctly (which we need more information to support), the risk of inflated classification performance is mitigated. However, we need the details to be able to vet that the bias-variance tradeoff was resolved effectively in this model. In addition, it would be nice to know the features that loaded highly on the final model to resolve the questions about what changes in the local BOLD dynamics from excitation and inhibition of the direct pathway.

      2. Local stimulation effects in the striatum

      Figure 3 is quite confusing. The classifier is supposed to predict stimulation (excitation or inhibition) on vs. stimulation off (control) periods. This would predict a single number (balanced prediction accuracy) per striatal nuclei. Yet the heat maps shown in this figure show classification accuracies for both stimulation and control conditions. Where do the two numbers come from? Also, given the extremely limited short-range lateral connectivity in the striatum, why are the only stimulation effects observed not in the subnucleus being stimulated (Cpl,dm,cd), but for adjacent subnuclei (CPre, CPivmv) and *only* for excitation conditions? This lack of direct change in BOLD dynamics at the stimulated site seems important and largely ignored.

      3. Autocorrelation findings.

      The one attempt to characterize what happens in the intra-region BOLD dynamics is the autocorrelation analysis reported on page 11 and in Figure 6. However this analysis a) only focuses on the thalamic nuclei (not also the cortical and the single striatal site shown to exhibit stimulation effects) and b) only focuses on a few time series measures. Why this limited focus of both target (thalamic nuclei) and measure (first lag of the autocorrelation)? There are many measures for characterizing the temporal characteristics of autocorrelated series from the hctsa analysis. This selective focus seems both narrow and incomplete.

      4. Connectivity results

      The changes in functional connectivity as a result of direct pathway stimulation (excitation and inhibition) are both fascinating and limited. There is a clear excitation/inhibition difference in effects, as shown in Figure 7 B-C. However, Figure 7B suggests something different than the change results shown in Figure 7C. It appears that the application of clozapine increases functional connectivity in the control mice (black line Fig. 7B). This effect is exaggerated in the inhibition condition, but (most importantly) direct pathway excitation does not really reveal a significant change in the BOLD connectivity patterns. Now this does not change the authors' overall conclusions (connectivity is suppressed with direct pathway excitation relative to control mice), but the nuance of what is happening in the control mice is important for interpretation purposes: direct pathway excitation does not necessarily decrease functional connectivity but does not express the increase in connectivity observed from the application of clozapine. This needs to be elaborated more.

      Along the same lines, there is an interesting disconnect between the intra-region results and the inter-region (connectivity) results. It is clear that resting BOLD dynamics in thalamic nuclei that project back to the striatum, as well as more unimodal cortical areas, change from direct pathway stimulation in the dorsal caudate. Yet, only one cortical region (MOp) with significant functional connectivity changes overlaps with the set of nuclei that exhibit intra-region BOLD changes. This suggests that local BOLD dynamics and global connectivity are largely disconnected effects. Yet this seems to be largely ignored in the current work. It would be nice to see more analysis, and discussion, of the intra-region and inter-region stimulation effects.

    2. Reviewer #2 (Public Review):

      In their manuscript, Markicevic et al. report that manipulation of D1 spiny neurons in the right dorsomedial striatum results in a behavioral effect observed in motor movement. This behavioral effect is accompanied by changes in BOLD fMRI changes as estimated by a classification approach and pairwise regional correlation. These brain-wide analyses reveal a number of important outcomes. First, alterations in signal dynamics are observed in the striatum most dominantly in the injection site when contrasting excitation to inhibition. Second, thalamic regions that have reciprocal anatomical connections with the injection site show greater classification accuracy. Third, evaluation of cortical regions demonstrates increased classification accuracy for unimodal regions including primary motor, visual, primary somatosensory, and posterior parietal association regions. Lastly, using pairwise correlations, a decrease is observed when comparing excitation to either inhibition or no modulation of activity in the primary motor cortex, anterior cingulate, and retrosplenial cortices.

      This report effectively demonstrates that excitation or inhibition of a large population of D1 spiny neurons results in disruption of basic motor behavior. The greatest strength of the work is derived from identifying that features in the time-series of regions in the thalamus that project and receive projections to the injected site are impacted as well unimodal cortical regions. Moreover, a differential effect is observed for excitatory drive relative to both no drive and inhibition. The use of the approach by Fulcher and Jones (2017) provides an important addition to the more commonly used pairwise correlation approach as it relies on the dynamics of the fMRI signal.

      While the methods adopted by the authors to acquire the data and evaluate the experimental manipulations are robust and the obtained results are compelling, the current analysis comes short of relating whether variation that can be estimated across the animals has an impact on these results. Specifically, the authors do not leverage the individual animal viral expression or impact on behavior to constrain and estimate the observed responses reported subsequently. Several reports in humans have used individual variability to estimate the relation between behavior and changes in the BOLD fMRI responses at rest, and a basic demonstration of this type of result has been achieved in mice. Applying a similar approach here would further strengthen the result reported here by identifying which regions are linked to the behavioral deficit (e.g., whether the primary motor cortex is linked to contraversive/ipsiversive rotations at the individual level).

      Complementing linking the behavior of individual animals to changes in the fMRI signal, an estimation of structure-function that is driven by each individual animal's expression map may enhance the current analysis approach by leveraging potential subtle expression variations to reveal whether the observed changes can be explained by the extent to which expression is different across animals. In addition, a quantification of the difference between the excitatory and inhibitory cohorts will rule out that differences in the impact on the fMRI signal were a result of unintentional group differences in expression extent.

      A significant weakness in the current version of the manuscript is the lack of quantification of the viral expression. Currently, the authors do not provide enough information on the extent of coverage of viral expression on average or at the individual level. In particular, while the authors are careful to use the Allen Mouse Brain Connectivity atlas to constrain the fMRI results, they do not relate the specific expression extent, to clearly communicate to the readers, which regions within the striatum are likely to have better representation given the actual expression levels. Moreover, the authors do not use their own nor the Allen Institute data to carry out a formal structure-function analysis (following Stafford et al., 2014 PNAS, for example). This is critical since the authors wish to infer on the impact of their manipulation on both cortical and thalamic regions while the precise region in the striatum that they affect is never quantified.

    3. Reviewer #3 (Public Review):

      By using chemogenetic manipulations of direct pathway neurons in the dorsomedial part of the striatum (DMS) of anesthetized mice combined with fMRI, Markicevic et al explore changes in BOLD dynamics at local (striatum) and macro-scale (brain-wide) levels. The article is appropriately written, and the main findings are well organized and presented in 7 figures. Figures 1 and 2 schematize the techniques and document the motor effects of chemogenetic manipulations. Figures 3-7 describe neural changes induced by these manipulations. The main strength of this work is the level of specificity of the chemogenetic manipulations, which combined with brain-wide functional exploration, provide a very useful map of the consequences of activating a specific striatal subpopulation. In my opinion, the main weakness of this work is that the results are under-discussed and not appropriately contextualized in the current views of the functions of the basal ganglia. My main concerns are exposed in the following lines:

      1. In the first finding the authors show that D1 activation/inactivation produces reliable changes in the infected region (DMS), but most importantly, also produced changes in adjacent areas, suggesting intra-striatal communication. The way the data is presented and discussed appears to be confirmatory of what has been previously described with electrophysiological recordings. In my opinion, the most important part of this section would be to fully describe the differences between activation and inactivation groups. Is interesting that opposite manipulations of D1 receptors produced very similar maps of discrimination (Fig. 3). Therefore, it would be necessary to discuss the meaning of obtaining similar classification accuracy indices with opposite manipulations. Perhaps, the use of SVM classifiers can be complemented with other analytical techniques to further disentangle the consequences of manipulating intrastriatal D1 receptors.

      2. The second finding (Fig. 4) indicates that thalamic regions forming "closed loops" with the striatum were more affected by chemogenetic manipulations. We knew from anatomical studies that the BG are part of anatomically segregated cortico-BG-thalamic loops. Therefore, it would be expected that these anatomical boundaries would somehow limit functional connectivity maps. Here again, I consider that the manuscript would be improved with further analysis or discussion. For example, it would be interesting to perform further analysis relating the previous section (local striatal connectivity) with this one. In this section, several thalamic nuclei presented higher levels of classification accuracy, but in the previous section, the authors showed that DMS manipulation also produced the same effects in different intrastriatal regions. Therefore, it is not possible to know if the thalamic effects are related to the manipulation of D1 in the DMS or its adjacent regions.

      3. In the third finding (Fig. 5) the authors show that the most "sensitive" cortical regions to the manipulations were classified as "unimodal". This is an interesting result; however, it would be necessary to at least provide further discussion on its potential meaning. It is important to consider that the cortical regions with significant changes, for example, primary sensorimotor cortices, mainly target the dorsolateral, not the dorsomedial striatum. In this context, would it be possible to establish a new analysis to characterize potential correlations between cortical regions and striatal subregions?

      4. The fourth finding (Figure 6) is that thalamic but not cortical regions presented low-frequency fluctuations. What is the meaning of an increase in slow fluctuations? Why did D1 activation (and not inactivation) induced this effect? Are striatal sub-regions also presenting these slow fluctuations?

      5. In the last finding (Figure 7), the authors explored potential changes in functional connectivity (FC) between the striatum and cortical and subcortical regions. Contrary to the results obtained with the SVM-based analytical tool, FC analysis revealed that D1 activation and inactivation produced opposite results, while D1 activation decreased FC in several cortical and subcortical regions, D1 inactivation increased it. While this set of data is clearly described, the implications of these relationships could be further discussed. For example, how do the authors explain that FC with SSp was not significantly changed with this analytical method, but was one of the most affected regions with the Balanced Classification Accuracy method?

      6. Finally, there is no section in the discussion where the behavioral effects observed in figure 2 are contextualized in the massive set of BOLD results presented in the following sections.

    1. Reviewer #1 (Public Review):

      The authors carried out a clever and systematic analysis. Most SNARE complex assembly reactions are thought to involve multi-subunit tethers, and it now seems possible that Uso1/p115 plays this role in the case of the ER-to-Golgi SNARE complex. In addition to documenting the main conclusions of the paper, they characterized Uso1 in various ways, including an analysis of how the different domains of Uso1 contribute to the higher-order structure of the protein and to interactions with other components.

      I have only one significant comment about the presentation. The concept that the mutant Uso1 rescues the loss of Rab1 by binding more tightly to SNAREs is reasonable and likely but is not formally proven by the data. Instead, the data show that the mutant binds better to Golgi membranes in the absence of Rab1 and also binds better to Bos1. It should be acknowledged that this correlation is merely suggestive.

    2. Reviewer #2 (Public Review):

      This is a very dense and thorough analysis of the role of Uso1 in Aspergillus using genetics, pulldown assays, and modelling.<br /> Uso1 has been established as an essential tethering factor that acts in conjunction with Rab1 to deliver ER-derived vesicles to the Golgi. The current picture is that Uso1 is a Rab1 effector, but the authors challenge this interpretation using a combination of genetics experiments, biochemical analysis of protein-protein interactions, and alphafold2 prediction.

      While Rab1 is essential, they identify strains of Aspergillus that bypass the need for Rab1, which carry two mutations in Uso1. They go on to show that Uso1 binds directly to the Bos1 and Bet1 components of the SNARE complex and that the rescue mutations cause tighter binding of the Uso1 globular head domain to Bos1 and (hypothetically) to the membrane. They support their genetics and biochemical analysis by doing structure predictions with alphafold2 and suggesting how these mutants might act. They also show that an overexpressed mutated monomeric globular domain of Uso1 (without the coiled-coil 'tether' that causes dimerisation) rescues growth defects of delta Uso1, suggesting the essential activity of Uso1 is not the tethering but its being part of the SNARE complex.

      The data is solid, and the interpretation is convincing, showing Uso1 is not 'merely' a tethering factor. It has multiple roles, and this study opens up new questions regarding what exactly is Uso1's function as part of the SNARE bundle, and also in which way the Rab1-mediated tethering and the SNARE complex aspects of Uso1 are linked and/or regulated.

      However, there are some aspects of this work that need to be strengthened/clarified including some of the modelling and the interpretation of the role of Uso1 dimerisation. Also, given the availability of models for all homologues, it would be interesting to test whether analogous Uso1 mutant in S.cerevisiae can also rescue rab1- lethality. This would suggest the new proposed role of Uso1 is a general feature, at least for fungi, rather than a particularity of Aspergillus.

    3. Reviewer #3 (Public Review):

      The manuscript by Bravo-Plaza et al. identifies and characterizes new mutations (E6K and G540S) in the Uso1 globular head domain that suppress the loss of function mutations in Rab1. Further experiments show that the combined E6K/G540S mutant restores apparent Golgi-localization of Uso1 in Rab1 deficient cells, that this mutant preferentially co-purifies with ER/Golgi SNARE proteins, that monomeric E6K/G540S globular head-domain binds more avidly to purified Bos1 SNARE protein than wild type head-domain, and that overexpression of E6K/G540S or wild type head-domain alone is sufficient for viability. Based on these findings the authors propose that long-distance tethering by Uso1 is dispensable and that the head domain provides an essential function to directly regulate ER/Golgi SNARE-dependent membrane fusion.

      Strengths of the study are that an unbiased screen was used to identify new Rab1 suppresser mutations that land in the Uso1 globular head domain. Characterization of these suppressor mutants reveals that SNARE binding activity of Uso1 resides in the head domain and that elevated expression of the Uso1 head domain is sufficient for viability. Imaging experiments document the localization and dynamics of Uso1 on Golgi compartments and biochemical studies show the properties and binding activity of Uso1 domain mutants. These are new findings and the conclusion that monomeric globular head-domain interacts with specific SNAREs to maintain viability is justified.

      Weaknesses are that it is well documented that both Rab1 and Uso1 activity can be bypassed by activation of ER/Golgi SNARE machinery either by overexpression of SNARE proteins or by the single copy SLY1-20 allele. Therefore, it was not surprising that tethering by the Uso1 coiled-coil domain is dispensable. The proposal that the E6K mutation in the head domain of Uso1 promotes membrane targeting was not well supported by experimental evidence. And while the AlphaFold modeling of Uso1 with the ER/Golgi fusion machinery was intriguing, the proposed molecular models remain speculative until further tested.

    1. Reviewer #1 (Public Review):

      This work by Stauber et al. is focused on understanding the signaling mechanisms that are associated with tendinopathy development, and by screening a panel of human tendinopathy samples, identified IL-6/JAK/STAT as a potential mediator of this pathology. Using an innovative explant model they delineated the requirement for IL-6 in the main body of the tendon to alter the dynamics of cells in the peritendinous synovial sheath space.

      The use of a publicly available existing dataset is considered a strength since this dataset includes expression data from several different human tendons experiencing tendinopathy. This facilitates the identification of potentially conserved regulators of the tendinopathy phenotype.

      The clear transcriptional shifts between WT and IL6-/- cores demonstrates the utility of the assembloid model, and supports the importance of IL6 in potentiating the cell response to this stimuli.

      There are two main concerns with the manuscript in its current form:<br /> First, the experimental approach does not directly assess proliferation, as such the conclusions regarding proliferation are not well supported. In the ex-vivo model, the use of cell counting approaches is somewhat acceptable since the system is constrained by the absence of potential influx of new cells. However, given the nearly unlimited supply of extrinsically derived cells in vivo (vs. the explant model), assessment of actual proliferation (e.g. Edu, BrdU, Ki67) is critical to support this conclusion.

      Second, the justification for the use of Scx-GFP+ cells as a progenitor population is not well supported. Indeed, in the discussion, Scx+ cells are treated as though they are uniformly a progenitor population, when the diversity of this population has been established by the cited studies, which do not suggest that these are progenitor populations. Additional definition/ delineation of these cells to identify the subset of these cells that may actually display other putative progenitor markers would support the conclusions. As it stands, the study currently provides important information on the impact of IL6 on Scx+ cells, but not tendon progenitors.

    2. Reviewer #2 (Public Review):

      The authors of this study describe a goal of elucidating the signaling pathways that are upregulated in tendinopathy in order to target these pathways for effective treatments. Their goal is honorable, as tendinopathy is a common debilitating condition with limited treatments. The authors find that IL-6 signaling is upregulated in human tendinopathy samples with transcriptomic and GSEA analyses. The evidence of their initial findings are strong, providing a clinically-relevant phenotype that can be further studied using animal models.

      Along these lines, the authors continue with an advanced in vitro system using the mouse tail tendon as the core with progenitors isolated from the Achilles tendon as the external sheath embedded in a hydrogel matrix. One question that comes to mind is whether the fibroblast progenitors in the extrinsic sheath of Achilles tendon is similar to those surrounding the tail tendon. The similarity of progenitors between different tendons is assumed with this model. I would consider this to be a minor issue, and would consider the in vitro system to be an additional strength of this study.

      In order to address the IL-6 signaling pathway, the authors use core tendons from IL-6 knockout mice and progenitors from wild-type mice. The reasoning behind this approach was a little confusing... is IL-6 expressed solely in the tendon core compared to the extrinsic sheath? Furthermore, is a co-culture system for 7 days appropriate to model tendinopathy without the supplementation of exogenous inflammatory compounds? The transcriptomic differences in Figure 3 seem to be subtle, and may perhaps suggest that it could be a model that more closely resembles steady state compared to tendinopathy. If so, is IL-6 still relevant during steady state?

      Nevertheless, the results presented in Figures 4 and 5 are impressive, demonstrating a link between IL-6 and fibroblast progenitor numbers and migration. Their experimental design in these figures show strong evidence, using Tocilizumab and recombinant IL-6 to rescue shown phenotypes. I would reduce the claims on proliferation, however, unless a proliferation-specific marker (e.g., Ki67, BrdU, EdU) is included in confocal analyses of Scx+ progenitors. The Achilles tendon injury model provides a nice in vivo confirmation of Scx-progenitor migration to the neotendon.

      Given their goal to elucidate signaling pathways that could be targeted in the clinic, I think it would significantly strengthen the study if they could measure tendon healing in IL-6 knockouts or in wild-type mice treated with IL-6 inhibitors, since conventional ablation of IL-6 may lead to the elevation of compensatory IL-6 superfamily ligands that could activate STAT signaling. The authors claim that reducing IL-6 signaling decreases transcriptomic signatures of tendinopathy, but IL-6 may be necessary to promote normal healing of the tendon following injury. It is supposed that a lack of Scx+ progenitor migration would delay tendon healing.

      Overall, the authors of this study elucidated IL-6 signaling in tendinopathy and provided a strong level of evidence to support their conclusions at the transcriptomic level. However, functional studies are needed to confirm these phenotypes and fully support their aims and conclusions. With these additional studies, this work has the potential to significantly influence treatments for those suffering from tendinopathy.

    1. Reviewer #3 (Public Review):

      The strongest aspects of this study are the structural analysis of the 90 residue KER domain. This is an important advance, discovering a founding member of a novel class of DNA binding motifs, termed a SAH-DBD (single alpha helix-DNA binding domain). Interestingly, they define a subregion of KER (termed "middle-A", residues 155-204 of Cac1) that has nearly the same DNA binding affinity and confers similar in vivo phenotypes as the full KER domain.

      This study also shows that the biological role of KER partially overlaps compensatory factors in vivo, both within the same Cac1 protein subunit (e.g. the WHD domain) and also with other proteins acting in parallel (e.g. Rtt106). That is, the presence of either WHD or Rtt106 renders the drug-resistance and silencing assays employed here insensitive to loss of the KER domain.

      However, the drug resistance and gene silencing phenotypes are inherently indirect measures of the most important claim of this work, that KER is a molecular ruler for DNA for the purpose of ensuring sufficiently large templates deposition of histone H3/H4 cargoes. Therefore, this study would be of greater impact if the authors more directly tested this measurement idea in assays that directly assess histone deposition. There are multiple options. Since the authors have in hand recombinant wild-type and mutant CAF-1 complexes, one could examine the number and/or spacing of nucleosomes formed during in vitro deposition reactions. Complementary in vivo experiments using the authors' existing mutant strains could be based on the finding that CAF-1 is particularly important for histone deposition onto nascent Okazaki fragments during DNA replication (Smith and Whitehouse, 2012; pmid: 22419157), and that the spacing pattern of nucleosomes on this DNA is greatly perturbed in cac1-delete cells.

    1. Reviewer #1 (Public Review):

      In this study, the authors examined the putative functions of hypothalamic groups identifiable through Foxb1 expression, namely the parvofox Foxb1 of the LHA and the PMd Foxb1, with emphasis on innate defensive responses. First, they reported that chemogenetic activation of Foxb1hypothalamic cell groups led to tachypnea. The authors tend to attribute this effect to the activation of hM3Dq expressed in the parvofox Foxb1 but did not rule out the participation of the PMd Foxb1 cell group which may as well have expressed hM3Dq, particularly considering the large volume (200 nl) of the viral construct injected. It is also noteworthy that the activation of the Foxb1hypothalamic cell groups in this experiment did not alter the gross locomotor activity, such as time spent immobile state. Thus, contrasts with the authors finding on the optogenetic activation of the Foxb1hypothalamic fibers projecting to the dorsolateral PAG. In the second experiment, the authors applied optogenetic ChR2-mediated excitation of the Foxb1+ cell bodies' axonal endings in the dlPAG leading to freezing and, in a few cases, bradycardia as well. The effective site to evoke freezing was the rostral PAGdl, and fibers positioned either ventral or caudal to this target had no response. Considering the pattern of Foxb1hypothalamic cell groups projection to the PAG, the fibers projecting to the rostral PAGdl are likely to arise from the PMd Foxb1 cell group, and not from the parvofox Foxb1 of the LHA. Here it is important to consider that optogenetic ChR2-mediated excitation of the axonal endings is likely to have activated the cell bodies originating these fibers, and one cannot ascertain whether the behavioral effects are related to the activation of the terminals in the PAGdl or the cell bodies originating the projection. Moreover, activation of PMd CCK cell group, which consists of around 90% of the PMd cells, evokes escape, and not freezing. According to the present findings, a specific population of PMd Foxb1 cells may be involved in producing freezing. In addition, only a small number of the animals with correct fiber placement presented sudden onset of bradycardia in response to the photostimulation. Considering the authors' findings, the Foxb1+ hypothalamic groups are likely to mediate behavioral responses related to innate defensive responses, where the parvofox Foxb1 of the LHA would be involved in promoting tachypnea and the PMd Foxb1group in mediating freezing and bradycardia. These findings are very interesting, and, at this point, they need to be tested in a scenario of real exposure to a natural predator.

    2. Reviewer #2 (Public Review):

      The authors aimed to examine the role of a group of neurons expressing Foxb1 in behaviors through projections to the dlPAG. Standard chemogenetic activation or inhibition and optogentic terminal activation or inhibition at local PAG were used and results suggested that, while activation led to reduced locomotion and breathing, inhibition led to a small degree of increased locomotion.

      The observed effects on breathing are evident and dramatic. However, this study needs significant improvements in terms of data analysis and presentation and some of studies seem incomplete; and therefore the data may not yet support the conclusion.

      1) Fig.1 has no experimental data and needs to be replaced with detailed pictures from the viral injected mice showing the projections diagrammed.

      2) Fig. 3 needs control pictures and statistical comparison with different conditions in c-Fos. Also expression in other nearby regions needs to be presented to demonstrate the specificity of the expression.

      3) Fig. 5, a great effort has been made to illustrate the point that CCK and Foxb1 are differentially expressed. Why not just perform a double in situ experiment to directly illustrate the point?

      4) Fig. 7 data on optogenetic stimulation on immobility and breathing, since not all mice showed the same phenotype, what is the criterion for allocating these mice to hit or no hit groups? Given the dramatically reduced breathing and locomotion, what is the temperature response? More data needs to be gathered to support that this is a defense behavior.

      5) The authors claim to target dlPAG. However, in the picture shown in Fig. 8C, almost all PAG contains ChR2 fibers and it is likely all the fibers will be activated by light. Thus, as presented, the data does not support the claim of the specificity on dlPAG. Also c-Fos data needs to be presented on the degree of activation of downstream PAG neurons after light exposure.

      6) Fig. 9 only showed one case. A statistical comparison needs to be presented.

      7) Optogentic terminal activation in the PAG will likely elicit back-propagation and subsequent activation of additional downstream brain sites of Foxb1 neurons. More experiments need to be done to assess this and as presented, the data does not support the role of PAG necessarily.

      8) The authors claim negative data from PVH-Cre mice. More data need to be presented to make this case.

      The conclusion, even as presented, adds to the known evidence of the PAG in the defense behavior.

    1. Reviewer #1 (Public Review):

      Somasundaram and colleagues explore the role of transcription factors in retinal ganglion cell (RGC) death and axonal regeneration after a disease relevant insult (mechanical axonal injury). The work significantly extends our knowledge of the role of MAPK and integrated stress response (ISR) in controlling RGC fate after injury. Specifically, the manuscript shows that after axonal injury PERK-activated ISR acts through Atf4 to drive a prodeath transcriptional response in RGCs, in part by crosstalk with the prodeath JUN transcriptional program. Also, and perhaps most interesting, the work shows that PERK-ATF4 pathway activation is pro-regenerative for RGC axons. A major plus of the manuscript is that many new RNA-seq datasets are generated that describe the major prodegenerative and proregenerative gene networks altered after axonal injury.

      A limitation of the study is that it does not directly compare the effect of inhibiting the PERK-ATF4 pathway with inhibiting JUN and/or JUN-CHOP double deficient animals. It would also be useful, for the cell survival experiments shown in Figure 1, to examine a longer time point than 14 days to understand the long-term consequence of manipulating the PERK-ATF4 pathway.

    2. Reviewer #2 (Public Review):

      This manuscript investigates the role of Perk (Protein kinase RNA-like endoplasmic reticulum kinase) and Atf4 (Activating Transcription Factor-4) in neurodegenerative and regenerative responses following optic nerve injury. The authors employed conditional knockout mice to examine the impact of the Perk/Atf4 pathway on transcriptional responses, with a particular focus on canonical Atf4 target genes and the involvement of C/ebp homologous protein (Chop).

      The study demonstrates that Perk primarily operates through Atf4 to stimulate both pro-apoptotic and pro-regenerative responses after optic nerve injury. This Perk/Atf4-dependent response encompasses canonical Atf4 target genes and limited contributions from Chop, exhibiting overlap with c-Jun-dependent transcription. Consequently, the Perk/Atf4 pathway appears crucial for coordinating neurodegenerative and regenerative responses to central nervous system (CNS) axon injury. Additionally, the authors observed that neuronal knockout of Atf4 mimics the neuroprotection resulting from Perk deficiency. Moreover, Perk or Atf4 knockout hinders optic axon regeneration facilitated by the deletion of the tumor suppressor Pten.

      These findings contrast with the transcriptional and functional outcomes reported for CRISPR targeting of Atf4 or Chop, revealing a vital role for the Perk/Atf4 pathway in orchestrating neurodegenerative and regenerative responses to CNS axon injury.

      However, the main concern is the overall data quality, which appears to be suboptimal. The transfection efficiency of AAV2-hSyn1-mTagBFP2-ires-Cre used in this study does not seem highly effective, as evidenced by the data presented in Supplementary Figure 1. The manuscript also contains several inconsistencies and a mix of methods in data collection, analysis, and interpretation, such as the labeling and quantification of RGCs and the combination of bulk and single-cell sequencing results.

      Despite these limitations, the study offers valuable insights into the role of the Perk/Atf4 pathway in determining neuronal fate after axon injury, emphasizing the significance of understanding the molecular mechanisms that govern neuronal survival and regeneration. This knowledge could potentially inform the development of targeted therapies to promote neuroprotection and CNS repair following injury.

    1. Reviewer #1 (Public Review):

      The study by Oikawa and colleagues demonstrates for the first time that a descending inhibitory pathway for nociception exists in non-mammalian organisms, such as Drosophila. This descending inhibitory pathway is mediated by a Drosophila neuropeptide called Drosulfakinin (DSK), which is homologous to mammalian cholecystokinin (CCK). The study creates and uses several Drosophila mutants to convincingly show that DSK negatively regulates nociception. They then use several sophisticated transgenic manipulations to demonstrate that a descending inhibitory pathway for nociception exists in Drosophila.

      Strengths:

      This study creates the possibility of using Drosophila to study descending nociceptive systems.

      CRISPR/Cas9 is used to generate mutants of dsk, CCKLR-17D1, and CCKLR-17D3. The authors then use these mutants to clearly show that DSK negatively regulates nociception.

      Several GAL4s are used to clearly show that these effects are likely mediated by two sets of neurons in the brain, MP1 and Sv.

      RNAi and rescue experiments further show that CCKLR-17D1, a DSK receptor, functions in Goro neurons to negatively regulate nociception.

      Thermogenetic experiments nicely show that activation of DSK neurons attenuates the nociceptive response.

      Weaknesses:

      Future studies should address how DSK negatively regulates nociception. An earlier study at the Drosophila nmj shows that loss of DSK signaling impairs neurotransmission and synaptic growth. In the current study, loss of CCKLR-17D1 in Goro neurons seems to increase intracellular calcium levels in the presence of noxious heat. An interesting future study would be the examination of the underlying mechanisms for this increase in intracellular calcium.

    2. Reviewer #2 (Public Review):

      This is an exceptional study that provides conclusive evidence for the existence of a descending pathway from the brain that inhibits nociceptive behavioral outputs in larvae of Drosophila melanogaster. The authors identify both molecular and neuronal/cellular components of this pathway. Converging lines of evidence and conclusive genetic experiments indicate that the neuropeptide, drosulfakinin (DSK), and its receptors (CCK1 and CCK2) function to inhibit nociception behaviors. Interestingly, the authors show that the relevant DSK neurons have cell bodies that are in the larval brain and that these neurons send projections into the thoracic ganglion and ventral nerve cord. Several lines of evidence support the hypothesis that fourth-order nociceptive neurons called Goro, are one relevant target for these outputs. RNAi knockdown of the CCK1 receptor in these cells sensitizes behavioral and physiological responses to noxious heat. Second, the axons of DSK neurons form physical contact with processes of Goro neurons as revealed by GRASP analysis. However, the authors' careful experiments indicate that the contacts between axons and Goro neurites might not be indicative of direct synapses and instead might operate through the bulk transmission of the peptidergic signals. The study raises many interesting questions for future study such as what behavioral contexts might depend on this pathway. Using the CAMPARI approach, the authors do not find that the DSK neurons are activated in response to nociceptive input but instead suggest that these cells may be tonically active in gating nociception. Future studies may find contexts in which the output of the DSK neurons is inhibited to facilitate nociception or contexts in which the cells are more active to inhibit nociception.

    3. Reviewer #3 (Public Review):

      This study describes a descending circuit that can modulate pain perception in the drosophila larvae. While descending inhibition is a major component of mammalian pain perception, it is not known if a similar circuit design exists in fruit flies. Overall the authors use clean logic to establish a role for DSK and its receptor in regulating nociception. The following concerns still stand:

      1) It's not completely clear why the authors are staining animals with an FLRFa antibody. Can the authors stain WT and DSK KO animals with a DSK antibody? Also, can the authors show in supplemental what antigen the FLRFa antibody was raised against, and what part of that peptide sequence is retained in the DSK sequence? This overall seems like a weakness in the study that could be improved on in some way by using DSK-specific tools.

      2) What is the phenotype of DSK-Gal4 x UAS-TET animals? They should be hyper-reactive. If it's lethal maybe try an inducible approach.

      3) Figure 9. This was not totally clear, but I think the authors were evaluating spontaneous (i.e. TRPA1-driven) rolling at 35C. The critical question is "Does activating DSK-expressing neurons suppress acute heat nociception?" and this hasn't really been addressed. The inclusion of PPK Gal4 + DSK Gal4 in the same animal clouds the overall conclusions the reader can draw. The essential experiment is to express UAS-dTRPA1 in DSK-Gal4 or GORO-Gal4 cells, heat the animals to ~29C, and then test latency to a thermal heat probe (over a range of sub and noxious temperatures). Basically, prove the model in Figure 10 showing ectopic activation or inhibition for each major step, then test heat probe responses.

      4) It would also then be interesting to see how strong the descending inhibition circuit is in the context of UV burn. If this is a real descending circuit, it should presumably be able to override sensitization after injury.

    1. Reviewer #1 (Public Review):

      stdpopsim is an existing, community-driven resource to support population genetics simulations across multiple species. This paper describes improvements and extensions to this resource and discusses various considerations of relevance to chromosome-scale evolutionary simulations. As such, the paper does not analyse data or present new results but rather serves as a general and useful guide for anyone interested in using the stdpopsim resource or in population genetics simulations in general.

      Two new features in stdpopsim are described, which expand the types of evolutionary processes that can be simulated. First, the authors describe the addition of the ability to simulate non-crossover recombination events, i.e. gene conversion, in addition to standard crossover recombination. This will allow for simulations that come closer to the actual recombination processes occurring in many species. Second, the authors mention how genome annotations can now be incorporated into the simulations, to allow different processes to apply to different parts of the genome - however, the authors note that this addition will be further detailed in a separate, future publication. These additions to stdpopsim will certainly be useful to many users and represent a step forward in the degree of ambition for realistic population genetics simulations.

      The paper also describes the expansion of the community-curated catalog of pre-defined, ready-to-use simulation set-ups for various species, from the previous 6 to 21 species (though not all new species have demographic models implemented, some have just population genetic parameters such as mutation rates and generation times). For each species, an attempt was made to implement parameters and simulations that are as realistic as possible with respect to what's known about the evolutionary history of that species, using only information that can be traced to the published literature. This process by which this was done appears quite rigorous and includes a quality-control process involving two people. Two examples are given, for Anopheles gambiae and Bos taurus. The detailed discussion of how various population genetic and demographic parameters were extracted from the literature for these two species usefully highlights the numerous non-trivial steps involved and showcases the great deal of care that underlies the stdpopsim resource.

      The paper is clearly written and well-referenced, and I have no technical or conceptual concerns. The paper will be useful to anyone interested in population genetics simulations, and will hopefully serve as an inspiration for the broader effort of making simulations increasingly more realistic and flexible, while at the same time trying to make them accessible not just to a small number of experts.

    2. Reviewer #2 (Public Review):

      Lauterbur et al. present a description of recent additions to the stdpopsim simulation software for generating whole-genome sequences under population genetic models, as well as detailed general guidelines and best practices for implementing realistic simulations within stdpopsim and other simulation software. Such realistic simulations are critical for understanding patterns in genetic variation expected under diverse processes for study organisms, training simulation-intensive models (e.g., machine learning and approximate Bayesian computation) to make predictions about factors shaping observed genetic variation, and for generating null distributions for testing hypotheses about evolutionary phenomena. However, realistic population genomic simulations can be challenging for those who have never implemented such models, particularly when different evolutionary parameters are taken from a variety of literature sources. Importantly, the goal of the authors is to expand the inclusivity of the field of population genomic simulation, by empowering investigators, regardless of model or non-model study system, to ultimately be able to effectively test hypotheses, make predictions, and learn about processes from simulated genomic variation. Continued expansion of the stdpopsim software is likely to have a significant impact on the evolutionary genomics community.

      Strengths:

      This work details an expansion from 6 to 21 species to gain a greater breadth of simulation capacity across the tree of life. Due to the nature of some of the species added, the authors implemented finite-site substitution models allowing for more than two allelic states at loci, permitting proper simulations of organisms with fast mutation rates, small genomes, or large effect sizes. Moreover, related to some of the newly added species, the authors incorporated a mechanism for simulating non-crossover recombination, such as gene conversion and horizontal gene transfer between individuals. The authors also added the ability to annotate and model coding genomic regions.

      In addition to these added software features, the authors detail guidelines and best practices for implementing realistic population genetic simulations at the genome-scale, including encouraging and discussing the importance of code review, as well as highlighting the sufficient parameters for simulation: chromosome level assembly, mean mutation rate, mean recombination rate or recombination map if available, effective size or more realistic demographic model if available, and mean generation time. Much of these best practices are commonly followed by population genetic modelers, but new researchers in the field seeking to simulate data under population genetic models may be unfamiliar with these practices, making their clear enumeration (as done in this work) highly valuable for a broad audience. Moreover, the mechanisms for dealing with issues of missing parameters discussed in this work are particularly useful, as more often than not, estimates of certain model parameters may not be readily available from the literature for a given study system.

      Weaknesses:

      An important update to the stdpopsim software is the capacity for researchers to annotate coding regions of the genome, permitting distributions of fitness effects and linked selection to be modeled. However, though this novel feature expands the breadth of processes that can be evaluated as well as is applicable to all species within the stdpopsim framework, the authors do not provide significant detail regarding this feature, stating that they will provide more details about it in a forthcoming publication. Compared to this feature, the additions of extra species, finite-site substitution models, and non-crossover recombination are more specialized updates to the software.

    3. Reviewer #3 (Public Review):

      Lauterbur et al. present an expansion of the whole-genome evolution simulation software "stdpopsim", which includes new features of the simulator itself, and 15 new species in their catalog of demographic models and genetic parameters (which previously had 6 species). The list of new species includes mostly animals (12), but also one species of plant, one of algae, and one of bacteria. While only five of the new animal species (and none of the other organisms) have a demographic model described in the catalog, those species showcase a variety of demographic models (e.g. extreme inbreeding of cattle). The authors describe in detail how to go about gathering genetic and demographic parameters from the literature, which is helpful for others aiming to add new species and demographic models to the stdpopsim catalog. This part of the paper is the most widely relevant not only for stdpopsim users but for any researcher performing population genomics simulations. This work is a concrete contribution towards increasing the number of users of population genomic simulations and improving reproducibility in research that uses this type of simulations.

    1. Reviewer #1 (Public Review):

      In this study, Dominici et. al. show that small molecule inhibition of Type I PRMTs in muscle stem cells (MSCs) can result in the expansion of this cell type in vitro, solving a major limitation in the field. Importantly, once the inhibitor is removed these stem cells differentiate "normally". This advance will likely facilitate CRISPR-based screening approaches and stem cell engraftment therapy. Furthermore, they show that when a mouse model of Duchenne muscular dystrophy is treated with these same inhibitors these mice rather rapidly gain grip strength, demonstrating the therapeutic value of these findings.

      Strengths:

      - Previous studies from the same group have shown that the conditional ablation of PRMT1 in MSCs results in the expansion of this cell type, but this expanded PRMT1-null MSC pool cannot terminate the myogenic differentiation program. This raises the question of whether PRMT1 small molecule inhibition of MSCs will also facilitate the expansion of these cells, and if the removal of the inhibitor after expansion will result in a large functional pool of MSCs, which could then be used for both in vitro and in vivo studies.

      - Using a combination of muscle fiber culture, myoblast culture, and single-cell RNA-seq, this is indeed what they show.

      - They also perform two types of in vivo experiments to validate their cell culture findings; 1) MSCs expanded under the treatment of MS023 were washed clean of the inhibitor and engrafted into the tibialis anterior muscle. These cells were marked with GFP to allow efficient tracking. Mice receiving the MS023-treated MSCs produced more than double the mature GFP+ muscle fibers than cells treated with DMSO. 2) A mouse model of Duchenne muscular dystrophy displayed grip strength improvement after just one treatment of MS023.

      - MS023 is a Type I PRMT inhibitor and thus can also target CARM1. CARM1 has been implicated in MSC function by the Rudnicki group. Importantly, they exclude a role for CARM1 in the expansion of MSC cell numbers by treatment with a very specific CARM1 inhibitor, TP064. Thus, indicating that PRMT1 inhibition is likely the main driver of this expansion phenotype.

    2. Reviewer #2 (Public Review):

      In this manuscript, Dominici et al. aim to determine whether the reversible inhibition of the type I protein arginine methyltransferases (PRMT) would maintain the stemness of muscle stem cells in culture and enable subsequent regenerative capacities. They demonstrate that the type I PRMT inhibitor MS023 enhances self-renewal and in vitro expansion of muscle stem cells isolated from mice. Using a very rigorous single-cell RNA-sequencing approach, they further demonstrate that distinct sub-populations of cells emerge under type I PRMT inhibition and that these cells entered the differentiation program more efficiently. Moreover, they revealed a shift in metabolism in these cells, which they confirmed in vitro. Finally, they demonstrate that MS023 enhances muscle stem cell engraftment in vivo and that the direct injection of MS023 increases muscle strength in a mice model of Duchenne muscular dystrophy.

      This study will have a great impact on the field of stem cells and offer potential therapeutic avenues for diseases such as Duchenne muscular dystrophy.

    3. Reviewer #3 (Public Review):

      Dominici et al studied the effects of the type I PRMT inhibitor MS023 on skeletal muscle stem cells (MuSCs) and on muscle strength in dystrophin-deficient mdx mice. The authors observed an enhanced proliferative capacity of cultured MuSCs with an increase of Pax7+/MyoD- cells. The observations are more or less in line with previous studies of the same group, describing reduced differentiation but enhanced proliferation of MuSCs after genetic inactivation of Prmt1. scRNA-seq identified different subpopulations of MuSCs, showing a shift to increased Pax7 expression and elevated oxidative phosphorylation and glycolysis after treatment with MS023. Treatment of MuSC with MS023 during expansion in vitro enhanced engraftment of MuSCs and treatment of dystrophic mdx mice increased muscle strength.

      Overall, the manuscript provides new insights into the beneficial effects of the type I PRMT inhibitor MS023 for skeletal muscle regeneration. The description of the MS023-induced transcriptional and metabolic changes in MuSC is interesting and the effects on MuSC transplantation and muscle strength are stunning. However, I have the following comments and concerns:

      * Control experiments with the TP-064 inhibitor (previously shown to be specific for CARM1/PRMT4) were not done for the transplantation and muscle strength experiments, which is a clear shortcoming in my view. Since MS023 is a non-selective inhibitor of type I PRMTs with comparable IC50 values for PRMT1 and PRMT4 (CARM1), and lower IC50 values for PRMT6 and PRMT8, it is still not clear whether the enhanced transplantation efficiency and the increased muscle strength is indeed only caused by inhibition of PRMT1. The authors justify their statements by pointing out that gene expression of Prmt1 is highest among the type I PRMTs in MuSCs, which is a rather poor argument, as seen by the strong effects caused by the inactivation of PRMT4.

      * Clustering of the M1-M5 subpopulations. I expressed my concern about the separation of the subclusters, which appear more or less in the same cloud. The authors answered that each cluster has some genes, which are only expressed in the respective cluster. I do not doubt this observation but apparently, the transcriptional differences are minor, otherwise one would have seen a much better separation of the subpopulations.

      * The authors have not done additional experiments but simply toned-down the statements about the relevance of the proposed "metabolic reprogramming" of MuSC by the type I PRMT inhibitor MS023, which was a major conclusion in the original submission. Again, the changes in the expression of metabolically relevant genes upon MS023 treatment are interesting and should be analyzed in respect to causality. It is not a solution to more or less disabandon the original hypothesis by changing the wording.

      * I specifically asked the authors to check whether the dramatic six-fold increase of MuSC engraftment after MS023 treatment really goes along with the incorporation of transplanted MuSC into the MuSC niche, raising concerns that a huge share of the transplanted cells may linger around in the interstitium. It should be very easy to identify and quantify transplanted MuSC outside and inside the basal lamina. Instead of doing the requested experiment, the authors argue about suppression of endogenous MuSC competition by irradiation, at the same time admitting that several GFP-negative fibers have formed.

      * I expressed my doubts that a 3-day treatment with MS023 is sufficient to dramatically enhance muscle function in mdx mice via "improvement" of the MuSC population, as reported by the authors, even 30 days after administration of MS023. It seems much more likely that MS023 exerts additional effects that are responsible for the dramatic improvement of muscle function in mdx mice. I maintain my view that this needs to be interrogated more carefully since the improvement of muscle function of dystrophic mice is a central point of the study. It has to be made clear whether this is really due to "improved" functions of MuSC. Many other processes might be involved or responsible for the effect (e.g. impact on inflammation?).

    1. Public Review:

      Barreat and Katzourakis analyze the evolutionary history of eukaryotic viruses (and related mobile elements) in the Bamfordvirae kingdom, and discuss potential scenarios regarding the origin of different viral taxa in this group. This version of their manuscript now includes a larger number of sequences to better represent diversity in these viral groups, and explored new evolutionary scenarios, including a "virophage-first" hypothesis now presented as the one best supported by phylogenetic analyses. The authors also present compelling analyses suggesting that the "nuclear escape" hypothesis in which these different viral groups separately "escaped" from nuclear (integrated) elements is not consistent with the current genomic and phylogenetic information available.

      This work is thus an important step in our collective understanding of the ancient evolutionary history of eukaryotic viruses, and more generally of the constraints and main drivers of virus evolution.

    1. Joint Public Review:

      In this manuscript, Xie et al report the development of SCA-seq, a multiOME mapping method that can obtain chromatin accessibility, methylation, and 3D genome information at the same time. This method is highly relevant to a few previously reported long read sequencing technologies. Specifically, NanoNome, SMAC-seq, and Fiber-seq have been reported to use m6A or GpC methyltransferase accessibility to map open chromatin, or open chromatin together with CpG methylation; Pore-C and MC-3C have been reported to use long read sequencing to map multiplex chromatin interactions, or together with CpG methylation. Therefore, as a combination of NanoNome/SMAC-seq/Fiber-seq and Pore-C/MC-3C, SCA-seq is one step forward. The authors tested SCA-seq in 293T cells and performed benchmark analyses testing the performance of SCA-seq in generating each data module (open chromatin and 3D genome). The QC metrics appear to be good and the methods, data and analyses broadly support the claims. However, there are some concerns regarding data analysis and conclusions, and some important information seems to be missing.

      1. The chromatin accessibility tracks from SCA-seq seem to be noisy, with higher background than DNase-seq and ATAC-seq (Fig. 2f, Fig. 4a and Fig. S5). Also, SCA-seq is much less sensitive than both DNase-seq and ATAC-seq (Figs. 2a and 2b). This and other limitations of SCA-seq (high background, high sequencing cost, requirement of specific equipment, etc) need to be carefully discussed.

      2. In Fig. 2f, many smaller peaks are present besides the major peaks. Are they caused by baseline DNA methylation? How many of the small methylation signals are called peaks? In Fig. 4a, it seems that the authors define many more enhancers from SCA-seq data than what will be defined from ATAC-seq or DHS. Are those additional enhancers false positives? Also, it is difficult to distinguish the gray "inaccessible segments" from the light purple "accessible segments.

      3. For 3D genome analysis, it is important to provide information about data yield from SCA-seq. With 30X sequencing depth, how many contacts are obtained (with long-read sequencing, this should be the number of ligation junctions)? How is the number compared to Hi-C.

      4. Fig 3j. Because SCA-seq only do GpC methylation, the capability to detect the footprint at individual CTCF peaks depends on the density of GpC nearby. Have the authors taken GpC density into account when defining CTCF sites with or without footprint?<br /> 5. This study only performs higher resolution chromatin interaction analysis based on individual read concatenates. It is unclear to me if the data have enough depth to perform loop analysis with Hi-C pipelines.

      6. It appears that SCA-seq is of low efficiency in detecting chromatin interactions. As shown in Fig. S7a, 65.4% of sequenced reads contained only one restriction enzyme (RE) fragment/segment (with no genomic contact), which is much higher than that reported in published PORE-C methods. In addition, Fig. S7g is very confusing and in conflict with Fig. S7a. For example, in Fig. S7g, 21.4% and 22.2% of CSA-seq concatemers contain one and two segments, whereas the numbers are 65.4% and 14.7% in Fig. S7a, respectively. Please explain.

      7. I disagree with the rationale of the entire Fig. S9. Biologically there is no evidence that chromatin accessibility will change due to genome interactions (the opposite is more likely), therefore the definition of "expected chromatin accessibility" is hard to believe. If the authors truly believe this is possible, they will need to test their hypothesis by deleting cohesin and check if the chromatin accessibility driven by "power center" are truly abolished. The math in Fig. S9 is also confusing. Firstly, the dimension of the contact matrix in Fig. S9 appears to be wrong, it should have 8 rows. Secondly, I don't understand why the interaction matrix is not symmetric. Third, if I understand correctly the diagonal of the matrix should be all 1, it is also hard to understand why the matrix only has 1, 0 or -1. It appears that the authors assume that the observed accessibility is a simple sum of the expected accessibility of all its interacting regions; this is wrong. In my opinion, the whole Fig. S9 should be deleted unless the authors can make sense of it and ideally also provide more evidence.